ANXIETY A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R EFERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright ©2003 by ICON Group International, Inc. Copyright ©2003 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Anxiety: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-597-83562-4 1. Anxiety-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
v
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on anxiety. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
vi
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications. Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vii
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes & Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
ix
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON ANXIETY ................................................................................................... 3 Overview ....................................................................................................................................... 3 The Combined Health Information Database ................................................................................ 3 Federally Funded Research on Anxiety ......................................................................................... 8 E-Journals: PubMed Central ....................................................................................................... 75 The National Library of Medicine: PubMed................................................................................ 78 CHAPTER 2. NUTRITION AND ANXIETY ....................................................................................... 299 Overview ................................................................................................................................... 299 Finding Nutrition Studies on Anxiety...................................................................................... 299 Federal Resources on Nutrition................................................................................................. 302 Additional Web Resources......................................................................................................... 303 CHAPTER 3. ALTERNATIVE MEDICINE AND ANXIETY ................................................................. 307 Overview ................................................................................................................................... 307 The Combined Health Information Database ............................................................................ 307 National Center for Complementary and Alternative Medicine ............................................... 309 Additional Web Resources......................................................................................................... 323 General References..................................................................................................................... 345 CHAPTER 4. DISSERTATIONS ON ANXIETY ................................................................................... 347 Overview ................................................................................................................................... 347 Dissertations on Anxiety........................................................................................................... 347 Keeping Current ........................................................................................................................ 391 CHAPTER 5. CLINICAL TRIALS AND ANXIETY.............................................................................. 393 Overview ................................................................................................................................... 393 Recent Trials on Anxiety........................................................................................................... 393 Keeping Current on Clinical Trials ........................................................................................... 413 CHAPTER 6. PATENTS ON ANXIETY .............................................................................................. 415 Overview ................................................................................................................................... 415 Patents on Anxiety .................................................................................................................... 415 Patent Applications on Anxiety ................................................................................................ 461 Keeping Current ........................................................................................................................ 476 CHAPTER 7. BOOKS ON ANXIETY ................................................................................................. 477 Overview ................................................................................................................................... 477 Book Summaries: Federal Agencies ........................................................................................... 477 Book Summaries: Online Booksellers ........................................................................................ 478 The National Library of Medicine Book Index........................................................................... 503 Chapters on Anxiety.................................................................................................................. 505 Directories ................................................................................................................................. 507 CHAPTER 8. MULTIMEDIA ON ANXIETY....................................................................................... 509 Overview ................................................................................................................................... 509 Video Recordings....................................................................................................................... 509 Bibliography: Multimedia on Anxiety....................................................................................... 514 CHAPTER 9. PERIODICALS AND NEWS ON ANXIETY.................................................................... 517 Overview ................................................................................................................................... 517 News Services and Press Releases ............................................................................................. 517 Newsletters on Anxiety ............................................................................................................. 520 Newsletter Articles .................................................................................................................... 520 Academic Periodicals covering Anxiety .................................................................................... 529 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 533 Overview ................................................................................................................................... 533 NIH Guidelines ......................................................................................................................... 533
x
Contents NIH Databases ...........................................................................................................................535 Other Commercial Databases .....................................................................................................541 The Genome Project and Anxiety...............................................................................................541 APPENDIX B. PATIENT RESOURCES ...............................................................................................545 Overview ....................................................................................................................................545 Patient Guideline Sources ..........................................................................................................545 Associations and Anxiety...........................................................................................................553 Finding Associations ..................................................................................................................557 APPENDIX C. RESEARCHING MEDICATIONS .................................................................................559 Overview ....................................................................................................................................559 U.S. Pharmacopeia .....................................................................................................................559 Commercial Databases ...............................................................................................................562 APPENDIX D. FINDING MEDICAL LIBRARIES ................................................................................563 Overview ....................................................................................................................................563 Preparation.................................................................................................................................563 Finding a Local Medical Library ................................................................................................563 Medical Libraries in the U.S. and Canada .................................................................................563
ONLINE GLOSSARIES ................................................................................................................569 Online Dictionary Directories ...................................................................................................573 ANXIETY DICTIONARY .............................................................................................................575 INDEX...............................................................................................................................................663
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with anxiety is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about anxiety, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to anxiety, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on anxiety. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to anxiety, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on anxiety. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON ANXIETY Overview In this chapter, we will show you how to locate peer-reviewed references and studies on anxiety.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and anxiety, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “anxiety” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: •
Anxiety in the Elderly: Anxiety and Its Treatment in the Elderly Source: International Psychogeriatrics. 11(1): 25-45. March 1999. Summary: This journal article reviews published research and clinical experience on treating phobic disorders, generalized anxiety, obsessive-compulsive disorder, panic disorder, mixed anxiety-depression, and mixed anxiety-dementia in the elderly. The authors discuss factors which may account for the fact that anxiety appears to be rare in established dementia; the relationships between agitation and anxiety and pain and anxiety; and whether treating anxiety could result in improved cognition. They present information on the few controlled studies available on interventions for anxiety in dementia, and suggest the possibility of using psychosocial therapies to treat anxiety, although limited data exist to support this option. The authors conclude that the
4
Anxiety
profusion of clinical recommendations on treating anxiety disorders contrasts with the lack of controlled clinical trials. Numerous references. •
Anxiety in Alzheimer's Disease: Prevalence and Comorbidity Source: Journal of Gerontology. 54A(7): M348-M352. 1999. Summary: This journal article describes a study investigating the prevalence and comorbidity of anxiety symptoms in 523 community-dwelling patients with Alzheimer's disease (AD) through interviews with caregivers and direct physical examination. Prevalence and association of anxiety to depression, other behavioral problems, level of cognitive and functional impairment, patient gender, and age were investigated. Anxiety symptoms occurred in 70 percent of subjects. They correlated with impairment of activities of daily living and other behavioral disturbances. Men were more likely to be angry and agitated; women were more likely to have symptoms of anxiety, fearfulness, or apprehension. Over 50 percent of the sample had both anxiety and symptoms of depression. The authors recommend more research into assessment and treatment of anxiety in patients with AD. 4 tables, 23 references. (AA-M).
•
Treatment of Anxiety in the Cognitively Impaired Elderly: Can Cognitive-Behavior Therapy Help? Source: International Psychogeriatrics. 10(2): 173-182. June 1998. Summary: This article presents an overview of cognitive-behavioral techniques used to treat anxiety in people with dementia. Anxiety, often results in a further decline in functioning. The authors review the literature on this subject and describe two cases focusing on anxiety management techniques modified to suit cognitively impaired older patients. Modifications include simplifying material, using more structured techniques, and recognizing the critical role of the patient's caregiver in therapy. The authors conclude that cognitive-behavior therapy can help reduce anxiety in patients with dementia. They suggest that neuropsychological evaluations should include management recommendations when anxiety is part of the clinical presentation. Addressing anxiety in patients with progressive brain damage may decrease the psychological impact of cognitive impairment and delay the loss of control over their lives. Potential benefits of this therapy include preventing hospitalization and increasing patients' self-esteem and independence. 2 tables, 32 references. (AA-M).
•
Depression, Anxiety, and Sleep Disturbances Source: International Psychogeriatrics. 8(Supplement 3): 415-418. 1996. Summary: This journal article discusses issues in the treatment of depression, anxiety, and sleep disturbances in patients with dementia. The author reviews evidence suggesting that both pharmacologic and nonpharmacologic therapies are effective for the treatment of depression, and that treatment for depression in dementia should focus not only on symptomatic relief but also on functional improvement. He notes that little attention has been given to the treatment of anxiety in patients with dementia, and advises that benzodiazepines should be used with caution in such patients because of the risk of worsening their cognitive function. He also discusses considerations in the effective management of sleep disturbance in patients with dementia, including the use of nonpharmacologic approaches such as activity programs, environmental interventions, and educational interventions.
Studies
•
5
Concurrent Validity of Measures of Anxiety, Depression, and Somatization in Elderly, Demented, Male Patients Source: Clinical Gerontologist. 15(1): 3-13. 1994. Summary: This study examined the correspondence of several measures of depression, anxiety, and somatic preoccupation in older medical patients with dementia. The Geriatric Depression Scale, the state anxiety portion of the State-Trait Anxiety Inventory, the Wahler Physical Symptoms Inventory, and a short form of the Minnesota Multiphasic Personality Inventory were read to 40 older males with dementia, who responded orally in a true-false format. Researchers also interviewed the patients and rated them on the Brief Outpatient Psychopathology Scale. The self-report measures of depression, anxiety, and somatization were found to be adequately related to corresponding interview ratings irrespective of the severity of cognitive deficits. These findings demonstrate that self-report tests may be used effectively with patients who would normally be excluded because of illiteracy, cognitive deficits, or sensory impairments. 3 tables, 36 references. (AA-M).
•
Historical Changes in the Subjective Experience of Alzheimer's Disease: The Role of Anxiety Source: American Journal of Alzheimer's Care and Related Disorders and Research. 6(3): 35-39. May-June 1991. Contact: Available from Prime National Publishing Corp. 470 Boston Post Road, Weston, MA 02193. (617) 899-2702. PRICE: Single issue $8.00. Call for information. Summary: This journal article describes the results of an historical study patients' subjective experience of Alzheimer's disease. In its investigation, the study used doctor's accounts of the psychological symptoms of patients with dementia, chosen in a representative manner from the medical literature in the years after 1870. The results suggest that an increase in levels of anxiety is the principal change that dementiaAlzheimer's patients seem to have experienced historically. It is suggested that this increase in anxiety about the disease may be dated back several decades. It is argued that possible causes for such increased anxiety might be the greater tendency to institutionalize Alzheimer's disease patients and a higher societal valuation placed on intellectual performance. It is concluded that, while contemporary psychological studies of anxiety in dementia are not numerous, more overt anxiety has been observed in the early confusional phase of Alzheimer's disease patients, and that the very prospect of institutionalization provokes anxiety. 29 references. (AA-M).
•
Response to Memory Training and Individual Differences in Verbal Intelligence and State Anxiety Source: American Journal of Psychiatry. 145(5): 636-639. May 1988. Summary: Researchers report on within-group analyses of two successful memorytraining treatments for older people and suggest attributes of people most likely to benefit from each type of training. A total of 40 older volunteers (average age 67 years), divided equally in 2 groups, participated in a name-face-recall study. According to the authors, participants' performance on the WAIS vocabulary subscale correlated with response to a treatment that combined mnemonics and verbal elaboration techniques, and scores on the Spielberger State-Trait Anxiety Inventory correlated with response to a treatment that combined mnemonics and relaxation techniques. The authors claim these results support the hypothesis that subjects scoring relatively high on a measure of
6
Anxiety
verbal intelligence would do relatively well in training to increase verbal elaboration, while those scoring relatively high on a measure of anxiety would do relatively well in training to reduce performance anxiety. 1 table, 31 references. (AA-M). •
Relieving the Anxiety and Fear of Dementia Source: Journal of Gerontological Nursing. 11(5): 8-11, 14-15. May 1985. Summary: Persons suffering from dementia present a variety of serious management problems in long-term care settings. In an attempt to deal with daily nursing problems more effectively and improve the function of patients with dementia, a special program was designed called SERVE. The program consists of music, exercise, touch, and relaxation, administered in a group setting for an hour three times a week. One of the concepts underlying this approach is a belief that many of the behavioral symptoms of dementia evolve from patients' responses to the environment and their personal awareness of cognitive deficits. The object of a session is to create an atmosphere of safety, predictability, and acceptance which will foster the release of patients' fear and anxiety. If participants can experience some degree of confidence and success, even a few hours a week, it will affect their sense of well-being and functioning outside the session. 34 references.
•
Anxiety and Depression in Patients With Primary Sjogren's Syndrome Source: Journal of Rheumatology. 27(1): 165-169. January 2000. Summary: This journal article provides health professionals with information on a study that examined the degree of anxiety and depression in patients who have Sjogren's syndrome (SS) and assessed their well being and general symptoms. A standardized questionnaire, the Hospital Anxiety and Depression Scale, was used to examine the degree of anxiety and depression in 62 patients with primary SS and in age matched healthy female controls. The Gothenburg quality of life instrument was used to assess well being and general symptoms. A total of 38 patients who had rheumatoid arthritis were used as patient controls. The study found that the patients who had primary SS had significantly higher scores for possible clinical anxiety and for possible clinical depression than reference groups. The physical and mental well being of the patients with primary SS was significantly reduced compared with controls. Furthermore, patients with primary SS complained more commonly of low mood, irritability, headache, gastrointestinal symptoms, and impaired concentration and memory than patients with RA. Sicca symptoms in the patients who had RA had no influence on their psychiatric symptoms. The article concludes that the results indicate that patients with primary SS often have psychiatric symptoms and diminished well being, which may affect their quality of life. 1 figure, 3 tables, and 38 references. (AA-M).
•
Mammography-related Anxiety: Effect of Preprocedural Patient Education Source: Women's Health Issues. 11(2):110-115, March-April 2001. Summary: Researchers conducted a survey of 613 women undergoing mammography regarding anxiety about the procedure and the expected results to determine the effect of preprocedural education on mammography-related anxiety. The group included 424 screening patients and 185 diagnostic patients. Among the 424 screening patients, 44 were having their first mammogram. The age distribution included 48 younger than age 40 years, 236 between age 40 and 50 years, 172 age 50 to 60 years, 102 between age 60 and 70 years, and 54 over the age of 70 years. The study population was 85.1 percent white, non-Hispanic; 6.4 percent Hispanic; 6.5 percent black, non-Hispanic; 1.5 percent
Studies
7
Native American, 0.8 percent Asian, and 0.7 percent other. Half the study population watched an educational videotape and half watched an entertaining movie in the waiting room. Anxiety levels about results were significantly higher than anxiety levels about the procedure. Women having their first mammography were significantly more anxious about the results than about the procedure. There was no difference in procedural or cancer anxiety levels among women shown the educational tape and those shown the entertaining movie. However, women watching the educational tape were more likely to say that they enjoyed the program than women watching the entertaining movie. The researchers conclude that the fear of discovering breast cancer generates most of mammography-related anxiety, and that preprocedural education did not affect procedural or cancer-related anxiety. 2 tables, 13 references. •
Anxiety and Compliance Among Women at High Risk for Breast Cancer Source: Annals of Behavioral Medicine. 23(4):298-303, Fall 2001. Summary: Researchers examined the relationship between (1) symptoms of depression and general anxiety, (2) women's feelings of vulnerability to cancer, (3) anxiety related to various cancer screening procedures, and (4) compliance with such procedures among women who had a familial risk for breast cancer. Data came from 430 consecutive women from the High Risk Clinic at the UCLA Revlon Breast Center. Participants completed the State-Trait Anxiety Inventory and responded to questions about their (1) perceived vulnerability; (2) anxiety experienced when undergoing mammograms, breast self-examinations (BSE's), and Papanicolaou (Pap) smear tests; and (3) compliance with cancer screening procedures. Data analysis indicated that women who attended programs targeting people at familial risk of breast cancer had significant symptoms of depression and general anxiety, and they vastly overestimated their risk for developing breast cancer. Their general anxiety related to anxiety about specific screening practices but not to their perceived vulnerability to cancer. Overall, neither general nor screening-specific anxiety related to women's compliance with screening, although there were significant associations between women's feelings of anxiety regarding BSE's and their actual performance of BSE. Participants reported high levels of compliance with Pap smears and mammograms. BSE appeared to be the only procedure for which compliance negatively related to procedure-specific anxiety. 4 tables, 23 references.
•
Effects of a Single Music Therapy Intervention on Anxiety, Discomfort, Satisfaction, and Compliance With Screening Guidelines in Outpatients Undergoing Flexible Sigmoidoscopy Source: Gastroenterology Nursing. 23(4):148-156, July-August 2000. Summary: Researchers evaluated the impact of a single music therapy intervention on anxiety, discomfort, satisfaction, and perceived compliance with colorectal cancer (CRC) screening guidelines among outpatients undergoing flexible sigmoidoscopy (SIG). They enrolled 64 persons, mean age 54.6 years, scheduled for a SIG examination as outpatients at a Midwestern tertiary care center in the study. The SIG examination was performed by a nurse endoscopist. The patients were randomized to receive music therapy or usual procedural care (control condition). Music therapy involved having the patient select a cassette of music to listen to while undergoing the procedure. The patients rated their anxiety before and after the SIG examination using the Strait Trait Anxiety Inventory (STAI) in a pretest/posttest design. The patients also rated their perceived discomfort, satisfaction, and willingness to comply with SIG screening guidelines (a SIG examination repeated at 3 to 5-year intervals) after the procedure. No
8
Anxiety
significant differences in the STAI scores were seen between patients assigned to the music therapy and control groups before SIG. Patients in the music therapy group reported significantly less anxiety and discomfort after SIG than those in the control group. No significant differences in perceived satisfaction or willingness to comply with SG screening guidelines were seen between the two groups. Researchers conclude that patient-selected music listening was effective in reducing anxiety associated with the examination, as well as reducing the reported levels of discomfort during SIG. 3 figures, 4 tables, 43 references.
Federally Funded Research on Anxiety The U.S. Government supports a variety of research studies relating to anxiety. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to anxiety. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore anxiety. The following is typical of the type of information found when searching the CRISP database for anxiety: •
Project Title: A LONGITUDINAL FOLLOW UP OF CHILDREN AT RISK FOR ANXIETY Principal Investigator & Institution: Rosenbaum, Jerrold F. Associate Professor; Massachusetts General Hospital 55 Fruit St Boston, Ma 02114 Timing: Fiscal Year 2001; Project Start 1-MAY-1993; Project End 1-JAN-2004 Summary: In the proposed study, we seek to address a basic scientific question: Is it possible to predict the development of anxiety disorders among young children whose parents have panic disorder (PD)? This question is straightforward, yet the answer has broad implications. Although it is well established that children of parents with PD are at high risk for anxiety disorders, only some of these children will develop psychopathology. The identification of a predictor would facilitate primary prevention by delineating a group of young children at very high risk for anxiety disorders among those already at risk by having a PD parent. During the prior funding period we have completed a cross-sectional study of over 200 children at risk for PD and comparison offspring of normal control parents. Our sample is unique in that the children have been identified and characterized extensively before they entered the age of risk for childhood anxiety disorders. These youngsters have already been assessed for behavioral inhibition, psychophysiological markers, and early signs of anxiety as well as for markers of psychosocial adversity. A subsample who have grown old enough to be
2 Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
Studies
9
reliably assessed for DSM-IV diagnoses, have already been assessed for psychopathology using structured clinical interviews. Therefore this valuable sample affords us the unique opportunity to track the development of dysfunction and psychopathology in prospectively followed children at risk for psychopathology. To our knowledge, this would represent the largest such sample followed longitudinally. As we describe in the Progress Report, our work suggests that multiple domains of measurement will be useful predictors of psychopathology in high risk children. These domains are: parental disorders, child temperament (as indexed by "behavioral inhibition to the unfamiliar" [BI]), psychophysiologic abnormalities, and psychosocial adversity. The proposed work seeks to validate these measures as predictors of subsequent psychopathology and dysfunction by following up the sample five years after their baseline evaluation. The main aims of this project were determined by our past 12 years of work studying BI and anxiety disorders among young children. Our three main aims are: l) to characterize the psychopathologic and functional outcomes of children at risk for panic disorder; 2) to determine predictors of adverse outcomes among children at risk for anxiety disorders; and 3) to characterize the developmental sequence of anxiety disorders in these children. Moreover, under separate funding, we are collecting DNA samples from this cohort of families. Thus, by assuring that DNA samples will be available in the future, we leave open the possibility that our sample will be useful for prospectively predicting psychiatric disorders and disability from putative anxiety genes. Given that we are also assessing adverse features of the environment, we will also be able to determine if gene-environment interactions play a role in the genesis of anxiety disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: AMYGDALAR NEUROPEPTIDES AND ANXIETY Principal Investigator & Institution: Wilson, Marlene A. Associate Professor; Pharmacology, Physiology and Neuroscience; University of South Carolina at Columbia Byrnes Bldg., Room 501 Columbia, Sc 29208 Timing: Fiscal Year 2002; Project Start 5-SEP-2002; Project End 1-AUG-2007 Summary: (provided by applicant): The amygdala is a brain structure that plays a crucial role in fear and anxiety, and the actions of anxiety-reducing compounds. The opioid peptide has also been shown to modulate anxiety-related responses within the amygdala. Using herpes virus-mediated gene transfer, we have demonstrated that overexpression of enkephalin in the amygdala enhances the anxiety-reducing influences of the benzodiazepine diazepam (Valium) in rats. These initial results demonstrate that herpes virus-mediated gene transfer can transiently alter expression of neuropeptides in confined brain sites of adult rats, and that these changes can modify behavioral responses. The present studies continue to utilize this powerful technique to examine the role of amygdalar enkephalin in regulating anxiety-related behaviors and the actions of anxiolytic drugs. Both decreases and cell-targeted increases in peptide expression will be examined in several animal models of anxiety. Aim 1 will verify the ability of virusmediated gene transfer to decrease and cell-specifically increase expression of enkephalin in select areas of amygdala. Anatomical and quantitative methods will assess changes in mRNA expression, while peptide changes will be assessed with immunohistochemistry and radioimmunoassay. AIM 2 examines if altered enkephalin expression in central amygdala modifies anxiety-related behaviors in additional animal tests of anxiety behaviors and/or the effectiveness of other anxiolytics in these tests. These studies 1) compare decreases with cell-specific increases in enkephalin expression, 2) test the activity of other anxiolytics (alcohol, the serotonergic compound buspirone),
10 Anxiety
and 3) tests effects in several models of anxiety. AIM 3 assesses the effects of pharmacological modulation of enkephalin activity in amygdala. Using more traditional techniques selective opioid receptor (mu, delta) agonists and antagonists will be locally applied in amygdala, and the effect of these compounds on responses to anxiolytic drugs will be tested. These studies will lead to a better understanding of the role of amygdala and enkephalin in anxiety and anxiolytic responses, as well as elucidate the differences between animal models of anxiety. This understanding may also suggest novel, avenues for development of treatments for anxiety or affective disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANIMAL MODELS OF FEAR AND ANXIETY Principal Investigator & Institution: Davis, Michael;; Emory University 1784 North Decatur Road Atlanta, Ga 30322 Timing: Fiscal Year 2003; Project Start 1-AUG-2003; Project End 0-JUN-2008 Summary: Five compounds (the CRH1 receptor antagonist SB723620, the NK1 antagonist G597599, the SSRI/5HT2A agonist Vilazodone, the antidepressant 8hydroxy-bupropion, and the type 4 phosphodiesterase inhbitor SB207499), provided by GlaxoSmithKline as part of The Emory-GSK-NIMH Collaborative Mood Disorders Initiative, will be evaluated for anti-fear and anxiolytic activity using fear-potentiated, light-enhanced, and CRH-enhanced startle paradigms (increased startle in the presence of cues that predict shock, during sustained illumination, or following i.c.v. corticotropin-releasing hormone infusions, respectively). Whereas light- and CRHenhanced startle (which are more akin to anxiety than to fear) are mediated by circuitry that includes the bed nucleus of the stria terminalis (BNST) but not the central nucleus of the amygdala (CeA), fear-potentiated startle is mediated by circuitry that includes the CeA but not the BNST. A central goal of the proposed studies will be to identify differing pharmacological vulnerabilities associated with BNST (anxiety) versus CeA (fear) dependent behaviors. In humans, anxiety disorders are more prevalent in women than in men and, in rats, light-enhanced startle is more robust in females than in males. Interestingly, the BNST is sexually dimorphic in both species. Thus, a second goal will be to compare the influence of gender on BNST- versus CeA-dependent responses, and to evaluate gender influences on drug responses in each model. These same compounds will be evaluated in other laboratories (separate applications) using different behavioral models and non-behavioral assays. It is hoped that this integrated effort will foster new approaches for the rapid evaluation of novel compounds with potential clinical utility. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ANXIETY & VAGAL CONTROL OF THE HEART IN CORONARY DISEASE Principal Investigator & Institution: Watkins, Lana L. Psychiatry; Duke University Durham, Nc 27706 Timing: Fiscal Year 2001; Project Start 1-JUN-1999; Project End 1-MAY-2003 Summary: Coronary heart disease continues to be the leading cause of death in the United States, despite risk factor reduction and technological advances in treatment options. Prospective studies implicate chronic anxiety as an independent risk factor for fatal coronary heart disease. In particular, anxiety increases the risk of sudden cardiac death substantially. The primary objective of the proposed research is to examine the role of reduced vagal control of heart rate in the increased risk of cardiac mortality associated with anxiety in a population with established coronary artery disease (CAD).
Studies 11
A second objective is to determine whether the effects of anxiety are independent of the effects of depression. Nine hundred and fifty CAD patients will be recruited for this study from patients hospitalized for elective cardiac catheterization. Anxiety will be measured by the Hospital Anxiety Scale, the Spielberger Trait Anxiety Inventory, and the Crown-Crisp Phobic Anxiety Scale. Symptoms of depression will be measured by the Montgomery-Asberg Depression Rating Scale, the Hospital Depression Scale, and the Beck Depression Inventory. Vagal control of heart rate will be determined using power spectral analysis to measure two indices of vagal control: baroreceptor-mediated vagal reflex cardiac control, and respiratory sinus arrhythmia. Patients will be followed at 6 months, l year, 2 years, and 3 years postcatheterization, and cardiac mortality data will be obtained, including non-sudden and sudden cardiac death. The data generated by this study will be used to examine the involvement of impaired vagal cardiac control in the risk of fatal coronary heart disease and sudden cardiac death associated with anxiety. Specifically, the proposed study will examine: (1) the relationship between anxiety and cardiac mortality; (2) the relationship between anxiety and vagal control; (3) the role played by reduced vagal control in mediating anxiety-related risk; and (4) the relationship between depression, vagal control and cardiac risk. Findings of a relationship between anxiety, reduced vagal control and sudden cardiac death would suggest the potential importance of early intervention in cardiac patients with anxiety disorders and would underscore the benefit of aggressive monitoring of arrhythmias in this population, which may ultimately translate to reduced mortality rates. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANXIETY AND PSYCHOLOGICAL VULNERABILITY IN CHEST PAIN Principal Investigator & Institution: White, Kamila S. Psychology; Boston University Charles River Campus 881 Commonwealth Avenue Boston, Ma 02215 Timing: Fiscal Year 2001; Project Start 4-MAY-2001; Project End 0-APR-2006 Summary: APPLICANT'S This application is a request for a Mentored Patient-Oriented Research Career Development Award (K23) from the NIMH to enable Dr. Kamila White to develop expertise in studying psychological factors in patients with noncardiac chest pain (NCCP). This applicant will work closely with her mentor, Dr. David Barlow, and co-mentors Drs. Ernest Gervino, Nicholas Covino (at Beth Israel Medical Center), Tim Brown, and Richard Mayou at Oxford University. Dr. White's short-term goals are to strengthen her theoretical, methodological, and statistical skills in clinical trials and in the study of NCCP. Her long-term goals are to develop an independent lab funded by external sources and to develop a network of research scientists central and peripheral to Boston University devoted to advancing the understanding of anxiety in noncardiac chest pain. The above goals will be accomplished through didactic training and formal investigation of anxiety and psychological vulnerability in patients with noncardiac chest pain who present to an urban, university-affiliated cardiology clinic. The majority of patients with chest pain and normal coronary angiograms complain of continuing chest pain, fear, and preoccupation with heart functioning. Recurrent chest pain and continued anxiety about heart functioning not only cause much personal discomfort but may also lead to significant disability. To date, research on NCCP has been largely descriptive and has been limited by lack of an empirically supported theoretical model. Longitudinal studies examining the causal role of anxiety and psychological risk factors have not been examined in NCCP, but represent an important approach to understanding the development and maintenance of pain in this population. The goals of the proposed research program are 1) to prospectively evaluate a theoretical model of
12 Anxiety
NCCP, 2) to examine the causal role of anxiety and psychological vulnerability factors in predicting long-term disability, and 3) to identify potential protective factors that may be important in intervening with this population. Data from this research program will allow Dr. White to establish an empirical foundation from which to apply these data to the development of novel interventions for patients with NCCP. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANXIETY DISORDERS AND MARITAL FUNCTIONING Principal Investigator & Institution: Zaider, Talia I. Psychology; Temple University 406 Usb, 083-45 Philadelphia, Pa 19122 Timing: Fiscal Year 2003; Project Start 0-JUL-2003; Project End 9-JUL-2005 Summary: (provided by applicant): The goal of the proposed study is to better understand the relationship between anxiety disorders and marital functioning. Although studies have shown that individuals with anxiety disorders experience their marriages as troubled, the immediate mechanisms by which anxiety disorders affect each partner remain poorly understood. The proposed study will address this issue by monitoring the daily experiences of 60 married couples in which one partner suffers from an anxiety disorder. Each partner will be asked to complete a brief structured questionnaire (diary) each day, on 14 consecutive days. This daily diary will inquire about levels of distress experienced by each partner, as well as perceptions of the quality of marital interactions on the day of reporting. Analyses will examine whether daily fluctuations in the anxiety levels experienced by patients with an anxiety disorder are related to changes in the levels of distress experienced by their spouses. The proposed study will further examine factors associated with changes in patient and spouse distress. Findings from this study will be used to inform existing theories on the interpersonal life of individuals with anxiety disorders, and to explore possible refinements in existing interventions. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ANXIETY IN A MOUSE MODEL OF RETT SYNDROME Principal Investigator & Institution: Mcgill, Bryan E. Pediatrics; Baylor College of Medicine 1 Baylor Plaza Houston, Tx 77030 Timing: Fiscal Year 2003; Project Start 1-SEP-2003; Project End 1-AUG-2007 Summary: (provided by applicant): Rett syndrome (RTT) is a childhood neurobehavioral disorder caused by mutations in the methyI-CpG-binding protein 2 (MECP2) gene, which encodes a transcriptional repressor. RTT is characterized by mental retardation, seizures, stereotypic movements, breathing dysfunction and anxiety. MECP2 mutations also have been linked to juvenile onset schizophrenia and bipolar disorder. Our lab generated a model of RTT (the Mecp2308/Y mouse) that recapitulates features of RTT including anxiety. The overall hypothesis is that MECP2 mutation causes the misregulation of stress-response genes, leading to anxiety in RTT and Mecp2308/Y mice. To test this hypothesis, the anxiety phenotype of Mecp2308/Y mice will be characterized in detail using behavioral and physiologic tests. The molecular basis of their behavior will be investigated using enzyme linked immunosorbent assay (ELISA) and autoradiography to examine serotonin (5-HT) and 5-HT receptors, respectively, in the Mecp2308/Y mouse brain. Finally, pharmacologic manipulation of 5-HT receptors will be performed in an attempt to alleviate anxiety in these mice. These studies will aid in understanding the basis of anxiety in Mecp2308/Y mice and may lead to the appropriate treatment of this aspect of RTT.
Studies 13
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANXIETY IN AFRICAN AMERICAN YOUTH Principal Investigator & Institution: Robin, Joanna A. Psychology; Temple University 406 Usb, 083-45 Philadelphia, Pa 19122 Timing: Fiscal Year 2003; Project Start 5-MAR-2004 Summary: (provided by applicant): The primary goal of the proposed study is to better understand the relationship between race and parenting and child anxiety. Although there have been numerous studies conducted on the relationship between parenting and child anxiety symptoms in primarily Caucasian samples, there is a paucity of research on the role of race in this relationship. Furthermore, studies that have investigated this relationship have failed to pay attention to role of socioeconomic status (SES). The proposed study will test whether race is a moderator in the relationship between parenting and child anxiety symptoms and whether SES moderates the relationship between parenting and child anxiety in African American Youth. Secondary goals will address the relationship between SES in the rates of anxiety in African American youth and the relationship between stressful life events and anxiety in African American Youth. Data from 128 African American youth and their maternal caregivers with low to medium SES will be collected. Furthermore, data already being collected from 64 Caucasian children and their maternal caregivers will be used. Findings from the proposed study will provide knowledge on the role of race and SES in the relationship between parenting and anxiety in youth. This knowledge will be beneficial for clinicians who work with minority populations and families of all classes of SES. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ANXIETY, DISINHIBITION, AND RISK FOR DRUG ABUSE Principal Investigator & Institution: Yonkers, Kimberly A. Associate Professor; Psychiatry; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2003; Project Start 5-SEP-1999; Project End 1-JUL-2004 Summary: This application requests funding for a four-year study to investigate psychophysiological markers for substance abuse in children ages 13-17 who are at high risk for substance abuse by virtue of their parental history for this condition. The rationale for the present proposal is to search for psychophysiological abnormalities associated with the two main dimensions of personality linked to substance abuse, that is, negative affectivity/anxiety and disinhibited/antisocial behaviors. Theorists have proposed a biobehavioral model based on responses to aversive and appetitive stimuli to explain the neurophysiological basis of motivational behaviors and to account for childhood mental disorders. The model posits that motivational behaviors is influenced by an arousal system, and by a behavioral inhibition system (BIS), which processes signals related to aversive stimuli, and a behavioral activation system (BAS), which processes signal related to rewards. Psychopathology is assumed to result from an imbalance within these systems. The major hypothesis for which we have preliminary support is that distinct deficits in arousal and/or affective responses underlie the relationship between substance abuse and both anxiety and disinhibited/antisocial personality. Specifically we will examine the following in children of parents with 1) substance abuse only, 2) substance abuse and comorbid anxiety disorder, 3) substance abuse and antisocial personality disorder, and 3) no psychiatric disorders: 1. startle potentiation and autonomic nervous system (ANS) measures of arousal to threat of aversive stimuli; 2. ANS responses to reward and to the removal of reward; 3.
14 Anxiety
Asymmetry of resting EEG; 4. the association between psychophysiological measures of BAS and BIS activity and temperamental characteristics associated with anxiety and disinhibited/antisocial behavior; 5. the effects of the gender of the offspring in the relationship between parental history and the offspring's psychophysiological, temperamental, and clinical characteristics; 6. phenotypic indices of vulnerability using combinations of clinical and psychophysiological measures. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANXIETY, PAIN, AND SELF-EFFICACY IN CHILDREN Principal Investigator & Institution: Jacob, Margaret C. History; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2003; Project Start 1-DEC-2002; Project End 0-NOV-2006 Summary: (provided by applicant): The proposed study will use both qualitative and quantitative methodologies to evaluate a multidisciplinary Pain Clinic at UCLA for the treatment of chronic pain in children, a problem which affects some 10-20% of children under 17, is often co-morbid with anxiety and depression disorders, and may establish behaviors which increase the risk of chronic pain syndrome and pain-associated disability in adulthood. The UCLA Pediatric Pain Clinic uses a biopsychosocial model to treat chronic pain in children and to promote behavioral and therapeutic change through enhancement of the child's sense of self-efficacy. The study will use oral history master narratives; validated quantitative measures of patient self-efficacy, selfmanagement (an indicator of function); validated quantitative measures of pain level, co-morbid anxiety and depression; and conversation analysis of physician-patient interactions to study the trajectory of change in the Pain Clinic patients and in patients with the same diagnosis drawn from two pediatric subspecialty clinics. Narratives of change drawn from the oral histories will be co-analyzed with scores on the pre and post-treatment quantitative measures and with observations of practitioner strategy and behavior in patient interactions. Our specific aims are: 1) to make a quantitative and qualitative comparison of the PPC treatment model with that used to treat persistent pain in two pediatric subspecialty clinics, comparing changes in patient pain level, anxiety, depression, self-efficacy and functioning; 2) to examine in depth the children's cognitive beliefs and affective reactions to pain, the sources of these beliefs and reactions, and the process of changes in cognition, anxiety and depression, and behavior during Clinic treatment; and 3) to use the quantitative and qualitative data gathered to identify specific factors within the PPC treatment model which may be further evaluated in the next phase, a controlled clinical trial of this model for the treatment of pain and co-morbid anxiety and depression. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: AROUSAL AND ANXIETY IN DYSFUNCTIONAL MEN AND WOMEN Principal Investigator & Institution: Barlow, David H. Director; Psychology; Boston University Charles River Campus 881 Commonwealth Avenue Boston, Ma 02215 Timing: Fiscal Year 2001; Project Start 1-SEP-1979; Project End 8-FEB-2002 Summary: Prior research on this project has produced a model of psychogenic sexual dysfunction integrating cognitive and affective processes. This model, which has most recently been expanded into a general theory of anxiety (Barlow, 1988), suggests that perception of a sexual context elicits negative affective responding in sexually dysfunctional patients, characterized by a preparatory coping set reflected in autonomic
Studies 15
arousal and the sense of a lack of control. An interaction of cognitive and affective processes is then associated with differential allocation of attention to a self-evaluative mode (self-focused attention). At interaction of cognitive and affective processes is then associated with differential allocation of attention to a self-evaluative mode (selffocused attention). At the extreme, this interferes with performance, several sets of recent data emanating from our laboratory seem to support this model. 1) differential levels of shock threat produce increases in erectile response in functionals (to a point) and a decrease in "nervousness". This contrasts to a decrease in erectile response and an increase in "nervousness" for dysfunctionals. 2) Neutral distraction produces decreased erectile responding in functionals but no change or even a slight increase in erectile responding in dysfunctionals. This directly parallels findings from a growing literature on depression (Musson & Alloy, 1988) in which depressed patients also perform better when they are distracted. Nevertheless, other data from an interesting new paradigm where subjects directly view their genital response via video monitor suggests that dysfunctionals are not necessarily turning their attention inward. This is supported by a new experiment using a misattribution paradigm where functional and dysfunctional subjects were given placebo pills with suggestions that one pill would increase erections while a second would decrease erections, etc. But, these and all prior experiments can only infer cognitive processes. Recent advances in cognitive psychology makes possible a series of studies examining more precisely attentional, allocations and biases, and the identification of mental representations or schema that differentiate functional and dysfunctional subjects. Adopting a model suggested by Mathews et al. (1989), it may be that dysfunctional subjects are initially vigilant (attentive) for threat- related sexual cues but will then avoid these cues in every manner possible when they become salient and under conditions of increased negative affect. The purpose of this series of studies is to explore more precisely the role of cognitive and attentional processes specified in our model of sexual dysfunction. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: BOTANICAL TREATMENTS IN SOCIAL ANXIETY DISORDER Principal Investigator & Institution: Connor, Kathryn M. Assistant Professor; Psychiatry; Duke University Durham, Nc 27706 Timing: Fiscal Year 2001; Project Start 1-JUL-2001; Project End 0-JUN-2006 Summary: (Provided by applicant): Complementary and alternative medicine (CAM) use has grown dramatically over the last decade, particularly of botanical treatments, which are often used for anxiety and depression. While some herbs possess neurochemical activity similar to that demonstrated by conventional psychotropic medications, little rigorous clinical scientific data support their effectiveness and safety. Through the proposed Research Career Development Award (RCDA), I hope to obtain the training and experience which will enable me explore these and other related research questions in the years to come. Short term goals and training activities during the 5-year RCDA period are as follows: (1) to receive advanced training in methodological and quantitative principles of clinical research leading to a master's degree in Health Science; (2) to learn about botanical medicine from the perspectives of pharmacognosy and as applied to general clinical practice, through guided readings, tutorials, and direct observation under the supervision of experts in these interdisciplinary fields; (3) to further understand pharmacologic principles as applied to phytomedicines, through directed readings and assessment of plasma levels of specific herbal constituents; (4) to develop a greater understanding of the regulatory environment for herbs and other dietary supplements, through supervised directed
16 Anxiety
readings and discussions; (5) to develop basic proficiency in reading German to enable me to read and understand published scientific literature; and (6) to determine the effectiveness and safety of phytomedicines in treating social anxiety disorder (SAD), a common, chronic and disabling condition with two subtypes (generalized (GSAD) and nongeneralized SAD, or performance anxiety). The research plan to address this final goal is as follows. In the first study, 56 GSAD subjects will be randomly assigned to double-blind treatment with either Hypericum perforatum (HYP) or placebo (PBO), up to 1800 mg/day, for 10 weeks. Response will be assessed with psychometrically valid scales. Plasma samples will be obtained and tested for the presence of individual HYP constituents. In the second study, 48 subjects with performance anxiety related to public speaking will randomly receive a one-time does of either Kava (KAV) or PBO, followed in one hour by participation in a role play test. Anxiety will be assessed at the following points: pretreatment baseline; posttreatment, pre-role play (e.g., anticipatory level); and posttreatment, post-role play (performance anxiety) to determine the effectiveness and safety of KAV relative to PBO. I hope that the skills developed during the award period will provide a cohesive framework for achieving my long term goal of becoming a clinician-researcher, investigating questions at the interface between psychiatry and botanical medicine. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CARDIOVASCULAR AUTONOMIC CONTROL IN STRESS AND ANXIETY Principal Investigator & Institution: Sloan, Richard P. Professor; Psychiatry; Columbia University Health Sciences Ogc New York, Ny 10032 Timing: Fiscal Year 2001; Project Start 1-APR-1998; Project End 1-JAN-2003 Summary: (Adapted from the Applicant's Abstract): This is an application for an Independent Scientist Award (K02) to study cardiovascular autonomic control in stress and anxiety. It is based on a research program whose focus is to explore the relationships among psychological/behavioral characteristics such as anxiety, hostility, depression, and physical conditioning, the central and autonomic nervous system, and the cardiovascular and respiratory systems. The application proposes a series of experiments deriving from a model which identifies blood pressure variability (BPV) as a potential mechanism by which psychological/psychiatric factors and health behaviors confer increased risk of coronary artery disease (CAD) and catastrophic cardiac events. While evidence suggests that psychological factors such as anxiety, depression, and hostility are associated with increased risk of CAD, the mechanisms by which these factors exert their pathogenic effects are only poorly understood. Our model holds that autonomic control of the heart serves a buffering or inhibitory function over oscillations in blood pressure, which recent research in vascular biology and dynamics suggests may have pathogenic effects on the endothelium, in the case of atherogenesis, and on plaque stability, in the case of catastrophic cardiac events. We recently have shown that under conditions of psychological stress, the magnitude of these blood pressure oscillations is inversely related to the degree of autonomic control of the heart, as measured by heart period variability (HPV). Thus, in subjects with high levels of cardiac autonomic control, blood pressure oscillations are minimal whereas in subjects with low levels of control, they are increased considerably. Since psychological/behavioral characteristics such as anxiety, depression, and hostility have been shown to be associated with lower levels of HPV, these characteristics may be associated with disinhibition of blood pressure oscillations, either at rest, or more likely, in response to psychological stress. Together, these findings suggest that the mechanism by which
Studies 17
psychological characteristics such as hostility have their pathogenic effect is through reduced inhibition of BPV responses to challenge, which in turn promotes atherogenesis and plaque rupture. In this application, 5 experimental tests of this model are proposed. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CBT AUGMENTATION OF PAROXETINE FOR SOCIAL ANXIETY Principal Investigator & Institution: Heimberg, Richard G. Psychology; Temple University 406 Usb, 083-45 Philadelphia, Pa 19122 Timing: Fiscal Year 2003; Project Start 5-AUG-2003; Project End 1-MAY-2007 Summary: (provided by applicant): Social anxiety disorder is a prevalent, chronic and disabling condition. Paroxetine has received FDA approval on the basis of its acute efficacy for this disorder, but much about longer-term management remains uncertain. There are virtually no data regarding next steps in treatment despite evidence that most patients who receive acute paroxetine therapy still exhibit significant residual symptoms. Furthermore, there are also no data regarding methods for minimizing relapse when medication is discontinued despite evidence that relapse rates in such circumstances are high. Cognitive-behavioral therapy (CBT) is a good candidate for augmenting paroxetine response and reducing relapse after medication discontinuation as it has been shown to be an effective treatment in its own right and often associated with lesser relapse than medication alone. Although CBT has been found to be useful in these circumstances for depression and panic disorder, there have been no similar studies in social anxiety disorder. This application will examine the ability of CBT to augment acute paroxetine response and reduce relapse following paroxetine discontinuation in social anxiety disorder. It will also examine the degree of residual symptoms and disability as well as rates of remission and improvements in quality of life in response to paroxetine alone or with the addition of CBT. Predictors of acute response and relapse after treatment is discontinued will also be explored. To achieve these ends, two hundred fifty patients will receive 12 weeks of open treatment with paroxetine. Patients showing at least some benefit will be randomized to continued paroxetine with or without CBT for 16 additional weeks. All treatment will then be tapered and patients will be followed for 24 additional weeks. Overall, this study should provide important information about the augmentation of paroxetine treatment for patients with social anxiety disorder, effective methods for reducing relapse, and who may benefit from paroxetine treatment or relapse when medication is withdrawn. It will also increase understanding of the interplay of psychosocial and pharmacological treatment methods and psychological and biological factors in patients' total response to treatment. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: CBT AUGMENTATION OF PAROXETINE FOR SOCIAL ANXIETY Principal Investigator & Institution: Liebowitz, Michael R.; New York State Psychiatric Institute 1051 Riverside Dr New York, Ny 10032 Timing: Fiscal Year 2003; Project Start 5-AUG-2003; Project End 1-MAY-2007 Summary: (provided by applicant): Social anxiety disorder is a prevalent, chronic and disabling condition. Paroxetine has received FDA approval on the basis of its acute efficacy for this disorder, but much about longer-term management remains uncertain. There are virtually no data regarding next steps in treatment despite evidence that most patients who receive acute paroxetine therapy still exhibit significant residual symptoms. Furthermore, there are also no data regarding methods for minimizing
18 Anxiety
relapse when medication is discontinued despite evidence that relapse rates in such circumstances are high. Cognitive-behavioral therapy (CBT) is a good candidate for augmenting paroxetine response and reducing relapse after medication discontinuation as it has been shown to be an effective treatment in its own right and often associated with lesser relapse than medication alone. Although CBT has been found to be useful in these circumstances for depression and panic disorder, there have been no similar studies in social anxiety disorder. This application will examine the ability of CBT to augment acute paroxetine response and reduce relapse following paroxetine discontinuation in social anxiety disorder. It will also examine the degree of residual symptoms and disability as well as rates of remission and improvements in quality of life in response to paroxetine alone or with the addition of CBT. Predictors of acute response and relapse after treatment is discontinued will also be explored. To achieve these ends, two hundred fifty patients will receive 12 weeks of open treatment with paroxetine. Patients showing at least some benefit will be randomized to continued paroxetine with or without CBT for 16 additional weeks. All treatment will then be tapered and patients will be followed for 24 additional weeks. Overall, this study should provide important information about the augmentation of paroxetine treatment for patients with social anxiety disorder, effective methods for reducing relapse, and who may benefit from paroxetine treatment or relapse when medication is withdrawn. It will also increase understanding of the interplay of psychosocial and pharmacological treatment methods and psychological and biological factors in patients' total response to treatment. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CD-ROM CHILD ANXIETY TREATMENT Principal Investigator & Institution: Harris, M S.; Workbook Publishing, Inc. 208 Llanfair Rd Ardmore, Pa 19003 Timing: Fiscal Year 2003; Project Start 4-MAR-2003; Project End 9-FEB-2004 Summary: (provided by applicant): This study will examine the feasibility and initial efficacy of a CD-ROM version of a cognitive-behavioral therapy (CBT) for anxiety disorders in youth. Anxiety disorders (Generalized Anxiety Disorder; Social Phobia; Separation Anxiety Disorder) are among the most prevalent psychopathological problems in youth and, if untreated, are said to be chronic in nature and to cause significant social and educational impairment. Recent empirical work based on randomized clinical trials suggests that various forms of CBT (e.g., individual, family, group) can be effective in reducing the presence of these very same anxiety disorders. Although studies have found a person-to-person therapeutic approach to be effective, anxious youth often do not seek help. The very nature of anxiety in youth includes a worrisome and perfectionist style and a self presentation that there isn't a problem. Therefore, many anxious youth do not seek or receive needed intervention. The use of a CD-ROM version of the CBT could increase, by significant magnitude, the number of anxious youth for whom a CBT treatment would become available. Further, for the more than 40 million Americans who have no health insurance, or inadequate insurance, a more accessible and affordable treatment modality is needed. Researchers agree that an examination of the viability of cost-effective therapy approaches is critical. The primary goal of this Phase I project is to develop a 14-session CD-ROM version of the CBT and to examine its efficacy by comparing pre-post treatment to pre-post waitlist. A final total of 12 participants, ages 8-13 years, will have been assessed via a structured diagnostic interview (by a reliable independent evaluator) and self-report measures to determine the presence of an anxiety disorder and to evaluate changes
Studies 19
before and after waitlist and before and after treatment (and at a 3-month follow-up after treatment completion). Successful completion of this Phase I project will enable a Phase II randomized clinical trial to evaluate the CD-ROM treatment versus the application of CBT in the customary one-to-one context. The long-term goals are to develop an effective and affordable CD-ROM version of CBT for anxious youth for use on PC-based (and Mac) systems that are available to a wide range of youth, educators, and therapists. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CHILD /ADOLESCENT ANXIETY MULTIMODAL TREATMENT STUDY Principal Investigator & Institution: Walkup, John T. Associate Professor; Psychiatry and Behavioral Scis; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 1-SEP-2002; Project End 1-MAY-2006 Summary: (provided by applicant): With point prevalence estimates ranging from 12 percent to 20 percent, anxiety disorders are among the most common conditions affecting children and adolescents. The three most commonly impairing childhoodonset anxiety disorders are separation anxiety disorder, social phobia and generalized anxiety disorder. As a group, these disorders routinely co-occur and cause clinically significant distress and impairment affecting school, social, and family functioning. Left untreated, these disorders leave children at risk for anxiety disorders, major depression and, in some cases, substance abuse extending into late adolescence and adulthood. Hence, effective treatments for childhood-onset anxiety disorders promise to alleviate and perhaps to prevent long-term morbidity and even mortality. In randomized controlled trials, we have shown that two monotherapies, cognitive-behavioral therapy (CBT) and the selective serotonin reuptake inhibitor (SSRI), fluvoxamine (FLV), are effective treatments for separation anxiety, social phobia, and generalized anxiety disorders in children and adolescents. Even though the monotherapies are effective a substantial number of patients remain symptomatic following treatment and, might have benefited from combined treatment. There are as yet no systematic, controlled studies comparing CBT and an SSRI, alone or in combination, against a control condition in the same patient population. This revised application proposes a four-year, six site, randomized controlled efficacy trial comparing cognitive-behavioral (CBT) and pharmacological treatment for youth ages 7 to 16 years with anxiety disorders. Phase I is a 12-week, random assignment acute efficacy study comparing CBT, FLV, their combination (n=90, each condition), and pill placebo control (n=48) in 318 (53/site) youth with DSM-IV primary diagnoses of separation anxiety, social phobia, and/or generalized anxiety disorder. Phase II involves a 6-month treatment maintenance period for Phase I responders. All subjects regardless of response status will be evaluated at all scheduled assessment points. In addition to comprehensive parent, child, clinician, and teacher reports, the primary outcome variables will be assessed by blind independent evaluators. Manualized intervention and assessment protocols plus state-of-the-art quality assurance and adverse event monitoring procedures insure uniform cross-site administration of the study protocol. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
20 Anxiety
•
Project Title: CHILDREN'S COMMUNICATION
ANXIETY
REGULATION
AND
MATERNAL
Principal Investigator & Institution: Sigman, Marian D. Professor; Mental Retardation Res Center; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2001; Project Start 4-SEP-2001; Project End 1-AUG-2003 Summary: (Applicant's Abstract): Does parental communication style affect emotion regulation among children who initially demonstrate high levels of fear and anxiety? Although recent correlational research has demonstrated a linkage between parental communication behaviors, such as excessive catastrophizing, and children's manifestations of fear and anxiety, it is not clear if parental communication behaviors directly influence children's ability to regulate these emotions. Alternatively, these parental communication behaviors may be elicited by children who express fears and anxieties more frequently than non-anxious children do. Experimental research designs would offer a more definitive test of these competing explanations of the extant correlational findings. Intervention studies, in particular, can test whether experimentally manipulating current family interaction patterns affects children's ability to regulate emotion. The proposed research will provide a preliminary experimental test of the relationship between parental communication behavior and children's regulation of fear and anxiety. Some 40 clinically anxious youth, aged 7-13, will be randomly assigned to a family intervention program for childhood anxiety problems, which includes extensive parent communication training, or-a child intervention program without parent training. By comparing these two interventions we will test if it is possible to improve parental communication behaviors-such as catastrophizing-through intensive parent training, above and beyond the effects of involving children in a child intervention program. We will then test the impact of this change in parental communication behaviors on children's ability to regulate fear and anxiety. Observational measures of parental communication behavior, children's emotion regulation strategies, and children's manifestations of fear and anxiety, as well as a measure of physiological arousal, will serve as the primary outcome measures. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CLINICAL STUDIES OF HUMAN ANXIETY DISORDERS Principal Investigator & Institution: Weissman, Myrna M. Professor; Columbia Univ New York Morningside 1210 Amsterdam Ave, Mc 2205 New York, Ny 10027 Timing: Fiscal Year 2003; Project Start 1-JAN-2003; Project End 1-DEC-2006 Summary: (provided by applicant): The overall aim of the Program Project Grant (PPG) is to understand the genetic basis for fear, anxiety and anxiety disorders in humans by identifying variant forms of genes that may contribute to pathological anxiety states. The underlying idea is that both learned and innate fear are tractable targets for genetic analyses in mice and humans. To accomplish this portion of the PPG dealing with human anxiety disorders Project 4 will provide well-characterized clinical samples and DNA from subjects with selected anxiety disorders (panic disorder, social anxiety disorder, and controls). Dimensional assessments of anxiety related temperaments, which cut across all clinical groups will provide another method for sample stratification. The clinical disorders have been selected where there is indication of heritability from family and/or twin studies; the clinical phenotypes are well defined and there is suggestive evidence for a relationship with fear conditioning and/or its neurobiological substrate and where hypotheses about candidate genes based on
Studies 21
marker, treatment or pathophysiologic studies can be developed. To maximize the likelihood that we are selecting cases with genetic etiology, we will select cases from families with multiple affected individuals. The dimensional assessments have been selected because of prior promising associations with specific polymorphisms related to anxiety and evidence for heritability. Since issues of design and control groups have not been resolved, we will use both family based "triads" (probands and two biological parents) and population controls (matched for ethnicity). The central hypothesis is that there are similarities in fear conditioning circuitry between animal models and human and that genes involved in the pathways associated with fear conditioning or innate fear may be involved in the development of human anxiety disorders, particularly panic disorder, social anxiety disorder (social phobias), and/or neuroticism or anxiety sensitivity. The specific aims of this project are: identification, clinical characterization and DNA extraction of subjects with panic disorder (N= 150); social anxiety disorder (social phobia) (N=150); selected to be at high genetic risk for anxiety disorders; non ill matched controls also assessed on quantitative trait dimension (N=150). We will also collect bloods from the biological parents of the panic and social anxiety disorder probands. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CLINICAL STUDIES OF HUMAN FEAR AND ANXIETY Principal Investigator & Institution: Fyer, Abby J. Professor; Columbia Univ New York Morningside 1210 Amsterdam Ave, Mc 2205 New York, Ny 10027 Timing: Fiscal Year 2003; Project Start 1-JAN-2003; Project End 1-DEC-2006 Summary: (provided by applicant): The overall goal of this Program Project is to identify trait alleles that contribute to variation in human fear and anxiety. Project 3 will provide a large community based human sample evaluated for cued fear conditioning and two heritable, clinically relevant dimensional anxiety measures (NEO Personality Inventory, Anxiety Sensitivity Index). Individuals will also provide a blood sample for DNA. The combined work of the neurobiology (Drs. Kandel and Hen, Projects 1A, 1B) and molecular genetics (Dr. Gilliam, Project 2) components of the program project will identify human candidate genes derived from knowledge of the molecular biology and neurocircuitry of fear conditioning and selected aspects of innate fear in animal models. These candidates will be scanned for allelic variance in the entire Project 3 sample to search for trait alleles for fear conditioning, the two dimensional assessments (NEO, ASI) and composite phenotypes derived from these measures. Data will be analyzed using both methods that regress continuous phenotypes to allelic variance across the whole sample and by comparison of phenotypic extremes. Trait alleles identified for any of these phenotypes will be evaluated as susceptibility loci for human anxiety disorders (Project 4, Dr. Weissman). The dimensional measures (NEO, ASI) will also be used as a "bridge" to further refine the selection of candidates and target sub-populations in the anxiety disorder subjects. As described in Project 2, the combined data from Projects 2, 3, 4 will be used to begin to explore multivariate models of anxiety that encompass the several phenotypes assessed in this grant. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: COGNITIVE TRAINING FOR SOCIAL ANXIETY Principal Investigator & Institution: Huppert, Jonathan D. Psychiatry; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104 Timing: Fiscal Year 2003; Project Start 1-JUN-2003; Project End 1-MAY-2007
22 Anxiety
Summary: (provided by applicant): This application proposes Jonathan D. Huppert, Ph.D. for a K23 Mentored Patient Oriented Research Career Development Award at the University of Pennsylvania. The overarching goal of this award is for the applicant to acquire expertise in information processing/cognitive science of anxiety disorders and to translate this knowledge to the treatment of anxiety disorders through an independent program of research funded by NIH. The four-year program discussed in this proposal is designed to accomplish this goal by through five aims: 1) to solidify his foundation in cognitive science and advanced research methods; 2) to establish a research program on cognitive training of social anxiety that will integrate cognitive science and clinical outcome research; 3) to write and publish empirical and theoretical papers about such an integration; 4) to create collaborative relationships with clinical and cognitive science faculty at the University of Pennsylvania as well as other experts in the field; and 5) to prepare for further funding for this programmatic line of research. These aims will be accomplished through a structured four-part plan: 1) to receive further formal instruction in cognitive science, advanced research design, and bioethics; 2) to obtain training and mentoring by a senior scientist experienced in this area (Edna B. Foa, Ph.D.) as well by a collaborator (Andrew M. Mathews, Ph.D.) and consultants (Colin M. MacLeod, Ph.D., Richard G. Heimberg, Ph.D., David M. Clark, Ph.D., and Xin Tu, Ph.D.); 3) to coordinate ongoing clinical research trials at the Center for the Treatment and Study of Anxiety; 4) to design and execute an original program of research. A series of studies examining the factors involved in the modification of interpretation and attentional biases in social anxiety will be conducted. The goal of these investigations is to create a cognitive training program that directly addresses the core biases involved in causing and maintaining social anxiety. First, a new measure of interpretation bias will be developed using contextual priming in order to have a measure that is less likely to be confounded by repeated administration. Simultaneously, the nature of attentional bias in social anxiety will be clarified in order to bring some resolution to conflicting findings in the literature. Then, potential for modifying interpretation bias will be examined. In parallel, parameters related to modifying attentional bias in social anxiety will be examined. In addition, the relationship between cognitive biases and cognitive-behavioral therapy outcome in patients diagnosed with social phobia will be evaluated. Based on these findings, a cognitive training program for social phobia will be developed and will be further evaluated in future research. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COMMUNITY CLINIC TEST OF YOUTH ANXIETY TREATMENT Principal Investigator & Institution: Weisz, John R. Psychology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2001; Project Start 1-SEP-1997; Project End 0-APR-2003 Summary: (Adapted from applicant's abstract): Structured, manualized treatments have been developed for numerous mental health problems and disorders among children and adolescents, and a number of these have shown strong beneficial effects in clinical trials. Such findings have led to proposals that the empirically supported treatments be used to improve outcomes of conventional clinic treatment, which some research suggests may not be very effective. But can these lab-tested treatments actually work in service-oriented clinics with referred youth? Available evidence cannot tell us, because the therapists, conditions, and clientele in the laboratory efficacy tests tend to differ so markedly from those of clinical practice. To assess the clinical potential of efficacy-tested treatments, we need effectiveness research that tests these treatments in the crucible of
Studies 23
clinical practice. To help begin this process, the proposed research focuses on a specific treatment program for a specific cluster of disorders: Kendall's (1994) cognitivebehavioral "Coping Cat" program for child and adolescent anxiety disorders. The program has shown unusually positive effects across a series of clinical trials in the U.S. and Australia, but it has never been tested in real-world clinical conditions. The proposed study will test the effectiveness of the treatment with clinic-referred youth, treated in community clinics, with the treatment carried out by clinic staff therapists. Some 128 youth, aged 9-14, referred for anxiety and diagnosed with anxiety disorders, will be randomly assigned to receive either the usual treatment in the clinic, or the Kendall program, carried out by clinic staff who have been trained to proficiency. Therapists for the two treatment conditions will also be chosen randomly, from a pool of volunteers. Outcome assessment at immediate post-treatment, 1-year, and 2-year follow-ups, will test effects across four domains of the Hoagwood, Jensen, Petti, and Burns (1996) services outcome model: (1) symptoms and diagnosis, (2) functioning, (3) consumer perspectives, and (4) systems (i.e., degree to which treatment reduces further service use). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COMMUNITY SOCIOECONOMIC CONTEXT, DEPRESSION AND ANXIETY Principal Investigator & Institution: Muntaner, Carles; Professor; None; University of Maryland Balt Prof School Baltimore, Md 21201 Timing: Fiscal Year 2002; Project Start 2-MAR-2002; Project End 8-FEB-2004 Summary: (provided by applicant): Socioeconomic position is a key determinant of individual mental health, including depression and anxiety disorders. Depression and anxiety disorders inflict major social and economic burden on families and communities. Recent studies suggest that the community socioeconomic context, in particular its degree of income inequality, contribute to a person's morbidity and mortality, even after individual socioeconomic position has been taken into account; a disturbing finding as income inequality has grown in the US during the last three decades. The proposed analyses will expand this research program on socioeconomic context to include psychiatric disorders. We will examine the relationship between socioeconomic residential context and the prevalence of major depression and anxiety disorders in Baltimore neighborhoods using the Epidemiologic Catchment Area- Follow Up survey sample, and in US counties, using the National Comorbidity Survey sample. In addition to income inequality, we will examine the relationship between alternative contextual socioeconomic indicators at the county and neighborhood levels (i.e., absolute income, poverty and social capital) and major depression and anxiety disorders. This will be the first population-based analysis to examine the association between residential socioeconomic context in relation to the prevalence of depression and anxiety disorders in the US. Our analysis will also make important methodological contributions to the field of psychiatric epidemiology. Socioeconomic context will be measured at the individual, neighborhood (FCA-F) and county (NCS) levels, and we will apply innovative statistical methods that are appropriate for the simultaneous analysis of two levels of data and interactions between contextual and individual-level variables. Testing hypothetical mechanisms that may relate contextual and individual socioeconomic attributes (e.g., age, gender, race/ethnicity, socioeconomic position) will be an area of concentration of this analysis, as it has been overlooked in most multilevel studies to date. The results of these analyses will have implications for local health
24 Anxiety
policy in urban neighborhoods and counties across the US that have the potential to reduce the social costs associated with depression and anxiety disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COMMUNITY VIOLENCE & YOUTH: PREVENTING ANXIETY DISORDERS Principal Investigator & Institution: Cooley-Quille, Michele R. Assistant Professor; Mental Hygiene; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 1-DEC-2001; Project End 0-NOV-2004 Summary: Community violence is a major public health problem most visible in lowincome, inner-city, predominantly ethnic minority communities. The public mental health impact of living in violent communities is significant, particularly for children. Most of the extant treatment and preventive interventions focus on the perpetrators of the violence, not on the youth who are its direct or indirect victims. Among the psychological correlates of community violence exposure are anxiety symptoms (e.g., fears, social withdrawal, intrusive thoughts, poor concentration, worry) and disorders (e.g., post-traumatic stress disorder, separation anxiety disorder). This is a request for a NIMH Pilot Effectiveness Trial for Mental Disorders Grant (R21) to support a 3- year pilot study of a school-based prevention and early intervention program with inner-city, primarily African American children at risk for anxiety disorders. This cognitivebehavioral intervention is based on the FRIENDS Anxiety Prevention Program that has demonstrated efficacy in reducing the rate of anxiety disorders and preventing the onset of new disorders in school samples of Australian children. Maintaining therapeutic integrity, the proposed project will broaden the FRIENDS target population by modifying the intervention to be culturally and contextually appropriate for inner-city ethnic minority youth exposed to community violence. Four-hundred 3rd-5th graders will be screened to identify those at risk for anxiety symptoms and disorders. 180 elementary school students from low-SES, high crime communities will be randomly assigned to either an anxiety prevention and early intervention group or a nonintervention comparison group. Child, parent and teacher assessments will be made at pre- and post- intervention, and 6-month follow-up. This project will contribute to the applicant's goal of studying and preventing the mental health effects of community violence by achieving the following aims: 1) To broaden the target population of an existing efficacious preventive and early intervention program from Australian children to inner-city, low-SES primarily African American children; and 2) To maintain the therapeutic integrity of the modified FRIENDS preventive and early intervention program among children from schools located in inner- city, high crime, low-SES communities. The results of this R21 project will facilitate the design and later implementation of a full-scale NIMH R01 preventive intervention effectiveness trial. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: COMORBID CHILDHOOD ANXIETY AND ASTHMA Principal Investigator & Institution: Goodwin, Renee D. Epidemiology; Columbia University Health Sciences Ogc New York, Ny 10032 Timing: Fiscal Year 2002; Project Start 1-APR-2002; Project End 1-MAR-2007 Summary: (provided by investigator): The applicant is requesting five years of funding through the Mentored Patient-Oriented Research Career Development Award (K23) program to enhance her technical and methodological skills in the investigation of the co-occurrence of anxiety disorders and asthma/allergy in youth. The ultimate goal is to
Studies 25
gain expertise in the relationship between the co-occurrence of anxiety disorders and asthma/allergy and the risk of severe psychopathology among youth, using longitudinal, epidemiologic research methodology and ultimately to identify preventive interventions. The applicant's strong academic background in human development, clinical psychology, and psychiatric epidemiology, and her research experience using a developmental paradigm to study risk for severe psychopathology among individuals with early-onset anxiety disorders provide an excellent foundation for this work. The proposed training goals include (1) further training to increase the applicant's knowledge of the relationship between respiratory pathophysiology and anxiety disorders; (2) advanced statistical training and experience with longitudinal data analysis and survey methods, and; (3) investigation of potential interventions that integrate research on anxiety disorders and asthma/allergy. These goals will all facilitate the applicant's pursuit of innovative, comprehensive, technologically efficient approaches to study these comorbidities in youth. The research plan for this Award is divided into four investigations which complement the proposed sequence of training activities and offer the applicant the opportunity to explore important cross-sectional and longitudinal data from epidemiologic clinical and community samples, as well as hands-on experience, in the first two studies, the applicant will analyze previously collected data (MECA & SED and Dunedin). In the third study, the applicant will collect her own asthma data prospectively (Network study), in an ongoing longitudinal epidemiologic clinical (psychiatric) investigation, while learning how to conduct a study. The fourth investigation will involve developing measures and collecting pilot data on asthma and anxiety in a clinical (medical) sample. The applicant's resulting ROl will address the developmental paradigm described above, which will be further tested and will include early intervention strategies to facilitate the identification and treatment of children who are at risk for severe psychopathology. That study will involve a longitudinal epidemiologic preventive intervention study aimed at reducing the risk of anxiety disorders among pediatric asthma/allergy patients. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COMPUTER BASED EXPOSURE THERAPY FOR SOCIAL ANXIETY Principal Investigator & Institution: Anderson, Page L. Phd; Virtually Better, Inc. 2450 Lawrenceville Hwy, Ste 101 Decatur, Ga 30033 Timing: Fiscal Year 2002; Project Start 0-MAR-2002; Project End 1-MAR-2004 Summary: (provided by applicant) This study will develop and test the feasibility of using virtual reality technology as a part of a computer-based exposure (CBE) self-help program to address public speaking fears. Public speaking anxiety is the most common fear among individuals, affecting up to 57 percent of the general population. Although cognitive-behavioral therapy is an effective treatment for social anxiety, many individuals do not seek treatment. Self-help programs are one popular alternative to psychiatric treatment. Primary goals of Phase I include are to develop a virtual environment for public speaking anxiety that can be used as a part of a CBE self-help program and to determine the effectiveness of CBE as compared to pre-treatment baseline. Ten participants who meet criteria for social phobia with a prominent fear of public speaking will be assessed using standardized measures prior to and following CBE and again at three-month follow-up. Phase II will test the relative efficacy of CBE and a cognitive-behavioral self-help manual for social anxiety versus a waitlist. The long-term objectives include the development of an effective and affordable self-help program utilizing virtual reality, leading to direct commercial access for anxiety sufferers to help them help themselves. PROPOSED COMMERCIAL APPLICATION:
26 Anxiety
The commercial applications include: (1) the sale of PC-based self-help program to individuals suffering with social anxiety, (2) the utilization of the program by therapists as an adjunct to treatment, (3) the training of researchers and therapists in using this technology in therapy. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CONTEXTUAL LEARNING, OPIATE TOLERENCE /ANXIETY PROCESSES Principal Investigator & Institution: Fanselow, Michael S. Professor; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 1-AUG-2002; Project End 1-JUL-2007 Summary: (provided by applicant): Pavlovian context conditioning plays a central role in fear and anxiety, stress-induced analgesia and opioid tolerance. Context-drug associations contribute to drug tolerance, drug-seeking and drug reinforcement. Stressinduced opioid analgesia typically occurs because the stressor has become associated with its context. Finally, the acquisition of context fear is regulated by opioids. Most of the knowledge about the mechanisms and processes of context conditioning come from the area of Pavlovian conditioned context fear. Component VI uses these advances to analyze context-dependent opioid tolerance. We will examine the hippocampal dependence of context-opioid associations in analgesic tolerance using both anatomical and genetic lesions. Additionally, we will determine if already acquired tolerance can be eliminated by manipulations that weaken established memories. Finally, a clear understanding of how specific endogenous opioid receptor types participate in the regulation of fear conditioning can be obtained by using knockout mice. Together, the aims of this section dissect the interactions between opioid systems, anxiety and contextual learning. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: CRF-TYPE-2 RECEPTOR ANTAGONISTS FOR ANXIETY Principal Investigator & Institution: Gogas, Kathleen R. Principle Scientist; Neurocrine Biosciences, Inc. 10555 Science Center Dr San Diego, Ca 92121 Timing: Fiscal Year 2002; Project Start 4-JAN-2002; Project End 3-JUL-2002 Summary: (provided by applicant): Since the CRF2 receptor was cloned in 1995, relatively little has been learned about its functional biology due primarily to the lack of pharmacological tools. Anatomical distribution data had suggested that the CRF2 receptor could be involved in feeding behaviors, which led to the idea that an antagonist to this receptor could have utility in treating eating disorders like anorexia nervosa. Recently, however, a selective peptide antagonist (antisauvagine-30) and agonist (urocortin II) have become available. Preliminary data obtained with antisauvagine-30 and urocortin II verified the importance of the CRF2 receptor in anorectic behavior, but the antisauvagine-30 (ASV-30) data also suggested that the CRF2 receptor may be involved in emotional behavior and anxiety. Thus, the potential therapeutic market for a CRF2 receptor antagonist could include a much broader spectrum of emotional disorders than anorexia nervosa. Therefore, we have proposed to investigate the possibility that the CRF2 receptor plays a role in anxious behavior, using ASV-30 and urocortin II as pharmacological tools. In anticipation of a positive finding, we have also proposed to begin the process of identifying a selective, high affinity, orally available CRF2 antagonist that could be used not only for the treatment of anorexia nervosa, but also for the treatment of anxiety disorders. Therefore, Phase I is focused: 1) on biological
Studies 27
proof of principle for the role of CRF2 receptors in anxiety, and 2) on the initial identification of a high affinity CRF2 antagonist. Phase II would follow up with the actual development of such an antagonist, fine-tuning for selectivity, oral bioavailability and safety. PROPOSED COMMERCIAL APPLICATION: A small molecule CRF2 receptor antagonist could represent an anti?anxiety therapeutic with a novel mechanism of action and the potential to provide an improved efficacy and side effect profile in comparison to available therapeutics. Anxiety disorders are the most common form of mental illness in the United States, with an estimated one year prevalence of 16.4%, and an estimated cost of $993/year/person (USDHHS, et al., 1999). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DEPRESSION AND ANXIETY AS NEURAL CONTROL PROCESSES Principal Investigator & Institution: Tucker, Don M. Ceo/Chief Scientist; Electrical Geodesics, Inc. 1850 Millrace Dr, Ste 3 Eugene, or 97403 Timing: Fiscal Year 2002; Project Start 1-SEP-1989; Project End 1-JUL-2007 Summary: (provided by applicant): Clinically significant states of depression and anxiety may be associated with negative biases in cognition and judgment. Previous studies have suggested that normal mood states may also produce mood-congruent cognitive biases. We theorize that the mood states of depression and anxiety are mechanisms through which the brain regulates its arousal, hedonic expectancy, and attention. By examining dense array event-related brain potential (ERP) measures as subjects evaluate daily life events, we observed evidence that mood-congruent expectancies can be observed as early as 300 ms into the evaluation process. Additional research has shown that, in addition to the widespread ERP effects of language manipulations, there are focal electrical changes over medial frontal cortex reflecting general attentional mechanisms, such as when subjects orient to a novel event or detect they have made an error. Because these medial frontal effects appear to reflect activity in the limbic cortex at the base of frontal motor pathways, a reasonable hypothesis is that emotionally significant evaluative decisions will also engage medial frontal activity. Recordings as subjects rated themselves with trait adjectives confirmed that the initial discrimination between good and bad traits was observed in medial frontal cortex, substantially before more widespread (P300/N400) effects were seen. These findings suggest that systematic experiments may clarify the self-regulatory functions of the limbic regions of the frontal lobe. These frontolimbic networks are implicated in depression and anxiety by both lesion and neuroimaging evidence. For the next project period, we propose a research program that will integrate the findings on moodcongruent cognitive biases with the findings on frontal lobe mechanisms of selfmonitoring. By coupling advanced measures of brain electrical responses with systematic psychological experiments, we may be able to clarify the normal mechanisms of affective self-regulation that may become exaggerated in mood disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: TREATMENTS
DEPRESSION
AND
ANXIETY--REFINING
EFFICACIOUS
Principal Investigator & Institution: Moras, Karla K. Assistant Professor; Psychiatry; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104 Timing: Fiscal Year 2001; Project Start 5-JUL-1997; Project End 0-JUN-2002 Summary: An Independent Scientist Award is sought to enable the applicant to devote major effort to mental health treatment research, specifically to the identification,
28 Anxiety
development, and refinement of efficacious and efficient treatments for the most common presenting problems of adult outpatients (e.g, depression, comorbid anxiety and depression, interpersonal problems). The award also is sought to augment the applicant's expertise in treatment research with training in mental health services research, cost-effectiveness evaluation, and advanced statistical techniques. The specific research aim f the award is to conduct two treatment development projects, each on a patient group that is poorly or incompletely responsive to existing treatments that have been found to be efficacious for patients with similar disorders and symptoms. One group is referred to as having "drug resistant depression" (DRD), the other group has a specific pattern of DSM-IV Anxiety and Mood Disorder comorbidity. The ultimate aim of the DRD work is to develop an effective combined cognitive therapy (CT) + drug treatment for DRD. Three immediate aims are to: (1) Extend CT to the treatment of DRD by integrating three existing forms of CT: CT for depression, CT for personality disorders, and CT for anxiety disorders; (2) develop a treatment manual for conducting CT + drug treatment that will optimize the efficacy of combined treatment for DRD, and (3) obtain outpatient pilot outcome data on the combined CT + drug treatment to determine if it merits further investigation in a controlled clinical trial. The second project extends the applicant's prior developmental research on a psychotherapy that integrates cognitive-behavioral anxiety control techniques (ACT) with Interpersonal Psychotherapy for Depression (IPT) for patients with DSM-IV Generalized Anxiety Disorder (GAD) and an independent Major Depressive Episode (MDE). Two central aims are to: (1) Evaluate the effects of two alternative strategies for sequencing the components of ACT + IPT on symptoms of anxiety and depression, and (2) obtain pilot data on ACT + IPT to compare with outcomes of diagnostically and symptomatically matched patients who receive CT at the University of Pennsylvania Center for Cognitive Therapy to evaluate the treatment's potential to have enhanced benefit for GAD + MDE, compared to existing standard treatments. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DEVELOPMENT OF A DISORDER-INDEPENDANT ANXIETY TREATMENT Principal Investigator & Institution: Norton, Peter J. Psychology; University of Nebraska Lincoln 14Th and R Sts Lincoln, Ne 68588 Timing: Fiscal Year 2001; Project Start 7-SEP-2001 Summary: (provided by applicant): This project will involve the development and preliminary empirical evaluation of a highly efficient cognitive-behavioral group treatment to address the core common features of anxiety-related disorders (Anxiety Treatment Protocol or ATP). Nearly one in four Americans experience an anxiety disorder during their lifetime with an annual cost of $42 billion per year in the U.S. Fortunately, effective treatments are available and a substantial proportion of the economic impact of anxiety disorders is avoidable through proper diagnosis and treatment. Although numerous empirically supported psychosocial and pharmacological approaches exist for the treatment of anxiety disorders, many individuals do not receive these treatments. A primary barrier to receiving the best psychosocial treatments is the lack of availability. This project will decrease the time and costs to learn new interventions, and is one strategy that is likely to overcome mental health providers? resistance to the adoption of empirically supported treatments. Recent reconceptualizations of anxiety-related disorders emphasize the shared commonalities among the anxiety disorders, rather than emphasizing the differences between the disorders. This theoretical work and a review of the empirically supported disorder-
Studies 29
specific interventions will guide the development of a broad-spectrum group intervention in which individuals with a variety of anxiety disorders will be treated together. The project has two phases - (1) development of the treatment protocol, and (2) initial open trial with pretreatment/posttreatment assessment followed by protocol revisions. The development of a broad-spectrum intervention has several advantages including: (1) improved dissemination as this intervention will be more cost-effective than learning separate treatment protocols for each anxiety disorder; (2) reduced costs to consumers by using a group modality; (3) matching an intervention strategy to the most recent theoretical work in anxiety; and (4) simplifying treatment for individuals with multiple anxiety disorders (up to 60 percent of cases). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DEVELOPMENTAL PRESCHOOLERS
EPIDEMIOLOGY
OF
ANXIETY
IN
Principal Investigator & Institution: Egger, Helen L. Psychiatry; Duke University Durham, Nc 27706 Timing: Fiscal Year 2001; Project Start 6-JAN-2001; Project End 1-DEC-2005 Summary: The purpose of this Mentored Patient-Oriented Research Career Development Award (K23) is to enable the candidate, a child psychiatrist, to became an independent research investigating the development pathways and causes of anxiety disorders in preschool children. The research goal is to place preschoolers' anxiety symptoms and disorders within the framework of developmental epidemiology by focusing on two questions: 1. What are the age-specific presentations of anxiety disorders in children ages 2 to 5 years old? (Nosology) 2. What are the relative contributions of genes and environment and their interaction in the early development of anxiety disorders? (etiology). This application details a program of training in infant/young child psychiatry, in behavioral and statistical genetics with an introduction to molecular genetics and genomics, and advanced training in pediatric anxiety disorders. The candidate is based in the Center for Developmental Epidemiology, Duke University Medical Center. Sponsors are child psychiatrists Adrian Angold MRCPsych (developmental psychopathology and measure development), Robert Emde MD, and Charles Zeanah MH (infant/young child psychiatry and assessment of young children), and John March MD (anxiety disorders). Lindon Eaves PhD, a leading behavioral geneticist, will provide mentoring in this area. The research plan includes: 1. A detailed review of current instrumentation for assessing preschool anxiety. 2. A pilot study of 60 children aged 36-72 months, using a multi-informant assessment protocol. DSM-IV and DC:0-3 diagnoses and symptoms will be assessed using the Preschool Age Psychiatric Assessment (PAPA), a structured parent interview developed by the candidate. 3. Analysis of data on 15,500 2-5 year-old twin pairs to examine the contributions of genes and shared and non-shared environmental factors to young children's anxiety symptoms. 4. Submission of an R01 application for a longitudinal, genetically-informed study of the development of anxiety disorders in preschool children. This work will make important contributions to the development of prevention and treatment interventions for young children and will contribute to our understanding of the etiology of childhood psychopathology. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: EARLY DEVELOPMENTAL PATHWAYS OF CHILDHOOD ANXIETY Principal Investigator & Institution: Warren, Susan L. Assistant Professor; Psychiatry and Behavioral Scis; George Washington University 2121 I St Nw Washington, Dc 20052
30 Anxiety
Timing: Fiscal Year 2001; Project Start 1-JUL-1998; Project End 0-JUN-2003 Summary: (Adapted from applicant's abstract): The long-term aim of this Mentored Clinical Scientist Award is to train the candidate to become an independent investigator, conducting studies in the development of anxiety disorders in children and adolescence. The candidate will obtain didactic training in developmental physiology and neurobiology, statistics, and research design at the University of Minnesota. Mentors include L. Alan Sroufe, Ph.D. (primary mentor), Jerome Kagan, Ph.D. (temperament), Megan Gunnar, Ph.D. (physiology), Charles Nelson, Ph.D. (neurobiology), Gail Bernstien, M.D. (childhood anxiety disorders), M. Katherine Shear, M.D. (adult anxiety disorders) and Robert Cudek, Ph.D. (statistics). The premise of the research is that anxiety disorders develop as the result of genetic influences, infant reactivity or temperament and physiology, in combination with particular interpersonal relationship experiences. A "developmental pathways" research strategy will be used with the examination of intermediate outcome markers or precursors to anxiety disorders (behavioral inhibition and anxious/resistant attachment). Because children of mothers with panic disorder and agoraphobia (PDAG) are more likely to develop anxiety disorders than children of mothers without psychopathology, infants of mothers with PDAG and controls will be studied to increment the likelihood of anxiety disorder precursors. Sixty-five women with PDAG and sixty-five women without any psychopathology will be recruited during their third trimester of pregnancy. Infant reactivity, temperament, physiology and mother-infant relationships will be studied longitudinally from birth to 14 months of age to determine the relative importance and interaction of these factors. Because intervention efforts can most easily be focused on parent-child relationships, this research will also seek to clarify which types of parentchild interactions promote behavioral inhibition and ultimately childhood anxiety disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: EFFECTS OF ANXIETY ON INTERHEMISPHERIC PROCESSING Principal Investigator & Institution: Compton, Rebecca J. Psychology; Haverford College Haverford, Pa 19041 Timing: Fiscal Year 2001; Project Start 1-SEP-2001; Project End 1-AUG-2004 Summary: (provided by investigator): Individuals with high levels of anxiety are known to exhibit cognitive processing abnormalities, such as heightened attention to potentially threatening information. Such processing abnormalities contribute to the pernicious thought patterns that can prolong clinical disorders. Yet, despite recent research describing attentional deficits in anxiety, little is currently known about the neural mechanisms contributing to these deficits. The present investigation examines the effects of anxiety on interhemispheric processing, a paradigmatic brain system for investigating selective attention. Prior research has demonstrated that interhemispheric processing, the division of relevant perceptual information between the left and right hemispheres, increases the cognitive capacity available for task performance and can aid in filtering out distracting, irrelevant information. Though many studies have investigated the interhemispheric processing of cognitive and perceptual information, virtually none have investigated the interhemispheric processing of emotional information. The present study is designed to meet three specific objectives: (1) the development of a measure of the interhemispheric transfer of emotional information; (2) examination of the effects of trait anxiety on interhemispheric transfer of emotional information; and (3) examination of the effects of evaluation stress on interhemispheric transfer of emotional information. The hypotheses to be tested are first, that trait-
Studies 31
anxious individuals are deficient overall in their utilization of interhemispheric resources; and second, that failure to suppress task-irrelevant threatening information from being communicated between the hemispheres is a characteristic of both trait anxiety and evaluation stress. Together, the three stages of the project integrate cognitive and neuropsychological approaches to emotion to advance knowledge regarding the effects of anxiety on processing of emotional information in the brain. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: EFFECTS OF HYDROTHERAPY ON ANXIETY AND PAIN IN LABOR Principal Investigator & Institution: Benfield, Rebecca D. Parent-Child Nursing; East Carolina University 1000 E 5Th St Greenville, Nc 27858 Timing: Fiscal Year 2003; Project Start 1-AUG-2003; Project End 1-JUL-2006 Summary: (provided by applicant): The candidate's long-term goals include: 1) testing and refining two theoretical models to explain the psychophysiological effects of anxiety and pain in labor and the effectiveness of hydrotherapy, and 2) gaining consultation and collaboration with other researchers and students using physiological measurement techniques in the laboratory and clinical settings. Immediate goals are to increase knowledge and skill in: (1) physiology, including general, neural/hormonal, and immersion; (2) physiological instrumentation, including radioimmunoassay (RIA), immunoenzymatic assay (EIA), high performance liquid chromatography (HPLC) and electromyography (EMG); (3) statistics, both general and repeated measures; and (4) professional growth, including preparation of manuscripts and grants, with the goal of becoming an independent scientist. The effects of intervention with hydrotherapy in labor are poorly understood though use has escalated. The proposed study will focus on the psychophysiological effects of hydrotherapy during labor and the physiological indicators of sympathetic nervous system and adrenocortical inhibition associated with immersion and the relaxation response. Using a repeated measures correlational design, data will be gathered from 15 healthy patients, immersed to the xiphoid in 37 degrees C water for 1 hour. Data will be collected prior to and at 15 and 45 minutes of hydrotherapy. Visual analogue scales (VAS) will measure anxiety and pain; physiological measures will include plasma catecholamines, cortisol, beta endorphin, oxytocin, plasma volume shift, and uterine contractility, and will be analyzed using HPLC, EIA, RIA, hemoglobin (HGB) and hematocrit (HCT), and abdominal EMG respectively. Statistical analyses will include a one-way within-subjects analysis of variance and Pearson r technique. While these physiological measures, excluding plasma volume shift, have not been previously used to study hydrotherapy in labor, it is anticipated that post intervention measures will reflect a decrease in parturient anxiety and pain, as will subjective measures. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: EFFECTS OF PARENTAL BEHAVIOR ON CHILD ANXIETY REGULATION Principal Investigator & Institution: Wood, Jeffrey J. Psychology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2001; Project Start 4-SEP-2001 Summary: (provided by applicant): Does parental communication style affect emotion regulation among children who initially exhibit high levels of fear and anxiety? Although recent correlational research has demonstrated a linkage between parental communication behaviors, such as excessive catastrophizing, and children?s
32 Anxiety
manifestations of fear and anxiety, it is not clear if parental communication behaviors directly influence children?s ability to regulate these emotions. Intervention studies can test whether experimentally manipulating current family interaction patterns affects children?s ability to regulate fear and anxiety. The proposed research will provide a preliminary experimental test of the relationship between parental communication behavior and children?s regulation of anxiety. Some 40 clinically anxious youth, aged 713, will be randomly assigned to a family intervention program for childhood anxiety problems, which includes extensive parent communication training, or a child intervention program without parent-training. The relative impact of the family intervention program versus the child intervention program for improving parental communication behaviors -- such as catastrophizing -- will be evaluated. Then, the impact of changes in parental communication behaviors on children?s ability to regulate fear and anxiety will be tested. Observed parenting and child anxiety as well as physiological arousal will serve as primary outcome measures. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: EMOTIONAL SUPPRESSION AND ANXIETY SENSITIVITY Principal Investigator & Institution: Feldner, Matthew T. Psychology; University of Vermont & St Agric College 340 Waterman Building Burlington, Vt 05405 Timing: Fiscal Year 2002; Project Start 6-AUG-2002 Summary: (provided by applicant): A 2 [group: high Anxiety Sensitivity Index (ASI), low ASI] X 2 (condition: inhibition, experimental control) mixed model research design will be employed with one, prolonged administration of 10% CO2. Participants will be non-clinical persons selected on the basis of their ASI scores with half scoring one standard deviation above and half below the mean of the standardization sample. Dependent measures will include self-rated anxiety and bodily distress, interpretative biases for threat information, and physiological indices of autonomic arousal. It is expected individuals high in Anxiety Sensitivity (AS) will experience greater negative emotional consequences in the inhibition condition relative to low AS individuals. We also expect response inhibition to increase interpretative biases for threat-related information, particularly within the group high in AS. The proposed study represents the first experimental test of the emotional and cognitive consequences of response inhibition in a panic-relevant paradigm, which holds direct implications for understanding the role of emotion regulation processes in the onset and maintenance of anxious and fearful responding to bodily perturbation. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: ESTROGEN EFFECTS ON ANXIETY RELATED NEURAL SYSTEMS Principal Investigator & Institution: Altemus, Margaret; Associate Professor; Psychiatry; Weill Medical College of Cornell Univ New York, Ny 10021 Timing: Fiscal Year 2001; Project Start 1-SEP-2000; Project End 1-JUL-2005 Summary: (Adapted from the Investigator's Abstract) This Mentored Clinical Scientist Development Award, a program of research and career development, is proposed to establish a foundation for future independent research in behavioral neuroscience, with a focus on reproductive hormones and emotional regulation. The research component of the proposal is a series of studies investigating the hypothesis that estrogen restrains fear associated behaviors. Clinical data indicates that reproductive hormones fluxes have profound effects on the course of anxiety disorders and depression, but the neurobiological determinants of these clinical observations are not well understood. The
Studies 33
specific aims of the research plan are to: 1) study the effects of estrogen on a battery of behavioral tests of anxiety; 2) examine the effects of estrogen on glucocorticoid and stress induced enhancement of fear behaviors; 3) examine the effects of estrogen on extrahypothalamic CRH and glucocorticoid receptors, a neuroendocrine system known to modulate fear and anxiety and 4) define the anatomic sites of estrogen action on fear behaviors. Fear associated neural circuits involving the amygsala, bed nucleus of the stria terminalis, and medial prefrontal cortex will be studied using local administration of estrogen and estrogen antagonists. The training portion of this proposal consists of basic neuroscience coursework and seminars as well as hands-on instruction in behavioral analysis and functional neuroanatomic techniques. Studies of the effects of estrogen on anxiety related neural systems provides an opportunity for the investigator to expand her area of expertise from clinical neuroendocrinology and clinical psychiatry to behavioral neuroscience where the effects of hormones on brain function can be studied more directly. This field of investigation is likely to improve understanding and treatment of anxiety and affective disorders, both of which are widely prevalent, chronic public health problems. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ETHANOL & ANXIETY: FEARFUL ADAPTATIONS IN THE AMYGDALA Principal Investigator & Institution: Mccool, Brian A. Medical Pharmacology & Toxicology; Texas A&M University Health Science Ctr College Station, Tx 77843 Timing: Fiscal Year 2001; Project Start 1-JUN-2001; Project End 1-MAY-2004 Summary: APPLICANT'S ABSTRACT: Ethanol's modulation of anxiety is a significant contributing factor to the abuse of this drug. For example, the punishment of withdrawal following chronic ethanol ingestion may help perpetuate abuse by the alcoholic individual. This intimate association between ethanol and anxiety is found in several species; and, the neural circuitry regulating fear and anxiety behaviors is also well conserved. Classic fear-conditional approaches have implicated the amygdala, a limbic forebrain area, as playing a pivotal role in the acquisition and expression of fear/anxiety behaviors. The amygdala is therefore a likely target for anxiety-related neuro-adaptive processes elicited by chronic ethanol abuse. Importantly, preliminary data suggests that chronic ethanol exposure causes facilitation of N-methyl-D-aspartate (NMDA) receptor function in dissociated amygdala neurons. Because amygdala NMDA receptors play an important role in fear-conditioned learning, we hypothesize that ethanol-induced adaptation in NMDA receptor function may result in an ethanoldependent, 'chemical' conditioning of this brain region. This hypothesis will be tested by two specific aims. Specific Aim #1 will characterize the effects of chronic ethanol exposure on NMDA receptors in dissociated amygdala neurons using whole-cell patch clamp electrophysiology combined with single-cell reverse transcription/polymerase chain reaction. These studies will provide cellular and molecular insight into the mechanism of chronic ethanol-induced alterations in NMDA receptor physiology. Specific Aim #2 will determine the neurophysiologic consequences of increased NMDAdependent synaptic plasticity within the amygdala to directly address chemical conditioning by chronic ethanol. This proposal provides a unique opportunity to examine the influences of chronic ethanol exposure on the molecular, cellular, and physiologic characteristics within the amygdala's fear/anxiety circuit. The proposed studies will also advance our knowledge of the fundamental neural mechanisms regulating ethanol abuse. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
34 Anxiety
•
Project Title: ETIOLOGIC CONNECTIONS OF AFFECTIVE AND ANXIETY DISORDERS Principal Investigator & Institution: Mackinnon, Dean F. Psychiatry and Behavioral Scis; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 7-AUG-2002; Project End 1-JUL-2007 Summary: (provided by applicant): Affective disorder are common, severe, recurrent, heterogeneous psycniatric diseases with an elusive pathophysiology. Their clinical and etiological complexity may obscure efforts to uncover mechanisms and tc discover therapeutic agents against those mechanisms. One common clinical feature that heightens complexity is comorbid anxiety. Combined anxiety and affective disorder syndromes exacerbate functional morbidity and suffering of patients, but may also present an opportunity to discover shared etiologic factors The candidate for this career development award is an academic psychiatrist at a teaching hospital with a strong historical commitment to medical research. The candidate has already established a reputation as a clinical specialist in affective disorders and has a research background in the genetics of affective disorder; by the end of the award period he plans to have established firmly a clinical and research direction aimed a comorbid anxiety and affective disorders, with fluency in psychophysiological methods. The award will facilitate this process by providing the time and resources to pursue further training in psychophysiology, neuroscience, and genetics. The starting points for the proposed research are 1) epidemiological findings that bipolar and panic disorders commonly occur together (comorbid risk), 2) symptom provocation studies ir panic disorder that reveal latent panic vulnerability in relatives of panic disorder patients (familial risk), and 3 family study results that show both familial and comorbid risk for panic disorder. The research program proposed here will address further questions about the relationship of panic and bipolar disorders by the use of carbon dioxide inhalation to provoke panic symptoms in study subjects ascertained for genetic linkage study of bipolar disorder. Risk of panic response to carbon dioxide in subjects without prior panic disorder will be analyzed as a function of familial and comorbid risk (as compared to the risk in positive and negative control subjects). If there is a specific genetic risk factor for both bipolar and panic disorder in a subset of families, then familial and comorbid risk will interact to produce higher risk of provoked panic than will either risk factor alone. Results of this work will then be applied to ongoing genetic studies of bipolar disorder, and will inform the candidate's further research into affective and anxiety disorder etiology. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: FAMILY BASED PREVENTION FOR CHILDHOOD ANXIETY Principal Investigator & Institution: Ginsburg, Golda S. Psychiatry and Behavioral Scis; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 5-MAR-2002; Project End 8-FEB-2007 Summary: The candidate proposes to use a mentored support period of five years for developing an expertise in child prevention intervention research. The grant will support training, course work, mentored relationships, empirical research, and other career development activities. The majority of this training will occur at JHU Schools of Medicine and Public Health. The following objectives will be achieved: 1) develop a theoretical, conceptual, and methodological understanding of child mental health preventive interventions; 2) learn biostatistical skills needed to analyze and interpret data from longitudinal prevention studies, 3) analyze an epidemiological longitudinal
Studies 35
data set, 4) design, implement, and evaluate a family-based prevention intervention for child anxiety, and 5) disseminate findings from above research and develop an intervention grant proposal. The primary research vehicle for achieving these objectives involve two related prevention studies. The specific aim of Study 1 is to examine the concurrent and long term impact of parental anxiety on children's development and functioning using an existing seven year longitudinal data set from an epidemiological sample of youth. The specific aim of Study 2 is to conduct a controlled pilot evaluation of a family-based prevention intervention for reducing current levels of anxiety and preventing the onset of anxiety disorders in the offspring of anxious parents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: FAMILY INTERACTION AND SOCIAL ANXIETY IN CHILDREN Principal Investigator & Institution: Morris, Tracy L. Associate Professor; Psychology; West Virginia University P. O. Box 6845 Morgantown, Wv 265066845 Timing: Fiscal Year 2001; Project Start 3-AUG-2001; Project End 1-JUL-2003 Summary: (provided by applicant): Understanding of the clinical manifestations of social anxiety in adult populations has increased dramatically in recent years. However, empirical data on the etiology and course of social anxiety in children is quite limited. Empirical investigation of potential pathways leading to the development of social anxiety will assist in the identification of children at risk for social phobia and may enhance efforts toward the development of early intervention or prevention programs. The primary aim of the study is the identification of differential styles of parent-child interaction associated with social anxiety, generalized anxiety, and depression. Participants will be recruited from siblings of participants in an ongoing longitudinal investigation being conducted by the principal investigator. Ninety-six children (aged 912) and their parents will serve as the sample for the proposed investigation. Participants will complete questionnaire symptom report measures, a diagnostic interview, and will participate in a series of laboratory tasks. The first task is actually an unstructured observation in which family members are left alone in a room for 5 minutes. Behavior will be videotaped and later coded for frequency of anxious verbalizations (e.g., comments about being observed, worry about performance). For the second task, families will discuss three hypothetical social scenarios (e.g., try-outs for the school play coming up next week)). Responses to scenarios will be coded for interpretation (threat v. no threat); proposed action of child (prosocial, avoidant, aggressive) and parents' support of child's proposed action. For the final task, children and their parents will work together to create two origami figures. Interactions will be videotaped for later coding. Coded interaction behaviors include such actions as praise, criticism, physical takeover, etc. Behaviors will be coded in 10-second intervals. Data will be analyzed primarily through a series of multiple regression procedures. Higher rates of anxious verbalizations during the unstructured observation are expected to be associated with higher levels of self-reported social anxiety. With respect to questionnaire data, parental encouragement of isolation is expected to emerge as the primary predictor of social anxiety, but not a significant predictor of general anxiety or depression. For the scenario discussion data, interpretation of threat is expected to be the primary predictor of child social anxiety, moderated by parental support. The origami interaction task data, will be analyzed with respect to whether aversive parenting strategies have any unique association with specific child symptoms or are merely associated with general negative outcome. For all analyses, potential interactions between parent- and child-gender will be explored. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
36 Anxiety
•
Project Title: FEAR AND THE ANXIETY DISORDERS: BRAIN AND BEHAVIOR Principal Investigator & Institution: Lang, Peter J. Graduate Research Professor; Clinical & Health Psychology; University of Florida Gainesville, Fl 32611 Timing: Fiscal Year 2001; Project Start 1-JUL-1982; Project End 0-APR-2003 Summary: (Applicant's Abstract): The plan of experiments emphasizes basic research on emotion as a framework for comparative clinical studies of phobic and anxious patients. The guiding theory of emotion is derived from animal research on functional brain activity in states of appetitive and defensive motivation. Work by Davis, LeDoux, Fanselow and others has defined a subcortical fear circuit, including the sensory thalamus, amygdala, and periaqueductal central gray. The startle reflex, and autonomic reactivity, are augmented in fearful animals, and this effect depends on an intact fear circuit (e.g., lesions of the amygdala eliminate potentiation). Research conducted on this project has demonstrated a parallel startle potentiation and autonomic change in human beings in fear conditioning, fear imagery, and while attending to unpleasant pictures and auditory stimulation. Exaggerated startle reactions also characterized specific anxiety diagnoses, and may vary with generality of psychopathology. The new basic research examines conical and subcortical reactivity (including brain sites of the animal model) in humans, using both scalp and subdural electrophysiological recording and functional magnetic resonance imaging to determine if fearful and aversive stimuli occasion hypothesized regional patterns of brain activity. Standardized picture stimuli (IAPS) and text evoked imagery, shown to reliably produce emotion related ANS and reflex responses, are presented to subjects in the magnet to determine if there are regional blood oxygen level differences between neutral, pleasant, and aversive stimuli, and how these effects are modulated by arousal. A parallel set of experiments will utilize the EEG to examine cortical responses (ERP and slow-wave) to these same stimuli. Subsequent EEG and fMRI studies will examine phobic subjects (volunteers selected from the normal population) while they view pictures of and/or mentally image, phobic and non-phobic objects. The new clinical research effort includes major anxiety patient assessment studies, using mental imagery and picture paradigms, and multi-measure psychophysiological recording. Comparative analyses are made among anxiety disorders. The sample includes simple and social phobia, panic, post-traumatic stress, obsessive- compulsive, and generalized anxiety disorders. It is planned that the new neural imaging techniques will be added to this clinical protocol, as procedures develop in the basic studies. Goals of the project are to sharpen psychophysiological distinctions between fear (as in phobia), a phasic defensive reaction to a specific stimulus, and anxiety (as in GAD), a more persistent tonic defensive set with components of inhibition and depression. and furthermore, to evaluate memorial, cognitive style, and temperament differences among anxiety disorders, to sharpen differential diagnosis and assess the significance of depressive co-morbidity. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: FLUVOXAMINE IN CHILDREN & ADOLESCENTS WITH ANXIETY DISORDERS Principal Investigator & Institution: Scahill, Lawrence D. Associate Professor; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2002; Project Start 1-JUL-2002; Project End 0-JUN-2007 Summary: The long-term goal of this project is to develop new and better treatments for children and adolescents with autism and related disorders. To this end, we plan to evaluate both pharmacological and psychosocial interventions to reduce target
Studies 37
behavioral problems and/or core symptoms of autism. Another long-term goal is identify biological predictors (e.g., specific genotypes) of treatment outcome. The third long-term goal is to develop better outcome measures in order to improve the precision of assessing treatment effects. The first aim of the current project is to compare low dose fluvoxamine to placebo in children and adolescents with pervasive developmental disorders (PDDs) accompanied by prominent anxiety symptoms. This drug was recently shown to be effective in the treatment of typically developing children with anxiety, but has not been well studied in children with PDD. Exploratory aims include: to examine the effect of fluvoxamine on social functioning in children and adolescents with PDD and anxiety symptoms; to examine the relationships between fluvoxamine level, extent of transporter blockade and clinical response (therapeutic effects and adverse effects such as behavioral activation); to examine the relationship between serotonin transporter genotypes and treatment response; to examine the distribution of anxiety symptoms in a large sample of children and adolescents with higher functioning forms of PDD and compare to normative data in typically developing children. Sixty subjects with PDD and an anxiety disorder will be recruited (30 per group) over a 4 1/2 year period (approximately 1 per month) and randomly assigned to low dose fluvoxamine or placebo for 8 weeks. Placebo non-responders will be offered open-label treatment after the double-blind phase. The primary outcome measure will be the Pediatric Anxiety Rating Scale scored by a blinded clinician. All subjects will be genotyped in order to evaluate the association between the serotonin transporter and clinical response. To address Aim # 5, we will survey 100-200 children between the ages of 10 and 18 years with higher functioning forms of PDD with 2 commonly used childhood anxiety questionnaires. These subjects will be ascertained from other projects in this Center and from ongoing projects here at Yale. Aims #1-4 will be accomplished by a randomized, double-blind, placebo-controlled trial of parallel groups. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: FLUVOXAMINE TREATMENT OF ANXIETY DISORDERS IN CHILDREN AND ADOLESCENTS Principal Investigator & Institution: Riddle, Mark A. Professor and Director; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2001 Summary: Although anxiety disorders are relatively common in children & adolescents, there are no controlled studies that have demonstrated efficacy of any treatment, either pharmacologic or psychosocial, for children & adolescents with anxiety disorders. Fluvoxamine is an SSRI that is marketed in the US for the treatment of obsessive compulsive disorder (OCD) in adults. Fluvoxamine has been used extensively throughout the world to treat a variety of anxiety & mood disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: FUNCTIONAL NEUROIMAGING IN ANXIETY AND FEAR Principal Investigator & Institution: Nitschke, Jack B. Psychology; University of Wisconsin Madison 750 University Ave Madison, Wi 53706 Timing: Fiscal Year 2002; Project Start 3-SEP-2002; Project End 1-AUG-2007 Summary: (provided by applicant) With a background in electrophysiological and neuropsychological measures for the study of anxiety, fear, and depression, the candidate is now actively moving into functional neuroimaging of these affective phenomena. Thus, the training plan focuses on functional neuroanatomy and fMRI
38 Anxiety
methodology. The immediate objective of neurobiologically distinguishing anticipatory and reactivity processes in anxiety put forward in this proposal is in direct service of his long-term goals of using neuroscience research to inform the conceptualization of anxiety, fear, and depression pathology and to contribute to the mitigation of the suffering and social liability associated with such psychopathology. A continuing dilemma in the field is the ambiguous use of constructs such as anxiety and fear. Anxiety is often employed as a unitary construct encompassing a variety of affective phenomena, including worry, fear, phobias, obsessions, and post-traumatic stress. Rather than to defend a particular definition on logical grounds, this proposal attempts to isolate anticipatory and reactivity processes as constituent subcomponents of anxiety that are firmly rooted in experimental operationalization. The 4 proposed fMRT Experiments are designed to interrogate the neural circuitry governing the anticipation of and reactivity to aversive and phobic pictures, including 4 target structures: ventral anterior cingulate cortex (ACC), orbital frontal cortex (OFC), medial prefrontal cortex (PFC), and insula. The ventral ACC is hypothesized to be relatively specific to anticipation of negative future outcomes, due to its involvement in response conflict. Based on their respective roles in the regulation, evaluation, and autonomic control of emotion, different areas of the medial PFC, OFC, and insula are hypothesized to be activated during anticipation of and reactivity to aversive/phobic stimuli. Replication of amygdala activation to the pictures is also expected, but the focus here is on the 4 less studied structures of this circuitry. In particular, the proposed research will attempt to fill in two gaps in existing knowledge: 1) the circuitry governing anticipation of aversive pictures and 2) the impact of anxiety disorders on brain structures mediating the anticipation of aversive and phobic stimuli. The research facilities available in this laboratory and the stimulation provided by faculty, scientists, postdoctoral fellows, students, and staff are ideally suited for the proposed studies and the candidate?s development. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: GENETIC STUDIES OF CHILDREN/ADOLESCENTS WITH ANXIETY DISORDERS Principal Investigator & Institution: Labellarte, Michael;; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2001 Summary: Anxiety disorders are relatively frequent in the pediatric population and are responsible for significant morbidity. We are currently conducting a clinical trial of fluvoxamine treatment of childhood and adolescent-onset anxiety disorders, specifically separation anxiety disorder, generalized anxiety disorder, and social phobia. This study is an opportunity to utilize a molecular genetic research design to study the genetics of anxiety in a pediatric population. This proposed study will examine three primary associations: 1) the presence of childhood-onset anxiety disorders and serotonin (5HT) related candidate genes, 2) temperament and 5HT related genes, and 3) response of childhood anxiety to treatment with fluvoxamine and 5HT related genes. Identification of specific genetic factors may lead to advanced prevantative and treatment strategies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: GENETICS OF FEAR AND ANXIETY DISORDERS Principal Investigator & Institution: Hettema, John M. Assistant Professor of Psychiatry; Psychiatry; Virginia Commonwealth University Richmond, Va 232980568
Studies 39
Timing: Fiscal Year 2002; Project Start 7-AUG-2002; Project End 1-JUL-2007 Summary: (provided by applicant): This K08 Mentored Clinical Scientist Development Award proposes to provide advanced research training in the genetics of fear and anxiety disorders for Dr. John M. Hettema, M.D., Ph.D. Dr. Kenneth S. Kendler, M.D., a world renowned researcher in psychiatric genetics, will serve as Dr. Hettema's primary sponsor. The training will take place at the Virginia Institute for Psychiatric and Behavioral Genetics of Virginia Commonwealth University, which provides a rich, stimulating environment for the conduct of training and research. Dr. Hettema proposes to receive training in epidemiology, statistical and molecular genetics, and experimental methods for measuring anxiety-related traits, including psychophysiology and neuroimaging. Specific research objectives include i) examining the stability, reliability, and heritability of self-report measures in anxiety disorders using a longitudinal design; ii) determine the extent to which the high comorbidity observed between the anxiety disorders is determined by genetic and environmental factors shared between them, including specific individual risk factors such as gender, early enviroment, stressful life events, etc. iii) determine the genetic correlations between neuroticism and the anxiety disorders and the causal relations between them; iv) elucidate the genetic and environmental factors underlying the increased risk for major depression caused by preexisting anxiety disorders and what effects gender has on this relationship; v) understand the genetic structure of fear conditioning in humans and to what extent this is shared with phobias. In addition, Dr. Hettema intends to apply knowledge gained in training to design pilot studies that incorporate experimentally derived anxiety-related measures from a genetically informative sample of twins from the Virginia Twin Registry, combining this data with the existing database of self-report anxiety measures. This research training plan will allow Dr. Hettema to emerge at the end of the proposal period as an independent researcher in the genetics of anxiety disorders, seeking to extend this work further by combining self-report and experimentally derived anxietyrelated measures with linkage and association studies to identify genetic loci and brain mechanisms involved in the anxiety disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: GUT TO BRAIN PATHWAYS FOR INFECTION-INDUCED ANXIETY Principal Investigator & Institution: Lyte, Mark; Professor; Minneapolis Medical Research Fdn, Inc. 600 Hfa Bldg Minneapolis, Mn 55404 Timing: Fiscal Year 2002; Project Start 1-APR-1994; Project End 0-JUN-2006 Summary: (provided by applicant): The experiments proposed in this application examine the effects of infectious microorganisms in the gastrointestinal tract on affect and behavior, effects posited to be mediated by stimulation of a visceral sensory pathway to the central nervous system (CNS). This proposal is based on the demonstration that a low-dose ("subclinical") infection with the food-borne pathogen Campylobacter jejuni induces anxiety-like behavior in orally challenged mice. As such, it differs from the current understanding of the mechanisms that govern the ability of infection to influence behavior since these infection-induced behavioral alterations occur in absence of obvious physical sickness symptoms that usually accompany infectioninduced behavioral alterations. Further, new data demonstrate that such subclinical infection results in the specific activation of regions within the brain associated with anxiety and that interruption of gut-brain pathways inhibits C. jejuni infection-induced brain activation. Thus, our Specific Aims are: 1) To determine the peripheral concomitants involved at the gut level that may be responsible for the ability of subclinical C. jejuni infection to induce anxiety-like behavior in mice. The degree of
40 Anxiety
behavioral alterations induced in response to oral challenge with C. jejuni will be assessed in conjunction with histochemical and immune analysis of infected animals to extend previous work. We will also examine whether a localized immune activation occurs in the absence of a systemic response; 2) To identify the specific visceral sensory pathways leading from the gut to the CNS that are activated following oral bacterial challenge. We will assess the expression of the activation marker c-fos in enteric and vagal sensory neurons as well as sensory neurons in the spinal chord, and determine the impact of selective hepatic and celiac vagotomy; and 3) To determine connectivity and neurochemical identities of neurons driven by C. jejuni infection that form a specific neurocircuitry leading to infection-induced alterations of behavior. Collectively, the above aims will seek to establish that certain behaviors may be modulated, in part, by infectious microorganisms within the gut through the "gut-to-brain" axis involving visceral sensory input. A link between the common occurrence of gastrointestinal infections, especially those which do not produce overt clinical symptoms indicative of infection, with anxiety may therefore identify a previously unidentified circumstance which may play a contributing role in regulating behavior. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: HARVARD BROWN ANXIETY RESEARCH PROJECT Principal Investigator & Institution: Keller, Martin B. Associate Professor; Psychiatry and Human Behavior; Brown University Providence, Ri 02912 Timing: Fiscal Year 2001; Project Start 1-APR-1995; Project End 0-JUN-2003 Summary: We propose to continue the Harvard/Brown Anxiety Research Program (HARP), a unique, naturalistic, prospective, multicenter study of 478 currently active subjects with anxiety disorders, for an additional 4 years of follow-up. This will enable us to create a complete master file with a minimum of 11 years of follow-up data on all active subjects and to incorporate new assessments and data analysis methods in order to address important unanswered questions and develop a comprehensive picture of the longitudinal course and outcome of 3 common anxiety disorders: panic disorder with and without a agoraphobia, generalized anxiety disorder, and social phobia. Our specific aims are to 1) comprehensively map patterns of course for the 3 anxiety disorders; 2) examine predictors/mediating variables, such as stressful life events, depression, substance abuse, and personality disorders, associated with the course of anxiety disorders; describe medication received and investigate the mediating effect of medication on course; 4) assess the relationship between psychosocial functioning and anxiety; symptom severity; and 5) examine the utility of a dimensional approach (i.e., anxiety - and mood-related traits) in characterizing the nature and course of the anxiety disorders and comorbid depressive disorders. Subjects will be evaluated at 6 month intervals with instruments that obtain detailed information on symptom status and severity, diagnostic status, treatment received, psychosocial functioning, and other domains. Since our earlier submission we have added new assessments that measure stressful life events, underlying mood- and anxiety-related traits, and symptom severity independent of diagnosis and functioning; we have also incorporated new data analysis methods in order to answer important questions about the anxiety disorders. To have sufficient statistical power to test our hypotheses, 4 more years of prospective observation are needed. The HARP data set is unique in its large number of subjects, comprehensiveness of assessment, and length of prospective follow-up. This proposal will allow us to more completely investigate the aims and hypotheses of the previously funded grant and to add new, previously unexplored aims and hypotheses generated by findings from HARP and other investigators during the past 4 years. Continuation of
Studies 41
HARP is expected to shed new light on clinically and theoretically important, innovative questions about a group of common and impairing disorders which have not been adequately addressed by previous research. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: HPA AXIS IN DEPRESSION AND ANXIETY Principal Investigator & Institution: Young, Elizabeth Ann. Professor; Psychiatry; University of Michigan at Ann Arbor 3003 South State, Room 1040 Ann Arbor, Mi 481091274 Timing: Fiscal Year 2001; Project Start 1-MAY-2001; Project End 0-APR-2006 Summary: (Applicant's abstract) This is a Research Scientist Award Application. I have received 15 years of salary support through the RSDA program and have become a leader in the area of HPA axis regulation in depression. Future studies proposed in this application will continue to explore hormonal abnormalities in depression and also in related anxiety disorders, panic disorder and PTSD. Current research indicates that depression is accompanied by abnormalities of the HPA axis, while anxiety disorders, particularly Panic Disorder, is accompanied by abnormalities of the central noradrenergic system, as reflected by a blunted growth hormone response to clonidine. Specific research aims in this proposal are I) to determine if abnormalities of central noradrenergic system are present in both pure depression, pure panic disorder and depression plus panic disorder. We will study a group of well characterized pure depressed, pure panic and mixed panic and depressed patients with the clonidine/growth hormone challenge to determine if all depressed patients manifest abnormalities in clonidine stimulated growth hormone release or if only those with comorbid panic symptoms manifest this abnormality. 2) To determine if abnormal activation of HPA axis secretion occurs in Panic Disorder patients. We will examine 24 hr urinary cortisol excretion, collected in 8 hrs segments in pure depressed, pure panic and and mixed panic and depressed patients. 3) To evaluate noradrenergic and HPA axis 'reactivity' to two simple challenges in pure depression, depression plus anxiety, panic disorder patients and normal controls. These challenges include orthostatic challenge and the Trier Social Stress Test (TSST). We hypothesize that panic disorder patients and depressed patients with co-morbid anxiety will demonstrate exaggerated catecholamine response to orthostatic challenge i.e increased reactivity. We hypothesize that depressed patients will have altered HPA axis responses to stress response while Panic Disorder patients will have normal HPA axis response to the TSST. 4 ) To determine if the abnormalities in basal HPA axis dysregulation, exaggerated responses to stress and blunted response to clonidine-growth hormone challenge studies occur in the same individuals and if the results of these biological studies support the nosological distinction between Panic Disorder, pure Major Depression and Major Depression with co-morbid Panic Disorder. Finally we will examine whether HPA axis and noradrenergic dysfunction reflect a common factor, degree of impairment, more than a specific mood and anxiety disorder. With regards to PTSD, we will explore whether decreases in urinary free cortisol and increases in urinary catecholamines are present in epidemiological sample of subjects exposed to trauma both with and without PTSD and normal subjects not exposed to trauma who are free of Psychiatric disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: IMPROVING PATIENT OUTCOMES IN ANXIETY DISORDERS Principal Investigator & Institution: Stein, Murray B. Professor; Psychiatry; University of California San Diego 9500 Gilman Dr, Dept. 0934 La Jolla, Ca 92093
42 Anxiety
Timing: Fiscal Year 2001; Project Start 7-JUL-2001; Project End 0-JUN-2006 Summary: (provided by applicant): This is a request for an NIMH Midcareer PatientOriented Investigator Award (K24). The purpose of the award is to enable Dr. Stein, an experienced and productive researcher in adult anxiety disorders clinical trials and epidemiology, to 1) enhance his knowledge of health services research theory and methods, and 2) to enhance his experience in developing and testing interventions for children and adolescents. The purpose of acquiring this additional expertise is to enable the candidate and his trainees to move more rapidly and successfully into effectiveness research, and to include children and adolescents in their studies. The research program builds upon an R01 held by the applicant as well as other ongoing studies aimed at improving care for patients with anxiety disorders in medical systems. Anxiety disorders, among the most common of all mental disorders, are associated with tremendous functional disability and reduced health-related quality of life. The working model for the applicant's research is that the primary care setting is the venue where anxiety disorders can and should be most successfully treated. Treatment, however, must be provided in a form that suits the context of the primary care healthcare delivery system. At the present time, this means that interventions must be relatively brief, they must be fairly easy to administer (i.e., extensive training of specialized mental health therapists is rarely feasible), and they must be generalizable to a wide array of patients and practice settings. Because anxiety disorders so often begin early in life, strategies to detect and treat anxiety disorders in pediatric healthcare settings are needed. The applicants work is geared toward the development, implementation, and testing of methods for detecting and treating anxiety and related disorders in medical (adult and pediatric) settings. The primary career goals that will be met by this award are: 1) To provide the applicant with protected time to continue his extensive mentorship of junior investigators in the conduct of outcome studies in anxiety disorders; 2) To provide the applicant with the opportunity to upgrade his research skills in several specific areas requisite to his transition into effectiveness research in adults and youth. These goals will be met through continued and expanded research activities, collaboration and individual consultation with senior scientists (in effectiveness research, and in treatment of behavioral disorders in children and adolescents) both locally and nationally, and graduate level course work in epidemiology, health services, biostatistics, and health economics at the San Diego State University School of Public Health. A K24 Award at this stage of the applicant's career will provide the time and resources needed to achieve these goals. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: IMPROVING QUALITY OF PRIMARY CARE FOR ANXIETY DISORDERS Principal Investigator & Institution: Rollman, Bruce L. Associate Professor of Medicine; Medicine; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2001; Project Start 0-SEP-1999; Project End 1-MAY-2003 Summary: Panic and generalized anxiety disorders (PD/GAD) are prevalent in primary care practice; responsible for significant morbidity; inadequately recognized and treated; and associated with excessive health services utilization. Given the availability of efficacious treatments for PD/GAD, this effectiveness study hypothesizes that enabling patients to participate in their care while simultaneously disseminating guideline-based treatments to their primary care physicians (PCP) via electronic medical record (EMR) will produce superior clinical outcomes to those achieved by simply
Studies 43
notifying the physician and patient of the diagnosis alone. Our patient intervention will be based on public-domain and commercially available information/self-management materials modified for local use. PCPs will receive treatment advice based on the American Psychiatric Association's anxiety guideline and other evidence-based treatment algorithms presented to them via EMR. Approximately 20 board-certified PCPs at two study sites will be randomized to either our intervention or control ( usual care ) group. Research assistants using a validated rapid screening and interview procedure will identify 247 patients experiencing PD/GAD upon presentation for primary care over an 18-month period. All study patients and PCPs will receive notification of the anxiety diagnosis from the investigators. Afterwards, according to PCP assignment: (1) patients may receive additional information on anxiety disorders and a structured anxiety self-management program administered over the telephone by a trained facilitator; and (2) PCPs may be exposed to guideline advice presented via EMR at the time of the clinical encounter. A research assistant blinded to the PCPs randomization status will conduct standardized telephone assessments with each study patient at 0, 2, 4, 8, and 12 months. The primary outcome criterion, a 50 percent reduction in subjects' levels of anxiety symptomatology at 4 months, will be assessed using the Hamilton Rating Scale for Anxiety. Secondary outcome criteria, such as functional status and health services utilization, will be assessed using parallel analyses at 12 months. This study will enhance our understanding of new methods to implement guideline-based care and the magnitude of benefits that can be expected. Study findings can: identify process factors that contribute to appropriate and effective care; stimulate the development of other patient self-management strategies; and distinguish patient subgroups most likely to respond to a collaborative-management approach for treatment of a debilitating chronic mental disorder. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: INDIVIDUAL DIFFERENCES IN ANXIETY: NEUROPEPTIDE-Y Principal Investigator & Institution: Primeaux, Stefany D. None; Lsu Pennington Biomedical Research Ctr 6400 Perkins Rd Baton Rouge, La 70808 Timing: Fiscal Year 2003; Project Start 7-AUG-2003 Summary: (provided by applicant): The proposed experiments will investigate individual differences in anxiety and the role of neuropeptide Y (NPY) in these differences. In addition, the relationship of NPY to anxiety and the anxiolytic and sedative effects of ethanol. In the proposed experiments, individual differences in anxiety levels will be determined by % time spent on the open arms of the elevated plus maze, and differences in NPY mRNA levels and NPY receptor densities will be assessed 'anxious' and 'non-anxious' rats. AIM 2 will investigate the effects of herpes virus mediated overexpression and underexpression of amygdalar NPY on anxiety-related behaviors in the elevated plus maze test. A time course of herpes virus mediated increases and decreases in NPY gene expression and NPY like immunoreactivity will be assessed using in situ hybridization and radioimmunoassays. Overexpression of amygdalar NPY is expected to reduce anxiety in this test. AIM 3 will investigate the effects of herpes virus mediated overexpression and underexpression of NPY on the anxiolytic and sedative effects of ethanol preference. Increased amygdalar NPY gene expression is expected to potentiate the anxiolytic and sedative effects of ethanol. Decreased amygdalar NPY gene expression is expected to attenuate the anxiolytic and sedative effects of ethanol. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
44 Anxiety
•
Project Title: INTERVENTION FOR CHILDREN AT RISK FOR ANXIETY DISORDERS Principal Investigator & Institution: Hirshfeld-Becker, Dina R.; Massachusetts General Hospital 55 Fruit St Boston, Ma 02114 Timing: Fiscal Year 2001; Project Start 1-MAR-1998; Project End 8-FEB-2003 Summary: This is an application for a Mentored Clinical Scientist Development Award with a focus on developing expertise in designing and evaluating early interventions for childhood anxiety disorders. The candidate proposes to build upon her experience studying behavioral inhibition as a risk factor for anxiety disorders by learning to apply this knowledge to benefit children at risk. Anxiety disorders represent the most prevalent category of childhood mental disorder. They have been shown to run in families, with children of parents with anxiety disorders at high risk to develop these disorders themselves. Studies by the candidate and her sponsors have identified behavioral inhibition as a temperamental risk factor for the development of childhood anxiety disorders. Children whose behavioral inhibition remains stable throughout early childhood and whose parents have multiple anxiety disorders appear at greatest risk. The ability to identify young children at high risk affords the opportunity for early intervention. Research Plan: The candidate proposes to refine and test an intervention for behaviorally-inhibited 4.0-5.9-year-old children of parents with panic disorder with agoraphobia to facilitate the children's learning strategies for reducing inhibition and managing anxiety. The twelve- week intervention includes parent-skills training and child anxiety management. It will be tested in a randomized controlled trial with proximal (three-month) and long-term (two-year) follow-up assessment for child behavioral inhibition and psychopathology. Environment: The proposed study will be based at the Massachusetts General Hospital and will complement a program of training and supervised research under the mentorship of Joseph Biederman, MD and co-sponsored by Jerrold F. Rosenbaum, MD, with consultation from experts in the areas of behavioral inhibition, childhood anxiety disorders and intervention research. Career development plan: Training will emphasize skills necessary for designing and evaluating interventions for anxious children and assessing psychological and familial vulnerability factors including child temperament, psychopathology, cognitive risk factors and family interactions. Coursework at the Harvard School of Public Health and tutorials in intervention research design, statistical methods, and methodology for longitudinal follow-up will complement supervision by the consultants. In this manner, the candidate will develop a critical fund of knowledge in childhood anxiety disorders, developmental psychopathology, intervention research, and statistical methodology which will lay the foundation for future independent investigation of intervention strategies for high risk children. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: KAVA KAVA IN GENERALIZED ANXIETY: A DOUBLE-BLIND TRIAL Principal Investigator & Institution: Davidson, Jonathan R. Professor; Psychiatry; Duke University Durham, Nc 27706 Timing: Fiscal Year 2001; Project Start 1-JUL-2000; Project End 8-FEB-2003 Summary: Kava Kava (KAV) is a plant-derived treatment which is widely used in Europe to treat anxiety states. Three double-blind trial in anxiety disorders have shown greater efficacy for KAV than placebo (PBO), and two have reported efficacy equal to benzodiazepines. However, a number of problems exist in respect to the design of these
Studies 45
trials, which restricts their generalizability. Nonetheless, evidence from both basic science and clinical studies support the likelihood of an anxiolytic effect of kava. With public interest in phytotherapy for depression and anxiety now on the rise in the US, we propose to evaluate KAV in generalized anxiety disorder (GAD), relative both to PBO and an active drug, venelafaxine-XR, known to be effective in GAD. We will enroll 124 patients into the study to obtain 93 completers (n = 31 KAV, n = 31 PBO, n = 31 VEN). After 8 weeks of treatment, subjects will undergo a one-week taper, followed by an additional week's observation. Doses of up to 280 mg/day standardized active kavalactone extract and 225 mg/day VEN, or matching PBO, will be used. The primary efficacy measure will be the HAM-A. Secondary measures will comprise the Clinical Global Impressions Improvement Scale (CGI-I), Hospital Anxiety and Depression Scale (HADS), Penn State Worry Inventory (PSWI), Montgomery-Asberg Depression Scale (MADRS), Clinical Global Impressions Severity Scale (CGI-S), Short Form-36 (SF-36), Work and Social Disability Scale (WSDS), Sheehan Disability Scale (SDS), and Work Productivity and Impairment Questionnaire (WPAI). Side-effects, vital signs, and laboratory measures will be monitored. Treatment will be monitored for treatment integrity and an independent rater will be used for key outcome assessments. The potential benefit of this study might be the identification of an effective herbal medical treatment for GAD which is safe and well tolerated. It will also contribute towards providing an answer to what is rapidly becoming a major public health question, namely what can we reasonably expect herbal treatments to offer? Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: LATENT APPLICATION
STRUCTURE
OF
ANXIETY--EVALUATION
AND
Principal Investigator & Institution: Ruscio, Ayelet M. Psychology; Pennsylvania State University-Univ Park 201 Old Main University Park, Pa 16802 Timing: Fiscal Year 2001; Project Start 1-APR-2001 Summary: The proposed research program aims to begin to test whether anxiety is categorical or dimensional in nature. In years 1 and 2 of the research program, a series of investigations will empirically evaluate the structural nature of three anxiety disorders: generalized anxiety disorder, posttraumatic stress disorder, and social phobia. Each disorder will he examined in large clinical and analogue samples using sophisticated taxometric procedures designed to test latent structures. Follow-up analyses will inspect the overlap between the three disorders to increase understanding of their frequent comorbidity. In years 3 and 4, a therapy outcome investigation will assess the efficacy of a classification scheme (either categorical or dimensional) derived from taxometric analysis of generalized anxiety disorder. The investigation will compare this classification scheme to traditional DSM-IV diagnosis on the relative ability to predict prognosis, treatment response, and functional outcome following a brief clinical intervention for chronic worry. Results of the proposed research are expected to enhance scientific understanding of the nature of anxiety, with important implications for the conceptualization, assessment, investigation, and treatment of the anxiety disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: LONG-TERM OUTCOME OF ANXIETY DISORDERS IN YOUTH Principal Investigator & Institution: Saavedra, Lissette M. Psychology; Florida International University Division of Sponsored Research and Training Miami, Fl 33199
46 Anxiety
Timing: Fiscal Year 2003; Project Start 1-MAY-2003; Project End 0-APR-2004 Summary: (provided by applicant): Recent epidemiological studies have indicated that phobic and anxiety disorders are some of the most prevalent psychiatric disorders in children and adolescents with prevalence rates ranging from 8 to 18%. There also now exists considerable evidence from both retrospective and prospective studies that anxiety disorders in children do not dissipate over time but are generally chronic. The childhood anxiety disorders treatment literature now contains a number of wellconceived and well-executed randomized controlled clinical trials that provide strong evidence for the efficacy of exposure-based psychosocial interventions using cognitive and behavioral procedures. To date, only two studies have conducted follow-up evaluations more than one year since post treatment in terms of evaluating presence/absence of the targeted disorder and levels of specific symptoms on questionnaires. Although important initial steps, there are several limitations of these studies that warrant attention. The purpose of the proposed study is to address these limitations in a more ethnically diverse sample of anxious children. Participants will consist of 100 youth and their parents who had participated in one of the two published randomized clinical trials on phobic and anxiety disorders in youth. A comparison group of 20 youth and their parents previously referred for anxiety and phobic disorder but who did not receive treatment will serve as a comparison. Long-term follow-up effects will be examined in terms of presence/absence of targeted anxiety disorder, the development of new disorders at multi-faceted symptom levels using interview schedules and questionnaires. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MAPPING THE NEURAL SUBSTRATE OF ANXIETY Principal Investigator & Institution: Luscher, Bernhard; Biology; Pennsylvania State University-Univ Park 201 Old Main University Park, Pa 16802 Timing: Fiscal Year 2001; Project Start 1-MAY-2001; Project End 0-APR-2004 Summary: (provided by applicant) The objective of this proposal is to identify the neural substrates underlying trait anxiety. We have found that heterozygosity of the GABAA receptor y2 subunit gene leads to a subtle impairment of postsynaptic GABAA receptor function and trait anxiety in mice. The selective behavioral and cognitive deficits of y20/~ mice, together with established knowledge on the neural circuitry of conditioned fear and the regional distribution of the GABAA receptor deficit in =y2 0/+ mice, allow predictions as to which brain regions mediate trait anxiety. We hypothesize that GABAA receptor deficits in the cerebral cortex and/or hippocampus of y2 0/ mice lead to trait anxiety and that a GABAA receptor deficit that is confmed to these brain regions will result in trait anxiety-like behavior similar to the phenotype of =y2 0/+ mice. In order to map the brain regions that mediate trait anxiety, we have generated a mouse line that allows spatiotemporally restricted inactivation of the y2 subunit gene by means of the Cre/loxP system. Upon Cre induced inactivation of the y2 subunit gene, GABAA receptor function will be impaired in selective brain regions defined by the Cre expression pattern of tissue-specific Cre-transgenes or by stereotaxically applied Creencoding virus. Subsequently, stereotaxic injection of Cre-recombinant virus will be used to further characterize trait anxiety. These experiments will include determination of the critical stage during development during which GABAergic deficits lead to trait anxiety. In addition, we will determine whether the cognitive deficits associated with trait anxiety reflect alteration of the acquisition or expression of conditioned fear. The neural circuits that are implicated in the anxiolytic action of the benzodiazepines have considerable anatomical overlap with the proposed neural circuits of trait anxiety and
Studies 47
are of therapeutic interest. To test this hypothesis, Cre-induced inactivation of the y2 subunit gene, which is essential for benzodizepine action, will be used to map the brain regions mediating the anxiolytic effect of benzodiazepines. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MARKERS OF RISK FOR ANXIETY DISORDERS Principal Investigator & Institution: Craske, Michelle G. Professor; Psychology; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 3-AUG-2002; Project End 1-JUL-2004 Summary: (provided by applicant): The goals of this project are to evaluate risk factors for anxiety disorders. This proposal is a cross-sectional high-risk (HR) design, comparing children with anxiety disorders (AD) to non-disordered children who are at high-risk (HR) based on parental anxiety disorders and non-disordered children at low risk (LR) for anxiety disorders based on the absence of parental psychopathology. Markers of risk for anxiety disorders are hypothesized to include evaluated sympathetic state, lowered vagal tone, selectivity of attention, evaluated reactivity to aversive stimuli, and stronger learning and retention of aversive associations. Thus, the three groups of participants (N=80), aged 7-12 years (pre-pubertal) and matched on gender, will be evaluated in terms of resting sympathetic state and vagal tone, attention to negative facial expressions, startle blink and cardiac reactivity to high decibel tones, with potentiation by "lights off", and rates of acquiring aversive conditioned responses to novel geometric figures paired with airpuffs. In addition, replication of startle and selective attention to facial expressions as well as measurement of recovery of aversive associations will be assessed one week later. Conditioning will be measured in terms of autonomic responses as well as eye gaze movement, and selectivity of attention will be measured using eye gaze. Measurement of eye gaze in youths to gauge ongoing conditioning and attentional processes represents a new methodology. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: MECHANISM OF INCREASED ANXIETY IN 5-HT1AR KNOCKOUT MICE Principal Investigator & Institution: Gross, Cornelius T. Ctr for Neurobiology Behavior; Columbia University Health Sciences Ogc New York, Ny 10032 Timing: Fiscal Year 2002; Project Start 1-MAY-2002; Project End 0-APR-2003 Summary: (provided by applicant): This award is designed to establish the candidate as a competitive researcher with expertise in both the behavioral as well as molecular analysis of anxiety-like behavior in mice. Following a three year period of postdoctoral research training in the analysis of anxiety-like behavior in mice, the candidate is seeking further training in the construction and molecular analysis of transgenic and knockout mice. Educational Plan: Specifically, the award will facilitate the acquisition of (1) knockout and transgenic technology for the tissue-specific and conditional expression of genes in mice, (2) gene expression profiling, or "genomics," techniques, (3) histochemical methods needed to identify and quantitate molecular and morphological changes in mice, (4) general knowledge in developmental neurobiology and anatomy via coursework, and (5) experience in effective laboratory mentoring and the responsible conduct of research. The first, second, and fifth areas of training will be provided by Dr. Rene Hen, while the third will be overseen by Dr. Bruce McEwen, both well known leaders in their fields. Research Plan: Anxiety disorders affect more than 12
48 Anxiety
percent of the population during their lifetime. Knockout mice lacking the serotonin 1A receptor (5-HT1AR knockout) show increased anxiety-like behavior and represent a valuable genetic model of anxiety disorders. We present preliminary evidence showing that, contrary to the commonly held notion in the field, the 5-HT1AR is not required in the adult for normal anxiety-like behavior, and that, instead, it is likely to play a critical role during development. The first part of the proposed research will use tissue-specific and conditional transgenic animals to define the critical tissue and time period for 5HTIA receptor function. The second part proposes to isolate and characterize critical genes involved in the anxiety-like behavior modulation by this receptor. Part of this approach will rely on an unbiased search for genes downstream of the 5-HT 1AR using gene expression profiling techniques. The identification of critical molecules in this circuit will be important for two reasons. First, they will offer new targets for developing more effective and specific anxiolytic drugs, and second, mutations in these genes may be important factors in the inheritance of vulnerability to anxiety. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MODEL OF SOCIAL ANXIETY AND COLLEGE STUDENT DRINKING Principal Investigator & Institution: Ham, Lindsay S. Psychology; University of Nebraska Lincoln 14Th and R Sts Lincoln, Ne 68588 Timing: Fiscal Year 2002; Project Start 5-FEB-2003 Summary: (provided by applicant): This study will involve the development and testing of a model examining the role of social anxiety in drinking levels and alcohol-related problems in referred and non-referred college students. College students may be at risk for developing alcohol use disorders. Young adults aged 18-24 show the highest rates of alcohol use and have the greatest percentage of problem drinkers. Problematic alcohol use in college students is a significant public health concern. Further, previous research has found a relationship between social anxiety disorder and problematic alcohol use. It may be that college students with symptoms of social anxiety may be particularly vulnerable to developing alcohol problems. However, inconsistencies in the alcohol, social anxiety, and alcohol expectancies relationships warrant further study including positive and negative expectancies and valuations of expectancies. The model will include alcohol expectancies and valuations, living environment, peer influence, academic and religious involvement, and gender as these are variables that have been correlated to alcohol use in past research and seem to be interrelated. There is a lack of comprehensive models of college student problematic alcohol use and social anxiety, and thus this research would close a gap in existing alcohol literature. The model will be based on clinical data from college students who participate in a motivational interviewing intervention called Alcohol Skills Training Program and a non-referral group of college students who have not participated in ASTP. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: MOLECULAR GENETIC STUDY OF FEAR AND ANXIETY Principal Investigator & Institution: Gilliam, T Conrad. Borne Professor of Genetics and Developm; Columbia Univ New York Morningside 1210 Amsterdam Ave, Mc 2205 New York, Ny 10027 Timing: Fiscal Year 2003; Project Start 1-JAN-2003; Project End 1-DEC-2006 Summary: (provided by applicant): In this program project we present a novel strategy for the identification of genes important for psychiatric disorders. The studies are aimed
Studies 49
at normal and pathological expressions of anxiety in humans, and focus specifically on learned and innate fear in mice. Because fear is a universal affect conserved throughout phylogeny, it is possible to model fear in mice - an organism that is suitable for both physiological and genetic analysis. Fear conditioning is a measure of an organism's basic ability to learn about new dangerous or threatening stimuli or environments, and to respond appropriately. The study of fear conditioning offers two very significant advantages for molecular genetic analysis: the behavioral paradigms can be closely mimicked in human subjects, and the neurocircuitry, and associated information processing systems that underlie these behaviors, are relatively well understood, and highly conserved among vertebrates. Since, in their most general sense, anxiety disorders represent a malfunction in the neural mechanisms that detect danger and mobilize adaptive responses to that danger, we propose that a subset of genes that harbor genetic determinants for learned or innate forms of fear will also harbor susceptibility alleles for human anxiety disorders. Thus, we propose a translational study of fear and anxiety that combines direct molecular genetic study of learned and innate forms of fear in mice with genetic analysis of anxiety related behaviors, traits, and disorders in humans. The Program Project consists of five independent Projects and a Training Component. 1. Genetic and Behavioral Models of Fear States in Mice- 1A. Learned Fear (Kandel) 2A. Innate Fear (Hen). 2.Translation from Mouse to Human Fear and Anxiety: Genetic and Genomic Approaches (Gilliam). 3. Clinical Studies of Human Fear and Anxiety (Fyer). 4. Clinical Studies of Human Anxiety Disorders (Weissman). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MOTHERS, DISSOCIATIVE STATES, & ANXIETY Principal Investigator & Institution: Hall, Howard R.; Case Western Reserve University 10900 Euclid Ave Cleveland, Oh 44106 Timing: Fiscal Year 2001 Summary: Cocaine is one of the most powerful addictive drugs of abuse, uses of which peaked around 1985 especially by women. The use of this drug has been associated with significant symptoms of anxiety. Dissociation is a defense mechanism used to cope with high levels of anxiety. The purpose of this study is to determine if cocaine using mothers show a greater tendency to employ dissociation as a means of coping with anxiety compared to non-cocaine using mothers. It has been suggested that failure to recognize dissociative states among clinical populations may account for poor therapeutic outcomes, particularly for dissociative-based conditions, such as for some eating disorders. If dissociation is observed within a cocaine using population, this finding would suggest the utility of specific therapeutic interventions such as hypnotherapy. Other therapy implications include focusing on teaching the individual to recognize her ability to dissociate. Such interventions might also have a positive impact on the development of their drug exposed infants. The following specific aims will be addressed: 1) To examine the level, extent and nature of anxiety symptoms reported by cocaine using versus non-cocaine using mothers. 2) To assess for tendencies toward dissociation as a coping mechanism for anxiety symptoms in cocaine using versus noncocaine using mothers. The following research hypotheses are being addressed: 1) Cocaine using mothers will demonstrate higher levels of anxiety than non using mothers. 2) Cocaine using mothers will demonstrate higher levels of three dimensions of dissociation than non using mothers as measured by a dissociation scale, a measure of absorption, and an assessment of hypnotizability. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
50 Anxiety
•
Project Title: NEUROBIOLOGY OF ANXIETY IN 5-HT1A RECEPTOR KNOCKOUT MICE Principal Investigator & Institution: Kirby, Lynn G.; Children's Hospital of Philadelphia 34Th St and Civic Ctr Blvd Philadelphia, Pa 19104 Timing: Fiscal Year 2002; Project Start 1-JAN-2002; Project End 1-DEC-2006 Summary: (provided by applicant): Dysfunction of the serotonin (5-HT) and gammaaminobutyric acid (GABA) systems have been implicated in anxiety since most clinically useful anxiolytic compounds act by stimulating either 5-HT-1a or benzodiazepine receptors that modulate GABA neurotransmission. The specific brain regions involved and the particular interactions between 5-HT and GABA neurotransmitter systems during anxiety and its therapeutic treatment are not well understood. The long-term goal of this proposal is to understand the cellular and molecular substrates of anxiety as well as the specific neural circuits that may be affected in this disorder in order to identify novel targets for anxiolytic treatment. The objective of this application is to examine the particular fear and anxiety states resulting from alterations in the 5-HT and GABA systems in different brain regions using behavioral, electrophysiological and molecular techniques in an animal model of anxiety: the 5-HT-1a knockout (1AKO) mouse. In AIM 1 I will compare the behavior of 1aKOs and wild-type controls (WTs) to dorsal raphe nucleus (DRN) system-dependent vs. median raphe nucleus (MRN) system-dependent models of fear and anxiety. These studies will indicate the particular fear/anxiety states demonstrated by 1aKO mice as well as the particular circuits disrupted by the genetic deletion. I will then use electrophysiological and molecular techniques in AIMS 2 and 3 to test the specific alterations of 5-HT and GABA neurotransmission in different neural circuits in 1aKOs. In AIM 2 I will measure membrane characteristics, 5-HT-1a and GABAA receptor-mediated responses in DRN and MRN of 1aKOs and WTs using brain slice electrophysiological recording techniques. In AIM 3 I will measure 5-HT-1a and GABAA receptor-mediated responses in amygdala or hippocampal slices from 1aKOs and WTs. I will compare the measured electrophysiological response of the cell with its GABAA receptor subunit expression. My hypothesis is that deletion of the 5-HT-1a receptor disrupts 5-HT neurotransmission in specific cell bodies and their projections, altering GABA neurotransmission and ultimately producing the anxious phenotype. The experiments described in this proposal will elucidate neural circuits and altered neurotransmission that may underlie the particular anxiety states expressed by this animal model of anxiety. These experiments will lead to a better understanding of the interactions between the 5-HT and GABA systems during the expression of chronic anxiety and may identify potential targets for novel pharmacological treatments of anxiety disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: NEUROBIOLOGY OF ANXIETY IN MICE LACKING 5HT 1A RECEPTOR Principal Investigator & Institution: Toth, Miklos; Associate Professor; Pharmacology; Weill Medical College of Cornell Univ New York, Ny 10021 Timing: Fiscal Year 2001; Project Start 3-SEP-2000; Project End 1-AUG-2005 Summary: (Adapted from the Investigator's Abstract) Functional abnormalities in the serotonin (5-HT) receptors have been consistently associated with anxiety. We have shown that inactivation of the 5-HTA receptor (5-HTAR) results in anxiety in mice. Surprisingly, we found that these mutant mice are insensitive to the anxiolytic effect of diazepam, a classical benzodiazepine (BZ). The importance of this finding is that a
Studies 51
significant proportion of patients suffering from generalized anxiety do not respond to BZs. Also, BZs are not particularly effective in other forms of anxiety such as panic attacks and phobias. Since BZs bind and facilitate the function of the BZ sensitive gamma-aminobutyric acid receptors (GABAAR) receptors, abnormalities in these receptors could underlie the BZ-resistant anxiety and the anxiety-like behavior of the 5HTAR mutant mice. Indeed, we found abnormalities in the subunit composition of GABAARs in mutant mice. Our data show that the 5-HT and GABA systems, two important neurotransmitter systems implicated in anxiety disorders, are mechanistically linked. The objective of this application is to elucidate key features of the 5-HTARmediated regulation of GABAAR subunits that have a relevance to the KO phenotype and that could be applied to the understanding of anxiety. We ask the following questions: 1) Is the expression of the GABAAR subunits sensitive to the dosage of the 5HTA receptor? Anxiety in heterozygote KO mice suggests that GABAAR subunit expression is sensitive to 5-HTAR dosage. This would imply a pathogenic role for 5HTAR hypofunction described in panic anxiety. 2) Are the abnormal GABAAR subunit levels in 5-HTAR KO mice caused by a developmental arrest in subunit expression? Dysregulation of GABAAR subunits may occur during development because 5-HTAR represents a developmental signal in brain. 3) Are particular regions within amygdala and hippocampus of 5-HTAR KO mice specifically associated with altered GABAAR subunit expression? 4) Is GABA and glutamate release altered in the amygdala and hippocampus of 5-HTAR KO mice? These changes may occur to compensate GABAAR subunit abnormalities. 5) Can 5-HTA receptor agonists alter the expression of GABAAR subunits? Increasing signaling through the 5-HTAR by agonists may elicit GABAAR subunit changes that are beneficial in anxiety. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEUROBIOLOGY OF REPEATED WITHDRAWAL INDUCED ANXIETY Principal Investigator & Institution: Breese, George R. Professor; University of North Carolina Chapel Hill Office of Sponsored Research Chapel Hill, Nc 27599 Timing: Fiscal Year 2003; Project Start 7-DEC-2002; Project End 0-NOV-2007 Summary: (provided by applicant): The anxiety of withdrawal from chronic ethanol exposure has been implicated in sustaining alcohol abuse. Work in our laboratory during the previous granting period demonstrated that repeated withdrawal from chronic ethanol exposure led to a sensitization of anxiety that accompanied withdrawal. Serotonin.a major neurotransmitter in brain.and the 5-HT2C and 5-HT1A receptor subtypes were implicated in this sensitization process associated with repeated withdrawals. The purpose of the present series of nvestigations is to extend these data to test specific hypotheses that define specific brain regions where the 5-HT2C and 5-HT1A receptors contribute to the sensitization of anxiety and that account for the neurobiological basis of the sensitization of the anxiety. Specific Aim 1 will test the hypothesis that release of serotonin in the amygdala is responsible for the sensitization of anxiety induced by multiple withdrawals from chronic ethanol exposures. This work will include microinjection studies to establish the importance of 5-HT2C receptors at this site in the withdrawal-induced anxiety. Additionally, studies will explore whether the raphe has a role in the release of serotonin during withdrawal from the multiple ethanol exposures that results in a sensitization of anxiety. Specific Aim 2 will test the hypothesis that 5-HT2C and 5-HT1A receptor number or sensitivity will be enhanced in selected brain regions by repeated withdrawals as contributing factors in the sensitization of anxiety following repeated withdrawals. Specific Aim 3 of this proposal
52 Anxiety
will test the hypothesis that specific proteins in the second messenger cascade downstream from the 5-HT2C and 5-HT1A receptors are persistently altered and are critical for sustaining the persistent anxiety induced by repeated withdrawals. Emphasis will be on the G-protein coupled pathways linked to PLC and adenylyl cyclase. Complementing these biochemical measures will be the use of "knock outs" of specific genes associated with proteins in the 5-HT2C and 5-HT1A receptor second messenger cascades to test in vivo the importance of specific messenger proteins in the pathways in sustaining the sensitization of anxiety observed with repeated withdrawals from chronic ethanol. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEW INTERVENTION FOR GERIATRIC ANXIETY IN PRIMARY CARE Principal Investigator & Institution: Wetherell, Julie L. Psychiatry; University of California San Diego 9500 Gilman Dr, Dept. 0934 La Jolla, Ca 92093 Timing: Fiscal Year 2003; Project Start 1-MAR-2003; Project End 9-FEB-2008 Summary: (provided by candidate): The overall goal of this five-year training award is to develop Julie Wetherell, Ph.D.'s expertise in the creation and adaptation of effective psychological interventions for older adults in the primary care setting. The career development plan builds on Dr. Wetherell's research training and background in clinical geropsychology. Dr. Wetherell is currently a postdoctoral fellow in Geriatric Psychiatry at UCSD, and she plans to take a faculty position in UCSD's Department of Psychiatry starting October, 2002. She has 13 articles and chapters published or in press, has made 15 presentations at regional and national scientific meetings, and received an individual NRSA grant from NIMH to fund her predoctoral research and training. The goals of the proposed training plan are as follows: 1) to develop Dr. Wetherell's expertise in research methodology, ethics, design, and statistical analysis of treatment outcome studies with older adults; 2) to increase her understanding of anxiety in late life in order to develop optimally effective interventions for these disorders; 3) to establish partnerships with primary care physicians and other health care personnel in order to !earn more about relevant issues in this setting and to develop collaborative projects; 4) to learn strategies for improving recruitment and retention of diverse older participants in clinical research; 5) to become proficient in functional assessment with older adults; 6) to become familiar with techniques for measuring the cost-effectiveness of mental health services; and 7) to build general skills necessary to develop an academic career, including teaching, supervising, and mentoring, presenting and publishing, writing grants, and developing collaborative networks. The plan includes structured coursework and consultation with experts in the fields of geriatric mental health interventions, anxiety disorders, psychological services in primary care, functional assessment, and evaluation of cost-effectiveness. Dr. Wetherell's firsthand research training will involve the development and randomized trial of a new intervention for geriatric anxiety in primary care. The proposed intervention, containing the elements of relaxation training, problem-solving, stimulus control, and life review, will be compared to a treatment as usual condition among a group of 52 primary care patients over the age of 60 with generalized anxiety disorder or clinically significant anxiety symptoms. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 53
•
Project Title: PAROXETINE ALCOHOLISM
FOR
SOCIAL
ANXIETY
DISORDER
AND
Principal Investigator & Institution: Randall, Carrie L. Professor; Psychiatry and Behavioral Scis; Medical University of South Carolina 171 Ashley Ave Charleston, Sc 29425 Timing: Fiscal Year 2002; Project Start 1-MAR-2002; Project End 8-FEB-2006 Summary: Social anxiety disorder (also known as social phobia) is an Axis I anxiety disorder characterized by intense fear and avoidance of social or performance situations in which one might be scrutinized. Its onset is typically in the early teen years. It is the third most common mental disorder in the United States, exceeded in prevalence only by depression and alcoholism. Approximately 20 percent of the individuals with social anxiety disorder have alcohol problems. Anecdotal and empirical evidence suggests that alcohol is used by some socially anxious individuals to self-medicate anxiety symptoms, a practice that could lead to alcohol abuse and/or dependence. The proposed project further explores the self-medication hypothesis through the use of a double-blind, randomized, placebo-controlled clinical trial. Paroxetine (a selective serotonin reuptake inhibitor) is the drug to be used in the study; it is the only medication with FDAapproval for the treatment of social anxiety disorder. Seventy individuals (n=35/group) who drink alcohol to cope with social anxiety symptoms and who meet DSM-IV criteria for the dual-diagnoses of social anxiety disorder and alcohol use disorders will be enrolled in the trial. All individuals will be seeking treatment for social anxiety disorder. The treatment phase will last 16 weeks. Dosing will start at 20 mg/day (paroxetine or placebo) and will increase gradually to a maximum dose of 60 mg/day. Each week during treatment and at the end of the trial, assessments will be made with standard instruments to determine the effect of paroxetine (versus placebo) on social anxiety severity, alcohol use, and more specifically, the intentional use of alcohol to cope with social anxiety symptoms. The overarching hypothesis is that because paroxetine will improve social anxiety severity, alcohol use and/or alcohol use for coping will also be reduced in the paroxetine-treated group. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PEDIATRIC ANXIETY DISORDERS IN PRIMARY CARE Principal Investigator & Institution: Wren, Frances J. Psychiatry and Behavioral Sci; Stanford University Stanford, Ca 94305 Timing: Fiscal Year 2001; Project Start 1-SEP-2001; Project End 1-AUG-2005 Summary: (Applicant's abstract): This proposal for a Mentored Clinical Scientist Career Development Award will prepare the candidate to independently design and conduct intervention studies for pediatric internalizing disorders in the primary care setting. Anxiety Disorders are the most common pediatric internalizing disorders. They are prevalent, impairing, often persistent, may be associated with increased health service use and are eminently treatable. Yet they are amongst the mental health disorders least likely to be recognized in primary care and, when recognized, are typically not optimally treated. Existing studies of community prevalence rates of Anxiety Disorders have not been linked to prognosis, functional impairment and treatment needs, with resultant difficulties in setting intervention thresholds for primary care. Over three and a half years, the proposed research study will recruit and follow for six months 200 school age children with anxiety disorder, identified by screening in a primary care practice. A detailed baseline evaluation will be obtained in order to study predictors of persistent anxiety disorder and of health service use and health care costs. A control
54 Anxiety
group will also be recruited and followed in order to estimate group differences in health care costs between anxious children and non-anxious children: The study is the first to focus specifically on childhood Anxiety Disorders in primary care, the first to study predictors of the six month course of childhood Anxiety Disorders and the first to explore associated health service use and costs. The data generated will yield clinical profiles of children in primary care whose anxiety is likely to be persistent or costly. This is a necessary step towards the long-term goal of designing intervention protocols to improve outcomes for anxious children in primary care and of evaluating costeffectiveness and cost offsets. The candidate is a board certified Child and Adolescent psychiatrist with ten years of post-residency experience, currently Medical Director for Clinical Program Development in Primary Care in the Division of Child and Adolescent Psychiatry at the University of Pittsburgh. Dr. David Brent will serve as preceptor. The consultant panel includes experienced investigators both in the phenomenology and treatment of pediatric Mood and Anxiety Disorders, and in mental health intervention in adult primary care. Course work and guided readings in epidemiology; biostatistics; research design, methods, and ethics; health services research concepts and procedures; health economics and policy; and relevant applications of information technology will complement the research plan. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PERSONALITY, ANXIETY, AND DEPRESSION IN COMMUNITY ADULTS Principal Investigator & Institution: Bienvenu, Oscar J. Psychiatry and Behavioral Scis; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2003; Project Start 2-SEP-2003; Project End 1-AUG-2008 Summary: (provided by applicant): This is a revised K23 application, the purpose of which is to prepare the Candidate for an independent career in the genetic epidemiology of personality and anxiety and depressive disorders. The overall focus of the research project is to determine how personality traits and anxiety and depressive disorders relate. There is currently little empirical data regarding such relationships in the general population, especially with a longitudinal perspective, multiple methods of assessment, and genetic informativeness. The proposed study provides a unique opportunity to investigate these issues, using data from the Baltimore Epidemiologic Catchment (ECA) Study, The Virginia Twin Study (VTS), and The Virginia Twin-Family Study of Adolescent Behavioral Development (v-rSABD). The specific aims of this proposal are: 1) To determine longitudinal relationships between normal personality traits and anxiety and depressive disorders, using data from the Baltimore ECA, V'I'S, and VTSABD cohorts; 2) To determine longitudinal relationships between personality disorder traits and anxiety and depressive disorders in adults, using data from the Baltimore ECA cohort; 3) To determine associations between personality traits and treatment seeking, using data from the Baltimore ECA cohort; and 4) To determine to what extent associations between neuroticism and extraversion and anxiety and depressive disorders reflect common genetic or environmental determinants, using data from the V'I'S and VTSABD cohorts. The products will include an enhanced understanding of the influence of personality traits on risk for and persistence of anxiety and depressive disorders, new information on the risk of development of personality disorder traits in adulthood as a complication of anxiety and depressive disorders, new knowledge regarding the influence of personality traits on treatment seeking, and a more detailed understanding of etiologic relationships between normal personality traits and anxiety and depressive disorders. The results will have implications for
Studies 55
prevention and other public health efforts. The Principal Investigator's research career development will be enhanced substantially through protected time for mentored analyses of longitudinal and twin data, and for relevant coursework. He will be guided by exceptionally talented mentors, including Drs. Gerald Nestadt, Kenneth Kendler, William Eaton, Kung-Yee Liang, Paul Costa, Murray Stein, Patrick Sullivan, and Lindon Eaves. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PHENOTYPICAL EXPRESSION OF ANXIETY AND SLEEP Principal Investigator & Institution: Sanford, Larry D. Associate Professor; Pathology and Anatomy; Eastern Virginia Medical School Norfolk, Va 23507 Timing: Fiscal Year 2001; Project Start 0-SEP-1999; Project End 1-MAY-2003 Summary: (adapted from the applicants' abstract) The long-term goal of this project is to further the understanding of how emotional factors influence sleep. Emotional state has a strong influence on sleep quality and amount. This statement can be attested to by almost everyone, and it is factually supported by the observed role of emotional factors in human sleep medicine, particularly sleep disorders related to a psychiatric condition. However, the role of emotion has virtually been ignored in basic sleep research, possibly because of the lack of a clear anatomical focus, or perhaps because of a lack of established models. It is now becoming increasingly apparent that the amygdala, the limbic center of emotion, has a strong modulatory role in the control of sleep. Inbred mouse strains are being examined in order to find models of anxiety and mood disorders. The investigators plan to study sleep in inbred mouse strains with differences in emotional reactivity in order to begin to understand how genetics and the environment interact in producing the effects of emotion on sleep. The investigators' strategy is to : 1) establish protocols for studying how emotion affects sleep in inbred mouse strains, 2) identify the anatomical regions that could account for strain differences in emotional reactivity as it affects sleep, and 3) determine the functional significance of these regions in the control of emotion and sleep. To accomplish these goals, the investigators will examine the effect of fear conditioning on sleep, identify the activated brain areas that affect sleep and examine the function of these regions by selectively preventing their activation in response to fear conditioning. These studies will help elucidate into how stress, emotion and environmental factors influence sleep. This work will advance the understanding of how stress and anxiety affect sleep and may give insight into sleep disorders such as insomnia and into mental disorders in which sleep is affected. The investigators findings may be especially relevant to posttraumatic stress disorder (PTSD), which is typically characterized by a prominent sleep disturbance in the aftermath of exposure to a psychologically traumatic stressor. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: PSYCHOBIOLOGY OF ANXIETY DISORDERS Principal Investigator & Institution: Gorman, Jack M. Professor; Psychiatry; Columbia University Health Sciences Ogc New York, Ny 10032 Timing: Fiscal Year 2001; Project Start 1-SEP-1987; Project End 1-AUG-2002 Summary: (Adapted from applicant's abstract): A competing continuation of a Senior Scientist Award (formerly Research Scientist Award) is requested. The main focus is the study of the neurobiology and treatment of anxiety disorders, particularly panic. The candidate has held three successive five-year "K" award grants from NIMH. Four main areas of research are proposed: 1) studies of respiratory physiology in PD; 2) the
56 Anxiety
relationships among respiratory, noradrenergic, and serotonergic function in PD; 3) developmental aspects of anxiety disorder including a preclinical model of anxiety, studies of anxious children, and development of a geriatric anxiety program; and 4) the role of CNS innervation in the cardiovascular response to acute and chronic stress. A hypothetical model is presented that will guide the candidate in studies attempting to elucidated biological aspects of PD and their relationship to cognitive and behavioral aspects. This includes placing respiratory abnormalities in panic in their proper perspective, testing relationships among several brain systems in the pathogenesis of panic, and studying the effects of early life traumatic stress on the biological and behavioral predisposition to anxiety disorder. Work on the "heart-brain" interaction includes studying heart transplant patients as a model of cardiac denervation in order to isolate the precise mechanisms by which the CNS controls cardiovascular function. In this proposed continuation period, particular attention will be placed on training in several neuroimaging techniques. Pilot single photon emission computerized tomography (SPECT) and positron emission tomography (PET) studies are described and plans for the use of functional magnetic resonance imaging to study carbon dioxide (C02) responsive zones of brain are also planned. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PSYCHOBIOLOGY OF CHILDHOOD ANXIETY AND DEPRESSION Principal Investigator & Institution: Ryan, Neal D. Professor; Psychiatry; University of Pittsburgh at Pittsburgh 350 Thackeray Hall Pittsburgh, Pa 15260 Timing: Fiscal Year 2001; Project Start 1-JUL-1986; Project End 3-SEP-2002 Summary: This is a competing project renewal focusing on clinical depressive and anxiety disorders in children. These disorders are frequent, chronic, recurrent, and associated with significant morbidity, functional impairment, and mortality. Three interrelated domains which are crucial furthering our understanding of this disorder will be studied: (1) the longitudinal episodic and chronic course of these disorders and their interrelationship within the developing child. (2) the role of early adversity and stressful life events in initiation and maintenance of depressive and anxiety disorders in this population and the potentialameliorative role of social supports. (3) The developing biological organism with specific measurable systems which appear strongly related to these disorders in children including: (a) frontal brain circuitry involved in withdrawalrelated negative affect, (b) the hypothalamic-pituitary-adrenal system, (c) sleep, (d) serotonergic systems, and (e) growth hormone control. A new sample of children with clinical anxiety disorders, children with clinical depression disorders and normal control children will be studied in three projects examining course, life events, and psychobiology. Those children along with depressed, "high risk" and normal children ascertained and studied psychobiologically in years 01-10 will be followed longitudinally with measures of life events and course. A separate "high risk"cohort of children followed prospectively since age 1 will be studied with sleep and cortisol measures in the home in order to export our work in the lab to a larger, more diverse population and to better understand the effects of very early development. Finally, a juvenile primate model will be used to elucidate the role of anxiety and stress in GH dysregulation and to identify the underlying neural circuity controlling this well replicated finding in these disorders in humans throughout the life span. This program project may lead to better prediction of risk and course and better prevention, treatment, and prophylaxis strategies for depressive and anxiety disorders in children. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 57
•
Project Title: RESPIRATORY PSYCHONEUROBIOLOGY OF ANXIETY Principal Investigator & Institution: Papp, Laszlo A. Assoc. Prof. of Clinical Psychiatry; Psychiatry; Columbia University Health Sciences Ogc New York, Ny 10032 Timing: Fiscal Year 2001; Project Start 6-MAR-1998; Project End 8-FEB-2003 Summary: (Adapted from applicant's abstract): An Independent Scientist Award is requested from NIMH for Dr. Laszlo Papp who completed a SDAC in 1996. During the term of the SDAC the candidate made significant progress in establishing the respiratory psychoneurobiology of anxiety and late-life anxiety disorders as his independent areas of research. His publication record is extensive and includes highly influential original and theoretical papers. He is in charge of two research units, and is the recipient of substantial independent research support including an R01. The proposal for the next five years is a logical continuation and expansion of his work and will critically examine the evidence for respiratory abnormalities being central to panic disorder. First, respiratory challenges will be conducted in the laboratory with sophisticated monitoring and analysis of respiratory parameters in varying cognitive behavioral environments; differences in dynamic and static lung functions between patients and controls will be assessed; and the findings will be correlated with ambulatory in vivo observations of respiration. Second, in order to establish specificity, these experiments will be expanded to include patients with special characteristics with regard to psychiatric and medical diagnoses and gender. Substance specificity will be examined by comparing the effects of different concentrations of carbon dioxide (CO2) inhalation and by optimizing ratings of response. Third, particular attention will be devoted to the effects of aging on the course of anxiety and on the manifestations of respiratory abnormalities through the life-span. Fourth, treatment studies will be conducted in order to assess the correlation of symptomatic improvement and respiration and to compare the effects of cognitive/behavioral and medication treatments on respiration. A comprehensive plan for professional growth focusing on respiratory physiology and geriatrics is also included. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: RODENT MODELS OF ANXIETY DISORDER TREATMENT Principal Investigator & Institution: Barad, Mark G. None; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2002; Project Start 9-SEP-2002; Project End 1-AUG-2005 Summary: (provided by applicant): Pavlovian fear conditioning is an important model both of human anxiety disorders and of learning. Extinction, the gradual reversal of fear conditioning, is similarly the explicit model for behavior therapy, one of the most effective treatments in psychiatry. Extinction of fear is also an important paradigm of active inhibitory learning that appears to depend on NMDA receptors in the amygdala. Despite its importance, the molecular and cellular substrates of extinction remain largely unstudied. The goal of this grant is to explore the molecular and physiological bases of the extinction of fear conditioning. I hypothesize that extinction may share many mechanisms with other forms of long-lasting learning and NMDA-receptor dependent synaptic plasticity. However, differences from other forms of learning will be especially informative, since they may suggest mechanisms specific to extinction. My preliminary studies have identified two such differences. First, massed training is more effective in generating extinction than is temporally distributed training. Our data suggest that extinction results from two opposing behavioral processes, a sensitizing effect of reminders, and a weakening effect of longer exposures to the conditional
58 Anxiety
stimulus. We have also found that extinction, but not acquisition or expression, of conditional fear depends on L-type voltage-gated calcium channels (LVGCC). I now propose 1) To optimize protocols in mice to maximally isolate the weakening (extinction) or sensitization of fear conditioning following presentations of unreinforced conditioned stimuli; 2) To dissect these two processes using systemic and intracerebral drug administration; 3) To explore protocols that generate LVGCC-dependent synaptic changes in amygdala; and 4) To use drugs to correlate such LVGCC-LTP with behavioral extinction. In particular, the project will explore the roles of neurotransmitters and second messengers that have already been implicated in the generation extinction, including adrenergic and dopaminergic, cholinergic and GABAergic systems, and MAP kinase. My goal is an academic career in fundamental neuroscience research with potential for rapid translational application to psychiatric treatment. I plan to pursue this goal focusing on the study of extinction of fear conditioning as an important homologous model of psychiatric treatment, and to develop the pharmacological and physiological skills to maximize my ability to perform a molecular and cellular dissection of this phenomenon. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ROLE OF AMYGDALA IN ETHANOL REINFORCEMENT AND ANXIETY Principal Investigator & Institution: Roberts, Amanda J. Assistant Professor; Scripps Research Institute 10550 N Torrey Pines Rd San Diego, Ca 92037 Timing: Fiscal Year 2001; Project Start 7-SEP-2001; Project End 1-AUG-2006 Summary: One of the primary goals of this 1NIA is to identify behavioral neuroadaptations that occur in the brain reward circuits associated with the extended amygdala and its connections that result in excessive ethanol consumption. In these proposed experiments, a model of excessive ethanol self-administration will be applied to several mouse lines/strains that have unique genotypes hypothesized to be related to the link between ethanol self-administration and extended amygdala function (anxietylike behaviors and reward function following dependence). Mice will be trained to selfadminister ethanol in an operant paradigm, made dependent using an ethanolcontaining liquid diet and then exposed to operant ethanol self-administration during repeated bouts of withdrawal. It is predicted that the development of an association between ethanol self-administration and the attenuation of affective withdrawal symptoms will result in excessive ethanol consumption. It is hypothesized that withdrawal is associated with increased I anxiety-like behavior and increased responsiveness to stressor exposure and that both contribute to increasing ethanol consumption in dependent animals. In addition, neurochemistry within the extended amygdala (central and medial nuclei of the amygdala and the BNST) will be manipulated in order to more directly characterize the role of this circuitry in excessive ethanol consumption. It is hypothesized that the corticotropin releasing factor (CRF) and opioid systems in the amygdala are involved in excessive ethanol selfadministration and anxiety-like behavior in dependent mice. The implication from these findings is that the control of anxiety in alcoholics is extremely important in reducing relapse. The investigation of neuronal systems that mediate anxiety with regard to their contribution to alcohol self- administration may ultimately lead to more effective treatment approaches to the chronically relapsing disease of alcoholism. This INIA makes use of several Genetic Animal Models Core Components, relates well to other INIA UOls, and also will provide input to the Gene Expression, Imaging and the Bioinformatics Cores.
Studies 59
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ROLE OF AMYGDALAR CRF RECEPTORS IN REGULATING ANXIETY Principal Investigator & Institution: Sajdyk, Tammy J. Psychiatry; Indiana Univ-Purdue Univ at Indianapolis 620 Union Drive, Room 618 Indianapolis, in 462025167 Timing: Fiscal Year 2001; Project Start 5-AUG-2001; Project End 1-JUL-2006 Summary: (provided by applicant): The following application is a request for a Mentored Research Scientist Development Award (K0l). The results of this proposal should lead not only to a broader knowledge of anxiety disorders, but also to the intellectual, analytical and technical skills needed to develop into a independent researcher within my chosen career field. The overall objective of the current proposal is to determine the role of corticotropin-releasing factor (CRF) and CRF-like peptides in the basolateral nucleus of the amygdala (BLA) as they relate to anxiety-like behavior. The specific hypotheses to be tested are (1) Acute stimulation of CRF receptors in the BLA by administration of CRF and Urocortin (Ucn) will produce a normal anxiety-like response in rats, (2) Repeated administration of Ucn into the BLA will induce a pathological state of anxiety-like behavior in rats, (3) Repeated administration of Ucn into the BLA of rats will induce intracellular changes similar to that described in calcium calmodulin kinase II-dependent (CaMKII) long-term potentiation (LTP) resulting in a pathological anxiety response, and (4) Repeated activation of CRF receptors in the BLA of rats will produce a long-term facilitation of the anxiety responses resembling a subtype of pathological anxiety, panic disorder. The behavioral paradigms utilized to measure anxiety for each set of experiments will be the social interaction (SI) test, elevated plus maze, and startle response. Microinjections of both agonists and antagonists of CRF receptors will be given into the BLA. The second hypothesis will be addressed by administering repeated injections of sub-threshold doses of a CRF agonist into the BLA. Both Ucn and CRF are able to 'prime' anxiety. Since Ucn has a higher affinity for CRF receptors, it was chosen as the peptide to conduct all the priming studies. To test the third hypothesis, I will administer the NMDA antagonist, AP5, or the non-NMDA antagonist, CNQX, along with Ucn to assess the development of an LTPlike phenomenon. KN-62 or AIP, CaMKII inhibitors, will be administered into the BLA to determine the role of CaMKII in the development of pathological anxiety. In addition, changes in CaMKII phosphorylation states within the BLA will be determined using western blots. Hypothesis four will be tested by determining whether the long term anxiety response seen in Ucn primed rats can be reversed with known anti-panic agents. Since some of my preliminary work has shown that the sodium lactate sensitivity seen in BMI primed animals is mediated via the subfornical organ (SFO, a circumventricular organ)-BLA connection, and it is known that individuals with panic disorder show a sensitivity to sodium lactate, we will examine this pathway in Ucn primed rats. Thus, a group of Ucn primed and sham primed rats will be administered sodium lactate infusions; then, using immunohistochemical staining for the immediate early gene product cfos, the brain areas involved in this abnormal response will be determined. Thus, the study will provide a greater understanding of the underlying neurobiology of pathological anxiety, in particular panic disorder. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: SEROTONERGIC MECHANISMS IN STRESS AND ANXIETY Principal Investigator & Institution: Gingrich, Jay A. Psychiatry; Columbia University Health Sciences Ogc New York, Ny 10032
60 Anxiety
Timing: Fiscal Year 2001; Project Start 1-JUL-1999; Project End 0-JUN-2004 Summary: (from applicant's abstract): The 5-HT2A receptor mediates some of the key effects of serotonin in the central nervous system. In this Mentored Clinical Scientist Development Award, a program of research is outlined that will investigate the role of the 5-HT2A receptor in modulating stress and anxiety responses. Alterations in serotonergic transmission via the 5-HT2A receptor have been implicated in human disorders such as depression, schizophrenia, and anxiety. In animal models the 5-HT2A receptor exhibits opposite effects on anxiety and stress at different times during development. In adults, stimulation of the 5-HT2A receptor appears to increase stress hormone release, increase analgesia and temperature, and increase anxiety-driven behaviors, while blockade of the 5-HT2A receptor acts to reduce these responses. In contrast, during critical periods of early postnatal development, activation of the 5HT2A receptor reduces stress and anxiety responses in adults via increased negative feedback of the HPA axis at the level of the hippocampus. As these mechanisms may play an important role in the development and expression of human stress and anxiety disorders, we propose to study this question with a genetic mouse model of 5-HT2A receptor dysfunction. This 5-HT2A receptor knockout mouse strain will be a useful tool to address the role of this receptor in the development, modulation, and integration of stress and anxiety responses. We propose a series of experiments that will examine the phenomenology and mechanisms of the behavioral and physiologic responses of 2A knockout mice during different stress paradigms. The career development of the candidate during this award will be provided by three outstanding mentors: Rene Hen (for transgenic expertise), Myron Hofer (for behavioral and phsyiological expertise), and Jack Gorman (to provide the candidate with clinical perspectives of anxiety and stress disorders). In addition, collaborative relationships with several experts has also been arranged with members of Dr. Hofer's Division and with Eric Kandel and Michael Meaney outside the Division. From the conduct of this research under their supervision, the candidate will expand his capabilities with advanced methods of transgenic technology, acquire new skills in behavioral and physiological analysis, and maintain an ongoing connection to reciprocal hypotheses that influence thinking in basic and clinical aspects of mental processes. The goal of this award is to generate new insights into the role of the 5-HT2A receptor in processes of stress and anxiety as well as provide the candidate with the continuity of support necessary to develop a program of funded research into basic genetic, neural, and behavioral mechanisms that are relevant for psychiatric disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SEROTONIN 1A RECEPTORS DURING DEVELOPMENT AND ANXIETY Principal Investigator & Institution: Hen, Rene; Associate Professor; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104 Timing: Fiscal Year 2002; Project Start 1-JUL-2002; Project End 0-JUN-2007 Summary: (provided by applicant): Mice lacking the serotonin 1A receptor (5-HT1A receptor knockout) display increased anxiety-like behavior in the open field, elevatedplus maze, and novelty-suppressed feeding tests, and serve as a genetic model of anxiety disorders. In order to determine in which brain region this receptor functions to modulate anxiety-like behavior, we have used gene targeting technology to create mice with conditional expression of the 5-HT1A receptor restricted to the forebrain. These forebrain "rescue" mice behave like wild-type mice in the open field, elevated-plus maze, and novelty-suppressed feeding tests, suggesting that receptor in this region is
Studies 61
sufficient to restore anxiety-like behavior. Turning off expression of the 5-HT1A receptor in these mice would be expected to revert their anxiety-like behavior to that found in knockout animals. Instead, 5-HT1A receptor inducible rescue mice, in which 5HT1A receptor expression was completely turned off during adulthood, continue to behave like wild-type mice suggesting that receptor expression to the adult is not required for normal anxiety-like behavior. This result can be explained if the 5HT1A receptor functions during a critical time period in development to establish normal anxiety-like behavior in the adult. This hypothesis is a radical departure from previous notions of the role of the 5-HT1A receptor in fear behavior, and is the starting point for the proposed investigations. First, the 5-HT1A receptor is hypothesized to be required during the first and second postnatal week (PO-P14) to establish normal anxiety-like behaviors in the adult. The 5-HT1A receptor forebrain rescue mice will be used to define more precisely the critical time period for 5-HT1A receptor function. Second, novel transgenic strategies will be applied to define more specifically the critical tissue mediating the expression of anxiety behavior. Either the cortex, hippocampus, or amygdala are hypothesized to be the critical structures because these regions show receptor expression in the 5-HT1A rescue mice and because of their known involvement in anxiety and depression in rodents and humans. Third, changes in anxiety-like behavior in the knockout and transgenic mice will be associated with changes in the expression of specific genes which mediate the function of the 5-HT1A receptor. An unbiased search for such candidate genes will be performed using gene expression profiling techniques. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SEROTONIN AND CRF PATHWAYS IN ANXIETY & HPA REGULATION Principal Investigator & Institution: Shekhar, Anantha; Professor; Psychiatry; Indiana Univ-Purdue Univ at Indianapolis 620 Union Drive, Room 618 Indianapolis, in 462025167 Timing: Fiscal Year 2003; Project Start 1-DEC-2002; Project End 0-NOV-2007 Summary: (provided by applicant): In this application, we propose to investigate the specific neural systems underlying the mechanisms that may lead to long-term sensitization of one of the 'anxiety regulating networks'. The overall hypothesis for the current proposal is that the state of 'anxiety' (measured by behavioral an physiological responses) in an animal is dependent upon sensitization of a distributed forebrain neural network (that includes the basolateral and central nuclei of the amygdala, bed nucleus of the stria terminalis and others) and a topographically organized serotonergic system in the caudal dorsal raph_ nucleus. The experiments described below have been designed to test this hypothesis under four Specific Aims: 1) To demonstrate that the critical components of the proposed neuronal network, specifically, the corticotropin releasing factor (CRF) containing neurons of BLA, CeA, BNST, and the serotonergic neurons of the dorsal raph_nucleus (DRN), are activated (as measured by c-fos activation) in a variety of 'anxiety' states. 2) To determine that repeated stimulation of CRF receptors, either CRF type 1 or 2 receptors (CRFR1 and CRFR2, respectively) within the above network results in 'priming' of chronic anxiety/stress states. 3) To characterize, using combined anatomical and electrophysiological techniques, the effects of stimulating the CRF receptors on the 5-HT neurons of the caudal DRN in control versus chronically anxious (such as those after repeated CRF stimulation) rate. 4) To determine the effects of early life events such as neonatal lipopolysaccharide (LPS) stress on the BLA, CeA, BNST and DRN network functions. All these studies will be utilizing
62 Anxiety
the following methods: a) whole animal behavioral and physiological responses; b) microinjection and immunohistochemical studies to elucidate pathways; c) patch-clamp studies to determine electrophysiological changes at the neuronal level; as well as d) pharmacological and molecular methods to understand regulation of messenger RNA levels that may contribute to long-term changes in cellular function. This proposal is a direct result of a NIMH research network development grant, HPA Regulation: CrossDisciplinary Research Networks (RO3 MH 60825) and has provided us with an opportunity to demonstrate the feasibility of this proposed international collaboration. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SMOKING AND ANXIETY IN POSTTRAUMATIC STRESS DISORDER Principal Investigator & Institution: Beckham, Jean C. Associate Professor; Psychiatry; Duke University Durham, Nc 27706 Timing: Fiscal Year 2001; Project Start 0-SEP-1998; Project End 1-JUL-2003 Summary: The relationship between anxiety and smoking in high-risk subgroups, such as patients with Post-traumatic Stress Disorder (PTSD), has received little empirical attention. Preliminary research indicates that 60% of PTSD combat veterans smoke, and that during a laboratory stressor, PTSD patients report greater smoking withdrawal symptoms in response to trauma- related Stroop cards. These results suggest that trauma-related material may serve as a cue for smoking in PTSD combat veterans. The first purpose of this proposal is to determine whether increased craving for cigarettes after Vietnam words occurs in veterans with PTSD as compared to veterans without PTSD or GAD patients, and whether PTSD patient groups experience greater relief from their symptoms, including PTSD reexperiencing and hyper-arousal symptoms after smoking. A well-established script-driven imagery procedure will be utilized to examine the effect of different scripts (disorder-related, general stress, neutral) across study groups, and the effect of nicotine on symptom reduction. The second purpose of this proposal is to explore the link between anxiety and smoking in the natural environment by comparing study groups. Subjects will monitor their smoking using an ambulatory heart rate monitor and diary. Besides potentially confirming parallel laboratory and real-world data on a relationship between anxiety and smoking, a naturalistic observation study will allow examination of whether the association between smoking and anxiety is due to other circumstances which co-occur with both anxiety and smoking. The ultimate goal of this research is to identify risk factors in subgroups of smokers who are at risk for increased smoking and difficulty in smoking cessation that could lead to important prevention and intervention efforts. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: SOCIAL ADOLESCENCE
ANXIETY
AND
ALCOHOL
INVOLVEMENT
IN
Principal Investigator & Institution: Tomlinson, Kristin L. Psychology; University of California San Diego 9500 Gilman Dr, Dept. 0934 La Jolla, Ca 92093 Timing: Fiscal Year 2002; Project Start 0-SEP-2002 Summary: (provided by applicant): There is mixed evidence regarding the relationship between social anxiety and alcohol use in adolescence, with some studies showing elevated risk and other studies indicating that social anxiety may protect against alcohol use. The proposed project intends to test whether there is a curvilinear relationship between social anxiety and alcohol use in early adolescence. In this model, moderate
Studies 63
levels of social anxiety are hypothesized to be positively correlated, and high levels negatively correlated with alcohol use. Motivation to affiliate with peers and "social behavior change" alcohol expectancies are hypothesized to moderate the relationship between social anxiety and alcohol use in early adolescence. Data from seventh and eighth grade students will be collected to examine these hypotheses during a period when social anxiety peaks for youth. Quadratic regression analyses will be used to examine the relationship between social anxiety and alcohol use. Hierarchical regression analyses run separately for males and females will be used to determine moderator impact. This research has potential to provide critical information for understanding how social anxiety is involved in the development of alcohol involvement in adolescence, and can help to interpret inconsistencies in the extant literature. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SOCIAL ANXIETY AND THE DIRECTION OF ATTENTIONAL FOCUS Principal Investigator & Institution: Kashdan, Todd B. Psychology; State University of New York at Buffalo 402 Crofts Hall Buffalo, Ny 14260 Timing: Fiscal Year 2001; Project Start 0-SEP-2001 Summary: (provided by applicant): The proposed research plan seeks to investigate the effects of social anxiety and attentional focus on positive affect (PA), curiosity, interpersonal closeness, and negative affect (NA) via experimental designs and treatment outcome studies. Socially anxious (SA) individuals tend to be preoccupied with negative thoughts, including expectations of being rejected, potentially interfering with their ability to be attentive and responsive during social interactions. In social interactions, listening and responding are important ingredients that lead to reciprocal self-disclosure and intimacy. Excessive self-focused attention may prevent attention from being allocated outward, toward other people, potentially impairing the quality and enjoyment of social interactions. The primary experimental study will test the hypotheses that: (1) self-focused attention will amplify the relationship between high-SA and low levels of PA, curiosity, poor social performance, and high NA during social interactions, (2) self-focused attention will amplify differences between high and low-SA groups for ratings of affect, self-disclosure, and social skills as measured by confederates and independent raters, (3) immediately following and the day after interactions, highSA individuals will demonstrate greater ruminative post-event cognitive processing and recall biases to negative stimuli relative to low-SA individuals. To test these hypotheses, an interpersonal closeness-generating experimental task, previously validated in a pilot study, will be employed. High and low-SA students will interact with same-sex confederates trained in standardized scripted roles. All participants will take part in both a self and external-focus experimental manipulation. In the self-focus condition, participants will answer questions while a camera is directed at them. In the externalfocus condition, participants will ask questions with the camera focused on the confederate. A secondary study is planned to test the potential moderating role of selffocused attention on symptom reduction and affectivity during the course of a cognitive-behavioral group treatment for depression. Comparisons will be made between individuals with depression vs. comorbid depression and social anxiety disorder. The overarching goal of this research is to identify the potential contributing role of attentional focus to the affect, motivation, and interpersonal behavior of SA individuals. A better understanding of these mechanisms could ultimately lead to the development of treatment modules designed to re-train attention from a self-orientation to a better balance of positively-valenced self and other orientation.
64 Anxiety
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SOCIAL ANXIETY IN NATIVE AMERICAN ADOLESCENTS Principal Investigator & Institution: West, Amy E. None; University of Virginia Charlottesville Box 400195 Charlottesville, Va 22904 Timing: Fiscal Year 2001; Project Start 7-SEP-2001 Summary: The primary goal of this study is to complete an analysis of the experience of social anxiety in a sample of rural Native American adolescents. Central to this proposal is the idea that individual and contextual factors interact to determine the risk for psychopathology in development. Individual factors, such as behaviorally inhibited temperament -- an early appearing, and stable tendency towards being shy, fearful, and easily upset in unfamiliar environments -- have been found to relate to the development of social anxiety in. adolescence (Mick & Telch,.1.998;.Hayward,.Killen,.Kraemer & Taylor, 1998). The nature of this association, however, and its contribution within an ecological context that also includes familial, peer, and community factors, has not been established. This project proposes multivariate analyses of the individual personality and familial, social, and cultural/community contexts in their contribution to the development of social anxiety in young adolescents. A community-based sample of rural Native American adolescents will allow for the particularly unique analysis of how culture and ethnic identity may play a role in the risk for social anxiety. Results from this study may allow for the specifications of multiple models of risk in this population, including differentiation between types of social anxiety and their specific characteristics, and nature of the associations among relevant individual and contextual factors in the prediction and experience of adolescent social anxiety. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: SPACIAL AND TEMPORAL ROLE OF THE 5-HT1AR IN ANXIETY Principal Investigator & Institution: Dulawa, Stephanie C. Ctr for Neurobiology Behavior; Columbia University Health Sciences Ogc New York, Ny 10032 Timing: Fiscal Year 2002; Project Start 3-MAR-2003; Project End 0-NOV-2005 Summary: (provided by applicant): This proposal aims to examine the role of 5-HT1A receptor in modulating anxiety. We aim to determine the brain region and developmental time point during which 5-HT1A receptors establish normal or "wildtype" (WT) anxiety levels for the lifetime of the animal. The proposed studies stem from our findings using inducible 5-HTIA rescue (1AR) mice, which conditionally express 5HTIA receptors only in certain postsynaptic sites. Our findings suggest that the expression of postsynaptic 5-HT1A receptors is required sometime between postnatal days 5 and 21 for mice to exhibit WT rather than 5-HT1A knockout (1AKO) (increased) anxiety levels in adulthood. We will use a combination of molecular biological and behavioral tools to test our hypotheses. We propose to further behaviorally characterize the existing 1AR mice to more narrowly define the critical time for the 5-HT1A receptor to establish WT anxiety levels. We also propose to generate multiple novel 1AR lines using the bacterial artificial chromosome (BAC) strategy to dissect more precisely where and when the lasting effect on anxiety levels, established by the 5-HTIA receptor, takes place. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 65
•
Project Title: STRESS AND 5-HT1B AUTORECEPTORS IN MODELS OF ANXIETY Principal Investigator & Institution: Clark, Michael S. Psychiatry and Behavioral Scis; University of Washington Seattle, Wa 98195 Timing: Fiscal Year 2002; Project Start 1-JUL-2002 Summary: (provided by applicant): Serotonin (5-HT)1B autoreceptors are localized in the axon terminals of serotonergic neurons and provide feedback inhibition of serotonin synthesis and release. However, 5-HT1B receptors are expressed in many neuron types, making pharmacological analysis nearly unable to discern which populations produce a particular behavioral or physiological effect. This has led to confusion about their role in depressive and anxiety symptoms associated with impaired serotonergic neurotransmission. Most 5-HT fibers projecting to regions involved in these functions arise from the dorsal (DRN) or median (MRN) raphe nuclei, but there is considerable uncertainty as to how 5-HT release from these nuclei is controlled in disease states. We have been using viral gene transfer to examine the effects of DRN 5-HT1B overexpression on stress-sensitivity in two anxiety-related behaviors - open field test (OFT) and elevated-plus maze (EPM). In agreement with previous results showing increased DRN 5-HT1B expression in learned helpless rats, we found 5-HT1B overexpression in DRM increases anxiety behaviors. I propose to extend these studies to examine effects of 5-HT1B overexpression in the MRN, where I anticipate increased magnitude of EPM effects due to the involvement of MRN in benzodiazepine actions in this assay. To further establish the role of increased 5-HT1B autoreceptor expression in these effects, I will determine if SB-224289, a 5-HT1B antagonist reverses them. Finally. I will examine the effects of a key modulator of stress, corticotropin releasing factor (CRF), on 5-HT1B expression in the DRN. Since DRN and amygdala are reciprocally connected via 5-HT and CRF, investigating the functional relationship between CRF and 5-HT1B autoreceptors may help explain the interactions that these brain regions have in fear and anxiety behaviors. CRF has complex effects on 5-HT release from DRN projections, perhaps because both CRF receptors (R1 and R2) are expressed in DRN. CRF-R1 appears to inhibit 5-HT release, while CRF-R2 is excitatory. We propose to investigate the effect of subchronic infusion of selective CRF agonists into DRN on 5-HT1B mRNA regulation and anxiety behaviors. Chronic R1 activation should accordingly decrease 5-HT1B expression in DRN while increasing anxiety related behavior, while chronic R2 activation should produce the opposite effects. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: STRESSOR CONTROLLABILITY: ANXIETY AND SEROTONIN Principal Investigator & Institution: Maier, Steven F. Professor; Psychology; University of Colorado at Boulder Boulder, Co 80309 Timing: Fiscal Year 2001; Project Start 1-APR-1993; Project End 1-MAR-2002 Summary: The degree of behavioral control which an organism has over a stressor (ability to alter the onset, termination, duration, intensity, or temporal pattern of the event) is an important determinant of the behavioral and physiological impact of the stressor. Numerous behavioral, neurochemical, hormonal, and immunological changes follow exposure to a stressor if it is uncontrollable, but not if the identical stressor is controllable. Effects such as these which depend on the uncontrollability of a stressor have been called "learned helplessness effects." They have played an important role in psychological theory, in understanding the physiology of stress, in understanding the environmental regulation of endogenous pain modulation mechanisms and immune function, and have been proposed to be involved in the etiology of numerous human
66 Anxiety
disorders. Depression, anxiety disorders, and post-traumatic stress disorder are but examples. Despite the seeming importance of stressor controllability and the considerable amount of research that has ben directed at explaining its operation, there is still no adequate general explanation at either the behavioral or physiological level. The present proposal is designed to directly test an integrated behavioral and physiological explanation of learned helplessness effects that has emerged during the previous grant period. This hypothesis includes both a description of the immediate neurochemical effects of uncontrollable stressors as well as a putative set of mechanisms for how the behavioral sequalae of such stressors are produced. At a behavioral level the critical argument is that uncontrollable stressors produce intense "anxiety" that dissipates over a 3-5 day period, and that many of the behavioral consequences of these stressors reflect this state of anxiety. At a physiological level it is argued that this state of anxiety involves a temporarily hyper-responsive serotonergic (5-HT) system originating from the dorsal raphe nucleus (DRN) and that the diverse behavioral outcomes of exposure to uncontrollable stressors are produced by excessive 5-HT released in projections of the DRN. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: RESPONSES
TACHYKININ
REGULATION
OF
ANXIETY
AND
STRESS
Principal Investigator & Institution: Heath, Mark J. Anesthesiology; Columbia University Health Sciences Ogc New York, Ny 10032 Timing: Fiscal Year 2002; Project Start 1-SEP-2002; Project End 1-AUG-2007 Summary: A major goal of surgical and anesthetic care is to control the physical and emotional stresses that occur before, during, and after surgery. The human body uses systems of hormones and neurotransmitters to mediate stress responses; by identifying and characterizing these systems it may be possible safely and effectively to reduce the stress of surgery and improve clinical outcomes. We previously generated a line of mice that are lacking the gene for the neurokinin 1 (NK1) receptor, a protein that belongs to a family called the tachykinin receptors. Mice that lack the NK1 receptor display greatly decreased anxiety in a series of behavioral tests. We have recently developed evidence suggesting that two brain nuclei, the locus coeruleus and the dorsal raphe nucleus, may be the sites at which NK1 receptors mediate anxiety and stress responses. These nuclei provide projections throughout the brain and release the neurotransmitters norepinephrine and serotonin. Additional evidence suggests that another tachykinin receptor, the neurokinin 2 (NK2) receptor, may also regulate anxiety in these nuclei. This proposal aims to test the hypothesis that NK1 and NK2 receptors located in the locus coeruleus and dorsal raphe nucleus regulate anxiety and stress responses by influencing the activities of these nuclei. The neuropeptides that bind to NK1 and NK2 receptors, substance P and neurokinin A, are present in the locus coeruleus and dorsal raphe nucleus, but the locations of the neurons that produce these transmitters are not known. Another goal of this proposal is to define the circuitry that underlies the anxiolytic effects of tachykinins in these nuclei. This research will provide a better understanding of the neural and endocrine systems that contribute to the stress of surgery, which may in turn contribute to the development of therapeutic interventions that improve surgical and anesthetic outcomes. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 67
•
Project Title: THE ANTECEDENTS AND IMPLICATIONS OF INTERGROUP ANXIETY Principal Investigator & Institution: Plant, E A. Psychology; Florida State University 118 North Woodward Avenue Tallahassee, Fl 323064166 Timing: Fiscal Year 2002; Project Start 1-JUN-2002; Project End 1-MAY-2003 Summary: The proposed work examines the factors that influence the course of interracial interactions. Research on intergroup relations has highlighted the importance of intergroup anxiety in determining people's responses toward outgroup members. Drawing upon previous theorizing from both the prejudice and social anxiety literatures, the proposed work offers a model of the antecedents and implications of anxiety in interracial interactions. Specifically, it is argued that intergroup anxiety results from a lack of positive previous experiences with outgroup members, negative expectation about the corse of interracial interactions, and a lack of personal motivation to respond without bias toward outgroup members. Further, this anxiety is posited to result in heightened hostility toward outgroup members and a desire to avoid interacting with outgroup members, particularly among people who are not personally motivated to respond without prejudice. Intergroup anxiety creates stress in people live's and can result in avoidant coping styles both of which have negative implications of people's psychological well-being. Avoidance of outgroup members can lead to feelings of social isolations among those people who are avoided, which has negative psychological and health-related implications. In addition, if anxiety results in hostility toward outgroup members, this hostility could be stressful for outgroup members and threaten their self-esteem. The proposed work tests the casual relationships in the model using a longitudinal survey approach and a laboratory experiment to examine by developing strategies and interventions to reduce anxiety and the concomitant avoidance, and hostility in interracial interactions. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: THE CLASSIFICATION OF ANXIETY DISORDER Principal Investigator & Institution: Brown, Timothy A. Research Associate Professor; Psychology; Boston University Charles River Campus 881 Commonwealth Avenue Boston, Ma 02215 Timing: Fiscal Year 2002; Project Start 1-APR-1984; Project End 0-NOV-2006 Summary: Most empirical evaluation of diagnostic systems of emotional disorders (e.g., DSM-IV) has occurred at the categorical/descriptive level (e.g., diagnostic reliability and comorbidity) or has examined categories in isolation of related disorders. These findings provide little information on the validity of our nosology and the validity of conceptual models of the etiology, nature, and course of emotional disorders. Expanding on our recent work, research in the next project phase will test hypotheses pertaining to structural models of anxiety and mood disorders and trait variables implicated in the etiology, comorbidity, expression, and course of these disorders. Over 1,750 patients will be assessed using the Anxiety Disorders Interview Schedule: Lifetime version and associated instruments of key features of anxiety and mood disorders and measures of core temperament and personality (e.g., negative affect, behavioral inhibition). Dimensional measures of DSM-IV disorder features and personality, collected crosssectionally and longitudinally, will be submitted to structural equation modeling to test competing models of the latent structure of DSM-IV emotional disorders, trait personality constructs, and their interrelationships. These studies will provide the first large- scale comparative evaluations of models of trait vulnerability and the influence of
68 Anxiety
such constructs on the course of emotional disorders. Further analyses will evaluate the generalizability of the DSM-IV structure and its relationships with higher-order personality dimensions across races, sexes, and ages. Longitudinal analyses will examine the covariation of disorder and personality constructs as a function of psychosocial treatment and across two-year follow-up. Collectively, findings will indicate: (a) the shared, and specific dimensions of anxiety and mood disorders; (b) the possible treatment resiliency of higher-order personality dimensions influencing the course of disorders; (c) important reconceptualizations of personality models of emotional disorders; (d) refinements to the diagnostic definitions of emotional disorders and their cross-cultural aspects in DSM-V. This work will enhance and complement biological approaches to these issues by suggesting a more valid and robust set of disorder and personality constructs on which to base investigations such as familial, genetic, and etiologic studies-these data will foster a fuller integration of biological and psychological approaches to the structure and pathogenesis of emotional disorders. Taxometric studies will be conducted on selected DSM-IV disorders and personality constructs to examine whether these phenomena operate on a continuum or as taxa. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DISORDERS
THE
GENETIC
EPIDEMIOLOGY
OF
JUVENILE
ANXIETY
Principal Investigator & Institution: Foley, Debra L. Assistant Professor; Human Genetics; Virginia Commonwealth University Richmond, Va 232980568 Timing: Fiscal Year 2001; Project Start 1-JUL-2000; Project End 0-JUN-2003 Summary: (Adapted from the Applicant's Abstract): Childhood psychiatric disorders demonstrate a discernable developmental chronology; certain juvenile anxiety disorders typically onset earlier than behavioral disorders, which typically onset earlier than affective disorders. Childhood anxiety disorders therefore represent one of the earliest expressions of psychopathologic risk. The relevance of early onset anxiety disorders for consequent juvenile and adult mental health is, however, poorly understood. Developmental genetic epidemiology provides a framework for identifying the continuities and discontinuities in genetic and environmental risk factor effects on the chronology of comorbidity by exploiting the information contained in the pattern of disorder overlap within and across time, within individuals and between relatives of different ages. We plan to analyze longitudinal data already collected at personal interview with a large population-based sample of juvenile twins and their parents to develop a detailed understanding of the developmental genetic epidemiology of the more common juvenile anxiety disorders (separation anxiety, overanxious disorder, phobias). Analyses of multi-wave data collected from an epidemiologic sample of twinfamilies will permit identification of (1) the genetic, familial environmental and individual-specific environmental influences on transient versus persistent disorder, (2) the continuity or discontinuity of these risk factors with those for contemporaneous and consequent risk for other anxiety, behavioral and affective disorders, and (3) the maternal and paternal psychiatric disorders associated with the familial transmission of risk. Identification of the genetic and environmental risk factors that underlie developmental trajectories and endpoints of early juvenile psychopathology will guide intervention and prevention efforts designed to minimize the progression and chronicity of mental disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 69
•
Project Title: TREATING ANXIETY IN PUBLIC SECTOR MEDICAL SETTINGS Principal Investigator & Institution: Roy-Byrne, Peter P. Professor; Psychiatry and Behavioral Scis; University of Washington Seattle, Wa 98195 Timing: Fiscal Year 2003; Project Start 1-DEC-2002; Project End 0-NOV-2007 Summary: (provided by candidate): This is a mid-career investigator award in patientoriented research that is designed to strengthen my research and further the development and growth of young investigators in the application of evidence based treatments, especially for anxiety disorders, in public sector medical settings. Poor and medically disadvantaged populations are clearly underrepresented in research studies, especially in treatment studies. We clearly need more clinical investigators to work in these settings and with these populations. There also is a need for public sector research infrastructures that will support state-of-the-art research. Finally, given the deficiencies in quality of care for anxiety disorders in most medical settings, but especially the public sector, we need to know how to best tailor and deliver evidence-based treatments. My three goals for this Mid-Career Investigator Award in Patient-Oriented Research (K24) are therefore (1) to crystallize a new career research focus in translational research that would increase the relevance, speed the development, and facilitate the utilization of research-focused treatments and services interventions for anxiety disorders in the public sector medical setting; (2) to create a practice infrastructure that supports state-ofthe-art research on the application of evidence based treatments in public sector medical settings; (3) to mentor junior investigators interested in research on the application of evidence-based treatments in the public sector. My broad background in clinical research will allow me to relate to the developing clinician-scientist across multiple levels of research interest and to steer them toward the field of services research. As my skills in this latter area evolve over the course of this award, I hope to be able to mentor them even more effectively in this specific area as well. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: TREATMENT EFFECTIVENESS FOR ANXIETY AND DEPRESSION Principal Investigator & Institution: Lang, Ariel J. Psychiatry; University of California San Diego 9500 Gilman Dr, Dept. 0934 La Jolla, Ca 92093 Timing: Fiscal Year 2002; Project Start 1-FEB-2002; Project End 1-JAN-2007 Summary: (provided by applicant): This Mentored Patient-Oriented Research Career Development Award will support the career development of the candidate in the area of mental health service research under the primary mentorship of Dr. Robert Kaplan at the University of California San Diego. This area is new to the candidate, and this award will provide training and mentorship necessary for her to develop into an independent mental health services researcher. The training plan includes (1) coursework in epidemiological methods, issues in health services, advanced statistical techniques and responsible conduct of research, (2) weekly seminars in services research, (3) regular consultation and directed readings with experienced researchers in this area, and (4) supervised experience in carrying out services research. The proposed research is intended to both build on the candidate's past experience and integrate new knowledge. The research will be to study the effectiveness of mental health intervention in the primary care setting in two phases. In the first phase, the outcomes of a brief cognitivebehavioral intervention for co-occurring symptoms of anxiety and depression will be compared to outcomes from the care that is normally received in primary care. Measured outcomes will include psychiatric symptoms, health and functional status, quality of life, patient satisfaction, and cost. The second phase of research will involve
70 Anxiety
pilot studies and preparation of a research project grant (RO1) application to test the generalizability of this intervention to community settings with administration by nonexpert clinicians. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: TREATMENT OF CHILD ANXIETY IN NONPSYCHIATRIC SETTINGS Principal Investigator & Institution: Masia, Carrie L. Psychiatry; New York University School of Medicine 550 1St Ave New York, Ny 10016 Timing: Fiscal Year 2002; Project Start 1-MAY-2002; Project End 0-APR-2007 Summary: Description (provided by applicant): Anxiety disorders in youth are highly prevalent and associated with long-term negative consequences (e.g., depression, substance use). Yet, these disorders often go unidentified and untreated. The purpose of this application is to address this problem by developing skills to implement and evaluate early detection and intervention programs for child anxiety disorders in nonpsychiatric settings, including schools and pediatric medical settings. To accomplish these goals, a career development plan has been designed to: (1) obtain training in efficacy and effectiveness research methods, (2) adapt empirically-supported assessments and treatments for school and medical settings, (3) learn about the barriers to screening and intervention for anxiety disorders in these environments, and (4) receive training in statistical methods applied to naturalistic assessment, longitudinal data, and evaluation of clinical trials. Training will be provided via formal coursework, supervision and consultation with a panel of experts, and a research plan that complements the career development activities outlined in this application. The proposed research project will evaluate the relative efficacy of a manualized schoolbased cognitive-behavioral intervention to an attention control condition for adolescents with social anxiety disorder in a 2 (intervention condition) by 3 (pre-intervention, postintervention, follow-up) mixed model factorial design with random assignment to condition and repeated measures on the second factor. It is expected that school-based cognitive-behavioral intervention will lead to significantly greater reduction of social phobia symptoms and greater improvement in general functioning than a non-specific intervention, and that these relative advantages will persist over time. Findings from this study will be used to inform the Candidate's application for an RO1 to conduct a full-scale study, and to guide the development of intervention programs in pediatric clinics. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: TREATMENT CHILDHOOD
OF
SEPARATION
ANXIETY
DISORDER
IN
Principal Investigator & Institution: Pincus, Donna B. Psychologist; Psychology; Boston University Charles River Campus 881 Commonwealth Avenue Boston, Ma 02215 Timing: Fiscal Year 2002; Project Start 7-AUG-2002; Project End 1-JUL-2007 Summary: (provided by applicant): This application is a request for a Mentored PatientOriented Research Career Development Award (K23) from the NIMH to foster the academic career development of the applicant, Donna B. Pincus, Ph.D. The applicant will work closely with her primary mentor, Dr. David Barlow, and co-mentors, Dr. Sheila Eyberg, Dr. Thomas Ollendick, Dr. Anne Marie Albano, and Dr. Simon Budman, to develop expertise in conducting clinical research to establish innovative and efficacious interventions for young children with anxiety disorders. In a career
Studies 71
development plan spanning five years, the applicant has delineated specific short-term and long-term goals to prepare her for a patient-oriented research career. Short term goals include obtaining additional didactic training and mentoring in several "core" areas that have been chosen to deepen her existing skills as well as expand her skills into new areas. The applicant's long term goals are to develop a programmatic line of research that is focused on developing efficacious, innovative treatments for childhood anxiety disorders, and to launch a highly productive research career as a clinical scientist. A formal research plan is proposed to investigate the most prevalent, yet most under-researched anxiety disorder in childhood: Separation Anxiety Disorder (SAD). Despite growing evidence that SAD is prevalent in young children and linked to later psychopathology, there have been few treatment studies investigating the efficacy of interventions for SAD; those that do exist typically have not included young children. Recent experimental evidence highlights the potential clinical utility of incorporating parents more centrally in the treatment of childhood anxiety disorders. The primary goal of the proposed research plan is to apply an existing, empirically supported parent training intervention (Parent-Child Interaction Therapy; PCIT) to the treatment of children ages 4-8 with SAD. Although originally designed as a treatment of oppositional children, PCIT incorporates each of the skills anxiety researchers have indicated as essential training components for reducing child anxiety, and thus, is expected to be effective in reducing children's separation fearful behaviors and in promoting improved parent-child interactions. The specific goals of this project are: (1) to evaluate the efficacy of PCIT for reducing separation anxious behaviors in young children (2) to assess long term maintenance of change at 3, 6, and 12 months following treatment (3) to investigate potential mechanisms of improvement. This research project will be the first controlled clinical trial that has been conducted with very young children with separation anxiety, and thus, will begin to fill in a significant gap in our knowledge of this at-risk population. This project will provide the applicant with a solid foundation of skills for the continued development of innovative, empirically validated interventions for children with anxiety disorders and their families. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: TREATMENT OUTCOMES FOR CHILDREN WITH ANXIETY DISORDERS Principal Investigator & Institution: Rynn, Moira A. Psychiatry; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104 Timing: Fiscal Year 2001; Project Start 2-AUG-2000; Project End 1-JUL-2005 Summary: This application proposes Moira A. Rynn, M.D. for a Mentored PatientOriented Research Career Development Award at the University of Pennsylvania. The aims of this program include: 1) to support my development into an independent research scientist; 2) to support and enhance my development as an investigator in anxiety disorders in children and adolescents; 3) to develop my ability to use my clinical experience to design and execute a protocol that will answer a proposed research question; and 4) to provide the groundwork for the preparation of an RO1 grant application based on the research performed during the award period. These aims will be accomplished through a structured four-part plan: 1) to complete a Master's of Science of Clinical Epidemiology, a program of formal academic courses and tutorials to enhance my research skills, under the supervision of Dr. Brian Strom; 2) to obtain research training and mentoring by a senior scientist who will serve as my sponsor (Karl Rickels, M.D.) as well as by a co-sponsor (Edna Foa, Ph.D) and collaborators (Elizabeth Weller, M.D., Irwin Lucki, Ph.D., John March, M.D., M.P.H., Brian Strom, M.D., M.P.H.,
72 Anxiety
and Philip C. Kendall, Ph.D., ABPP); 3) to participate in several ongoing psychopharmacological trials for anxiety and depression in both children and adults in the Mood and Anxiety Disorders Section; and 4) to design and execute an original clinical research treatment protocol. Children aged 8 to 12 years and 11 months who meet the diagnosis of generalized anxiety disorder, separation anxiety disorder, or anxiety disorder nos will enter a randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of 50 mg sertraline per day (Pt N = 60). I also will evaluate the moderating effect the presence of parental psychopathology has on the child's level of impairment, onset of disorder and response to medication treatment. Families will be followed for one year to collect for further research. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: TWIN COMORBIDITY
STUDY
OF
SEPARATION
ANXIETY
DISORDER
Principal Investigator & Institution: Cronk, Nikole J. Psychological Sciences; University of Missouri Columbia 310 Jesse Hall Columbia, Mo 65211 Timing: Fiscal Year 2003; Project Start 1-JUN-2003; Project End 1-MAY-2005 Summary: (provided by applicant): Comorbidity among anxiety and depressive disorders has been well documented, yet the etiological pathways contributing to this comorbidity are not clearly understood. Most of the research regarding the genetic and environmental sources of comorbidity among these disorders has been conducted using adult samples and suggests that genetic and nonshared environmental sources of covariation are important. Relatively little is known about the behavioral genetic aspects of comorbidity among anxiety and depressive disorders in children and adolescents. In an effort to extend the current knowledge regarding the comorbidity of internalizing disorders to younger populations, the proposed research will employ data from a large population-based sample of female twins to explore the comorbidity among Separation Anxiety Disorder (SAD), Depression (DEP) and Generalized Anxiety Disorder (GAD) and parse the sources of comorbidity into latent genetic and environmental factors using multivariate genetic analyses. In addition, the proposed research seeks to further clarify the nature of comorbidity of SAD with DEP and GAD by including measured personality (introversion and neuroticism) and environmental characteristics (socioeconomic disadvantage and paternal absence) in multivariate genetic analyses. Advances have been made in the study of comorbidity as well as personality and environmental characteristics as risk factors for internalizing disorders among youth; yet, these areas of study remain largely independent of one another. The proposed project seeks to integrate these areas of investigation. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: USING AL TO ENHANCE VR ANXIETY DISORDER TREATMENT Principal Investigator & Institution: Santos, Eugene;; Argus Vr International 270 Farmington Ave, Ste 202 Farmington, Ct 06032 Timing: Fiscal Year 2002; Project Start 7-SEP-2002; Project End 6-MAR-2003 Summary: (provided by applicant) This project will develop an artificial intelligence to provide the core functionality for virtual reality and computer based treatments for anxiety disorders. The use of artificial intelligence offers a number of advantages over existing treatments: (1) artificial intelligence provides personalized treatment - using multiple real time physiologic and subjective anxiety feedback loops, it adjusts exposure stimuli "on the fly" to maximize outcome, (2) as an autonomous system, it has the
Studies 73
potential to be used safely in a wide range of applications from therapist guided interventions to minimal therapist contact interventions to self guided treatment, (3) it is adaptive and flexible, continuously learning what works and doesn't work, applying those changes in real time, and storing them for later use, (4) it can monitor levels of presence and adjust patient/exposure variables to ensure the depth of presence necessary to benefit from virtual reality treatments, and (5) it has the potential to increase retention in treatment by monitoring factors that predict drop out and adjusting exposure to minimize their effect. During Phase I eighty phobic and nonphobic participants will be used to build, assess, and validate the artificial intelligence. This is the first application of artificial intelligence to virtual reality treatments for anxiety disorders. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: VASOPRESSIN RECEPTORS, SOCIAL BEHAVIORS, & ANXIETY Principal Investigator & Institution: Bielsky, Isadora F. Psychiatry and Behavioral Scis; Emory University 1784 North Decatur Road Atlanta, Ga 30322 Timing: Fiscal Year 2003; Project Start 6-MAR-2004 Summary: (provided by applicant): Vasopressin (AVP) is a peptide produced in the brain and released both centrally and peripherally. The central actions of AVP include effects on both social and non-social behaviors. Two main subtypes of AVP receptors exist in the brain, namely V1alpha and V1beta. It is unclear via which receptor subtype AVP acts to affect these behaviors. Understanding the mechanisms behind AVP's effects on anxiety and social recognition is particularly important given the relationship between these behaviors and human disorders such as anxiety disorder and autism. The aims of this proposal are to use mice with a null mutation in the V1alpha receptor (V1aRKO) to better understand how AVP affects anxiety and social behavior. In the first aim, the V1aRKO mice will be behaviorally and neurochemically phenotyped to assess the effects of a null mutation in the V1aR. In the second aim, differences in c-fos-IR between the V1aRKOs and WT animals will be used to determine neuroanatomical regions involved in anxiety and social behavior. In the third aim, a V1aR viral vector will be used to re-express the V1aR in specific neuroanatomical regions, in an attempt to alter the anxiety and social behavior of the KO mice. These experiments will further our understanding of the mechanisms involved in AVP mediated anxiety and social behavior. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: VENTILATORY PHYSIOLOGY IN CHILDREN AT RISK FOR ANXIETY Principal Investigator & Institution: Klein, Rachel G. Professor; Psychiatry; New York University School of Medicine 550 1St Ave New York, Ny 10016 Timing: Fiscal Year 2001; Project Start 8-SEP-1999; Project End 1-MAY-2003 Summary: The proposed investigation addresses the biology of risk for anxiety disorders. It derives from important parallel scientific concerns regarding the association between adult and child anxiety disorders, coupled with concerns regarding the mechanisms which underlie this association. The study specifically evolves from findings that link childhood separation anxiety disorder (SAD) and adult panic disorder (PD). These findings include: family studies noting elevated rates of SAD in offspring of adults with PD; longitudinal studies linking childhood SAD to adult PD; and biological studies finding CO2-hypersensitivity in children with SAD. CO2-hypersensitivity is also
74 Anxiety
found in both adults with PD and non-ill adult relatives of patients with PD. Taken together, these findings point to the existence of a latent vulnerability to PD reflected in the respiratory system. We propose to examine respiratory function in children at high risk for panic disorder. Major hypotheses are that at risk children, compared to controls, exhibit more variable respiration and hypersensitivity to CO2 exposure as manifested by greater symptomatic and physiologic responses to the inhalation of 5 percent of CO2. We hypothesize that such abnormalities will occur among offspring even in the absence of an anxiety disorder. Aims are addressed through the study of ventilatory measures in offspring, ages nine-to-17, of adults with PD, as compared to offspring of adults with a) social phobia but not panic disorder, b) major depression but neither panic disorder nor social phobia, and c) no mental disorder. A total of nearly 350 children and their parents have been systematically assessed in an ongoing diagnostic study of children at highrisk for anxiety. In the proposed work, diagnosis will be updated with separate interviewers for each family member. Children will undergo a CO2 inhalation procedure in their home with a validated apparatus. Outcome measures consist of: i) pre-experimental respiratory variability, as well as ii) the symptomatic, and iii) physiological response to CO2. A series of studies conducted by the investigative team finds that these factors distinguish adults with PD and children with SAD from relevant contrast groups. Respiratory variables will be rated blind to parental and child diagnosis. The inclusion of offspring from pathological comparison groups, together with offspring of normals, provides a rigorous test of hypothesized diagnostic specificity in the relationship between respiratory factors and anxiety in both children and adults. The proposed study follows naturally from the investigative team's prior work and capitalizes on the availability of a well-characterized sample. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: VIDEO FEEDBACK/COGNITIVE PREPARATION FOR SPEECH ANXIETY Principal Investigator & Institution: Rodebaugh, Thomas L. Psychology; University of North Carolina Chapel Hill Office of Sponsored Research Chapel Hill, Nc 27599 Timing: Fiscal Year 2001; Project Start 5-SEP-2001 Summary: Models of social phobia suggest that unrealistically negative self- perceptions of performance are a significant factor in the maintenance of chronic social anxiety. Recent evidence has suggested that videotape feedback of speeches can create positive change in the self-perception of anxious public speakers. Furthermore, video feedback has appeared most effective when (1) participants show particularly distorted negative self-perceptions and (2) the intervention is preceded by a cognitive preparation, during which participants are encouraged to form a vivid image of what they expect to see on the videotape. The proposed research is designed to more stringently evaluate the above conclusions, with additional tests of participant personality variables that, given current theories of social anxiety, should interfere with the effects of video feedback. A test of whether the effects of these personality variables are moderated by the use of cognitive preparation will also be included. Finally, the role of self-efficacy, a construct that has been shown to be related to change in phobic behavior, will be evaluated in regard to the video feedback paradigm. In order to address the above questions, approximately 120 speech-anxious undergraduate students will receive two sessions of video feedback either (a) with cognitive preparation or (b) with a placebo preparation. Analyses will include ANOVA, regression analyses, and a form of structural equation modeling. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies 75
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “anxiety” (or synonyms) into the search box. This search gives you access to fulltext articles. The following is a sample of items found for anxiety in the PubMed Central database: •
Altered anxiety and weight gain in corticotropin-releasing hormone-binding proteindeficient mice. by Karolyi IJ, Burrows HL, Ramesh TM, Nakajima M, Lesh JS, Seong E, Camper SA, Seasholtz AF. 1999 Sep 28; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=18079
•
Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study. by Teixeira JM, Fisk NM, Glover V. 1999 Jan 16; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=27690
•
Boundary anxiety. by Shanner L. 2002 Nov 26; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=134143
•
Bullying in schools: self reported anxiety, depression, and self esteem in secondary school children. by Salmon G, James A, Smith DM. 1998 Oct 3; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=28678
•
Changes in physicians' computer anxiety and attitudes related to clinical information system use.. by Brown SH, Coney RD. 1994 Sep 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=116220
•
Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. by Rotzinger S, Vaccarino FJ. 2003 May; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=161741
•
Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. by Kessler D, Lloyd K, Lewis G, Gray DP. 1999 Feb 13; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=27737
•
Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase C[epsilon]. by Hodge CW, Raber J, McMahon T, Walter H, Sanchez-Perez AM, Olive MF, Mehmert K, Morrow AL, Messing RO. 2002 Oct 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=151152
•
Detection of depression and anxiety in primary care: follow up study. by Kessler D, Bennewith O, Lewis G, Sharp D. 2002 Nov 2; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=131021
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html. With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print. 3 4
76 Anxiety
•
Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. by Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH. 1998 Dec 8; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=24573
•
Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety. by Simpson JR Jr, Drevets WC, Snyder AZ, Gusnard DA, Raichle ME. 2001 Jan 16; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=14649
•
Evidence for an Involvement of the Brain Cholecystokinin B Receptor in Anxiety. by Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN. 1991 Feb 15; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=50970
•
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. by Santarelli L, Gobbi G, Debs PC, Sibille EL, Blier P, Hen R, Heath MJ. 2001 Feb 13; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=29356
•
Hepatitis associated with Kava, a herbal remedy for anxiety. by Escher M, Desmeules J, Giostra E, Mentha G. 2001 Jan 20; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=26591
•
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. by Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L, Escorihuela RM, Fernandez-Teruel A, Wiesenfeld-Hallin Z, Xu XJ, Hardemark A, Betsholtz C, Herlenius E, Fredholm BB. 2001 Jul 31; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=55434
•
Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. by Kash SF, Tecott LH, Hodge C, Baekkeskov S. 1999 Feb 16; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=15565
•
Increased anxiety and synaptic plasticity in estrogen receptor [beta]-deficient mice. by Krezel W, Dupont S, Krust A, Chambon P, Chapman PF. 2001 Oct 9; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=59805
•
Increased anxiety of mice lacking the serotonin1A receptor. by Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. 1998 Sep 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=27964
•
Influence of symptoms of anxiety on treatment of depression in later life in primary care: questionnaire survey. by Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA. 1999 Feb 27; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=27763
•
Neuroactive steroids and anxiety disorders. by Melledo JM, Baker GB. 2002 May; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=161645
•
Orphan anxiety. by Walker JR, Koob GF. 1997 Dec 23; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=33793
Studies 77
•
Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol. by Morrow JD, McManus K, Tait GR, Bellavance F, Chrapko W, Lara N, Le Melledo JM. 2003 Mar; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=161733
•
Persistent Elevations of Cerebrospinal Fluid Concentrations of CorticotropinReleasing Factor in Adult Nonhuman Primates Exposed to Early-Life Stressors: Implications for the Pathophysiology of Mood and Anxiety Disorders. by Coplan JD, Andrews MW, Rosenblum LA, Owens MJ, Friedman S, Gorman JM, Nemeroff CB. 1996 Feb 20; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=39991
•
Phantom pain, anxiety, depression, and their relation in consecutive patients with amputated limbs: case reports. by Fisher K, Hanspal RS. 1998 Mar 21; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=28494
•
Point mutant mice with hypersensitive [alpha]4 nicotinic receptors show dopaminergic deficits and increased anxiety. by Labarca C, Schwarz J, Deshpande P, Schwarz S, Nowak MW, Fonck C, Nashmi R, Kofuji P, Dang H, Shi W, Fidan M, Khakh BS, Chen Z, Bowers BJ, Boulter J, Wehner JM, Lester HA. 2001 Feb 27; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=30217
•
Prevalence of anxiety and depressive illness and help seeking behaviour in African Caribbeans and white Europeans: two phase general population survey. by Shaw CM, Creed F, Tomenson B, Riste L, Cruickshank JK. 1999 Jan 30; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=27715
•
Rapid resolution of social anxiety disorder, selective mutism, and separation anxiety with paroxetine in an 8-year-old girl. by Lehman RB. 2002 Mar; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=161642
•
Regulation of T cell activation, anxiety, and male aggression by RGS2. by Oliveirados-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, Siderovski DP, Penninger JM. 2000 Oct 24; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=17331
•
Routinely administered questionnaires for depression and anxiety: systematic review. by Gilbody SM, House AO, Sheldon TA. 2001 Feb 17; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=26571
•
Self-hypnosis for anxiety associated with severe asthma: a case report. by Anbar RD. 2003; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=169186
•
Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. by Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R. 1998 Nov 24; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=24398
•
Stillbirth as risk factor for depression and anxiety in the subsequent pregnancy: cohort study. by Hughes PM, Turton P, Evans CD. 1999 Jun 26; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=31099
78 Anxiety
•
The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. by Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. 2003; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=161819
•
The Hospital Anxiety And Depression Scale. by Snaith RP. 2003; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=183845
•
Urocortin-Deficient Mice Display Normal Stress-Induced Anxiety Behavior and Autonomic Control but an Impaired Acoustic Startle Response. by Wang X, Su H, Copenhagen LD, Vaishnav S, Pieri F, Do Shope C, Brownell WE, De Biasi M, Paylor R, Bradley A. 2002 Sep; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=exter nal&artid=135620
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with anxiety, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “anxiety” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for anxiety (hyperlinks lead to article summaries): •
“Danger is lurking everywhere”. the relation between anxiety and threat perception abnormalities in normal children. Author(s): Muris P, Luermans J, Merckelbach H, Mayer B. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2000 June; 31(2): 12336. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11132116&dopt=Abstract
•
“PSA-itis”: knowledge of serum prostate specific antigen and other causes of anxiety in men with metaststic prostate cancer. Author(s): Lofters A, Juffs HG, Pond GR, Tannock IF. Source: The Journal of Urology. 2002 December; 168(6): 2516-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12441952&dopt=Abstract
PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
6
Studies 79
•
A 3-year comparison of dental anxiety treatment outcomes: hypnosis, group therapy and individual desensitization vs. no specialist treatment. Author(s): Moore R, Brodsgaard I, Abrahamsen R. Source: European Journal of Oral Sciences. 2002 August; 110(4): 287-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12206590&dopt=Abstract
•
A 46-year-old man with anxiety and nightmares after a motor vehicle collision. Author(s): Stein MB. Source: Jama : the Journal of the American Medical Association. 2002 September 25; 288(12): 1513-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12243639&dopt=Abstract
•
A call to action: overcoming anxiety through active coping. Author(s): LeDoux JE, Gorman JM. Source: The American Journal of Psychiatry. 2001 December; 158(12): 1953-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11729007&dopt=Abstract
•
A clinical taxonomy of dizziness and anxiety in the otoneurological setting. Author(s): Furman JM, Jacob RG. Source: Journal of Anxiety Disorders. 2001 January-April; 15(1-2): 9-26. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11388360&dopt=Abstract
•
A cognitive therapy model of social anxiety problems: potential limits on its effectiveness? Author(s): Hughes I. Source: Psychology and Psychotherapy. 2002 December; 75(Pt 4): 411-35. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12626132&dopt=Abstract
•
A comparison of the Composite International Diagnostic Interview (CIDI-Auto) with clinical assessment in diagnosing mood and anxiety disorders. Author(s): Komiti AA, Jackson HJ, Judd FK, Cockram AM, Kyrios M, Yeatman R, Murray G, Hordern C, Wainwright K, Allen N, Singh B. Source: The Australian and New Zealand Journal of Psychiatry. 2001 April; 35(2): 22430. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11284905&dopt=Abstract
80 Anxiety
•
A comparison of two self-report measures of children's social anxiety in clinic and community samples. Author(s): Epkins CC. Source: Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 2002 March; 31(1): 69-79. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11845653&dopt=Abstract
•
A component analysis of cognitive-behavioral therapy for generalized anxiety disorder and the role of interpersonal problems. Author(s): Borkovec TD, Newman MG, Pincus AL, Lytle R. Source: Journal of Consulting and Clinical Psychology. 2002 April; 70(2): 288-98. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11952187&dopt=Abstract
•
A conceptual model of cultural predictors of anxiety among Japanese American and part-Japanese American adolescents. Author(s): Williams JK, Goebert D, Hishinuma E, Miyamoto R, Anzai N, Izutsu S, Yanagida E, Nishimura S, Andrade N, Baker FM. Source: Cultural Diversity & Ethnic Minority Psychology. 2002 November; 8(4): 320-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12416318&dopt=Abstract
•
A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale. Author(s): Oakman J, Van Ameringen M, Mancini C, Farvolden P. Source: Journal of Clinical Psychology. 2003 January; 59(1): 149-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12508338&dopt=Abstract
•
A contemporary protocol to assist primary care physicians in the treatment of panic and generalized anxiety disorders. Author(s): Rollman BL, Herbeck Belnap B, Reynolds CF, Schulberg HC, Shear MK. Source: General Hospital Psychiatry. 2003 March-April; 25(2): 74-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12676419&dopt=Abstract
•
A controlled trial of music and pre-operative anxiety in Chinese men undergoing transurethral resection of the prostate. Author(s): Yung PM, Chui-Kam S, French P, Chan TM. Source: Journal of Advanced Nursing. 2002 August; 39(4): 352-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12139647&dopt=Abstract
Studies 81
•
A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression. Author(s): Barbee JG, Billings CK, Bologna NB, Townsend MH. Source: Journal of Affective Disorders. 2003 February; 73(3): 229-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12547291&dopt=Abstract
•
A follow-up study of posttraumatic stress disorder, anxiety, and depression in Australian victims of domestic violence. Author(s): Mertin P, Mohr PB. Source: Violence Vict. 2001 December; 16(6): 645-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11863063&dopt=Abstract
•
A general anxiety-prone cognitive style in anxiety disorders. Author(s): Uhlenhuth EH, Starcevic V, Warner TD, Matuzas W, McCarty T, Roberts B, Jenkusky S. Source: Journal of Affective Disorders. 2002 August; 70(3): 241-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12128236&dopt=Abstract
•
A longitudinal analysis of anxiety and depressive symptoms. Author(s): Wetherell JL, Gatz M, Pedersen NL. Source: Psychology and Aging. 2001 June; 16(2): 187-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11405307&dopt=Abstract
•
A longitudinal investigation of anxiety sensitivity in adolescence. Author(s): Weems CF, Hayward C, Killen J, Taylor CB. Source: Journal of Abnormal Psychology. 2002 August; 111(3): 471-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12150423&dopt=Abstract
•
A longitudinal study of the etiology of separation anxiety. Author(s): Poulton R, Milne BJ, Craske MG, Menzies RG. Source: Behaviour Research and Therapy. 2001 December; 39(12): 1395-410. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11758698&dopt=Abstract
•
A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Author(s): Westen D, Morrison K. Source: Journal of Consulting and Clinical Psychology. 2001 December; 69(6): 875-99. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11777114&dopt=Abstract
82 Anxiety
•
A piece of my mind. A mutual anxiety. Author(s): Wellbery C. Source: Jama : the Journal of the American Medical Association. 2003 July 16; 290(3): 305. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12865356&dopt=Abstract
•
A pilot study addressing the effect of aromatherapy massage on mood, anxiety and relaxation in adult mental health. Author(s): Edge J. Source: Complementary Therapies in Nursing & Midwifery. 2003 May; 9(2): 90-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12697161&dopt=Abstract
•
A placebo-controlled study of Kava kava in generalized anxiety disorder. Author(s): Connor KM, Davidson JR. Source: International Clinical Psychopharmacology. 2002 July; 17(4): 185-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12131602&dopt=Abstract
•
A population study of anxiety and depression among persons who report whiplash traumas. Author(s): Wenzel HG, Haug TT, Mykletun A, Dahl AA. Source: Journal of Psychosomatic Research. 2002 September; 53(3): 831-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12217459&dopt=Abstract
•
A population-based twin study of generalized anxiety disorder in men and women. Author(s): Hettema JM, Prescott CA, Kendler KS. Source: The Journal of Nervous and Mental Disease. 2001 July; 189(7): 413-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11504317&dopt=Abstract
•
A preliminary study of achievement, attitudes toward success in mathematics, and mathematics anxiety with technology-based instruction in brief calculus. Author(s): Alkhateeb HM. Source: Psychological Reports. 2002 February; 90(1): 47-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11899011&dopt=Abstract
•
A priori expectancy bias and its relation to shock experience and anxiety: a naturalistic study in patients with an automatic implantable cardioverter defibrillator. Author(s): Pauli P, Wiedemann G, Dengler W, Kuhlkamp V. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2001 September; 32(3): 159-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11934128&dopt=Abstract
Studies 83
•
A prospective study of 86 new patients with social anxiety disorder. Author(s): Allgulander C, Nilsson B. Source: Acta Psychiatrica Scandinavica. 2001 June; 103(6): 447-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11401659&dopt=Abstract
•
A qualitative investigation of the temporal patterning of the precompetitive anxiety response. Author(s): Hanton S, Mellalieu SD, Young SG. Source: Journal of Sports Sciences. 2002 November; 20(11): 911-28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12430992&dopt=Abstract
•
A qualitative study of patients' views on anxiety and depression. Author(s): Kadam UT, Croft P, McLeod J, Hutchinson M. Source: The British Journal of General Practice : the Journal of the Royal College of General Practitioners. 2001 May; 51(466): 375-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11360702&dopt=Abstract
•
A questionnaire to measure general practitioners' attitudes to their role in the management of patients with depression and anxiety. Author(s): McCall L, Clarke DM, Rowley G. Source: Aust Fam Physician. 2002 March; 31(3): 299-303. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11926164&dopt=Abstract
•
A randomised, double-blind, placebo-controlled, comparative study of topical skin analgesics and the anxiety and discomfort associated with venous cannulation. Author(s): Speirs AF, Taylor KH, Joanes DN, Girdler NM. Source: British Dental Journal. 2001 April 28; 190(8): 444-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11352393&dopt=Abstract
•
A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Author(s): de Godoy DV, de Godoy RF. Source: Archives of Physical Medicine and Rehabilitation. 2003 August; 84(8): 1154-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12917854&dopt=Abstract
•
A randomized trial of aromatherapy to reduce anxiety before abortion. Author(s): Wiebe E. Source: Effective Clinical Practice : Ecp. 2000 July-August; 3(4): 166-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11183431&dopt=Abstract
84 Anxiety
•
A randomized trial of the effectiveness of cognitive-behavioral therapy and supportive counseling for anxiety symptoms in older adults. Author(s): Barrowclough C, King P, Colville J, Russell E, Burns A, Tarrier N. Source: Journal of Consulting and Clinical Psychology. 2001 October; 69(5): 756-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11680552&dopt=Abstract
•
A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. Author(s): Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD. Source: The Journal of Clinical Psychiatry. 2002 January; 63(1): 66-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11838629&dopt=Abstract
•
A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. Author(s): Bonne O, Shemer Y, Gorali Y, Katz M, Shalev AY. Source: The Journal of Clinical Psychiatry. 2003 March; 64(3): 282-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12716269&dopt=Abstract
•
A relaxation training program to increase self-efficacy for anxiety control in Alzheimer family caregivers. Author(s): Fisher PA, Laschinger HS. Source: Holistic Nursing Practice. 2001 January; 15(2): 47-58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12119919&dopt=Abstract
•
A review and meta-analysis of the genetic epidemiology of anxiety disorders. Author(s): Hettema JM, Neale MC, Kendler KS. Source: The American Journal of Psychiatry. 2001 October; 158(10): 1568-78. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11578982&dopt=Abstract
•
A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). Author(s): Versiani M. Source: World J Biol Psychiatry. 2000 January; 1(1): 27-33. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12607230&dopt=Abstract
•
A review of the literature: interventions to maximize capacity to consent and reduce anxiety of women with learning disabilities preparing for a cervical smear test. Author(s): Broughton S. Source: Health Services Management Research : an Official Journal of the Association of University Programs in Health Administration / Hsmc, Aupha. 2002 August; 15(3): 17385. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12184837&dopt=Abstract
Studies 85
•
A self-report questionnaire for measuring separation anxiety in adulthood. Author(s): Manicavasagar V, Silove D, Wagner R, Drobny J. Source: Comprehensive Psychiatry. 2003 March-April; 44(2): 146-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12658624&dopt=Abstract
•
A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Author(s): Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G, Chilcott J. Source: Health Technology Assessment (Winchester, England). 2002; 6(22): 1-89. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12433315&dopt=Abstract
•
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Author(s): Cramer JA, De Rue K, Devinsky O, Edrich P, Trimble MR. Source: Epilepsy & Behavior : E&B. 2003 April; 4(2): 124-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12697136&dopt=Abstract
•
A systematic review of the safety of kava extract in the treatment of anxiety. Author(s): Stevinson C, Huntley A, Ernst E. Source: Drug Safety : an International Journal of Medical Toxicology and Drug Experience. 2002; 25(4): 251-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11994028&dopt=Abstract
•
A therapeutic approach to children and adolescents with anxiety disorders and associated comorbid conditions. Author(s): Manassis K, Monga S. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 January; 40(1): 115-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11195553&dopt=Abstract
•
A treatment plan for HIPAA anxiety disorder. Author(s): Tomes JP. Source: Behav Healthc Tomorrow. 2001 June; 10(3): Sr21-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11419266&dopt=Abstract
•
A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Author(s): Chantarujikapong SI, Scherrer JF, Xian H, Eisen SA, Lyons MJ, Goldberg J, Tsuang M, True WR. Source: Psychiatry Research. 2001 September 20; 103(2-3): 133-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11549402&dopt=Abstract
86 Anxiety
•
Absorption kinetics of paracetamol are not influenced by high anxiety levels in preoperative patients. Author(s): Schwarz N, Banditt P, Gerlach KL, Meyer FP. Source: Int J Clin Pharmacol Ther. 2002 September; 40(9): 419-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12358158&dopt=Abstract
•
Accuracy of general practitioner's prognosis of the 1-year course of depression and generalised anxiety. Author(s): Brink RH, Ormel J, Tiemens BG, Os TW, Smit A, Jenner JA, Meer KV. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2001 January; 178(1): 18-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11136205&dopt=Abstract
•
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Author(s): Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D. Source: Depression and Anxiety. 2002; 16(1): 4-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12203668&dopt=Abstract
•
Activation of the arousal response and impairment of performance increase with anxiety and stressor intensity. Author(s): Noteboom JT, Barnholt KR, Enoka RM. Source: Journal of Applied Physiology (Bethesda, Md. : 1985). 2001 November; 91(5): 2093-101. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11641349&dopt=Abstract
•
Acupuncture treatment for 157 cases of anxiety neurosis. Author(s): Zhang H, Zeng Z, Deng H. Source: J Tradit Chin Med. 2003 March; 23(1): 55-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12747204&dopt=Abstract
•
Adaptation as a sensorial profile in trait anxiety: a study with virtual reality. Author(s): Viaud-Delmon I, Ivanenko YP, Berthoz A, Jouvent R. Source: Journal of Anxiety Disorders. 2000 November-December; 14(6): 583-601. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11918093&dopt=Abstract
•
Adult oncology and chronically ill patients: comparison of depression, anxiety and caregivers' quality of life. Author(s): Sherif T, Jehani T, Saadani M, Andejani AW. Source: East Mediterr Health J. 2001 May; 7(3): 502-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12690772&dopt=Abstract
Studies 87
•
Adult separation anxiety: psychometric properties of a new structured clinical interview. Author(s): Cyranowski JM, Shear MK, Rucci P, Fagiolini A, Frank E, Grochocinski VJ, Kupfer DJ, Banti S, Armani A, Cassano G. Source: Journal of Psychiatric Research. 2002 March-April; 36(2): 77-86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11777496&dopt=Abstract
•
Adverse effects of maternal antenatal anxiety on children: causal effect or developmental continuum? Author(s): Oates MR. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2002 June; 180: 478-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12042222&dopt=Abstract
•
Aetiology of dental anxiety in children: a review of the literature. Author(s): Folayan MO, Klingberg G, Aghanwa A, Idehen E. Source: Niger J Med. 2001 July-September; 10(3): 106-11. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11806007&dopt=Abstract
•
Affective information processing and the assessment of anxiety. Author(s): Lang PJ, Cuthbert BN. Source: J Behav Assess. 1984 December; 6(4): 369-95. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11540862&dopt=Abstract
•
Affective neuroscience and the development of social anxiety disorder. Author(s): Pine DS. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 689-705. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723628&dopt=Abstract
•
Affective style among smokers: understanding anxiety sensitivity, emotional reactivity, and distress tolerance using biological challenge. Author(s): Zvolensky MJ, Feldner MT, Eifert GH, Brown RA. Source: Addictive Behaviors. 2001 November-December; 26(6): 901-15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768551&dopt=Abstract
•
Age and sex differences for anxiety in relation to family size, birth order, and religiosity among Kuwaiti adolescents. Author(s): Abdel-Khalek AM. Source: Psychological Reports. 2002 June; 90(3 Pt 1): 1031-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12090494&dopt=Abstract
88 Anxiety
•
Age differences in symptoms of depression and anxiety: examining behavioral medicine outpatients. Author(s): Goldberg JH, Breckenridge JN, Sheikh JI. Source: Journal of Behavioral Medicine. 2003 April; 26(2): 119-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12776382&dopt=Abstract
•
Age, debt and anxiety. Author(s): Drentea P. Source: Journal of Health and Social Behavior. 2000 December; 41(4): 437-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11198567&dopt=Abstract
•
Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Author(s): Osborne RH, Elsworth GR, Hopper JL. Source: European Journal of Cancer (Oxford, England : 1990). 2003 April; 39(6): 755-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12651200&dopt=Abstract
•
Agreement in symptoms of anxiety and depression between patients and GPs: the influence of ethnicity. Author(s): Comino EJ, Silove D, Manicavasagar V, Harris E, Harris MF. Source: Family Practice. 2001 February; 18(1): 71-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11145632&dopt=Abstract
•
AIDS anxieties of adolescents: determinants of “state” and “trait” anxiety dimensions in a linear structural model. Author(s): Strehlow U, Kampmann G. Source: The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine. 1993 September; 14(6): 475-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8241206&dopt=Abstract
•
Alcohol use disorders and anxiety disorders: relation to the P300 event-related potential. Author(s): Enoch MA, White KV, Harris CR, Rohrbaugh JW, Goldman D. Source: Alcoholism, Clinical and Experimental Research. 2001 September; 25(9): 1293300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11584148&dopt=Abstract
•
Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being. Author(s): Burns L, Teesson M. Source: Drug and Alcohol Dependence. 2002 December 1; 68(3): 299-307. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12393224&dopt=Abstract
Studies 89
•
Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Author(s): Degenhardt L, Hall W, Lynskey M. Source: Addiction (Abingdon, England). 2001 November; 96(11): 1603-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11784457&dopt=Abstract
•
Alcoholism, anxiety, and opioid-dopaminergic interactions. Author(s): Sher L. Source: Psychopharmacology. 2003 January; 165(2): 202-3. Epub 2002 November 12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12428151&dopt=Abstract
•
'All his anxiety resolved itself into a sigh and dissolved into apathy and drowsiness.' Ivan Goncharov, Russian novelist, Obolomov (1859). Author(s): Dalgleish DJ. Source: Anaesthesia. 2001 April; 56(4): 376. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11284835&dopt=Abstract
•
Alternative and complementary modalities for managing stress and anxiety. Author(s): Keegan L. Source: Critical Care Nurse. 2000 June; 20(3): 93-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11876219&dopt=Abstract
•
Alternative psychotherapy approaches for social anxiety disorder. Author(s): Lipsitz JD, Marshall RD. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 817-29. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723635&dopt=Abstract
•
Ambient odor of orange in a dental office reduces anxiety and improves mood in female patients. Author(s): Lehrner J, Eckersberger C, Walla P, Potsch G, Deecke L. Source: Physiology & Behavior. 2000 October 1-15; 71(1-2): 83-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11134689&dopt=Abstract
•
Amygdaloid regional cerebral blood flow and subjective fear during symptom provocation in anxiety disorders. Author(s): Fredrikson M, Furmark T. Source: Annals of the New York Academy of Sciences. 2003 April; 985: 341-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12724169&dopt=Abstract
90 Anxiety
•
An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. Author(s): Lloyd-Williams M, Friedman T, Rudd N. Source: Journal of Pain and Symptom Management. 2001 December; 22(6): 990-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11738161&dopt=Abstract
•
An anxiety, personality and altitude symptomatology study during a 31-day period of hypoxia in a hypobaric chamber (experiment 'Everest-Comex 1997'). Author(s): Nicolas M, Thullier-Lestienne F, Bouquet C, Gardette B, Gortan C, Joulia F, Bonnon M, Richalet JP, Therme P, Abraini JH. Source: Journal of Environmental Psychology. 1999 December; 19(4): 407-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11543191&dopt=Abstract
•
An association between depression, anxiety and thyroid function--a clinical fact or an artefact? Author(s): Engum A, Bjoro T, Mykletun A, Dahl AA. Source: Acta Psychiatrica Scandinavica. 2002 July; 106(1): 27-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12100345&dopt=Abstract
•
An elderly woman with severe anxiety associated with anticipated use of an interpreter. Author(s): Parnes BL, Westfall JM. Source: The Journal of the American Board of Family Practice / American Board of Family Practice. 2003 May-June; 16(3): 255-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12755255&dopt=Abstract
•
An examination of the tripartite model of anxiety and depression and its application to youth. Author(s): Laurent J, Ettelson R. Source: Clinical Child and Family Psychology Review. 2001 September; 4(3): 209-30. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11783739&dopt=Abstract
•
An expanded childhood anxiety sensitivity index: its factor structure, reliability, and validity in a non-clinical adolescent sample. Author(s): Muris P. Source: Behaviour Research and Therapy. 2002 March; 40(3): 299-311. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11863240&dopt=Abstract
Studies 91
•
An experimental investigation of thought suppression and anxiety in children. Author(s): Gaskell SL, Wells A, Calam R. Source: The British Journal of Clinical Psychology / the British Psychological Society. 2001 March; 40(Pt 1): 45-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11317948&dopt=Abstract
•
An investigation into the relationship between salivary cortisol, stress, anxiety and depression. Author(s): Vedhara K, Miles J, Bennett P, Plummer S, Tallon D, Brooks E, Gale L, Munnoch K, Schreiber-Kounine C, Fowler C, Lightman S, Sammon A, Rayter Z, Farndon J. Source: Biological Psychology. 2003 February; 62(2): 89-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12581685&dopt=Abstract
•
An obese man with anxiety, sweating, and headache. Author(s): McCormick JD, Diguilio D, Adelman HM. Source: Hosp Pract (Off Ed). 2001 September 15; 36(9): 21-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11565739&dopt=Abstract
•
Anatomical MRI findings in mood and anxiety disorders. Author(s): Brambilla P, Barale F, Caverzasi E, Soares JC. Source: Epidemiol Psichiatr Soc. 2002 April-June; 11(2): 88-99. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12212470&dopt=Abstract
•
Animal models of anxiety and depression: how are females different? Author(s): Palanza P. Source: Neuroscience and Biobehavioral Reviews. 2001 May; 25(3): 219-33. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11378178&dopt=Abstract
•
Antenatal anxiety predicts child behavioral/emotional problems independently of postnatal depression. Author(s): O'Connor TG, Heron J, Glover V; Alspac Study Team. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 December; 41(12): 1470-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12447034&dopt=Abstract
•
Antenatal anxiety, parenting and behavioural/emotional problems in children. Author(s): Barlow J. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2002 November; 181: 440-1; Author Reply 441. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12411273&dopt=Abstract
92 Anxiety
•
Anthrax and anthrax anxiety: Sverdlovsk revisited. Author(s): Sepkowitz KA. Source: International Journal of Infectious Diseases : Ijid : Official Publication of the International Society for Infectious Diseases. 2001; 5(4): 178-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11962347&dopt=Abstract
•
Anthropometric profiles and social physique anxiety of physical education professionals from India. Author(s): Mookerjee S, Singh J, Cashi T. Source: Percept Mot Skills. 2002 February; 94(1): 47-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11883588&dopt=Abstract
•
Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam. Author(s): Wolf DL, Desjardins PJ, Black PM, Francom SR, Mohanlal RW, Fleishaker JC. Source: Journal of Clinical Psychopharmacology. 2003 February; 23(1): 51-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12544376&dopt=Abstract
•
Anticipatory autonomic response to a public speaking task in women: the role of trait anxiety. Author(s): Gonzalez-Bono E, Moya-Albiol L, Salvador A, Carrillo E, Ricarte J, GomezAmor J. Source: Biological Psychology. 2002; 60(1): 37-49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12100844&dopt=Abstract
•
Anticipatory caregiving anxiety among older women and men. Author(s): Laditka SB, Pappas-Rogich M. Source: J Women Aging. 2001; 13(1): 3-18. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11217184&dopt=Abstract
•
Antidepressants for generalized anxiety disorder. Author(s): Kapczinski F, Lima MS, Souza JS, Schmitt R. Source: Cochrane Database Syst Rev. 2003; (2): Cd003592. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12804478&dopt=Abstract
•
Antidepressants in social anxiety disorder. Author(s): Nardi AE. Source: Arquivos De Neuro-Psiquiatria. 2001 September; 59(3-A): 637-42. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11588653&dopt=Abstract
Studies 93
•
Anxiety across the life span: epidemiological evidence and treatment data. Author(s): Balon R. Source: Depression and Anxiety. 2001; 13(4): 184-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11413565&dopt=Abstract
•
Anxiety affects the postural sway of the antero-posterior axis in college students. Author(s): Wada M, Sunaga N, Nagai M. Source: Neuroscience Letters. 2001 April 20; 302(2-3): 157-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11290411&dopt=Abstract
•
Anxiety after severe pediatric closed head injury. Author(s): Vasa RA, Gerring JP, Grados M, Slomine B, Christensen JR, Rising W, Denckla MB, Riddle MA. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 February; 41(2): 148-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11837404&dopt=Abstract
•
Anxiety among clients for plastic surgery. Author(s): Valente SM. Source: Plastic Surgical Nursing : Official Journal of the American Society of Plastic and Reconstructive Surgical Nurses. 2002 Summer; 22(2): 55-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12244761&dopt=Abstract
•
Anxiety among university students in South Africa. Author(s): Pillay AL, Edwards SD, Sargent C, Dhlomo RM. Source: Psychological Reports. 2001 June; 88(3 Pt 2): 1182-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11597073&dopt=Abstract
•
Anxiety among women who have undergone fertility therapy and who are considering multifetal pregnancy reduction: trends and implications. Author(s): Britt DW, Risinger ST, Mans M, Evans MI. Source: J Matern Fetal Neonatal Med. 2003 April;13(4):271-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12854930&dopt=Abstract
•
Anxiety and affective style: role of prefrontal cortex and amygdala. Author(s): Davidson RJ. Source: Biological Psychiatry. 2002 January 1; 51(1): 68-80. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11801232&dopt=Abstract
94 Anxiety
•
Anxiety and Alzheimer's disease. Author(s): Ferretti L, McCurry SM, Logsdon R, Gibbons L, Teri L. Source: Journal of Geriatric Psychiatry and Neurology. 2001 Spring; 14(1): 52-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11281317&dopt=Abstract
•
Anxiety and anger among family practice residents: a South Carolina family practice research consortium study. Author(s): Michels PJ, Probst JC, Godenick MT, Palesch Y. Source: Academic Medicine : Journal of the Association of American Medical Colleges. 2003 January; 78(1): 69-79. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12525412&dopt=Abstract
•
Anxiety and anxiety disorders. Author(s): Karasic D. Source: Focus. 1996 November; 11(12): 5-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12206111&dopt=Abstract
•
Anxiety and arousal: physiological changes and their perception. Author(s): Hoehn-Saric R, McLeod DR. Source: Journal of Affective Disorders. 2000 December; 61(3): 217-24. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11163423&dopt=Abstract
•
Anxiety and attention to threatening pictures. Author(s): Yiend J, Mathews A. Source: The Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology. 2001 August; 54(3): 665-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11548029&dopt=Abstract
•
Anxiety and compliance among women at high risk for breast cancer. Author(s): Lindberg NM, Wellisch D. Source: Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 2001 Fall; 23(4): 298-303. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11761347&dopt=Abstract
•
Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Author(s): Jarrett ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Source: Digestive Diseases and Sciences. 2003 February; 48(2): 386-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12643620&dopt=Abstract
Studies 95
•
Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Author(s): Dahlen I, Janson C. Source: Chest. 2002 November; 122(5): 1633-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12426264&dopt=Abstract
•
Anxiety and depression as correlates of self-reported behavioural inhibition in normal adolescents. Author(s): Muris P, Merckelbach H, Schmidt H, Gadet BB, Bogie N. Source: Behaviour Research and Therapy. 2001 September; 39(9): 1051-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11520011&dopt=Abstract
•
Anxiety and depression as risk factors for oral lichen planus. Author(s): Vallejo MJ, Huerta G, Cerero R, Seoane JM. Source: Dermatology (Basel, Switzerland). 2001; 203(4): 303-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11752817&dopt=Abstract
•
Anxiety and depression before and after the menopause. Author(s): Sagsoz N, Oguzturk O, Bayram M, Kamaci M. Source: Archives of Gynecology and Obstetrics. 2001 January; 264(4): 199-202. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11205708&dopt=Abstract
•
Anxiety and depression in an internal medicine resident continuity clinic: difficult diagnoses. Author(s): Didden DG, Philbrick JT, Schorling JB. Source: International Journal of Psychiatry in Medicine. 2001; 31(2): 155-67. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11760860&dopt=Abstract
•
Anxiety and depression in an older research population and their impact on clinical outcomes in a randomised controlled trial. Author(s): Allsup SJ, Gosney MA. Source: Postgraduate Medical Journal. 2002 November; 78(925): 674-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12496325&dopt=Abstract
•
Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Author(s): Montazeri A, Jarvandi S, Haghighat S, Vahdani M, Sajadian A, Ebrahimi M, Haji-Mahmoodi M. Source: Patient Education and Counseling. 2001 December 1; 45(3): 195-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11722855&dopt=Abstract
96 Anxiety
•
Anxiety and depression in children: a test of the positive-negative affect model. Author(s): Lee LC, Rebok GW. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 April; 41(4): 419-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11931598&dopt=Abstract
•
Anxiety and depression in hospitalized patients in resistant organism isolation. Author(s): Catalano G, Houston SH, Catalano MC, Butera AS, Jennings SM, Hakala SM, Burrows SL, Hickey MG, Duss CV, Skelton DN, Laliotis GJ. Source: Southern Medical Journal. 2003 February; 96(2): 141-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12630637&dopt=Abstract
•
Anxiety and depression in Iranian breast cancer patients before and after diagnosis. Author(s): Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M. Source: European Journal of Cancer Care. 2000 September; 9(3): 151-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11881724&dopt=Abstract
•
Anxiety and depression in mothers of children undergoing bone marrow transplant: symptom prevalence and use of the Beck depression and Beck anxiety inventories as screening instruments. Author(s): Manne S, Nereo N, DuHamel K, Ostroff J, Parsons S, Martini R, Williams S, Mee L, Sexson S, Lewis J, Vickberg SJ, Redd WH. Source: Journal of Consulting and Clinical Psychology. 2001 December; 69(6): 1037-47. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11777107&dopt=Abstract
•
Anxiety and depression in the first year of medical residency training. Author(s): Peterlini M, Tiberio IF, Saadeh A, Pereira JC, Martins MA. Source: Medical Education. 2002 January; 36(1): 66-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11849526&dopt=Abstract
•
Anxiety and depression in twin and sib pairs extremely discordant and concordant for neuroticism: prodromus to a linkage study. Author(s): Kirk KM, Birley AJ, Statham DJ, Haddon B, Lake RI, Andrews JG, Martin NG. Source: Twin Research : the Official Journal of the International Society for Twin Studies. 2000 December; 3(4): 299-309. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11463151&dopt=Abstract
Studies 97
•
Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder. Author(s): Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J. Source: Journal of Clinical Psychopharmacology. 2002 June; 22(3): 267-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12006897&dopt=Abstract
•
Anxiety and depression. Natural mood remedies. Author(s): Miller MC. Source: Newsweek. 2002 December 2; 140(23): 70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12501517&dopt=Abstract
•
Anxiety and depression: incidence and patterns in patients after coronary artery bypass graft surgery. Author(s): McCrone S, Lenz E, Tarzian A, Perkins S. Source: Applied Nursing Research : Anr. 2001 August; 14(3): 155-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11481594&dopt=Abstract
•
Anxiety and depression: the impact of shared characteristics on diagnosis and treatment. Introduction. Author(s): Kessler RC, Wittchen HU. Source: Acta Psychiatrica Scandinavica. Supplementum. 2000; (406): 5-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11131469&dopt=Abstract
•
Anxiety and depressive states in multiple chemical sensitivity. Author(s): Tonori H, Aizawa Y, Ojima M, Miyata M, Ishikawa S, Sakabe K. Source: The Tohoku Journal of Experimental Medicine. 2001 February; 193(2): 115-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11318027&dopt=Abstract
•
Anxiety and explicit alcohol-related memory in problem drinkers. Author(s): Zack M, Toneatto T, MacLeod CM. Source: Addictive Behaviors. 2002 May-June; 27(3): 331-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12118624&dopt=Abstract
•
Anxiety and fear. Discriminant validity in the child and adolescent practitioner's perspective. Author(s): Pavuluri MN, Henry D, Allen K. Source: European Child & Adolescent Psychiatry. 2002 December; 11(6): 273-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12541006&dopt=Abstract
98 Anxiety
•
Anxiety and feelings of medical students conducting their first gynecological examination. Author(s): Abraham S, Chapman M, Taylor A, McBride A, Boyd C. Source: Journal of Psychosomatic Obstetrics and Gynaecology. 2003 March; 24(1): 39-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12685338&dopt=Abstract
•
Anxiety and functional status after childbirth. Author(s): McVeigh CA. Source: Aust Coll Midwives Inc J. 2000 March; 13(1): 14-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11107372&dopt=Abstract
•
Anxiety and functional status in older primary care patients. Author(s): Upadhyaya AK, Lyness JM, Cox C, Seidlitz L, Caine ED. Source: International Journal of Psychiatry in Medicine. 2000; 30(3): 221-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11209990&dopt=Abstract
•
Anxiety and genetically engineered mice. Author(s): Diller LH, Carey WB. Source: The New England Journal of Medicine. 2002 November 14; 347(20): 1626; Author Reply 1626. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12432058&dopt=Abstract
•
Anxiety and HIV infection. Author(s): Elliott A. Source: Step Perspect. 1998 Winter; 98(1): 11-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11365209&dopt=Abstract
•
Anxiety and pain suppress the natural killer cell activity in oral surgery outpatients. Author(s): Koga C, Itoh K, Aoki M, Suefuji Y, Yoshida M, Asosina S, Esaki K, Kameyama T. Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2001 June; 91(6): 654-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11402277&dopt=Abstract
•
Anxiety and poor glycemic control: a meta-analytic review of the literature. Author(s): Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, Lustman PJ. Source: International Journal of Psychiatry in Medicine. 2002; 32(3): 235-47. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12489699&dopt=Abstract
Studies 99
•
Anxiety and position-dependent neurologic findings due to autonomic dysreflexia. Author(s): Freudenreich O, Murray GB. Source: Psychosomatics. 2001 January-February; 42(1): 81-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11161127&dopt=Abstract
•
Anxiety and postoperative pain in children who undergo major orthopedic surgery. Author(s): Lamontagne LL, Hepworth JT, Salisbury MH. Source: Applied Nursing Research : Anr. 2001 August; 14(3): 119-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11481590&dopt=Abstract
•
Anxiety and pulmonary embolism. Author(s): Egermayer P. Source: N Z Med J. 2001 February 9; 114(1125): 49. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11277480&dopt=Abstract
•
Anxiety and repression in attention and retention. Author(s): Terry WS, Burns JS. Source: The Journal of General Psychology. 2001 October; 128(4): 422-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11892889&dopt=Abstract
•
Anxiety and substance use comorbidity among inpatients with schizophrenia. Author(s): Goodwin RD, Amador XF, Malaspina D, Yale SA, Goetz RR, Gorman JM. Source: Schizophrenia Research. 2003 May 1; 61(1): 89-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12648739&dopt=Abstract
•
Anxiety and surgical recovery. Reinterpreting the literature. Author(s): Munafo MR, Stevenson J. Source: Journal of Psychosomatic Research. 2001 October; 51(4): 589-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11595247&dopt=Abstract
•
Anxiety and the prediction of task duration: a preliminary analysis. Author(s): Kelly WE. Source: The Journal of Psychology. 2002 January; 136(1): 53-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12022778&dopt=Abstract
•
Anxiety and the schizophrenic process: clinical and epidemiological evidence. Author(s): Turnbull G, Bebbington P. Source: Social Psychiatry and Psychiatric Epidemiology. 2001 May; 36(5): 235-43. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11515701&dopt=Abstract
100 Anxiety
•
Anxiety and trail making test scores in a sample of cocaine abusers. Author(s): Roberts C, Horton AM Jr. Source: The International Journal of Neuroscience. 2003 May; 113(5): 747-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12745631&dopt=Abstract
•
Anxiety and uncertainty in informed decision making. Author(s): Goodman A, Houck K. Source: Journal of Women's Health & Gender-Based Medicine. 2001 March; 10(2): 93-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11268292&dopt=Abstract
•
Anxiety as a barrier to risk management. Author(s): Firth-Cozens J. Source: Quality & Safety in Health Care. 2002 June; 11(2): 115. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12448797&dopt=Abstract
•
Anxiety as a differential factor in epileptic versus psychogenic pseudoepileptic seizures. Author(s): Owczarek K. Source: Epilepsy Research. 2003 January; 52(3): 227-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12536055&dopt=Abstract
•
Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Author(s): Willinger U, Lenzinger E, Hornik K, Fischer G, Schonbeck G, Aschauer HN, Meszaros K; European fluvoxamine in alcoholism study group. Source: Alcohol and Alcoholism (Oxford, Oxfordshire). 2002 November-December; 37(6): 609-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12414556&dopt=Abstract
•
Anxiety associated with comorbid depression. Author(s): Moller HJ. Source: The Journal of Clinical Psychiatry. 2002; 63 Suppl 14: 22-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12562115&dopt=Abstract
•
Anxiety at a time of crisis. Author(s): Stonebridge L. Source: Hist Workshop J. 1998 Spring; (45): 171-82. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11620088&dopt=Abstract
Studies 101
•
Anxiety at the frontier of molecular medicine. Author(s): Weinberger DR. Source: The New England Journal of Medicine. 2001 April 19; 344(16): 1247-9. Review. Erratum In: N Engl J Med 2001 July 26; 345(4): 304. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11309643&dopt=Abstract
•
Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Author(s): Addolorato G, Capristo E, Ghittoni G, Valeri C, Masciana R, Ancona C, Gasbarrini G. Source: Scandinavian Journal of Gastroenterology. 2001 May; 36(5): 502-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11346203&dopt=Abstract
•
Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Author(s): Hu WH, Wong WM, Lam CL, Lam KF, Hui WM, Lai KC, Xia HX, Lam SK, Wong BC. Source: Alimentary Pharmacology & Therapeutics. 2002 December; 16(12): 2081-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12452941&dopt=Abstract
•
Anxiety comorbidity in referred children and adolescents with dysthymic disorder. Author(s): Masi G, Mucci M, Favilla L, Millepiedi S. Source: Psychopathology. 2001 September-October; 34(5): 253-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11799320&dopt=Abstract
•
Anxiety disorder after laparoscopic refundoplication as a cause of dysphagia. Author(s): Kamolz T, Bammer T, Pointner R. Source: Surgical Endoscopy. 2002 February; 16(2): 360-1. Epub 2001 November 16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11967703&dopt=Abstract
•
Anxiety disorders and disability secondary to urinary incontinence among adults over age 50. Author(s): Bogner HR, Gallo JJ, Swartz KL, Ford DE. Source: International Journal of Psychiatry in Medicine. 2002; 32(2): 141-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12269595&dopt=Abstract
•
Anxiety disorders and major depression, together or apart. Author(s): Levine J, Cole DP, Chengappa KN, Gershon S. Source: Depression and Anxiety. 2001; 14(2): 94-104. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11668662&dopt=Abstract
102 Anxiety
•
Anxiety disorders and the emergence of sex differences in major depression. Author(s): Breslau N, Chilcoat H, Schultz LR. Source: J Gend Specif Med. 1998 December; 1(3): 33-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11279862&dopt=Abstract
•
Anxiety disorders and the onset of depression among adults in the community. Author(s): Goodwin RD. Source: Psychological Medicine. 2002 August; 32(6): 1121-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12214791&dopt=Abstract
•
Anxiety disorders associated with traumatic brain injuries. Author(s): Hiott DW, Labbate L. Source: Neurorehabilitation. 2002; 17(4): 345-55. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12547982&dopt=Abstract
•
Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary. Author(s): Rihmer Z, Szadoczky E, Furedi J, Kiss K, Papp Z. Source: Journal of Affective Disorders. 2001 December; 67(1-3): 175-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11869765&dopt=Abstract
•
Anxiety disorders comorbidity in mood disorder subgroups: data from a mood disorders clinic. Author(s): Yerevanian BI, Koek RJ, Ramdev S. Source: Journal of Affective Disorders. 2001 December; 67(1-3): 167-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11869764&dopt=Abstract
•
Anxiety disorders following miscarriage. Author(s): Geller PA, Klier CM, Neugebauer R. Source: The Journal of Clinical Psychiatry. 2001 June; 62(6): 432-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11465520&dopt=Abstract
•
Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. Author(s): Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Source: The Journal of Clinical Psychiatry. 2003 March; 64(3): 331-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12716276&dopt=Abstract
Studies 103
•
Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. Author(s): Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Source: Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2002 July 15; 20(14): 3137-48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12118028&dopt=Abstract
•
Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Author(s): Masi G, Toni C, Perugi G, Mucci M, Millepiedi S, Akiskal HS. Source: Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2001 November; 46(9): 797-802. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11761630&dopt=Abstract
•
Anxiety disorders in children: intervention strategies for the primary care setting. Author(s): Clift G. Source: Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners. 2002 September-October; 16(5): 253-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12226594&dopt=Abstract
•
Anxiety disorders in subjects seeking treatment for eating disorders: a DSM-IV controlled study. Author(s): Godart NT, Flament MF, Curt F, Perdereau F, Lang F, Venisse JL, Halfon O, Bizouard P, Loas G, Corcos M, Jeammet P, Fermanian J. Source: Psychiatry Research. 2003 March 25; 117(3): 245-58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12686367&dopt=Abstract
•
Anxiety disorders in the elderly. Author(s): Carmin CN, Wiegartz PS, Scher C. Source: Current Psychiatry Reports. 2000 February; 2(1): 13-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11122926&dopt=Abstract
•
Anxiety disorders. Author(s): Chen JP, Reich L, Chung H. Source: The Western Journal of Medicine. 2002 September; 176(4): 249-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12208831&dopt=Abstract
•
Anxiety disorders. Helping patients regain stability and calm. Author(s): Dugue M, Neugroschl J. Source: Geriatrics. 2002 August; 57(8): 27-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12201227&dopt=Abstract
104 Anxiety
•
Anxiety disorders. How to recognize and treat the medical symptoms of emotional illness. Author(s): Lang AJ, Stein MB. Source: Geriatrics. 2001 May; 56(5): 24-7, 31-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11373949&dopt=Abstract
•
Anxiety disorders: treatment considerations. Author(s): Antai-Otong D. Source: Nurs Clin North Am. 2003 March; 38(1): 35-44. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12712667&dopt=Abstract
•
Anxiety in a cohort of Swiss women participating in a mammographic screening programme. Author(s): Meystre-Agustoni G, Paccaud F, Jeannin A, Dubois-Arber F. Source: Journal of Medical Screening. 2001; 8(4): 213-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11743038&dopt=Abstract
•
Anxiety in cataract surgery: pilot study. Author(s): Foggitt PS. Source: Journal of Cataract and Refractive Surgery. 2001 October; 27(10): 1651-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11687366&dopt=Abstract
•
Anxiety in epilepsy--based on two case reports. Author(s): Baran B, Farkas M, Rajna P. Source: Ideggyogy Sz. 2002 September 20; 55(9-10): 303-10. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12503244&dopt=Abstract
•
Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids. Author(s): Meienberg F, Bucher HC, Sponagel L, Zinkernagel C, Gyr N, Battegay M. Source: Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology. 2002 June 15; 132(23-24): 321-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12362283&dopt=Abstract
•
Anxiety in high-functioning children with autism. Author(s): Gillott A, Furniss F, Walter A. Source: Autism : the International Journal of Research and Practice. 2001 September; 5(3): 277-86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11708587&dopt=Abstract
Studies 105
•
Anxiety in Japanese women after elective abortion. Author(s): Kishida Y. Source: Journal of Obstetric, Gynecologic, and Neonatal Nursing : Jognn / Naacog. 2001 September-October; 30(5): 490-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11572529&dopt=Abstract
•
Anxiety in major depression. Author(s): Grucza RA. Source: The American Journal of Psychiatry. 2001 September; 158(9): 1535-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11532763&dopt=Abstract
•
Anxiety in medical patients. Author(s): House A, Stark D. Source: Bmj (Clinical Research Ed.). 2002 July 27; 325(7357): 207-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142312&dopt=Abstract
•
Anxiety in older adults. Assessment and management of three common presentations. Author(s): Sheikh JI. Source: Geriatrics. 2003 May; 58(5): 44-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12756681&dopt=Abstract
•
Anxiety in pregnancy bad for women, bad for babies. Author(s): Rosser J. Source: Pract Midwife. 1999 May; 2(5): 4-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12024613&dopt=Abstract
•
Anxiety in the first attack of vertigo. Author(s): Pollak L, Klein C, Rafael S, Vera K, Rabey JM. Source: Otolaryngology and Head and Neck Surgery. 2003 June; 128(6): 829-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12825034&dopt=Abstract
•
Anxiety is a good indicator for somatic symptom reduction through behavioral medicine intervention in a mind/body medicine clinic. Author(s): Nakao M, Fricchione G, Myers P, Zuttermeister PC, Baim M, Mandle CL, Medich C, Wells-Federman CL, Martin Arcari P, Ennis M, Barsky AJ, Benson H. Source: Psychotherapy and Psychosomatics. 2001 January-February; 70(1): 50-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11150939&dopt=Abstract
106 Anxiety
•
Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients. Author(s): Linnet J, Jemec GB. Source: International Journal of Dermatology. 2001 October; 40(10): 632-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11737422&dopt=Abstract
•
Anxiety levels in women attending colposcopy clinics for treatment for cervical intraepithelial neoplasia: a randomised trial of written and video information. Author(s): Freeman-Wang T, Walker P, Linehan J, Coffey C, Glasser B, Sherr L. Source: Bjog : an International Journal of Obstetrics and Gynaecology. 2001 May; 108(5): 482-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11368133&dopt=Abstract
•
Anxiety management. Author(s): Horseman RE. Source: J Calif Dent Assoc. 2003 April; 31(4): 362, 361. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12793509&dopt=Abstract
•
Anxiety measures and their relationship to adolescent suicidal ideation and behavior. Author(s): Valentiner DP, Gutierrez PM, Blacker D. Source: Journal of Anxiety Disorders. 2002; 16(1): 11-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12171211&dopt=Abstract
•
Anxiety mediates the association between anxiety sensitivity and coping-related drinking motives in alcoholism treatment patients. Author(s): Kushner MG, Thuras P, Abrams K, Brekke M, Stritar L. Source: Addictive Behaviors. 2001 November-December; 26(6): 869-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768549&dopt=Abstract
•
Anxiety medications in palliative care. Author(s): Caldwell PK. Source: The American Journal of Nursing. 2003 May; 103(5): 15; Author Reply 15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12759597&dopt=Abstract
•
Anxiety reaction in children during removal of their plaster cast with a saw. Author(s): Katz K, Fogelman R, Attias J, Baron E, Soudry M. Source: The Journal of Bone and Joint Surgery. British Volume. 2001 April; 83(3): 388-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11341425&dopt=Abstract
Studies 107
•
Anxiety scores before and after prenatal testing for congenital anomalies. Author(s): Kowalcek I, Huber G, Lammers C, Brunk J, Bieniakiewicz I, Gembruch U. Source: Archives of Gynecology and Obstetrics. 2003 January; 267(3): 126-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12552321&dopt=Abstract
•
Anxiety sensitivity among children of parents with anxiety disorders: a controlled high-risk study. Author(s): Mannuzza S, Klein RG, Moulton JL, Scarfone N, Malloy P, Vosburg SK, Klein DF. Source: Journal of Anxiety Disorders. 2002; 16(2): 135-48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12194540&dopt=Abstract
•
Anxiety sensitivity and depression in multiple chemical sensitivities and asthma. Author(s): Caccappolo-van Vliet E, Kelly-McNeil K, Natelson B, Kipen H, Fiedler N. Source: Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 2002 October; 44(10): 890-901. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12391767&dopt=Abstract
•
Anxiety sensitivity and drug or alcohol use in individuals with anxiety and substance use disorders. Author(s): DeHaas RA, Calamari JE, Bair JP, Martin ED. Source: Addictive Behaviors. 2001 November-December; 26(6): 787-801. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768545&dopt=Abstract
•
Anxiety sensitivity and fear of pain in children. Author(s): Muris P, Vlaeyen JW, Meesters C, Vertongen S. Source: Percept Mot Skills. 2001 April; 92(2): 456-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11361307&dopt=Abstract
•
Anxiety sensitivity and major depression: examination of affective state dependence. Author(s): Cox BJ, Enns MW, Freeman P, Walker JR. Source: Behaviour Research and Therapy. 2001 November; 39(11): 1349-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11686269&dopt=Abstract
•
Anxiety sensitivity and other emotionality traits in predicting headache medication use in patients with recurring headaches: implications for abuse and dependency. Author(s): Asmundson GJ, Wright KD, Norton PJ, Veloso F. Source: Addictive Behaviors. 2001 November-December; 26(6): 827-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768547&dopt=Abstract
108 Anxiety
•
Anxiety sensitivity and panic attack symptomatology among low-income AfricanAmerican adolescents. Author(s): Ginsbur GS, Drake KL. Source: Journal of Anxiety Disorders. 2002; 16(1): 83-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12171215&dopt=Abstract
•
Anxiety sensitivity and panic disorder. Author(s): McNally RJ. Source: Biological Psychiatry. 2002 November 15; 52(10): 938-46. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12437935&dopt=Abstract
•
Anxiety sensitivity and PTSD among female victims of intimate partner violence. Author(s): Lang AJ, Kennedy CM, Stein MB. Source: Depression and Anxiety. 2002; 16(2): 77-83. Erratum In: Depress Anxiety. 2003; 17(1): 49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12219339&dopt=Abstract
•
Anxiety sensitivity as a predictor of the development of panic symptoms, panic attacks, and panic disorder: a prospective study. Author(s): Plehn K, Peterson RA. Source: Journal of Anxiety Disorders. 2002; 16(4): 455-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12213039&dopt=Abstract
•
Anxiety sensitivity as a specific and unique marker of anxious symptoms in youth psychiatric inpatients. Author(s): Joiner TE Jr, Schmidt NB, Schmidt KL, Laurent J, Catanzaro SJ, Perez M, Pettit JW. Source: Journal of Abnormal Child Psychology. 2002 April; 30(2): 167-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12008656&dopt=Abstract
•
Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorder. Author(s): Koszycki D, Bradwejn J. Source: Psychiatry Research. 2001 March 25; 101(2): 137-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11286817&dopt=Abstract
Studies 109
•
Anxiety sensitivity in adolescents at risk for psychopathology. Author(s): Pollock RA, Carter AS, Avenevoli S, Dierker LC, Chazan-Cohen R, Merikangas KR. Source: Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 2002 September; 31(3): 343-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12149972&dopt=Abstract
•
Anxiety sensitivity in adolescents: factor structure and relationships to trait anxiety and symptoms of anxiety disorders and depression. Author(s): Muris P, Schmidt H, Merckelbach H, Schouten E. Source: Behaviour Research and Therapy. 2001 January; 39(1): 89-100. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11125726&dopt=Abstract
•
Anxiety sensitivity in social phobia: comparison between social phobics with and without panic attacks. Author(s): Scott EL, Heimberg RG, Jack MS. Source: Depression and Anxiety. 2000; 12(4): 189-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11195754&dopt=Abstract
•
Anxiety sensitivity in the prediction of pain-related fear and anxiety in a heterogeneous chronic pain population. Author(s): Zvolensky MJ, Goodie JL, McNeil DW, Sperry JA, Sorrell JT. Source: Behaviour Research and Therapy. 2001 June; 39(6): 683-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11400712&dopt=Abstract
•
Anxiety sensitivity index: normative data and its differentiation from trait anxiety. Author(s): Sandin B, Chorot P, McNally RJ. Source: Behaviour Research and Therapy. 2001 February; 39(2): 213-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11153974&dopt=Abstract
•
Anxiety sensitivity, anxiety, and depression in older patients and their relation to hypochondriacal concerns and medical illnesses. Author(s): Bravo IM, Silverman WK. Source: Aging & Mental Health. 2001 November; 5(4): 349-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11767983&dopt=Abstract
110 Anxiety
•
Anxiety sensitivity, controllability, and experiential avoidance and their relation to drug of choice and addiction severity in a residential sample of substance-abusing veterans. Author(s): Forsyth JP, Parker JD, Finlay CG. Source: Addictive Behaviors. 2003 July; 28(5): 851-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12788261&dopt=Abstract
•
Anxiety sensitivity, panic, and depressed mood: a reanalysis teasing apart the contributions of the two levels in the hierarchial structure of the Anxiety Sensitivity Index. Author(s): Zinbarg RE, Brown TA, Barlow DH, Rapee RM. Source: Journal of Abnormal Psychology. 2001 August; 110(3): 372-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11502080&dopt=Abstract
•
Anxiety sensitivity, self-reported motives for alcohol and nicotine use, and level of consumption. Author(s): Novak A, Burgess ES, Clark M, Zvolensky MJ, Brown RA. Source: Journal of Anxiety Disorders. 2003; 17(2): 165-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12614660&dopt=Abstract
•
Anxiety sensitivity: predictor of sleep-related impairment and medication use in chronic insomnia. Author(s): Vincent N, Walker J. Source: Depression and Anxiety. 2001; 14(4): 238-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11754132&dopt=Abstract
•
Anxiety sensitivity: relations to psychopathy, DSM-IV personality disorder features, and personality traits. Author(s): Lilienfeld SO, Penna S. Source: Journal of Anxiety Disorders. 2001 September-October; 15(5): 367-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11583071&dopt=Abstract
•
Anxiety sensitivity: relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder. Author(s): Brown RA, Kahler CW, Zvolensky MJ, Lejuez CW, Ramsey SE. Source: Addictive Behaviors. 2001 November-December; 26(6): 887-99. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768550&dopt=Abstract
Studies 111
•
Anxiety symptoms in elderly patients with depression: what is the best approach to treatment? Author(s): Lenze EJ, Mulsant BH, Shear MK, Houck P, Reynolds III CF. Source: Drugs & Aging. 2002; 19(10): 753-60. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12390052&dopt=Abstract
•
Anxiety with panic disorder linked to chromosome 9q in Iceland. Author(s): Thorgeirsson TE, Oskarsson H, Desnica N, Kostic JP, Stefansson JG, Kolbeinsson H, Lindal E, Gagunashvili N, Frigge ML, Kong A, Stefansson K, Gulcher JR. Source: American Journal of Human Genetics. 2003 May; 72(5): 1221-30. Epub 2003 April 04. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12679899&dopt=Abstract
•
Anxiety, affect, and activity in teenagers: monitoring daily life with electronic diaries. Author(s): Henker B, Whalen CK, Jamner LD, Delfino RJ. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 June; 41(6): 660-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12049440&dopt=Abstract
•
Anxiety, arousal and visual attention: a mechanistic account of performance variability. Author(s): Janelle CM. Source: Journal of Sports Sciences. 2002 March; 20(3): 237-51. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11999479&dopt=Abstract
•
Anxiety, attitudes, and sex roles of male college students in a “Buddy Program” for persons with disabilities. Author(s): Gaje GD Jr, Saylor C, DeRoma V. Source: Psychological Reports. 2002 June; 90(3 Pt 2): 1211-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12150409&dopt=Abstract
•
Anxiety, cognitive performance, and cognitive decline in normal aging. Author(s): Wetherell JL, Reynolds CA, Gatz M, Pedersen NL. Source: The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 2002 May; 57(3): P246-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11983736&dopt=Abstract
•
Anxiety, coping strategies, and coping behaviors in patients undergoing head and neck cancer surgery. Author(s): Dropkin MJ. Source: Cancer Nursing. 2001 April; 24(2): 143-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11318262&dopt=Abstract
112 Anxiety
•
Anxiety, delirium, and pain in the intensive care unit. Author(s): Szokol JW, Vender JS. Source: Critical Care Clinics. 2001 October; 17(4): 821-42. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11762263&dopt=Abstract
•
Anxiety, depression and anger suppression in infertile couples: a controlled study. Author(s): Fassino S, Piero A, Boggio S, Piccioni V, Garzaro L. Source: Human Reproduction (Oxford, England). 2002 November; 17(11): 2986-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12407062&dopt=Abstract
•
Anxiety, depression and functional capacity in older women with mitral valve stenosis. Author(s): Shuldham C, Goodman H, Fleming S, Tattersall K, Pryse-Hawkins H. Source: International Journal of Nursing Practice. 2001 October; 7(5): 322-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11811430&dopt=Abstract
•
Anxiety, depression and informed consent in patients referred to a radiotherapy department. Author(s): Cazzaniga LF, Maroni D, Bianchi E, Bossi A, Cagna E, Cosentino D, Palmieri L, Scandolaro L, Valli MC. Source: Tumori. 2003 March-April; 89(2): 176-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12841667&dopt=Abstract
•
Anxiety, depression and stressful life events among medical students: a prospective study in Antalya, Turkey. Author(s): Aktekin M, Karaman T, Senol YY, Erdem S, Erengin H, Akaydin M. Source: Medical Education. 2001 January; 35(1): 12-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11123589&dopt=Abstract
•
Anxiety, depression, and insomnia. Author(s): Larzelere MM, Wiseman P. Source: Primary Care. 2002 June; 29(2): 339-60, Vii. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12391715&dopt=Abstract
•
Anxiety, depression, and the content of worries. Author(s): Diefenbach GJ, McCarthy-Larzelere ME, Williamson DA, Mathews A, Manguno-Mire GM, Bentz BG. Source: Depression and Anxiety. 2001; 14(4): 247-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11754134&dopt=Abstract
Studies 113
•
Anxiety, depression, hunger and body composition: III. Their relationships in obese patients. Author(s): Cugini P, Cilli M, Salandri A, Ceccotti P, Di Marzo A, Rodio A, Fontana S, Pellegrino AM, De Francesco GP, Coda S, De Vito F, Colosi L, Petrangeli CM, Giovannini C. Source: Eat Weight Disord. 1999 September; 4(3): 115-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11234239&dopt=Abstract
•
Anxiety, fears, and phobias in persons with Williams syndrome. Author(s): Dykens EM. Source: Developmental Neuropsychology. 2003; 23(1-2): 291-316. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12730029&dopt=Abstract
•
Anxiety, stress and coping strategies among University of South Pacific students. Author(s): Fuatai L, Soon-Schuster F. Source: Pac Health Dialog. 2001 March; 8(1): 83-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12017843&dopt=Abstract
•
Anxiety/aggression--driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis. Author(s): Van Praag HM. Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2001 May; 25(4): 893-924. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11383984&dopt=Abstract
•
Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. Author(s): Hurley KE, Miller SM, Costalas JW, Gillespie D, Daly MB. Source: Journal of Women's Health & Gender-Based Medicine. 2001 March; 10(2): 18999. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11268302&dopt=Abstract
•
Anxiety-related attentional biases and their regulation by attentional control. Author(s): Derryberry D, Reed MA. Source: Journal of Abnormal Psychology. 2002 May; 111(2): 225-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12003445&dopt=Abstract
•
Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. Author(s): McNaughton N, Gray JA. Source: Journal of Affective Disorders. 2000 December; 61(3): 161-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11163419&dopt=Abstract
114 Anxiety
•
Anxiolytic premedication reduces preoperative anxiety and pain during oocyte retrieval. A randomized double-blinded placebo-controlled trial. Author(s): Ng EH, Miao B, Ho PC. Source: Human Reproduction (Oxford, England). 2002 May; 17(5): 1233-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11980744&dopt=Abstract
•
Anxious genes, emerging themes. Commentary on Belzung “The genetic basis of the pharmacological effects of anxiolytics” and Olivier et al. “The 5-HT(1A) receptor knockout mouse and anxiety”. Author(s): Rodgers RJ. Source: Behavioural Pharmacology. 2001 November; 12(6-7): 471-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11742141&dopt=Abstract
•
Application of Ledoux's neurobiological findings in treating anxiety disorders. Author(s): Goldman DS. Source: The Journal of the American Academy of Psychoanalysis. 2000 Winter; 28(4): 701-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11317514&dopt=Abstract
•
Are anxiety and depression related to gastrointestinal symptoms in the general population? Author(s): Haug TT, Mykletun A, Dahl AA. Source: Scandinavian Journal of Gastroenterology. 2002 March; 37(3): 294-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11916191&dopt=Abstract
•
Are impaired childhood motor skills a risk factor for adolescent anxiety? Results from the 1958 U.K. birth cohort and the National Child Development Study. Author(s): Sigurdsson E, Van Os J, Fombonne E. Source: The American Journal of Psychiatry. 2002 June; 159(6): 1044-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12042195&dopt=Abstract
•
Asian American-white American differences in expressions of social anxiety: a replication and extension. Author(s): Okazaki S, Liu JF, Longworth SL, Minn JY. Source: Cultural Diversity & Ethnic Minority Psychology. 2002 August; 8(3): 234-47. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12143101&dopt=Abstract
•
As-needed use of benzodiazepines in managing clinical anxiety: incidence and implications. Author(s): Westra HA, Stewart SH. Source: Current Pharmaceutical Design. 2002; 8(1): 59-74. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11812250&dopt=Abstract
Studies 115
•
Assessing behavioral health using OASIS: part 2: cognitive impairment, problematic behaviors, and anxiety. Author(s): Raue PJ, Brown EL, Murphy CF, Bruce ML. Source: Home Healthcare Nurse. 2002 April; 20(4): 230-5; Quiz 236. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11984191&dopt=Abstract
•
Assessing older adults with generalized anxiety: a replication and extension. Author(s): Stanley MA, Novy DM, Bourland SL, Beck JG, Averill PM. Source: Behaviour Research and Therapy. 2001 February; 39(2): 221-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11153975&dopt=Abstract
•
Assessing the perceived predictability of anxiety-related events: a report on the perceived predictability index. Author(s): Zvolensky MJ, Eifert GH, Lejuez CW, Hopko DR, Forsyth JP. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2000 SeptemberDecember; 31(3-4): 201-18. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11494957&dopt=Abstract
•
Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence. Author(s): Posternak MA, Mueller TI. Source: The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2001 Winter; 10(1): 48-68. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11268828&dopt=Abstract
•
Assessment of anxiety and depression in adolescents with mental retardation. Author(s): Masi G, Brovedani P, Mucci M, Favilla L. Source: Child Psychiatry and Human Development. 2002 Spring; 32(3): 227-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11893172&dopt=Abstract
•
Assessment of anxiety in young children. Author(s): Warren SL, Dadson N. Source: Current Opinion in Pediatrics. 2001 December; 13(6): 580-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11753111&dopt=Abstract
•
Assessment of anxiety sensitivity in young American Indians and Alaska Natives. Author(s): Zvolensky MJ, McNeil DW, Porter CA, Stewart SH. Source: Behaviour Research and Therapy. 2001 April; 39(4): 477-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11280345&dopt=Abstract
116 Anxiety
•
Assessment of pain, depression, and anxiety by visual analogue scale in Japanese women with rheumatoid arthritis. Author(s): Tamiya N, Araki S, Ohi G, Inagaki K, Urano N, Hirano W, Daltroy LH. Source: Scandinavian Journal of Caring Sciences. 2002 June; 16(2): 137-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12000666&dopt=Abstract
•
Assessment of state and trait anxiety in subjects with anxiety and depressive disorders. Author(s): Kennedy BL, Schwab JJ, Morris RL, Beldia G. Source: The Psychiatric Quarterly. 2001 Fall; 72(3): 263-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11467160&dopt=Abstract
•
Association between allergy and anxiety disorders in youth. Author(s): Kovalenko PA, Hoven CW, Wu P, Wicks J, Mandell DJ, Tiet Q. Source: The Australian and New Zealand Journal of Psychiatry. 2001 December; 35(6): 815-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11990892&dopt=Abstract
•
Association of anxiety with reduced baroreflex cardiac control in patients after acute myocardial infarction. Author(s): Watkins LL, Blumenthal JA, Carney RM. Source: American Heart Journal. 2002 March; 143(3): 460-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11868052&dopt=Abstract
•
Association of fear auras with mood and anxiety disorders after temporal lobectomy. Author(s): Kohler CG, Carran MA, Bilker W, O'Connor MJ, Sperling MR. Source: Epilepsia. 2001 May; 42(5): 674-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11380577&dopt=Abstract
•
Association of polymorphisms of the estrogen receptor gene with anxiety-related traits in children and adolescents: a longitudinal study. Author(s): Prichard Z, Jorm AF, Prior M, Sanson A, Smart D, Zhang Y, Huttley G, Easteal S. Source: American Journal of Medical Genetics. 2002 March 8; 114(2): 169-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11857578&dopt=Abstract
•
Associations between anxiety and marital adjustment. Author(s): Dehle C, Weiss RL. Source: The Journal of Psychology. 2002 May; 136(3): 328-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12206281&dopt=Abstract
Studies 117
•
Associations between juvenile and adult forms of separation anxiety disorder: a study of adult volunteers with histories of school refusal. Author(s): Silove D, Manicavasagar V, Drobny J. Source: The Journal of Nervous and Mental Disease. 2002 June; 190(6): 413-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12080215&dopt=Abstract
•
Associations of blood glucose control with self-efficacy and rated anxiety/depression in type II diabetes mellitus patients. Author(s): Ikeda K, Aoki H, Saito K, Muramatsu Y, Suzuki T. Source: Psychological Reports. 2003 April; 92(2): 540-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12785638&dopt=Abstract
•
Associative learning deficits increase symptoms of anxiety in humans. Author(s): Grillon C. Source: Biological Psychiatry. 2002 June 1; 51(11): 851-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12022957&dopt=Abstract
•
Attachment behaviors, depression, and anxiety in nonoffending mothers of child sexual abuse victims. Author(s): Lewin L, Bergin C. Source: Child Maltreatment. 2001 November; 6(4): 365-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11675819&dopt=Abstract
•
Attachment-related dynamics: what can we learn from self-reports of avoidance and anxiety? Author(s): Feeney JA. Source: Attachment & Human Development. 2002 September; 4(2): 193-200. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12467512&dopt=Abstract
•
Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data. Author(s): Sheehan DV. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 19: 26-31. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11577788&dopt=Abstract
•
Attention deficit hyperactivity disorder, combined type (ADHD-CT): differences in blood pressure (BP) due to posture and the child report of anxiety. Author(s): Vance AL, Costin J, Maruff P. Source: European Child & Adolescent Psychiatry. 2002 February; 11(1): 24-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11942425&dopt=Abstract
118 Anxiety
•
Attention, arousal and expectancies in anxiety and sexual disorders. Author(s): van den Hout M, Barlow D. Source: Journal of Affective Disorders. 2000 December; 61(3): 241-56. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11163425&dopt=Abstract
•
Attentional and physiological characteristics of patients with dental anxiety. Author(s): Johnsen BH, Thayer JF, Laberg JC, Wormnes B, Raadal M, Skaret E, Kvale G, Berg E. Source: Journal of Anxiety Disorders. 2003; 17(1): 75-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12464290&dopt=Abstract
•
Auditory event-related potentials in panic and generalised anxiety disorders. Author(s): Turan T, Esel E, Karaaslan F, Basturk M, Oguz A, Yabanoglu I. Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2002 January; 26(1): 123-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11853102&dopt=Abstract
•
Auricular acupressure as a treatment for anxiety in prehospital transport settings. Author(s): Kober A, Scheck T, Schubert B, Strasser H, Gustorff B, Bertalanffy P, Wang SM, Kain ZN, Hoerauf K. Source: Anesthesiology. 2003 June; 98(6): 1328-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12766639&dopt=Abstract
•
Auricular acupuncture: a potential treatment for anxiety. Author(s): Wang SM, Kain ZN. Source: Anesthesia and Analgesia. 2001 February; 92(2): 548-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11159266&dopt=Abstract
•
Avoidance of dental visits: the predictive validity of three dental anxiety scales. Author(s): Haugejorden O, Klock KS. Source: Acta Odontologica Scandinavica. 2000 December; 58(6): 255-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11196400&dopt=Abstract
•
Baccalaureate nursing students' experiences of anxiety producing situations in the clinical setting. Author(s): Kim KH. Source: Contemp Nurse. 2003 April; 14(2): 145-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12785605&dopt=Abstract
Studies 119
•
Background and history of the interface between anxiety and vertigo. Author(s): Balaban CD, Jacob RG. Source: Journal of Anxiety Disorders. 2001 January-April; 15(1-2): 27-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11388357&dopt=Abstract
•
Back-neck pain and symptoms of anxiety and depression: a population-based twin study. Author(s): Reichborn-Kjennerud T, Stoltenberg C, Tambs K, Roysamb E, Kringlen E, Torgersen S, Harris JR. Source: Psychological Medicine. 2002 August; 32(6): 1009-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12214782&dopt=Abstract
•
Behavior Evaluation Scale: validity in studies on social anxiety. Author(s): Akillas E. Source: Psychological Reports. 2002 December; 91(3 Pt 1): 979-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12530753&dopt=Abstract
•
Behavioral assessment of social anxiety in females with Turner or fragile X syndrome. Author(s): Lesniak-Karpiak K, Mazzocco MM, Ross JL. Source: Journal of Autism and Developmental Disorders. 2003 February; 33(1): 55-67. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708580&dopt=Abstract
•
Behavioral characteristics related to substance abuse and risk-taking, sensationseeking, anxiety sensitivity, and self-reinforcement. Author(s): Wagner MK. Source: Addictive Behaviors. 2001 January-February; 26(1): 115-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11196285&dopt=Abstract
•
Behavioral genetics as a tool for developmental psychology: anxiety and depression in children and adolescents. Author(s): Eley TC. Source: Clinical Child and Family Psychology Review. 1999 March; 2(1): 21-36. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11324094&dopt=Abstract
•
Behavioral genetics: anxiety under interrogation. Author(s): Toye AA, Cox R. Source: Current Biology : Cb. 2001 June 26; 11(12): R473-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11448789&dopt=Abstract
120 Anxiety
•
Behavioural inhibition and symptoms of anxiety and depression: is there a specific relationship with social phobia? Author(s): Neal JA, Edelmann RJ, Glachan M. Source: The British Journal of Clinical Psychology / the British Psychological Society. 2002 November; 41(Pt 4): 361-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12437791&dopt=Abstract
•
Benzodiazepine discontinuation in generalized anxiety disorder. Author(s): Gupta R, Gupta N, Avasthi A. Source: The American Journal of Psychiatry. 2002 February; 159(2): 321-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11823290&dopt=Abstract
•
Benzodiazepine treatment of anxiety or insomnia in substance abuse patients. Author(s): Ciraulo DA, Nace EP. Source: The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2000 Fall; 9(4): 276-9; Discussion 280-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11155783&dopt=Abstract
•
Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder). Author(s): Jefferson JW. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 1: 50-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11206035&dopt=Abstract
•
Biased attentional behavior in childhood anxiety. A review of theory and current empirical investigation. Author(s): Ehrenreich JT, Gross AM. Source: Clinical Psychology Review. 2002 September; 22(7): 991-1008. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12238250&dopt=Abstract
•
Biases in eye movements to threatening facial expressions in generalized anxiety disorder and depressive disorder. Author(s): Mogg K, Millar N, Bradley BP. Source: Journal of Abnormal Psychology. 2000 November; 109(4): 695-704. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11195993&dopt=Abstract
•
Biochemical markers of anxiety and depression. Author(s): Rafter D. Source: Psychiatry Research. 2001 August 5; 103(1): 93-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11472794&dopt=Abstract
Studies 121
•
Biochemical relapse in prostate cancer: is PSA promoting stress and anxiety? Author(s): Slovin S. Source: Medgenmed [electronic Resource] : Medscape General Medicine. 2002 August 28; 4(3): 11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12466754&dopt=Abstract
•
Biological differences in depression and anxiety across races and ethnic groups. Author(s): Lin KM. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 13: 13-9; Discussion 20-1. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11434414&dopt=Abstract
•
Blood pressure and symptoms of depression and anxiety: a prospective study. Author(s): Shinn EH, Poston WS, Kimball KT, St Jeor ST, Foreyt JP. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 2001 July; 14(7 Pt 1): 660-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11482304&dopt=Abstract
•
Botanical medicines for anxiety: do they have a place? Author(s): Davidson J. Source: Current Psychiatry Reports. 2002 August; 4(4): 245-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12126591&dopt=Abstract
•
Brain chemistry reflects dual states of pain and anxiety in chronic low back pain. Author(s): Grachev ID, Fredrickson BE, Apkarian AV. Source: Journal of Neural Transmission (Vienna, Austria : 1996). 2002 October; 109(10): 1309-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12373563&dopt=Abstract
•
Brain electrical tomography in depression: the importance of symptom severity, anxiety, and melancholic features. Author(s): Pizzagalli DA, Nitschke JB, Oakes TR, Hendrick AM, Horras KA, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, Pascual-Marqui RD, Davidson RJ. Source: Biological Psychiatry. 2002 July 15; 52(2): 73-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12113998&dopt=Abstract
•
Brain function in social anxiety disorder. Author(s): Argyropoulos SV, Bell CJ, Nutt DJ. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 707-22. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723629&dopt=Abstract
122 Anxiety
•
Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Author(s): Anand A, Shekhar A. Source: Annals of the New York Academy of Sciences. 2003 April; 985: 370-88. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12724172&dopt=Abstract
•
Brain wave synchronizers: a potential tool for reducing dental stress and anxiety. Author(s): Morse DR. Source: Dent Today. 2000 October; 19(10): 118-20, 122-5. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12524816&dopt=Abstract
•
Brief report: citalopram in child and adolescent depression with anxiety. Author(s): Schaller JL, Behar D. Source: Medgenmed [electronic Resource] : Medscape General Medicine. 2001 October 31; 3(5): 1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11698908&dopt=Abstract
•
Brief virtual reality therapy for public speaking anxiety. Author(s): Harris SR, Kemmerling RL, North MM. Source: Cyberpsychology & Behavior : the Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society. 2002 December; 5(6): 543-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12556117&dopt=Abstract
•
Burn patients' pain and anxiety experiences. Author(s): Byers JF, Bridges S, Kijek J, LaBorde P. Source: The Journal of Burn Care & Rehabilitation. 2001 March-April; 22(2): 144-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11302603&dopt=Abstract
•
By the way, doctor. Your article about anxiety in the March 2002 issue neglected to mention the herb kava as a treatment for anxiety. I've been using it, and I thought its effectiveness for anxiety was widely accepted. Why did you omit it? Author(s): Robb-Nicholson C. Source: Harvard Women's Health Watch. 2002 April; 9(8): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11959540&dopt=Abstract
•
Can pre-colposcopy sessions reduce anxiety at the time of colposcopy? A prospective randomised study. Author(s): Byrom J, Clarke T, Neale J, Dunn PD, Hughes GM, Redman CW, Pitts M. Source: Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology. 2002 July; 22(4): 415-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12521468&dopt=Abstract
Studies 123
•
Can we use anxiolytics during pregnancy without anxiety? Author(s): Addis A, Dolovich LR, Einarson TR, Koren G. Source: Can Fam Physician. 2000 March; 46: 549-51. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10751993&dopt=Abstract
•
Cancer patients' anxiety. Author(s): Sundar S, Symonds P. Source: Lancet. 2003 May 17; 361(9370): 1746-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12767769&dopt=Abstract
•
Capsulotomy for refractory anxiety disorders: long-term follow-up of 26 patients. Author(s): Ruck C, Andreewitch S, Flyckt K, Edman G, Nyman H, Meyerson BA, Lippitz BE, Hindmarsh T, Svanborg P, Mindus P, Asberg M. Source: The American Journal of Psychiatry. 2003 March; 160(3): 513-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12611833&dopt=Abstract
•
Cardiac anxiety in patients self-referred for electron beam tomography. Author(s): Carmin CN, Wiegartz PS, Hoff JA, Kondos GT. Source: Journal of Behavioral Medicine. 2003 February; 26(1): 67-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12690947&dopt=Abstract
•
Cardiac deceleration in elite golfers as modified by noise and anxiety during putting. Author(s): Hassmen P, Koivula N. Source: Percept Mot Skills. 2001 June; 92(3 Pt 2): 947-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11565938&dopt=Abstract
•
Career group counseling in undecided college female seniors' state anxiety and career indecision. Author(s): Peng H. Source: Psychological Reports. 2001 June; 88(3 Pt 2): 996-1004. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11597093&dopt=Abstract
•
Case of a 73-year-old man with dementia and a likely pheochromocytoma mistaken for an anxiety disorder. Author(s): Prokhorova M, Fritz S. Source: Psychosomatics. 2002 January-February; 43(1): 82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11927767&dopt=Abstract
124 Anxiety
•
Casting anxiety in small group facilitation: faculty development via role play. Author(s): Kim S, Stevens NG, Pinsky L. Source: Medical Education. 2003 May; 37(5): 489. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12709215&dopt=Abstract
•
Castration anxiety and phobias. Author(s): Cogan R, Larrabee LK, Wyatt IM, Ontiberoz A, Waters SK, Werner ML, Miller AL, Lovelady AC, Hurt TJ, Hardin ED 3rd, Gonzalez PM. Source: Psychological Reports. 2002 December; 91(3 Pt 2): 1244-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12585544&dopt=Abstract
•
Causal modeling of relations among learning history, anxiety sensitivity, and panic attacks. Author(s): Stewart SH, Taylor S, Jang KL, Cox BJ, Watt MC, Fedoroff IC, Borger SC. Source: Behaviour Research and Therapy. 2001 April; 39(4): 443-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11280342&dopt=Abstract
•
Center-based prevalence of anxiety and depression in women of the northern areas of Pakistan. Author(s): Dodani S, Zuberi RW. Source: J Pak Med Assoc. 2000 May; 50(5): 138-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11242710&dopt=Abstract
•
Cerebral blood flow and anxiety in older men: an analysis of resting anterior asymmetry and prefrontal regions. Author(s): Tankard CF, Waldstein SR, Siegel EL, Holder LE, Lefkowitz D, Anstett F, Katzel LI. Source: Brain and Cognition. 2003 June; 52(1): 70-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12812806&dopt=Abstract
•
CF carrier testing in a high risk population: anxiety, risk perceptions, and reproductive plans of carrier by “non-carrier” couples. Author(s): Callanan NP, Cheuvront BJ, Sorenson JR. Source: Genetics in Medicine : Official Journal of the American College of Medical Genetics. 1999 November-December; 1(7): 323-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11263543&dopt=Abstract
•
Challenges and early experiences in the development of an anxiety clinic in the public health sector. Author(s): Wagner R, Manicavasagar V, Silove D. Source: General Hospital Psychiatry. 2002 November-December; 24(6): 406-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12490342&dopt=Abstract
Studies 125
•
Characteristics of parent- and child-reported anxiety in psychostimulant medication naive, clinically referred children with attention deficit hyperactivity disorder, combined type (ADHD-CT). Author(s): Vance A, Costin J, Barnett R, Luk E, Maruff P, Tonge B. Source: The Australian and New Zealand Journal of Psychiatry. 2002 April; 36(2): 234-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11982546&dopt=Abstract
•
Characteristics of patients with social phobia and their treatment in specialized clinics for anxiety disorders in the Netherlands. Author(s): Dingemans AE, van Vliet IM, Couvee J, Westenberg HG. Source: Journal of Affective Disorders. 2001 July; 65(2): 123-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11356235&dopt=Abstract
•
Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR. Author(s): Montgomery SA, Sheehan DV, Meoni P, Haudiquet V, Hackett D. Source: Journal of Psychiatric Research. 2002 July-August; 36(4): 209-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12191625&dopt=Abstract
•
Chemical mapping of anxiety in the brain of healthy humans: an in vivo 1H-MRS study on the effects of sex, age, and brain region. Author(s): Grachev ID, Apkarian AV. Source: Human Brain Mapping. 2000 December; 11(4): 261-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11144755&dopt=Abstract
•
Childhood adversities associated with major depression and/or anxiety disorders in a community sample of Ontario: issues of co-morbidity and specificity. Author(s): Levitan RD, Rector NA, Sheldon T, Goering P. Source: Depression and Anxiety. 2003; 17(1): 34-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12577276&dopt=Abstract
•
Childhood adversity and anxiety versus dysthymia co-morbidity in major depression. Author(s): Harkness KL, Wildes JE. Source: Psychological Medicine. 2002 October; 32(7): 1239-49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12420893&dopt=Abstract
•
Childhood and early-onset anxiety: treatment and biomarker studies. Author(s): McCracken JT, Walkup JT, Koplewicz HS. Source: The Journal of Clinical Psychiatry. 2002; 63 Suppl 6: 8-11. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12027119&dopt=Abstract
126 Anxiety
•
Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Author(s): Otto MW, Pollack MH, Maki KM, Gould RA, Worthington JJ 3rd, Smoller JW, Rosenbaum JF. Source: Depression and Anxiety. 2001; 14(4): 209-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11754127&dopt=Abstract
•
Children choosing between general anaesthesia or inhalation sedation for dental extractions: the effect on dental anxiety. Author(s): Arch LM, Humphris GM, Lee GT. Source: International Journal of Paediatric Dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children. 2001 January; 11(1): 41-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11309872&dopt=Abstract
•
Children with prepubertal-onset major depressive disorder and anxiety grown up. Author(s): Weissman MM, Wolk S, Wickramaratne P, Goldstein RB, Adams P, Greenwald S, Ryan ND, Dahl RE, Steinberg D. Source: Archives of General Psychiatry. 1999 September; 56(9): 794-801. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12884885&dopt=Abstract
•
Children's art as a helpful index of anxiety and self-esteem with plastic surgery. Author(s): Lukash FN. Source: Plastic and Reconstructive Surgery. 2002 May; 109(6): 1777-86; Discussion 17878. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11994573&dopt=Abstract
•
Children's knowledge, anticipatory anxiety, procedural distress, and recall of esophagogastroduodenoscopy. Author(s): Lewis Claar R, Walker LS, Barnard JA. Source: Journal of Pediatric Gastroenterology and Nutrition. 2002 January; 34(1): 68-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11753168&dopt=Abstract
•
Chronic fatigue and anxiety/depression: a twin study. Author(s): Roy-Byrne P, Afari N, Ashton S, Fischer M, Goldberg J, Buchwald D. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2002 January; 180: 29-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11772848&dopt=Abstract
Studies 127
•
Cigarette smoking and anxiety disorders. Author(s): Beerachee Y, Coulson EJ, Kay NL, McKinnon IG, Sarkar L. Source: Jama : the Journal of the American Medical Association. 2001 February 14; 285(6): 732; Author Reply 732-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11176898&dopt=Abstract
•
Cigarette smoking and anxiety disorders. Author(s): MacCorquodale DW. Source: Jama : the Journal of the American Medical Association. 2001 February 14; 285(6): 732; Author Reply 732-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11176897&dopt=Abstract
•
Citalopram in children and adolescents with depression or anxiety. Author(s): Baumgartner JL, Emslie GJ, Crismon ML. Source: The Annals of Pharmacotherapy. 2002 November; 36(11): 1692-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12398561&dopt=Abstract
•
Clinical significance and comorbidity of subthreshold depression and anxiety in the community. Author(s): Preisig M, Merikangas KR, Angst J. Source: Acta Psychiatrica Scandinavica. 2001 August; 104(2): 96-103. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11473502&dopt=Abstract
•
Clinical validation of an anxiety and depression screening test for intensive inhospital rehabilitation. Author(s): Vedana L, Baiardi P, Sommaruga M, Galli M, Neri M, Pedretti RF, Tramarin R, Bertolotti G. Source: Monaldi Arch Chest Dis. 2002 September; 58(2): 101-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12418422&dopt=Abstract
•
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. Author(s): Lerner AG, Gelkopf M, Skladman I, Rudinski D, Nachshon H, Bleich A. Source: International Clinical Psychopharmacology. 2003 March; 18(2): 101-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12598822&dopt=Abstract
•
Coffee increases state anxiety in males but not in females. Author(s): Botella P, Parra A. Source: Human Psychopharmacology. 2003 March; 18(2): 141-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12590408&dopt=Abstract
128 Anxiety
•
Cognition in childhood anxiety: conceptual, methodological, and developmental issues. Author(s): Alfano CA, Beidel DC, Turner SM. Source: Clinical Psychology Review. 2002 November; 22(8): 1209-38. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12436811&dopt=Abstract
•
Cognitive biases in anxiety disorders and their effect on cognitive-behavioral treatment. Author(s): Craske MG, Pontillo DC. Source: Bulletin of the Menninger Clinic. 2001 Winter; 65(1): 58-77. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11280959&dopt=Abstract
•
Cognitive change and enhanced coping: missing mediational links in cognitive behavior therapy with anxiety-disordered children. Author(s): Prins PJ, Ollendick TH. Source: Clinical Child and Family Psychology Review. 2003 June; 6(2): 87-105. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12836579&dopt=Abstract
•
Cognitive coping and anxiety symptoms among people who seek help for fear of flying. Author(s): Kraaij V, Garnefski N, Van Gerwen L. Source: Aviation, Space, and Environmental Medicine. 2003 March; 74(3): 273-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12650276&dopt=Abstract
•
Cognitive coping strategies and symptoms of depression and anxiety: a comparison between adolescents and adults. Author(s): Garnefski N, Legerstee J, Kraaij VV, Van Den Kommer T, Teerds J. Source: Journal of Adolescence. 2002 December; 25(6): 603-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12490178&dopt=Abstract
•
Cognitive ERPs in depressive and anxiety disorders during tonal and phonetic oddball tasks. Author(s): Bruder GE, Kayser J, Tenke CE, Leite P, Schneier FR, Stewart JW, Quitkin FM. Source: Clin Electroencephalogr. 2002 July; 33(3): 119-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12192661&dopt=Abstract
•
Cognitive functioning in chronic fatigue syndrome and the role of depression, anxiety, and fatigue. Author(s): Short K, McCabe M, Tooley G. Source: Journal of Psychosomatic Research. 2002 June; 52(6): 475-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12069872&dopt=Abstract
Studies 129
•
Cognitive orientation, precompetition, and actual competition anxiety in collegiate softball players. Author(s): Wilson GS, Steinke JS. Source: Research Quarterly for Exercise and Sport. 2002 September; 73(3): 335-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12230341&dopt=Abstract
•
Cognitive theories of generalized anxiety disorder. Author(s): Aikins DE, Craske MG. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 57-74, Vi. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225509&dopt=Abstract
•
Cognitive, affective, and physiological expressions of anxiety symptomatology among Mexican migrant farmworkers: predictors and generational differences. Author(s): Hovey JD, Magana CG. Source: Community Mental Health Journal. 2002 June; 38(3): 223-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12046676&dopt=Abstract
•
Cognitive-behavior therapy for late-life generalized anxiety disorder in primary care: preliminary findings. Author(s): Stanley MA, Hopko DR, Diefenbach GJ, Bourland SL, Rodriguez H, Wagener P. Source: The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry. 2003 January-February; 11(1): 92-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12527544&dopt=Abstract
•
Cognitive-behavioral intervention effects on adolescents' anxiety and pain following spinal fusion surgery. Author(s): LaMontagne LL, Hepworth JT, Cohen F, Salisbury MH. Source: Nursing Research. 2003 May-June; 52(3): 183-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12792259&dopt=Abstract
•
Cognitive-behavioral models of social anxiety disorder. Author(s): Roth DA, Heimberg RG. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 753-71. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723631&dopt=Abstract
•
Cognitive-behavioral therapy for generalized anxiety disorder with integrations from interpersonal and experiential therapies. Author(s): Borkovec TD, Newman MG, Castonguay LG. Source: Cns Spectr. 2003 May; 8(5): 382-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12766694&dopt=Abstract
130 Anxiety
•
Cognitive-behavioral therapy for social anxiety disorder. Author(s): Radomsky AS, Otto MW. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 805-15. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723634&dopt=Abstract
•
Cognitive-behavioral therapy for social anxiety disorder: current status and future directions. Author(s): Heimberg RG. Source: Biological Psychiatry. 2002 January 1; 51(1): 101-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11801235&dopt=Abstract
•
Cognitive-behavioral therapy for social anxiety disorder: supporting evidence and future directions. Author(s): Hambrick JP, Weeks JW, Harb GC, Heimberg RG. Source: Cns Spectr. 2003 May; 8(5): 373-81. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12766693&dopt=Abstract
•
Cognitive-behavioral therapy with a six-year-old boy with separation anxiety disorder: a case study. Author(s): Dia DA. Source: Health & Social Work. 2001 May; 26(2): 125-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11378998&dopt=Abstract
•
Cognitive-behavioral treatment of anxiety disorders in children: long-term (6-year) follow-up. Author(s): Barrett PM, Duffy AL, Dadds MR, Rapee RM. Source: Journal of Consulting and Clinical Psychology. 2001 February; 69(1): 135-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11302272&dopt=Abstract
•
Cognitive-behavioral treatment of generalized anxiety disorder among adolescents: a case series. Author(s): Leger E, Ladouceur R, Dugas MJ, Freeston MH. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 March; 42(3): 327-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12595786&dopt=Abstract
•
Cognitive-behavioral treatment of late-life generalized anxiety disorder. Author(s): Stanley MA, Beck JG, Novy DM, Averill PM, Swann AC, Diefenbach GJ, Hopko DR. Source: Journal of Consulting and Clinical Psychology. 2003 April; 71(2): 309-19. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12699025&dopt=Abstract
Studies 131
•
Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder. Author(s): Chavira DA, Stein MB. Source: Journal of Child and Adolescent Psychopharmacology. 2002 Spring; 12(1): 47-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12014595&dopt=Abstract
•
Comment on “Convergent validity of the Collett-Lester Fear of Death and Templer Death Anxiety Scales in Egyptian male college students”. Author(s): Lester D. Source: Psychological Reports. 2002 December; 91(3 Pt 1): 940. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12530748&dopt=Abstract
•
Commentary: Anxiety, sensitivity and the pain experience. Author(s): Asmundson GJ. Source: European Journal of Pain (London, England). 2001; 5(1): 23-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11394919&dopt=Abstract
•
Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany. Author(s): Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U, Broese T, Broocks A, Burtscheidt W, Cimander KF, Degkwitz P, Driessen M, Ehrenreich H, Fischbach E, Folkerts H, Frank H, Gurth D, Havemann-Reinecke U, Heber W, Heuer J, Hingsammer A, Jacobs S, Krampe H, Lange W, Lay T, Leimbach M, Lemke MR, Leweke M, Mangholz A, Massing W, Meyenberg R, Porzig J, Quattert T, Redner C, Ritzel G, Rollnik JD, Sauvageoll R, Schlafke D, Schmid G, Schroder H, Schwichtenberg U, Schwoon D, Seifert J, Sickelmann I, Sieveking CF, Spiess C, Stiegemann HH, Stracke R, Straetgen HD, Subkowski P, Thomasius R, Tretzel H, Verner LJ, Vitens J, Wagner T, Weirich S, Weiss I, Wendorff T, Wetterling T, Wiese B, Wittfoot J. Source: Alcohol and Alcoholism (Oxford, Oxfordshire). 2001 May-June; 36(3): 219-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11373258&dopt=Abstract
•
Comorbid anxiety and mood disorders among persons with social anxiety disorder. Author(s): Erwin BA, Heimberg RG, Juster H, Mindlin M. Source: Behaviour Research and Therapy. 2002 January; 40(1): 19-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11762424&dopt=Abstract
•
Comorbid anxiety disorders in civilians seeking treatment for posttraumatic stress disorder. Author(s): Zayfert C, Becker CB, Unger DL, Shearer DK. Source: Journal of Traumatic Stress. 2002 February; 15(1): 31-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11936720&dopt=Abstract
132 Anxiety
•
Comorbidity between eating disorders and anxiety disorders: a review. Author(s): Godart NT, Flament MF, Perdereau F, Jeammet P. Source: The International Journal of Eating Disorders. 2002 November; 32(3): 253-70. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12210640&dopt=Abstract
•
Comorbidity fails to account for the relationship of expressed emotion and perceived criticism to treatment outcome in patients with anxiety disorders. Author(s): Renshaw KD, Chambless D, Steketee G. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2001 September; 32(3): 145-58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11934127&dopt=Abstract
•
Comorbidity in childhood anxiety disorders and treatment outcome. Author(s): Kendall PC, Brady EU, Verduin TL. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 July; 40(7): 787-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11437017&dopt=Abstract
•
Comorbidity in generalized anxiety disorder. Author(s): Noyes R Jr. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 41-55. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225508&dopt=Abstract
•
Comorbidity in generalized anxiety disorder: impact and implications. Author(s): Stein DJ. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 11: 29-34; Discussion 35-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11414548&dopt=Abstract
•
Comorbidity of anxiety and depression in children and adolescents: an integrative review. Author(s): Seligman LD, Ollendick TH. Source: Clinical Child and Family Psychology Review. 1998 June; 1(2): 125-44. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11324302&dopt=Abstract
•
Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Author(s): Tamam L, Ozpoyraz N. Source: Psychopathology. 2002 July-August; 35(4): 203-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12239436&dopt=Abstract
Studies 133
•
Comorbidity of dependent personality disorder and separation anxiety disorder in addictive disorders and in healthy subjects. Author(s): Loas G, Atger F, Perdereau F, Verrier A, Guelfi JD, Halfon O, Lang F, Bizouard P, Venisse JL, Perez-Diaz F, Corcos M, Flament M, Jeammet P; Reseau Institut National de la Sante et de la Recherche Medicale (INSERM) No. 494013. Source: Psychopathology. 2002 July-August; 35(4): 249-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12239442&dopt=Abstract
•
Comorbidity of depression and anxiety disorders in later life. Author(s): Lenze EJ, Mulsant BH, Shear MK, Alexopoulos GS, Frank E, Reynolds CF 3rd. Source: Depression and Anxiety. 2001; 14(2): 86-93. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11668661&dopt=Abstract
•
Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Author(s): Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP. Source: Headache. 2000 November-December; 40(10): 818-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11135026&dopt=Abstract
•
Comorbidity of mood and anxiety disorders: the rule, not the exception? Author(s): Nemeroff CB. Source: The American Journal of Psychiatry. 2002 January; 159(1): 3-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11772680&dopt=Abstract
•
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. Author(s): Pollack MH. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 12: 24-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11430615&dopt=Abstract
•
Comparative levels of psychological distress, stress symptoms, depression and anxiety after childbirth--a prospective population-based study of mothers and fathers. Author(s): Skari H, Skreden M, Malt UF, Dalholt M, Ostensen AB, Egeland T, Emblem R. Source: Bjog : an International Journal of Obstetrics and Gynaecology. 2002 October; 109(10): 1154-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12387470&dopt=Abstract
134 Anxiety
•
Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine. Author(s): Smith MS, Martin-Herz SP, Womack WM, Marsigan JL. Source: Pediatrics. 2003 April; 111(4 Pt 1): E376-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12671155&dopt=Abstract
•
Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. Author(s): Simon NM, Smoller JW, Fava M, Sachs G, Racette SR, Perlis R, Sonawalla S, Rosenbaum JF. Source: Journal of Psychiatric Research. 2003 May-June; 37(3): 187-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12650739&dopt=Abstract
•
Comparison between two models of experimental anxiety in healthy volunteers and panic disorder patients. Author(s): Graeff FG, Silva M, Del Ben CM, Zuardi AW, Hetem LA, Guimaraes FS. Source: Neuroscience and Biobehavioral Reviews. 2001 December; 25(7-8): 753-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11801299&dopt=Abstract
•
Comparison of anxiety assessments between clinicians and patients with acute myocardial infarction in cardiac critical care units. Author(s): O'Brien JL, Moser DK, Riegel B, Frazier SK, Garvin BJ, Kim KA. Source: American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses. 2001 March; 10(2): 97-103. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11244678&dopt=Abstract
•
Comparison of anxiety response levels in patients who are HIV-positive and patients who are not. Author(s): Weiner AA, Zemnick C, Ganda K. Source: J Mass Dent Soc. 2002 Fall; 51(3): 12-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12380033&dopt=Abstract
•
Compulsive checking behaviors in generalized anxiety disorder. Author(s): Schut AJ, Castonguay LG, Borkovec TD. Source: Journal of Clinical Psychology. 2001 June; 57(6): 705-15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11344459&dopt=Abstract
Studies 135
•
Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice. Author(s): Proudfoot J, Goldberg D, Mann A, Everitt B, Marks I, Gray JA. Source: Psychological Medicine. 2003 February; 33(2): 217-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622301&dopt=Abstract
•
Computer-related anxiety: examining the impact of technology-specific affect on the performance of a computerized neuropsychological assessment measure. Author(s): Browndyke JN, Albert AL, Malone W, Schatz P, Paul RH, Cohen RA, Tucker KA, Gouvier WD. Source: Applied Neuropsychology. 2002; 9(4): 210-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12584075&dopt=Abstract
•
Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Author(s): Randall CL, Thomas S, Thevos AK. Source: Alcoholism, Clinical and Experimental Research. 2001 February; 25(2): 210-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11236835&dopt=Abstract
•
Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. Author(s): Wood JJ, Piacentini JC, Bergman RL, McCracken J, Barrios V. Source: Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 2002 September; 31(3): 335-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12149971&dopt=Abstract
•
Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Author(s): Cohen H, Buskila D, Neumann L, Ebstein RP. Source: Arthritis and Rheumatism. 2002 March; 46(3): 845-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11920428&dopt=Abstract
•
Conquering dysfunctional anxiety: what you say to yourself matters! Author(s): Lyon BL. Source: Reflect Nurs Leadersh. 2000; 26(4): 33-5, 45. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11987388&dopt=Abstract
136 Anxiety
•
Consensus statement on depression, anxiety, and cardiovascular disease. Author(s): Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Roose SP, Sheps DS; International Consensus Group on Depression and Anxiety. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 24-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108818&dopt=Abstract
•
Consensus statement on depression, anxiety, and functional gastrointestinal disorders. Author(s): Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Lydiard RB, Mayer EA; International Consensus Group on Depression and Anxiety. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 48-51. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108822&dopt=Abstract
•
Consensus statement on depression, anxiety, and oncology. Author(s): Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Jones RD, Berard RM; International Consensus Group on Depression and Anxiety. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 64-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108825&dopt=Abstract
•
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. Author(s): Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 11: 53-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11414552&dopt=Abstract
•
Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. Author(s): Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Kirmayer LJ, Lepine JP, Lin KM, Tajima O, Ono Y. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 13: 47-55. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11434419&dopt=Abstract
•
Considerations in the management of the patient with comorbid depression and anxiety. Author(s): Sekula LK, DeSantis J, Gianetti V. Source: Journal of the American Academy of Nurse Practitioners. 2003 January; 15(1): 23-33. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12613410&dopt=Abstract
Studies 137
•
Considerations in the treatment of anxiety disorders: a pharmacoeconomic review. Author(s): Grudzinski AN. Source: Expert Opinion on Pharmacotherapy. 2001 October; 2(10): 1557-69. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11825299&dopt=Abstract
•
Considering the clinical utility of performance-based measures of childhood anxiety. Author(s): Vasey MW, Lonigan CJ. Source: Journal of Clinical Child Psychology. 2000 December; 29(4): 493-508. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11126629&dopt=Abstract
•
Construct validity of the Global Assessment of Functioning Scale for clients with anxiety disorder. Author(s): Schwartz RC, Del Prete-Brown T. Source: Psychological Reports. 2003 April; 92(2): 548-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12785640&dopt=Abstract
•
Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction. Author(s): Kramer ML, Ross J, Davidson JR. Source: The Journal of Nervous and Mental Disease. 2001 May; 189(5): 328-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11379978&dopt=Abstract
•
Contemporary management of comorbid anxiety and depression in geriatric patients. Author(s): Doraiswamy PM. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 12: 30-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11430616&dopt=Abstract
•
Contingency-competence-control-related beliefs and symptoms of anxiety and depression in a young adolescent sample. Author(s): Muris P, Schouten E, Meesters C, Gijsbers H. Source: Child Psychiatry and Human Development. 2003 Summer; 33(4): 325-39. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12723904&dopt=Abstract
•
Contrasting two accounts of anxiety-linked attentional bias: selective attention to varying levels of stimulus threat intensity. Author(s): Wilson E, MacLeod C. Source: Journal of Abnormal Psychology. 2003 May; 112(2): 212-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12784830&dopt=Abstract
138 Anxiety
•
Convergent validity of the Collett-Lester Fear of Death and Templer Death Anxiety Scales in Egyptian male college students. Author(s): Abdel-Khalek AM. Source: Psychological Reports. 2002 June; 90(3 Pt 1): 849-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12090517&dopt=Abstract
•
Coping effectiveness training reduces depression and anxiety following traumatic spinal cord injuries. Author(s): Kennedy P, Duff J, Evans M, Beedie A. Source: The British Journal of Clinical Psychology / the British Psychological Society. 2003 March; 42(Pt 1): 41-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12675978&dopt=Abstract
•
Coping measurement and the state effect of depression and anxiety in psychiatric outpatients. Author(s): Uehara T, Sakado K, Sato T, Takizawa R. Source: Psychopathology. 2002 January-February; 35(1): 48-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12006748&dopt=Abstract
•
Coping style of substance-abuse patients: effects of anxiety and mood disorders on coping change. Author(s): Franken IH, Hendriks VM, Haffmans PM, van der Meer CW. Source: Journal of Clinical Psychology. 2001 March; 57(3): 299-306. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11241361&dopt=Abstract
•
Coping with anxiety in later life. Author(s): Frazier LD, Waid LD, Fincke C. Source: Journal of Gerontological Nursing. 2002 December; 28(12): 40-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12567825&dopt=Abstract
•
Coping with anxiety. Author(s): Kalb C. Source: Newsweek. 2003 February 24; 141(8): 50-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12800598&dopt=Abstract
•
Correlates of anxiety, hostility, depression, and psychosocial adjustment in parents of NICU infants. Author(s): Doering LV, Moser DK, Dracup K. Source: Neonatal Netw. 2000 August; 19(5): 15-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11949109&dopt=Abstract
Studies 139
•
Correlates of autobiographical memory specificity: the role of depression, anxiety and childhood trauma. Author(s): Wessel I, Meeren M, Peeters F, Arntz A, Merckelbach H. Source: Behaviour Research and Therapy. 2001 April; 39(4): 409-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11280340&dopt=Abstract
•
Correlates of death anxiety in Pakistan. Author(s): Suhail K, Akram S. Source: Death Studies. 2002 January; 26(1): 39-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11865882&dopt=Abstract
•
Correlation between anxiety and oppositionality in a children's mood and anxiety disorder clinic. Author(s): Garland EJ, Garland OM. Source: Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2001 December; 46(10): 953-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11816317&dopt=Abstract
•
Corticosteroids in relation to fear, anxiety and psychopathology. Author(s): Korte SM. Source: Neuroscience and Biobehavioral Reviews. 2001 March; 25(2): 117-42. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11323078&dopt=Abstract
•
Corticotropin releasing factor antagonists--the new anti-anxiety magic bullets? Author(s): Blessing WW. Source: Curr Opin Investig Drugs. 2001 April; 2(4): 537-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11566013&dopt=Abstract
•
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Author(s): Reul JM, Holsboer F. Source: Current Opinion in Pharmacology. 2002 February; 2(1): 23-33. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11786305&dopt=Abstract
•
Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions. Author(s): Bakshi VP, Kalin NH. Source: Biological Psychiatry. 2000 December 15; 48(12): 1175-98. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11137059&dopt=Abstract
140 Anxiety
•
Course and outcome of anxiety disorders in adolescents. Author(s): Essau CA, Conradt J, Petermann F. Source: Journal of Anxiety Disorders. 2002; 16(1): 67-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12171214&dopt=Abstract
•
Covert fears and anxiety in asthma and congenital heart disease. Author(s): Gupta S, Mitchell I, Giuffre RM, Crawford S. Source: Child: Care, Health and Development. 2001 July; 27(4): 335-48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11437837&dopt=Abstract
•
Critical care nurses' assessment of patients' anxiety: reliance on physiological and behavioral parameters. Author(s): Frazier SK, Moser DK, Riegel B, McKinley S, Blakely W, Kim KA, Garvin BJ. Source: American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses. 2002 January; 11(1): 57-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11789483&dopt=Abstract
•
Critical care nurses' beliefs about and reported management of anxiety. Author(s): Frazier SK, Moser DK, Daley LK, McKinley S, Riegel B, Garvin BJ, An K. Source: American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses. 2003 January; 12(1): 19-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12526233&dopt=Abstract
•
Cross validation of the Social Anxiety Scale for Adolescents in a high school sample. Author(s): Myers MG, Stein MB, Aarons GA. Source: Journal of Anxiety Disorders. 2002; 16(2): 221-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12194546&dopt=Abstract
•
Cross-cultural aspects of social anxiety disorder. Author(s): Stein DJ, Matsunaga H. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 773-82. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723632&dopt=Abstract
•
Cultural dimensions of anxiety and truth telling. Author(s): Faysman K. Source: Oncology Nursing Forum. 2002 June; 29(5): 757-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12064323&dopt=Abstract
Studies 141
•
Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment. Author(s): Kirmayer LJ. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 13: 22-8; Discussion 29-30. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11434415&dopt=Abstract
•
Curbing test anxiety. Author(s): Fitzgerald MA. Source: Adv Nurse Pract. 2002 July; 10(7): 18. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12420544&dopt=Abstract
•
Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. Author(s): Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Source: Journal of Abnormal Psychology. 2001 November; 110(4): 585-99. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11727948&dopt=Abstract
•
Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders. Author(s): Krystal JH, D'Souza DC, Sanacora G, Goddard AW, Charney DS. Source: The Medical Clinics of North America. 2001 May; 85(3): 559-77. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11349473&dopt=Abstract
•
Day surgery preoperative anxiety reduction and coping strategies. Author(s): Grieve RJ. Source: British Journal of Nursing (Mark Allen Publishing). 2002 May 23-June 12; 11(10): 670-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12048453&dopt=Abstract
•
Day-to-day relationships between self-awareness, daily events, and anxiety. Author(s): Nezlek JB. Source: Journal of Personality. 2002 April; 70(2): 249-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11908847&dopt=Abstract
•
Death anxiety among Chinese elderly people in Hong Kong. Author(s): Wu AM, Tang CS, Kwok TC. Source: Journal of Aging and Health. 2002 February; 14(1): 42-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11892760&dopt=Abstract
142 Anxiety
•
Death anxiety and attitudes toward the elderly among older adults: the role of gender and ethnicity. Author(s): Depaola SJ, Griffin M, Young JR, Neimeyer RA. Source: Death Studies. 2003 May; 27(4): 335-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12749378&dopt=Abstract
•
Death anxiety and HIV disease. Author(s): Templer DI, Greer RC. Source: Focus. 1996 November; 11(12): 1-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12206109&dopt=Abstract
•
Death anxiety and religiosity among Lithuanian health and social service professionals. Author(s): Roff LL, Butkeviciene R, Klemmack DL. Source: Death Studies. 2002 November; 26(9): 731-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12385343&dopt=Abstract
•
Death anxiety in brain tumour patients and their spouses. Author(s): Adelbratt S, Strang P. Source: Palliative Medicine. 2000 November; 14(6): 499-507. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11219880&dopt=Abstract
•
Death beliefs, superstitious beliefs and health anxiety. Author(s): James A, Wells A. Source: The British Journal of Clinical Psychology / the British Psychological Society. 2002 March; 41(Pt 1): 43-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11931677&dopt=Abstract
•
Death obsession in Egyptian samples: differences among people with anxiety disorders, schizophrenia, addictions, and normals. Author(s): Abdel-Khalek AM. Source: Death Studies. 2002 June; 26(5): 413-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12046617&dopt=Abstract
•
Debilitative and facilitative perceptions of trait anxiety among students in a college golf class. Author(s): Cunningham GB, Ashley FB. Source: Percept Mot Skills. 2002 June; 94(3 Pt 1): 739-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12081275&dopt=Abstract
Studies 143
•
Defense mechanisms in Chinese patients with comorbid anxiety and depression. Author(s): Yuan Y, Zhang XB, Wu AQ. Source: The Journal of Nervous and Mental Disease. 2002 April; 190(4): 265-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11960090&dopt=Abstract
•
Defense styles and Personality dimensions of research subjects with anxiety and depressive disorders. Author(s): Kennedy BL, Schwab JJ, Hyde JA. Source: The Psychiatric Quarterly. 2001 Fall; 72(3): 251-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11467159&dopt=Abstract
•
Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Author(s): Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A. Source: Archives of General Psychiatry. 2003 February; 60(2): 133-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12578430&dopt=Abstract
•
Delayed posttraumatic stress disorder (PTSD) and predictors of first onset of PTSD in patients with anxiety disorders. Author(s): Zlotnick C, Bruce SE, Shea MT, Keller MB. Source: The Journal of Nervous and Mental Disease. 2001 June; 189(6): 404-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11434644&dopt=Abstract
•
Delimiting the boundaries of generalized anxiety disorder: differentiating high worriers with and without GAD. Author(s): Ruscio AM. Source: Journal of Anxiety Disorders. 2002; 16(4): 377-400. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12213034&dopt=Abstract
•
Dental anxiety among Israeli dental students: a 4-year longitudinal study. Author(s): Peretz B, Mann J. Source: European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe. 2000 August; 4(3): 133-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11168477&dopt=Abstract
•
Dental anxiety among young adolescent patients in Israel. Author(s): Peretz B, Efrat J. Source: International Journal of Paediatric Dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children. 2000 June; 10(2): 126-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11310097&dopt=Abstract
144 Anxiety
•
Dental anxiety and regularity of dental attendance in younger adults. Author(s): Quteish Taani DS. Source: Journal of Oral Rehabilitation. 2002 June; 29(6): 604-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12071931&dopt=Abstract
•
Dental anxiety in patients seeking care at the University Dental Hospital in Sri Lanka. Author(s): Ekanayake L, Dharmawardena D. Source: Community Dent Health. 2003 June; 20(2): 112-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12828272&dopt=Abstract
•
Dental anxiety in relation to mental health and personality factors. A longitudinal study of middle-aged and elderly women. Author(s): Hagglin C, Hakeberg M, Hallstrom T, Berggren U, Larsson L, Waern M, Palsson S, Skoog I. Source: European Journal of Oral Sciences. 2001 February; 109(1): 27-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11330931&dopt=Abstract
•
Dental anxiety reduction and dental attendance after treatment in a dental fear clinic: a follow-up study. Author(s): Aartman IH, de Jongh A, Makkes PC, Hoogstraten J. Source: Community Dentistry and Oral Epidemiology. 2000 December; 28(6): 435-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11106016&dopt=Abstract
•
Dental attendance and anxiety among public and private school children in Jordan. Author(s): Taani DQ. Source: Int Dent J. 2002 February; 52(1): 25-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11931218&dopt=Abstract
•
Dental caries, age and anxiety: factors influencing sedation choice for children attending for emergency dental care. Author(s): Carson P, Freeman R. Source: Community Dentistry and Oral Epidemiology. 2001 February; 29(1): 30-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11153561&dopt=Abstract
•
Dental phobic patients' view of dental anxiety and experiences in dental care: a qualitative study. Author(s): Abrahamsson KH, Berggren U, Hallberg L, Carlsson SG. Source: Scandinavian Journal of Caring Sciences. 2002 June; 16(2): 188-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12000673&dopt=Abstract
Studies 145
•
Depression and anxiety among partners of European-American and Latino patients with type 2 diabetes. Author(s): Fisher L, Chesla CA, Skaff MM, Mullan JT, Kanter RA. Source: Diabetes Care. 2002 September; 25(9): 1564-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12196428&dopt=Abstract
•
Depression and anxiety and outcomes of coronary artery bypass surgery. Author(s): Pignay-Demaria V, Lesperance F, Demaria RG, Frasure-Smith N, Perrault LP. Source: The Annals of Thoracic Surgery. 2003 January; 75(1): 314-21. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12537248&dopt=Abstract
•
Depression and anxiety disorders among Jews from the former Soviet Union five years after their immigration to Israel. Author(s): Zilber N, Lerner Y, Eidelman R, Kertes J. Source: International Journal of Geriatric Psychiatry. 2001 October; 16(10): 993-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11607945&dopt=Abstract
•
Depression and anxiety disorders associated with headache frequency. The NordTrondelag Health Study. Author(s): Zwart JA, Dyb G, Hagen K, Odegard KJ, Dahl AA, Bovim G, Stovner LJ. Source: European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 2003 March; 10(2): 147-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12603289&dopt=Abstract
•
Depression and anxiety disorders. Author(s): Brown CS. Source: Obstetrics and Gynecology Clinics of North America. 2001 June; 28(2): 241-68. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11430175&dopt=Abstract
•
Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Author(s): Creed F, Morgan R, Fiddler M, Marshall S, Guthrie E, House A. Source: Psychosomatics. 2002 July-August; 43(4): 302-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12189256&dopt=Abstract
•
Depression and anxiety in adults with congenital heart disease: a pilot study. Author(s): Bromberg JI, Beasley PJ, D'Angelo EJ, Landzberg M, DeMaso DR. Source: Heart & Lung : the Journal of Critical Care. 2003 March-April; 32(2): 105-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12734533&dopt=Abstract
146 Anxiety
•
Depression and anxiety in chronic hepatitis B: effect of hepatitis B virus infection on psychological state in childhood. Author(s): Arslan N, Buyukgebiz B, Ozturk Y, Akay AP. Source: Turk J Pediatr. 2003 January-March; 45(1): 26-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12718367&dopt=Abstract
•
Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Author(s): Yohannes AM, Baldwin RC, Connolly MJ. Source: International Journal of Geriatric Psychiatry. 2000 December; 15(12): 1090-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11180464&dopt=Abstract
•
Depression and anxiety in hyperthyroidism. Author(s): Demet MM, Ozmen B, Deveci A, Boyvada S, Adiguzel H, Aydemir O. Source: Archives of Medical Research. 2002 November-December; 33(6): 552-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12505101&dopt=Abstract
•
Depression and anxiety in memory clinic attenders and their carers: implications for evaluating the effectiveness of cognitive rehabilitation interventions. Author(s): Clare L, Wilson BA, Carter G, Breen K, Berrios GE, Hodges JR. Source: International Journal of Geriatric Psychiatry. 2002 October; 17(10): 962-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12325058&dopt=Abstract
•
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. Author(s): Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A, Zivadinov R. Source: Journal of Neurology. 2001 May; 248(5): 416-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11437165&dopt=Abstract
•
Depression and anxiety in older women. Author(s): Goldstein MZ. Source: Primary Care. 2002 March; 29(1): 69-80, Vi. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11856659&dopt=Abstract
•
Depression and anxiety in oncology: the oncologist's perspective. Author(s): Jones RD. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 52-5; Discussion 56-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108823&dopt=Abstract
Studies 147
•
Depression and anxiety in oncology: the psychiatrist's perspective. Author(s): Berard RM. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 58-61; Discussion 62-3. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108824&dopt=Abstract
•
Depression and anxiety in patients with epilepsy. Author(s): Piazzini A, Canger R. Source: Epilepsia. 2001; 42 Suppl 1: 29-31; Discussion 35-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11422352&dopt=Abstract
•
Depression and anxiety in people with inflammatory bowel disease. Author(s): Kurina LM, Goldacre MJ, Yeates D, Gill LE. Source: Journal of Epidemiology and Community Health. 2001 October; 55(10): 716-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11553654&dopt=Abstract
•
Depression and anxiety symptoms in relation to anthropometry and metabolism in men. Author(s): Ahlberg AC, Ljung T, Rosmond R, McEwen B, Holm G, Akesson HO, Bjorntorp P. Source: Psychiatry Research. 2002 October 10; 112(2): 101-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12429356&dopt=Abstract
•
Depression and anxiety--separate or continuum? Author(s): Kasper S. Source: World J Biol Psychiatry. 2001 October; 2(4): 162-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12587144&dopt=Abstract
•
Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Author(s): Pitzalis MV, Iacoviello M, Todarello O, Fioretti A, Guida P, Massari F, Mastropasqua F, Russo GD, Rizzon P. Source: American Heart Journal. 2001 May; 141(5): 765-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11320364&dopt=Abstract
•
Depression, anxiety and adjustment in renal replacement therapy: a quality of life assessment. Author(s): Zimmermann PR, de Figueiredo CE, Fonseca NA. Source: Clinical Nephrology. 2001 November; 56(5): 387-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11758010&dopt=Abstract
148 Anxiety
•
Depression, anxiety and quality of life among scheduled cosmetic surgery patients: multicentre prospective study. Author(s): Meningaud JP, Benadiba L, Servant JM, Herve C, Bertrand JC, Pelicie Y. Source: Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery. 2001 June; 29(3): 177-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11465258&dopt=Abstract
•
Depression, anxiety and quality of life: outcome 9 months after facial cosmetic surgery. Author(s): Meningaud JP, Benadiba L, Servant JM, Herve C, Bertrand JC, Pelicier Y. Source: Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery. 2003 February; 31(1): 46-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553927&dopt=Abstract
•
Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Author(s): Aydin IO, Ulusahin A. Source: General Hospital Psychiatry. 2001 March-April; 23(2): 77-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11313075&dopt=Abstract
•
Depression, anxiety levels and general psychological profile in Behcet's disease. Author(s): Calikoglu E, Onder M, Cosar B, Candansayar S. Source: Dermatology (Basel, Switzerland). 2001; 203(3): 238-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11701978&dopt=Abstract
•
Depression, anxiety, and associated health status in low-income Chinese patients. Author(s): Lubetkin EI, Jia H, Gold MR. Source: American Journal of Preventive Medicine. 2003 May; 24(4): 354-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12726874&dopt=Abstract
•
Depression, anxiety, and asthenia in advanced illness. Author(s): Hinshaw DB, Carnahan JM, Johnson DL. Source: Journal of the American College of Surgeons. 2002 August; 195(2): 271-7; Discussion 277-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12168975&dopt=Abstract
•
Depression, anxiety, and hopelessness in sexually abused adolescent girls. Author(s): Pillay AL, Schoubben-Hesk S. Source: Psychological Reports. 2001 June; 88(3 Pt 1): 727-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11508011&dopt=Abstract
Studies 149
•
Depression, anxiety, and relevant cognitions in persons with mental retardation. Author(s): Glenn E, Bihm EM, Lammers WJ. Source: Journal of Autism and Developmental Disorders. 2003 February; 33(1): 69-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12708581&dopt=Abstract
•
Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. Author(s): Sheps DS, Sheffield D. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 12-6; Discussion 17-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108816&dopt=Abstract
•
Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective. Author(s): Roose SP. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 19-22; Discussion 23. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108817&dopt=Abstract
•
Depression, anxiety, and the gastrointestinal system. Author(s): Mayer EA, Craske M, Naliboff BD. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 28-36; Discussion 37. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108819&dopt=Abstract
•
Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C. Author(s): Lehman CL, Cheung RC. Source: The American Journal of Gastroenterology. 2002 October; 97(10): 2640-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12385453&dopt=Abstract
•
Depressive and anxiety disorders in women with HIV infection. Author(s): Morrison MF, Petitto JM, Ten Have T, Gettes DR, Chiappini MS, Weber AL, Brinker-Spence P, Bauer RM, Douglas SD, Evans DL. Source: The American Journal of Psychiatry. 2002 May; 159(5): 789-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11986133&dopt=Abstract
•
Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Author(s): Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpe S. Source: Life Sciences. 2002 September 6; 71(16): 1837-48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12175700&dopt=Abstract
150 Anxiety
•
Despite the remarkable advances in oral health care, pain and anxiety continue to be significant deterrents for seeking dental services. Author(s): Morse Z. Source: J Dent Educ. 2002 June; 66(6): 689. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12117088&dopt=Abstract
•
Detection of depression and anxiety in primary care: follow up study. Author(s): Kessler D, Bennewith O, Lewis G, Sharp D. Source: Bmj (Clinical Research Ed.). 2002 November 2; 325(7371): 1016-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12411363&dopt=Abstract
•
Determinants of consultation rate in patients with anxiety and depressive disorders in primary care. Author(s): Ronalds C, Kapur N, Stone K, Webb S, Tomenson B, Creed F. Source: Family Practice. 2002 February; 19(1): 23-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11818346&dopt=Abstract
•
Development and testing of a Faces Scale for the assessment of anxiety in critically ill patients. Author(s): McKinley S, Coote K, Stein-Parbury J. Source: Journal of Advanced Nursing. 2003 January; 41(1): 73-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12519290&dopt=Abstract
•
Development of a short form of the Test Anxiety Inventory (TAI). Author(s): Taylor J, Deane FP. Source: The Journal of General Psychology. 2002 April; 129(2): 127-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12153130&dopt=Abstract
•
Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders. Author(s): de Kemp EC, Moleman P, Hoogduin CA, Broekman TG, Goedhart A, Schaap CP, van den Berg PC. Source: Psychopharmacology. 2002 February; 160(1): 67-73. Epub 2001 November 21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11862375&dopt=Abstract
•
Diagnostic efficiency of symptoms in the diagnosis of DSM-IV: generalized anxiety disorder in youth. Author(s): Pina AA, Silverman WK, Alfano CA, Saavedra LM. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2002 October; 43(7): 959-67. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12405483&dopt=Abstract
Studies 151
•
Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Author(s): Love AW, Kissane DW, Bloch S, Clarke D. Source: The Australian and New Zealand Journal of Psychiatry. 2002 April; 36(2): 24650. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11982548&dopt=Abstract
•
Differences in anxiety and role experiences between three age groups of women with heart disease. Author(s): Plach SK, Napholz L, Kelber ST. Source: Archives of Psychiatric Nursing. 2001 August; 15(4): 195-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11498813&dopt=Abstract
•
Differential metabolization of the impact of life events on subjects hospitalized for depressive and anxiety disorders: case-control study. Author(s): Amiel-Lebigre F, Chevalier A. Source: Social Psychiatry and Psychiatric Epidemiology. 2002 February; 37(2): 74-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11931091&dopt=Abstract
•
Differential occurrence of comorbidity within childhood anxiety disorders. Author(s): Verduin TL, Kendall PC. Source: Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 2003 June; 32(2): 290-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12679288&dopt=Abstract
•
Differential relationships between anxiety and treatment-associated pain reduction among male and female chronic pain patients. Author(s): Edwards R, Augustson E, Fillingim R. Source: The Clinical Journal of Pain. 2003 July-August; 19(4): 208-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12840614&dopt=Abstract
•
Differentiating anxiety and depression in older adults with generalized anxiety disorder. Author(s): Beck JG, Novy DM, Diefenbach GJ, Stanley MA, Averill PM, Swann AC. Source: Psychological Assessment. 2003 June; 15(2): 184-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12847778&dopt=Abstract
•
Directionality of affective priming: effects of trait anxiety and activation level. Author(s): Maier MA, Berner MP, Pekrun R. Source: Experimental Psychology. 2003; 50(2): 116-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12693196&dopt=Abstract
152 Anxiety
•
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Author(s): Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC. Source: International Clinical Psychopharmacology. 2000 November; 15(6): 319-28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11110007&dopt=Abstract
•
Disability measurement in the anxiety disorders: comparison of three brief measures. Author(s): Sanderson K, Andrews G, Jelsma W. Source: Journal of Anxiety Disorders. 2001 July-August; 15(4): 333-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11474818&dopt=Abstract
•
Discrepancies between attainment and importance of life values and anxiety and depression in gastrointestinal cancer patients and their spouses. Author(s): Nordin K, Wasteson E, Hoffman K, Glimelius B, Sjoden PO. Source: Psycho-Oncology. 2001 November-December; 10(6): 479-89. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11747060&dopt=Abstract
•
Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Author(s): Gatch MB. Source: Life Sciences. 2003 August 1; 73(11): 1347-67. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12850497&dopt=Abstract
•
Dissecting GABAergic and serotonergic involvement in anxiety. Commentary on Belzung “The genetic basis of the pharmacological effects of anxiolytics” and Olivier et al. “The 5-HT(1A) receptor knockout mouse and anxiety”. Author(s): Finn DA. Source: Behavioural Pharmacology. 2001 November; 12(6-7): 467-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11742140&dopt=Abstract
•
Dissociating anxiety from pain: mapping the neuronal marker N-acetyl aspartate to perception distinguishes closely interrelated characteristics of chronic pain. Author(s): Grachev ID, Fredickson BE, Apkarian AV. Source: Molecular Psychiatry. 2001 May; 6(3): 256-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11326290&dopt=Abstract
•
Dissolving the burden of generalized anxiety disorder. Author(s): Ninan PT. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 19: 5-10. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11577790&dopt=Abstract
Studies 153
•
Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario. Author(s): Kessler RC, Berglund PA, Dewit DJ, Ustun TB, Wang PS, Wittchen HU. Source: Int J Methods Psychiatr Res. 2002; 11(3): 99-111. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12459823&dopt=Abstract
•
Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Author(s): Borsini F, Podhorna J, Marazziti D. Source: Psychopharmacology. 2002 September; 163(2): 121-41. Epub 2002 August 08. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12202959&dopt=Abstract
•
Do anxiety and depression have a common pathophysiological mechanism? Author(s): Boyer P. Source: Acta Psychiatrica Scandinavica. Supplementum. 2000; (406): 24-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11131467&dopt=Abstract
•
Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? Author(s): Trivedi MH, Rush AJ, Carmody TJ, Donahue RM, Bolden-Watson C, Houser TL, Metz A. Source: The Journal of Clinical Psychiatry. 2001 October; 62(10): 776-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11816866&dopt=Abstract
•
Do panic patients process unconditioned fear vs. conditioned anxiety differently than normal subjects? Author(s): Del-Ben CM, Vilela JA, Hetem LA, Guimaraes FS, Graeff FG, Zuardi AW. Source: Psychiatry Research. 2001 November 30; 104(3): 227-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11728612&dopt=Abstract
•
Do patient information booklets increase perioperative anxiety? Author(s): Gillies MA, Baldwin FJ. Source: European Journal of Anaesthesiology. 2001 September; 18(9): 620-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11553258&dopt=Abstract
•
Do preoperative anxiety and depression affect quality of recovery and length of stay after hip or knee arthroplasty? Author(s): Brull R, McCartney CJ, Chan VW. Source: Canadian Journal of Anaesthesia = Journal Canadien D'anesthesie. 2002 January; 49(1): 109. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11782344&dopt=Abstract
154 Anxiety
•
Do threatening stimuli draw or hold visual attention in subclinical anxiety? Author(s): Fox E, Russo R, Bowles R, Dutton K. Source: Journal of Experimental Psychology. General. 2001 December; 130(4): 681-700. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11757875&dopt=Abstract
•
Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome? Author(s): Masand PS, Gupta S, Schwartz TL, Kaplan D, Virk S, Hameed A, Lockwood K. Source: Psychosomatics. 2002 November-December; 43(6): 451-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12444227&dopt=Abstract
•
Does cognitive-behavioural therapy influence the long-term outcome of generalized anxiety disorder? An 8-14 year follow-up of two clinical trials. Author(s): Durham RC, Chambers JA, MacDonald RR, Power KG, Major K. Source: Psychological Medicine. 2003 April; 33(3): 499-509. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12701670&dopt=Abstract
•
Does light pressure effleurage reduce pain and anxiety associated with genetic amniocentesis? A randomized clinical trial. Author(s): Fischer RL, Bianculli KW, Sehdev H, Hediger ML. Source: The Journal of Maternal-Fetal Medicine. 2000 September-October; 9(5): 294-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11132586&dopt=Abstract
•
Does pretreatment anxiety predict response to either bupropion SR or sertraline? Author(s): Rush AJ, Batey SR, Donahue RM, Ascher JA, Carmody TJ, Metz A. Source: Journal of Affective Disorders. 2001 April; 64(1): 81-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11292522&dopt=Abstract
•
Does religious psychotherapy improve anxiety and depression in religious adults? A review of randomized controlled studies. Author(s): Berry D. Source: Int J Psychiatr Nurs Res. 2002 October; 8(1): 875-90. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12448875&dopt=Abstract
•
Does sexual violence contribute to elevated rates of anxiety and depression in females? Author(s): Fergusson DM, Swain-Campbell NR, Horwood LJ. Source: Psychological Medicine. 2002 August; 32(6): 991-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12214797&dopt=Abstract
Studies 155
•
Does the Edinburgh Postnatal Depression Scale measure anxiety? Author(s): Brouwers EP, van Baar AL, Pop VJ. Source: Journal of Psychosomatic Research. 2001 November; 51(5): 659-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11728506&dopt=Abstract
•
Does the presence of anxiety affect the validity of a screening test for depression in the elderly? Author(s): Sinoff G, Ore L, Zlotogorsky D, Tamir A. Source: International Journal of Geriatric Psychiatry. 2002 April; 17(4): 309-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11994883&dopt=Abstract
•
Does the severity of mood and anxiety symptoms predict health care utilization? Author(s): Nease DE Jr, Volk RJ, Cass AR. Source: The Journal of Family Practice. 1999 October; 48(10): 769-77. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12224674&dopt=Abstract
•
Does timely assessment affect the anxiety associated with an abnormal mammogram result? Author(s): Haas J, Kaplan C, McMillan A, Esserman LJ. Source: Journal of Women's Health & Gender-Based Medicine. 2001 July-August; 10(6): 599-605. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11559457&dopt=Abstract
•
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. Author(s): Stahl SM. Source: The Journal of Clinical Psychiatry. 2002 September; 63(9): 756-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12363113&dopt=Abstract
•
Drug mechanisms in anxiety. Author(s): Bourin M, Hascoet M. Source: Curr Opin Investig Drugs. 2001 February; 2(2): 259-65. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11816841&dopt=Abstract
•
Drug treatment of anxiety disorders in children. Author(s): Coyle JT. Source: The New England Journal of Medicine. 2001 April 26; 344(17): 1326-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11320394&dopt=Abstract
156 Anxiety
•
DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability. Author(s): Slade T, Andrews G. Source: Social Psychiatry and Psychiatric Epidemiology. 2001 January; 36(1): 45-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11320807&dopt=Abstract
•
DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being. Author(s): Hunt C, Issakidis C, Andrews G. Source: Psychological Medicine. 2002 May; 32(4): 649-59. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12102379&dopt=Abstract
•
DSM-IV-defined anxiety disorder symptoms in South African children. Author(s): Muris P, Schmidt H, Engelbrecht P, Perold M. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 November; 41(11): 1360-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12410079&dopt=Abstract
•
Dynamics of acoustical evoked potentials on a background of habituation to verbal stimulus in persons with different individual anxiety levels. Author(s): Savostyanov AN, Illjutchenok RJ, Savostyanova DA. Source: Acta Biol Hung. 2002; 53(4): 575-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12501939&dopt=Abstract
•
Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. Author(s): Smith EL, Hann DM, Ahles TA, Furstenberg CT, Mitchell TA, Meyer L, Maurer LH, Rigas J, Hammond S. Source: Journal of Pain and Symptom Management. 2001 April; 21(4): 323-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11312047&dopt=Abstract
•
Early discharge of preterm infants followed by domiciliary nursing care: parents' anxiety, assessment of infant health and breastfeeding. Author(s): Ortenstrand A, Winbladh B, Nordstrom G, Waldenstrom U. Source: Acta Paediatrica (Oslo, Norway : 1992). 2001 October; 90(10): 1190-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11697434&dopt=Abstract
•
Eating disorders: relations with inconsistent discipline, anxiety, and drinking among college women. Author(s): Ross LT, Gill JL. Source: Psychological Reports. 2002 August; 91(1): 289-98. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12353794&dopt=Abstract
Studies 157
•
Editorial: imagining anxiety. Author(s): Marks R. Source: Focus. 1996 November; 11(12): 2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12206110&dopt=Abstract
•
Educating patients about symptoms of anxiety in the wake of neurological illness. Author(s): Dattilio FM. Source: The Journal of Neuropsychiatry and Clinical Neurosciences. 2002 Summer; 14(3): 354-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12154162&dopt=Abstract
•
Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers. Author(s): Miller HE, Deakin JF, Anderson IM. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2000 February; 176: 182-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10755058&dopt=Abstract
•
Effect of anxiety on the experience of pain in implant insertion. Author(s): Eli I, Schwartz-Arad D, Baht R, Ben-Tuvim H. Source: Clinical Oral Implants Research. 2003 February; 14(1): 115-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12562373&dopt=Abstract
•
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Author(s): Russell JM, Koran LM, Rush J, Hirschfeld RM, Harrison W, Friedman ES, Davis S, Keller M. Source: Depression and Anxiety. 2001; 13(1): 18-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11233456&dopt=Abstract
•
Effect of kava extract on vagal cardiac control in generalized anxiety disorder: preliminary findings. Author(s): Watkins LL, Connor KM, Davidson JR. Source: Journal of Psychopharmacology (Oxford, England). 2001 December; 15(4): 283-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11769822&dopt=Abstract
•
Effect of music on anxiety of women awaiting breast biopsy. Author(s): Haun M, Mainous RO, Looney SW. Source: Behavioral Medicine (Washington, D.C.). 2001 Fall; 27(3): 127-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11985186&dopt=Abstract
158 Anxiety
•
Effect of negative air ions on computer operation, anxiety and salivary chromogranin A-like immunoreactivity. Author(s): Nakane H, Asami O, Yamada Y, Ohira H. Source: International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 2002 October; 46(1): 85-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12374649&dopt=Abstract
•
Effect of nicotine and nicotinic receptors on anxiety and depression. Author(s): Picciotto MR, Brunzell DH, Caldarone BJ. Source: Neuroreport. 2002 July 2; 13(9): 1097-106. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12151749&dopt=Abstract
•
Effect of posterior temporal-parietal hematoma on orbital frontal chemistry in relation to a cognitive and anxiety state: a combined 1H-MRS and neuropsychological study of an unusual case as compared with 16 healthy subjects. Author(s): Grachev ID, Kumar R, Swarnkar A, Chang JK, Ramachandran TS. Source: Journal of Chemical Neuroanatomy. 2002 March; 23(3): 223-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11861128&dopt=Abstract
•
Effect of pre-instruction on anxiety levels of patients undergoing magnetic resonance imaging examination. Author(s): Selim MA. Source: East Mediterr Health J. 2001 May; 7(3): 519-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12690774&dopt=Abstract
•
Effect of structured preoperative teaching on anxiety levels of patients scheduled for cataract surgery. Author(s): Morrell G. Source: Insight (American Society of Ophthalmic Registered Nurses). 2001 January; 26(1): 4-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11246179&dopt=Abstract
•
Effect of task-relevant cues and state anxiety on motor performance. Author(s): Hardy L, Mullen R, Martin N. Source: Percept Mot Skills. 2001 June; 92(3 Pt 1): 943-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11453229&dopt=Abstract
•
Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Author(s): Andreatini R, Sartori VA, Seabra ML, Leite JR. Source: Phytotherapy Research : Ptr. 2002 November; 16(7): 650-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12410546&dopt=Abstract
Studies 159
•
Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis. Author(s): Montgomery SA, Mahe V, Haudiquet V, Hackett D. Source: Journal of Clinical Psychopharmacology. 2002 December; 22(6): 561-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12454555&dopt=Abstract
•
Effects of a single music therapy intervention on anxiety, discomfort, satisfaction, and compliance with screening guidelines in outpatients undergoing flexible sigmoidoscopy. Author(s): Chlan L, Evans D, Greenleaf M, Walker J. Source: Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates. 2000 July-August; 23(4): 148-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11310081&dopt=Abstract
•
Effects of a traditional herbal supplement on anxiety in patients with generalized anxiety disorder. Author(s): Mills PJ, Farag NH, Newton RP, Parry BL. Source: Journal of Clinical Psychopharmacology. 2002 August; 22(4): 443-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12172353&dopt=Abstract
•
Effects of acute exercise on state anxiety in breast cancer survivors. Author(s): Blanchard CM, Courneya KS, Laing D. Source: Oncology Nursing Forum. 2001 November-December; 28(10): 1617-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11759309&dopt=Abstract
•
Effects of alcoholism, anxiety and depression on P300 in women: a pilot study. Author(s): Bauer LO, Costa L, Hesselbrock VM. Source: J Stud Alcohol. 2001 September; 62(5): 571-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11702796&dopt=Abstract
•
Effects of an educational intervention on the anxiety of women awaiting mastectomies. Author(s): Belleau FP, Hagan L, Masse B. Source: Can Oncol Nurs J. 2001 Fall; 11(4): 172-80. English, French. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11842449&dopt=Abstract
•
Effects of animal-assisted therapy on patients' anxiety, fear, and depression before ECT. Author(s): Barker SB, Pandurangi AK, Best AM. Source: The Journal of Ect. 2003 March; 19(1): 38-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12621276&dopt=Abstract
160 Anxiety
•
Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Author(s): Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A. Source: Brain Research. 2002 October 18; 952(2): 188-99. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12376179&dopt=Abstract
•
Effects of antenatal stress and anxiety: Implications for development and psychiatry. Author(s): Glover V, O'Connor TG. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2002 May; 180: 389-91. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11983632&dopt=Abstract
•
Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Author(s): Tercyak KP, Lerman C, Peshkin BN, Hughes C, Main D, Isaacs C, Schwartz MD. Source: Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 2001 May; 20(3): 217-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11403219&dopt=Abstract
•
Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. Author(s): Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Source: Journal of Psychosomatic Research. 2000 October; 49(4): 229-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11119779&dopt=Abstract
•
Effects of hand massage on anxiety in cataract surgery using local anesthesia. Author(s): Kim MS, Cho KS, Woo H, Kim JH. Source: Journal of Cataract and Refractive Surgery. 2001 June; 27(6): 884-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11408136&dopt=Abstract
•
Effects of massage on pain and anxiety during labour: a randomized controlled trial in Taiwan. Author(s): Chang MY, Wang SY, Chen CH. Source: Journal of Advanced Nursing. 2002 April; 38(1): 68-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11895532&dopt=Abstract
•
Effects of music on patient anxiety. Author(s): Mok E, Wong KY. Source: Aorn Journal. 2003 February; 77(2): 396-7, 401-6, 409-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12619853&dopt=Abstract
Studies 161
•
Effects of music therapy on anxiety in ventilator-dependent patients. Author(s): Wong HL, Lopez-Nahas V, Molassiotis A. Source: Heart & Lung : the Journal of Critical Care. 2001 September-October; 30(5): 37687. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11604980&dopt=Abstract
•
Effects of negative and positive mood phrases on priming of alcohol words in young drinkers with high and low anxiety sensitivity. Author(s): Zack M, Poulos CX, Fragopoulos F, MacLeod CM. Source: Experimental and Clinical Psychopharmacology. 2003 May; 11(2): 176-85. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12755462&dopt=Abstract
•
Effects of patient-controlled music therapy during coronary angiography on procedural pain and anxiety distress syndrome. Author(s): Bally K, Campbell D, Chesnick K, Tranmer JE. Source: Critical Care Nurse. 2003 April; 23(2): 50-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12725195&dopt=Abstract
•
Effects of phase I cardiac rehabilitation on anxiety of patients hospitalized for coronary artery bypass graft in Taiwan. Author(s): Ku SL, Ku CH, Ma FC. Source: Heart & Lung : the Journal of Critical Care. 2002 March-April; 31(2): 133-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11910388&dopt=Abstract
•
Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Author(s): Salmon P. Source: Clinical Psychology Review. 2001 February; 21(1): 33-61. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11148895&dopt=Abstract
•
Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Author(s): Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S. Source: Psychological Medicine. 2001 July; 31(5): 847-58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11459382&dopt=Abstract
•
Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials. Author(s): Stahl SM, Mendels J, Schwartz GE. Source: Journal of Clinical Psychopharmacology. 2002 August; 22(4): 388-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12172338&dopt=Abstract
162 Anxiety
•
Effects of regular exercise on anxiety, depression, and quality of life in maintenance hemodialysis patients. Author(s): Suh MR, Jung HH, Kim SB, Park JS, Yang WS. Source: Renal Failure. 2002 May; 24(3): 337-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12166700&dopt=Abstract
•
Effects of varying levels of anxiety within social situations: relationship to memory perspective and attributions in social phobia. Author(s): Coles ME, Turk CL, Heimberg RG, Fresco DM. Source: Behaviour Research and Therapy. 2001 June; 39(6): 651-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11400710&dopt=Abstract
•
Effects of video information on pre-colonoscopy anxiety and knowledge: a randomized trial. Author(s): Jabbar A, Wright R. Source: Gastrointestinal Endoscopy. 2001 January; 53(1): 140-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11203714&dopt=Abstract
•
Effects of video information on preoperative anxiety level and tolerability of joint lavage in knee osteoarthritis. Author(s): Ayral X, Gicquere C, Duhalde A, Boucheny D, Dougados M. Source: Arthritis and Rheumatism. 2002 Aug15; 47(4): 380-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12209483&dopt=Abstract
•
Effects of women's stress-elicited physiological activity and chronic anxiety on fetal heart rate. Author(s): Monk C, Myers MM, Sloan RP, Ellman LM, Fifer WP. Source: Journal of Developmental and Behavioral Pediatrics : Jdbp. 2003 February; 24(1): 32-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12584483&dopt=Abstract
•
Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. Author(s): Llorca PM, Spadone C, Sol O, Danniau A, Bougerol T, Corruble E, Faruch M, Macher JP, Sermet E, Servant D. Source: The Journal of Clinical Psychiatry. 2002 November; 63(11): 1020-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12444816&dopt=Abstract
Studies 163
•
Efficacy and safety of nitrous oxide in alleviating pain and anxiety during painful procedures. Author(s): Kanagasundaram SA, Lane LJ, Cavalletto BP, Keneally JP, Cooper MG. Source: Archives of Disease in Childhood. 2001 June; 84(6): 492-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11369566&dopt=Abstract
•
Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety. Author(s): Chaudhry HR, Qureshi Z, Tareen IA, Yazdani I. Source: J Pak Med Assoc. 2002 November; 52(11): 518-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12585372&dopt=Abstract
•
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder. Author(s): Stocchi F, Nordera G, Jokinen RH, Lepola UM, Hewett K, Bryson H, Iyengar MK; Paroxetine Generalized Anxiety Disorder Study Team. Source: The Journal of Clinical Psychiatry. 2003 March; 64(3): 250-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12716265&dopt=Abstract
•
Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: evaluation in a controlled clinical trial. Author(s): Ladouceur R, Dugas MJ, Freeston MH, Leger E, Gagnon F, Thibodeau N. Source: Journal of Consulting and Clinical Psychology. 2000 December; 68(6): 957-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11142548&dopt=Abstract
•
Efficacy of Bach-flower remedies in test anxiety: a double-blind, placebo-controlled, randomized trial with partial crossover. Author(s): Walach H, Rilling C, Engelke U. Source: Journal of Anxiety Disorders. 2001 July-August; 15(4): 359-66. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11474820&dopt=Abstract
•
Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Author(s): Malsch U, Kieser M. Source: Psychopharmacology. 2001 September; 157(3): 277-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11605083&dopt=Abstract
•
Efficacy of olanzapine in social anxiety disorder: a pilot study. Author(s): Barnett SD, Kramer ML, Casat CD, Connor KM, Davidson JR. Source: Journal of Psychopharmacology (Oxford, England). 2002 December; 16(4): 365-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12503837&dopt=Abstract
164 Anxiety
•
Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study. Author(s): Stein DJ, Versiani M, Hair T, Kumar R. Source: Archives of General Psychiatry. 2002 December; 59(12): 1111-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12470127&dopt=Abstract
•
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. Author(s): Silverstone PH, Salinas E. Source: The Journal of Clinical Psychiatry. 2001 July; 62(7): 523-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11488362&dopt=Abstract
•
Electrodermal hyporeactivity and antisocial behavior: does anxiety mediate the relationship? Author(s): Fowles DC. Source: Journal of Affective Disorders. 2000 December; 61(3): 177-89. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11163420&dopt=Abstract
•
Electroencephalographic asymmetries in adolescents with major depression: influence of comorbidity with anxiety disorders. Author(s): Kentgen LM, Tenke CE, Pine DS, Fong R, Klein RG, Bruder GE. Source: Journal of Abnormal Psychology. 2000 November; 109(4): 797-802. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11196007&dopt=Abstract
•
Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety. Author(s): Simpson JR Jr, Drevets WC, Snyder AZ, Gusnard DA, Raichle ME. Source: Proceedings of the National Academy of Sciences of the United States of America. 2001 January 16; 98(2): 688-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11209066&dopt=Abstract
•
Enhanced stress reactivity in paediatric anxiety disorders: implications for future cardiovascular health. Author(s): Monk C, Kovelenko P, Ellman LM, Sloan RP, Bagiella E, Gorman JM, Pine DS. Source: The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2001 June; 4(2): 199-206. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11468091&dopt=Abstract
Studies 165
•
Epidemiology, burden, and disability in depression and anxiety. Author(s): Lepine JP. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 13: 4-10; Discussion 11-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11434418&dopt=Abstract
•
Escitalopram : a review of its use in the management of major depressive and anxiety disorders. Author(s): Waugh J, Goa KL. Source: Cns Drugs. 2003; 17(5): 343-62. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12665392&dopt=Abstract
•
Ethnic influences on body awareness, trait anxiety, perceived risk, and breast and gynecologic cancer screening practices. Author(s): Foxall MJ, Barron CR, Houfek JF. Source: Oncology Nursing Forum. 2001 May; 28(4): 727-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11383186&dopt=Abstract
•
Etiology and pathogenesis of anxiety disorders. Author(s): Sher L. Source: Medical Hypotheses. 2001 July; 57(1): 101-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11421635&dopt=Abstract
•
Etizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma-evaluation by computed tomography. Author(s): Hirashima Y, Kuwayama N, Hamada H, Hayashi N, Endo S. Source: Neurol Med Chir (Tokyo). 2002 February; 42(2): 53-5; Discussion 56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11944589&dopt=Abstract
•
Evaluating and treating anxiety disorders in medical settings. Author(s): Ball S, Goddard A, Shekhar A. Source: Journal of Postgraduate Medicine. 2002 October-December; 48(4): 317-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12571395&dopt=Abstract
•
Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety. Author(s): De Leo V, la Marca A, Morgante G, Lanzetta D, Florio P, Petraglia F. Source: Maturitas. 2001 August 25; 39(2): 185-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11514117&dopt=Abstract
166 Anxiety
•
Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Author(s): Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I. Source: Acta Psychiatrica Scandinavica. 2003 March; 107(3): 216-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12580829&dopt=Abstract
•
Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Author(s): Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J. Source: Biological Psychiatry. 2003 February 15; 53(4): 304-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12586449&dopt=Abstract
•
Evolution and social anxiety. The role of attraction, social competition, and social hierarchies. Author(s): Gilbert P. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 723-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723630&dopt=Abstract
•
Exacerbation of pain by anxiety is associated with activity in a hippocampal network. Author(s): Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R, Matthews PM, Rawlins JN, Tracey I. Source: The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 2001 December 15; 21(24): 9896-903. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11739597&dopt=Abstract
•
Examining outcome variability: correlates of treatment response in a child and adolescent anxiety clinic. Author(s): Southam-Gerow MA, Kendall PC, Weersing VR. Source: Journal of Clinical Child Psychology. 2001 September; 30(3): 422-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11501258&dopt=Abstract
•
Exercise dependence, social physique anxiety, and social support in experienced and inexperienced bodybuilders and weightlifters. Author(s): Hurst R, Hale B, Smith D, Collins D. Source: British Journal of Sports Medicine. 2000 December; 34(6): 431-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11131230&dopt=Abstract
Studies 167
•
Explaining retrospective reports of symptoms in patients undergoing chemotherapy: anxiety, initial symptom experience, and posttreatment symptoms. Author(s): Rabin C, Ward S, Leventhal H, Schmitz M. Source: Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 2001 March; 20(2): 91-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11315733&dopt=Abstract
•
Facial expression recognition in adolescents with mood and anxiety disorders. Author(s): McClure EB, Pope K, Hoberman AJ, Pine DS, Leibenluft E. Source: The American Journal of Psychiatry. 2003 June; 160(6): 1172-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12777278&dopt=Abstract
•
Fact or artifact--a comment on “Subpopulations of early separation anxiety: relevance to risk of adult anxiety disorders”. Author(s): Stravynski A, Amado D. Source: Journal of Affective Disorders. 2001 October; 66(2-3): 281. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11578683&dopt=Abstract
•
Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Author(s): Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A. Source: Psychology and Psychotherapy. 2002 June; 75(Pt 2): 165-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12396762&dopt=Abstract
•
Factor structure of the Hospital Anxiety and Depression (HAD) scale. Author(s): Friedman S, Even C, Samuelian JC, Guelfi JD. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2002 August; 181: 165-6; Author Reply 166. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12151294&dopt=Abstract
•
Factor structure of the hospital anxiety and depression scale in older patients with major depression. Author(s): Flint AJ, Rifat SL. Source: International Journal of Geriatric Psychiatry. 2002 February; 17(2): 117-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11813272&dopt=Abstract
•
Factor structure, reliability, and validity of the Beck Anxiety Inventory in adolescent psychiatric inpatients. Author(s): Osman A, Hoffman J, Barrios FX, Kopper BA, Breitenstein JL, Hahn SK. Source: Journal of Clinical Psychology. 2002 April; 58(4): 443-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11920696&dopt=Abstract
168 Anxiety
•
Factorial structure of the revised mathematics anxiety rating scale for undergraduate education majors. Author(s): Bowd AD, Brady PH. Source: Psychological Reports. 2002 August; 91(1): 199-200. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12353782&dopt=Abstract
•
Factors affecting dental attendance following treatment for dental anxiety in primary dental care. Author(s): Dailey YM, Crawford AN, Humphris G, Lennon MA. Source: Prim Dent Care. 2001 April; 8(2): 51-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11405047&dopt=Abstract
•
Factors affecting depression and anxiety in female Japanese patients with rheumatoid arthritis. Author(s): Takeda T, Morimoto N, Kinukawa N, Nagamine R, Shutou T, Tashiro N. Source: Clin Exp Rheumatol. 2000 November-December; 18(6): 735-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11138338&dopt=Abstract
•
Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Author(s): Ishikura R, Morimoto N, Tanaka K, Kinukawa N, Yoshizawa S, Horiuchi T, Nakashima H, Otsuka T. Source: Clinical Rheumatology. 2001; 20(6): 394-400. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11771521&dopt=Abstract
•
Factors associated with dental anxiety among older people in Britain. Author(s): Bedi R, McGrath C. Source: Gerodontology. 2000 December; 17(2): 97-103. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11813685&dopt=Abstract
•
Factors associated with dental anxiety and attendance in middle-aged and elderly women. Author(s): Hagglin C, Hakeberg M, Ahlqwist M, Sullivan M, Berggren U. Source: Community Dentistry and Oral Epidemiology. 2000 December; 28(6): 451-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11106018&dopt=Abstract
•
Factors underlying anxiety in HIV testing: risk perceptions, stigma, and the patientprovider power dynamic. Author(s): Worthington C, Myers T. Source: Qualitative Health Research. 2003 May; 13(5): 636-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12756685&dopt=Abstract
Studies 169
•
Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines. Author(s): Tabiner M, Youings S, Dennis N, Baldwin D, Buis C, Mayers A, Jacobs PA, Crolla JA. Source: American Journal of Human Genetics. 2003 March; 72(3): 535-8. Epub 2003 January 24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12548501&dopt=Abstract
•
Familial aggregation of anxiety-related quantitative traits in generalized social phobia: clues to understanding “disorder” heritability? Author(s): Stein MB, Chartier MJ, Lizak MV, Jang KL. Source: American Journal of Medical Genetics. 2001 January 8; 105(1): 79-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11425006&dopt=Abstract
•
Familial and personal handedness in phobic anxiety disorder. Author(s): Chemtob CM, Curtis GC, Van Houten W, Guss J. Source: The Journal of Nervous and Mental Disease. 2002 April; 190(4): 267-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11960091&dopt=Abstract
•
Familial correlates of social anxiety in children and adolescents. Author(s): Bogels SM, van Oosten A, Muris P, Smulders D. Source: Behaviour Research and Therapy. 2001 March; 39(3): 273-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11227809&dopt=Abstract
•
Familial predictors of treatment outcome in childhood anxiety disorders. Author(s): Crawford AM, Manassis K. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 October; 40(10): 1182-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11589531&dopt=Abstract
•
Familial psychiatric illness and posttraumatic stress disorder: findings from a family study of substance abuse and anxiety disorders. Author(s): Dierker LC, Merikangas KR. Source: The Journal of Clinical Psychiatry. 2001 September; 62(9): 715-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11681768&dopt=Abstract
•
Families of children with cancer: the impact on anxiety experienced by fathers. Author(s): Mu PF, Ma FC, Hwang B, Chao YM. Source: Cancer Nursing. 2002 February; 25(1): 66-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11838722&dopt=Abstract
170 Anxiety
•
Families of Chinese children with malignancy: the factors impact on mother's anxiety. Author(s): Mu PF, Ma FC, Ku SM, Shu HQ, Hwang B, Kuo BI. Source: Journal of Pediatric Nursing. 2001 August; 16(4): 287-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11498824&dopt=Abstract
•
Fatigue and patterns of pain in fibromyalgia: correlations with anxiety, depression and co-morbidity in a female county sample. Author(s): Kurtze N, Svebak S. Source: The British Journal of Medical Psychology. 2001 December; 74(Pt 4): 523-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11780799&dopt=Abstract
•
Fatigue, anxiety, and depression in long-term survivors of testicular cancer. Author(s): Fossa SD, Dahl AA, Loge JH. Source: Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2003 April 1; 21(7): 1249-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12663711&dopt=Abstract
•
Fear and anxiety in patients at different time-points in the coronary artery bypass process. Author(s): Koivula M, Tarkka MT, Tarkka M, Laippala P, Paunonen-Ilmonen M. Source: International Journal of Nursing Studies. 2002 November; 39(8): 811-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12379299&dopt=Abstract
•
Fear and anxiety in patients awaiting coronary artery bypass grafting. Author(s): Koivula M, Paunonen-Ilmonen M, Tarkka MT, Tarkka M, Laippala P. Source: Heart & Lung : the Journal of Critical Care. 2001 July-August; 30(4): 302-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11449217&dopt=Abstract
•
Fear and anxiety: animal models and human cognitive psychophysiology. Author(s): Lang PJ, Davis M, Ohman A. Source: Journal of Affective Disorders. 2000 December; 61(3): 137-59. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11163418&dopt=Abstract
•
Fear of being overwhelmed and psychoanalytic theories of anxiety. Author(s): Hurvich M. Source: Psychoanalytic Review. 2000 October; 87(5): 615-49. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11242776&dopt=Abstract
Studies 171
•
Febrile seizures and parental anxiety: does information help? Author(s): Flury T, Aebi C, Donati F. Source: Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology. 2001 September 22; 131(37-38): 556-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11759176&dopt=Abstract
•
Fever education: does it reduce parent fever anxiety? Author(s): O'Neill-Murphy K, Liebman M, Barnsteiner JH. Source: Pediatric Emergency Care. 2001 February; 17(1): 47-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11265909&dopt=Abstract
•
Finding a home for post-traumatic stress disorder in biological psychiatry. Is it a disorder of anxiety, mood, stress, or memory? Author(s): Sullivan GM, Gorman JM. Source: The Psychiatric Clinics of North America. 2002 June; 25(2): 463-8, Ix. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12136510&dopt=Abstract
•
First-time hospitalisation for depressive and/or anxiety disorders and severe life events. Author(s): Amiel-Lebigre F, Lacalmontie E, Menard F. Source: Social Psychiatry and Psychiatric Epidemiology. 2002 December; 37(12): 586-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12545236&dopt=Abstract
•
FISH, flexible joints and panic: are anxiety disorders really expressions of instability in the human genome? Author(s): Collier DA. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2002 December; 181: 457-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12456511&dopt=Abstract
•
Five-year incidence of dental anxiety in an adult population. Author(s): Maggirias J, Locker D. Source: Community Dent Health. 2002 September; 19(3): 173-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12269464&dopt=Abstract
•
Fluoxetine for the treatment of childhood anxiety disorders. Author(s): Birmaher B, Axelson DA, Monk K, Kalas C, Clark DB, Ehmann M, Bridge J, Heo J, Brent DA. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 April; 42(4): 415-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12649628&dopt=Abstract
172 Anxiety
•
Fluoxetine treatment of depressed patients with comorbid anxiety disorders. Author(s): Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M. Source: Journal of Psychopharmacology (Oxford, England). 2002 September; 16(3): 2159. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12236627&dopt=Abstract
•
Fluvoxamine for the treatment of anxiety disorders in children and adolescents. Author(s): Isaacs E. Source: The New England Journal of Medicine. 2001 August 9; 345(6): 466-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11496864&dopt=Abstract
•
Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary opentrial data. Author(s): Wylie ME, Miller MD, Shear MK, Little JT, Mulsant BH, Pollock BG, Reynolds CF 3rd. Source: Journal of Geriatric Psychiatry and Neurology. 2000 Spring; 13(1): 43-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10753007&dopt=Abstract
•
Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis. Author(s): Rausch JL, Hobby HM, Shendarkar N, Johnson ME, Li J. Source: Journal of Clinical Psychopharmacology. 2001 April; 21(2): 139-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11270909&dopt=Abstract
•
Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents. Author(s): Cheer SM, Figgitt DP. Source: Paediatric Drugs. 2001; 3(10): 763-81. Review. Erratum In: Paediatr Drugs 2001; 3(11): 801. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11706925&dopt=Abstract
•
Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Author(s): Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Source: Archives of General Psychiatry. 2003 June; 60(6): 618-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12796225&dopt=Abstract
Studies 173
•
Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. Author(s): Porter VR, Buxton WG, Fairbanks LA, Strickland T, O'Connor SM, Rosenberg-Thompson S, Cummings JL. Source: The Journal of Neuropsychiatry and Clinical Neurosciences. 2003 Spring; 15(2): 180-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12724459&dopt=Abstract
•
From adaptive emotion to dysfunction: an attachment perspective on social anxiety disorder. Author(s): Vertue FM. Source: Personality and Social Psychology Review : an Official Journal of the Society for Personality and Social Psychology, Inc. 2003; 7(2): 170-91. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12676646&dopt=Abstract
•
Frontal brain hypoactivity as a biological substrate of anxiety in patients with panic disorders. Author(s): Akiyoshi J, Hieda K, Aoki Y, Nagayama H. Source: Neuropsychobiology. 2003; 47(3): 165-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12759561&dopt=Abstract
•
Functional impairment in COPD patients: the impact of anxiety and depression. Author(s): Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S. Source: Psychosomatics. 2000 November-December; 41(6): 465-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11110109&dopt=Abstract
•
Further defining anxiety and depressive disorders. Introduction. Author(s): Kennedy BL, Schwab JJ. Source: The Psychiatric Quarterly. 2001 Fall; 72(3): 249-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11467158&dopt=Abstract
•
Further evidence for the reliability and validity of the Modified Dental Anxiety Scale. Author(s): Humphris GM, Freeman R, Campbell J, Tuutti H, D'Souza V. Source: Int Dent J. 2000 December; 50(6): 367-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11197195&dopt=Abstract
174 Anxiety
•
Further evidence of association between behavioral inhibition and social anxiety in children. Author(s): Biederman J, Hirshfeld-Becker DR, Rosenbaum JF, Herot C, Friedman D, Snidman N, Kagan J, Faraone SV. Source: The American Journal of Psychiatry. 2001 October; 158(10): 1673-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11579001&dopt=Abstract
•
Gender differences in cardiovascular and electrodermal responses to public speaking task: the role of anxiety and mood states. Author(s): Carrillo E, Moya-Albiol L, Gonzalez-Bono E, Salvador A, Ricarte J, GomezAmor J. Source: International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 2001 November; 42(3): 253-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11812392&dopt=Abstract
•
Gender differences in the etiology of anxiety sensitivity: a twin study. Author(s): Jang KL, Stein MB, Taylor S, Livesley WJ. Source: J Gend Specif Med. 1999 March-April; 2(2): 39-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11252860&dopt=Abstract
•
Gender, anxiety, and experimental pain sensitivity: an overview. Author(s): Jones A, Zachariae R. Source: J Am Med Womens Assoc. 2002 Spring; 57(2): 91-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11991428&dopt=Abstract
•
Gender, ethnicity, and physician-patient communication about depression and anxiety in primary care. Author(s): Sleath B, Rubin RH. Source: Patient Education and Counseling. 2002 December; 48(3): 243-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12477609&dopt=Abstract
•
Generalised anxiety disorder. Author(s): Gale C, Oakley-Browne M. Source: Clin Evid. 2002 June; (7): 883-95. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12230712&dopt=Abstract
•
Generalised anxiety disorder: treatment options. Author(s): Sramek JJ, Zarotsky V, Cutler NR. Source: Drugs. 2002; 62(11): 1635-48. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12109925&dopt=Abstract
Studies 175
•
Generalization of social anxiety to sporting and athletic situations: gender, sports involvement, and parental pressure. Author(s): Norton PJ, Burns JA, Hope DA, Bauer BK. Source: Depression and Anxiety. 2000; 12(4): 193-202. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11195755&dopt=Abstract
•
Generalized anxiety and depression in primary care: prevalence, recognition, and management. Author(s): Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J. Source: The Journal of Clinical Psychiatry. 2002; 63 Suppl 8: 24-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12044105&dopt=Abstract
•
Generalized anxiety and panic disorder. Author(s): Rabatin J, Keltz LB. Source: The Western Journal of Medicine. 2002 May; 176(3): 164-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12016238&dopt=Abstract
•
Generalized anxiety disorder and clinical worry episodes in young women. Author(s): Hoyer J, Becker ES, Margraf J. Source: Psychological Medicine. 2002 October; 32(7): 1227-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12420892&dopt=Abstract
•
Generalized anxiety disorder and peptic ulcer disease among adults in the United States. Author(s): Goodwin RD, Stein MB. Source: Psychosomatic Medicine. 2002 November-December; 64(6): 862-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12461190&dopt=Abstract
•
Generalized anxiety disorder in children and adolescents. Author(s): Wagner KD. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 139-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225504&dopt=Abstract
•
Generalized anxiety disorder in older adults: examining the relation between clinician severity ratings and patient self-report measures. Author(s): Hopko DR, Bourland SL, Stanley MA, Beck JG, Novy DM, Averill PM, Swann AC. Source: Depression and Anxiety. 2000; 12(4): 217-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11195758&dopt=Abstract
176 Anxiety
•
Generalized anxiety disorder in patients with major depression: is DSM-IV's hierarchy correct? Author(s): Zimmerman M, Chelminski I. Source: The American Journal of Psychiatry. 2003 March; 160(3): 504-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12611832&dopt=Abstract
•
Generalized anxiety disorder in primary care: emerging issues in management and treatment. Author(s): Culpepper L. Source: The Journal of Clinical Psychiatry. 2002; 63 Suppl 8: 35-42. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12044106&dopt=Abstract
•
Generalized anxiety disorder in the elderly. Author(s): Dada F, Sethi S, Grossberg GT. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 155-64. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225505&dopt=Abstract
•
Generalized anxiety disorder in women. Author(s): Howell HB, Brawman-Mintzer O, Monnier J, Yonkers KA. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 165-78. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225506&dopt=Abstract
•
Generalized anxiety disorder. Author(s): Gale CK, Oakley-Browne M. Source: American Family Physician. 2003 January 1; 67(1): 135-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12537176&dopt=Abstract
•
Generalized anxiety disorder. Author(s): Gorman JM. Source: Clinical Cornerstone. 2001; 3(3): 37-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11351785&dopt=Abstract
•
Generalized anxiety disorder. An important clinical concern. Author(s): Hidalgo RB, Davidson JR. Source: The Medical Clinics of North America. 2001 May; 85(3): 691-710. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11349480&dopt=Abstract
•
Generalized anxiety disorder: diagnosis, neurobiology, and treatment. Author(s): Ninan PT. Source: Psychopharmacology Bulletin. 2001 Winter; 35(1): 65-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12397871&dopt=Abstract
Studies 177
•
Generalized anxiety disorder: nature and course. Author(s): Wittchen HU, Hoyer J. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 11: 15-9; Discussion 20-1. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11414546&dopt=Abstract
•
Generalized anxiety disorder: prevalence, burden, and cost to society. Author(s): Wittchen HU. Source: Depression and Anxiety. 2002; 16(4): 162-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12497648&dopt=Abstract
•
GENESiS: creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings. Author(s): Sham PC, Sterne A, Purcell S, Cherny S, Webster M, Rijsdijk F, Asherson P, Ball D, Craig I, Eley T, Goldberg D, Gray J, Mann A, Owen M, Plomin R. Source: Twin Research : the Official Journal of the International Society for Twin Studies. 2000 December; 3(4): 316-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11463153&dopt=Abstract
•
Genetic and environmental influences on separation anxiety disorder symptoms and their moderation by age and sex. Author(s): Feigon SA, Waldman ID, Levy F, Hay DA. Source: Behavior Genetics. 2001 September; 31(5): 403-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11777169&dopt=Abstract
•
Genetic and environmental influences on the temporal association between earlier anxiety and later depression in girls. Author(s): Silberg JL, Rutter M, Eaves L. Source: Biological Psychiatry. 2001 June 15; 49(12): 1040-9. Erratum In: Biol Psychiatry 2001 September 1; 50(5): 393. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11430845&dopt=Abstract
•
Genetic animal models of anxiety. Author(s): Finn DA, Rutledge-Gorman MT, Crabbe JC. Source: Neurogenetics. 2003 April; 4(3): 109-35. Epub 2003 March 29. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12687420&dopt=Abstract
•
Genetic basis of anxiety-like behaviour: a critical review. Author(s): Clement Y, Calatayud F, Belzung C. Source: Brain Research Bulletin. 2002 January 1; 57(1): 57-71. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11827738&dopt=Abstract
178 Anxiety
•
Genetic moderation of environmental risk for depression and anxiety in adolescent girls. Author(s): Silberg J, Rutter M, Neale M, Eaves L. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2001 August; 179: 116-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11483472&dopt=Abstract
•
Genetics and brain function: implications for the treatment of anxiety. Author(s): Uhde TW. Source: Biological Psychiatry. 2000 December 15; 48(12): 1142-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11137054&dopt=Abstract
•
Gestational diabetes mellitus: is a diagnosis associated with an increase in maternal anxiety and stress in the short and intermediate term? Author(s): Daniells S, Grenyer BF, Davis WS, Coleman KJ, Burgess JA, Moses RG. Source: Diabetes Care. 2003 February; 26(2): 385-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12547867&dopt=Abstract
•
Glasgow Anxiety Scale for people with an Intellectual Disability (GAS-ID): development and psychometric properties of a new measure for use with people with mild intellectual disability. Author(s): Mindham J, Espie CA. Source: Journal of Intellectual Disability Research : Jidr. 2003 January; 47(Pt 1): 22-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12558692&dopt=Abstract
•
Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial. Author(s): Manassis K, Mendlowitz SL, Scapillato D, Avery D, Fiksenbaum L, Freire M, Monga S, Owens M. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 December; 41(12): 1423-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12447028&dopt=Abstract
•
Have drug companies hyped social anxiety disorder to increase sales. No: Efforts to relieve human suffering deserve rewards. Author(s): Sheehan DV. Source: The Western Journal of Medicine. 2001 December; 175(6): 365. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11733416&dopt=Abstract
Studies 179
•
Have drug companies hyped social anxiety disorder to increase sales. Yes: marketing hinders discovery of long-term solutions. Author(s): Healy D. Source: The Western Journal of Medicine. 2001 December; 175(6): 364. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11733415&dopt=Abstract
•
Health functioning impairments associated with posttraumatic stress disorder, anxiety disorders, and depression. Author(s): Zayfert C, Dums AR, Ferguson RJ, Hegel MT. Source: The Journal of Nervous and Mental Disease. 2002 April; 190(4): 233-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11960084&dopt=Abstract
•
Health perception, pain, and disability as correlates of anxiety and depression symptoms in primary care patients. Author(s): Wu LR, Parkerson GR Jr, Doraiswamy PM. Source: The Journal of the American Board of Family Practice / American Board of Family Practice. 2002 May-June; 15(3): 183-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12038724&dopt=Abstract
•
Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety. Author(s): Wan GJ, Crown WH, Berndt ER, Finkelstein SN, Ling D. Source: Int J Clin Pract. 2002 July-August; 56(6): 434-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12166541&dopt=Abstract
•
Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia. Author(s): Quadri A, Vakil N. Source: Alimentary Pharmacology & Therapeutics. 2003 March 15; 17(6): 835-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12641506&dopt=Abstract
•
Health-related quality of life, anxiety and depression in patients with midgut carcinoid tumours. Author(s): Larsson G, Sjoden PO, Oberg K, Eriksson B, von Essen L. Source: Acta Oncologica (Stockholm, Sweden). 2001; 40(7): 825-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11859981&dopt=Abstract
180 Anxiety
•
Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study. Author(s): Fortanier C, Kuentz M, Sutton L, Milpied N, Michalet M, Macquart-Moulin G, Faucher C, Le Corroller AG, Moatti JP, Blaise D. Source: Bone Marrow Transplantation. 2002 January; 29(2): 145-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11850709&dopt=Abstract
•
Heart rate and QT variability in children with anxiety disorders: a preliminary report. Author(s): Yeragani VK, Rao KA, Pohl R, Jampala VC, Balon R. Source: Depression and Anxiety. 2001; 13(2): 72-7. Erratum In: Depress Anxiety 2001; 13(4): 198. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11301923&dopt=Abstract
•
Heartbeat awareness and heart rate reactivity in anxiety sensitivity: a further investigation. Author(s): Stewart SH, Buffett-Jerrott SE, Kokaram R. Source: Journal of Anxiety Disorders. 2001 November-December; 15(6): 535-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11764311&dopt=Abstract
•
Heavy drinking among college students is influenced by anxiety sensitivity, gender, and contexts for alcohol use. Author(s): Lawyer SR, Karg RS, Murphy JG, McGlynn FD. Source: Journal of Anxiety Disorders. 2002; 16(2): 165-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12194542&dopt=Abstract
•
Helpless attributions and depression in adolescents: the roles of anxiety, event valence, and demographics. Author(s): Waschbusch DA, Sellers DP, LeBlanc M, Kelley ML. Source: Journal of Adolescence. 2003 April; 26(2): 169-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12581725&dopt=Abstract
•
Hepatitis associated with Kava, a herbal remedy for anxiety. Author(s): Escher M, Desmeules J, Giostra E, Mentha G. Source: Bmj (Clinical Research Ed.). 2001 January 20; 322(7279): 139. Erratum In: Bmj 2001 May 5; 322(7294): 1097. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11159570&dopt=Abstract
•
Heritability of social anxiety-related concerns and personality characteristics: a twin study. Author(s): Stein MB, Jang KL, Livesley WJ. Source: The Journal of Nervous and Mental Disease. 2002 April; 190(4): 219-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11960082&dopt=Abstract
Studies 181
•
High altitudes, anxiety, and panic attacks: is there a relationship? Author(s): Roth WT, Gomolla A, Meuret AE, Alpers GW, Handke EM, Wilhelm FH. Source: Depression and Anxiety. 2002; 16(2): 51-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12219335&dopt=Abstract
•
High prevalence of anxiety symptoms in hospitalized geriatric patients. Author(s): Kvaal K, Macijauskiene J, Engedal K, Laake K. Source: International Journal of Geriatric Psychiatry. 2001 July; 16(7): 690-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11466747&dopt=Abstract
•
Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms. Author(s): Rusch BD, Abercrombie HC, Oakes TR, Schaefer SM, Davidson RJ. Source: Biological Psychiatry. 2001 December 15; 50(12): 960-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11750892&dopt=Abstract
•
Historical overview of the relationship between anxiety disorders and affective disorders. Author(s): Himmelhoch J, Levine J, Gershon S. Source: Depression and Anxiety. 2001; 14(2): 53-66. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11668658&dopt=Abstract
•
History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. Author(s): Rutledge T, Reis SE, Olson M, Owens J, Kelsey SF, Pepine CJ, Reichek N, Rogers WJ, Merz CN, Sopko G, Cornell CE, Sharaf B, Matthews KA; Women's Ischemia Syndrome Evaluation (WISE). Source: Journal of the American College of Cardiology. 2001 March 1; 37(3): 780-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11693752&dopt=Abstract
•
History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. Author(s): Safren SA, Gershuny BS, Marzol P, Otto MW, Pollack MH. Source: The Journal of Nervous and Mental Disease. 2002 July; 190(7): 453-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12142846&dopt=Abstract
•
Home oxygen therapy in infants with bronchopulmonary dysplasia: assessment of parental anxiety. Author(s): Zanardo V, Freato F. Source: Early Human Development. 2001 October; 65(1): 39-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11520627&dopt=Abstract
182 Anxiety
•
Hopkins Symptoms Checklist 25(HSCL-25) Urdu translation: an instrument for detecting anxiety and depression in torture and trauma victims. Author(s): Halepota AA, Wasif SA. Source: J Pak Med Assoc. 2001 July; 51(7): 255-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11558218&dopt=Abstract
•
Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Author(s): Mykletun A, Stordal E, Dahl AA. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2001 December; 179: 540-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11731359&dopt=Abstract
•
How does one manage a patient with an anxiety disorder who has been selfmedicating with psychotropic drugs? Author(s): Wilson A. Source: Journal of Psychiatry & Neuroscience : Jpn. 1999 November; 24(5): 483. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11499430&dopt=Abstract
•
How to deal with anxiety. Author(s): Lemonick M. Source: Time. 2001 October 29; 158(19): 91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11699136&dopt=Abstract
•
How to ease a patient's anxiety. Author(s): Ater J. Source: Nursing. 2003 June; 33(6): 86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12807125&dopt=Abstract
•
Human defensive behaviors to threat scenarios show parallels to fear- and anxietyrelated defense patterns of non-human mammals. Author(s): Caroline Blanchard D, Hynd AL, Minke KA, Minemoto T, Blanchard RJ. Source: Neuroscience and Biobehavioral Reviews. 2001 December; 25(7-8): 761-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11801300&dopt=Abstract
•
Hydroxyzine for generalized anxiety disorder. Author(s): Sagduyu K. Source: The Journal of Clinical Psychiatry. 2003 March; 64(3): 343. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12716285&dopt=Abstract
Studies 183
•
Hyperhidrosis in social anxiety disorder. Author(s): Davidson JR, Foa EB, Connor KM, Churchill LE. Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2002 December; 26(7-8): 1327-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12502021&dopt=Abstract
•
Hyperventilation, anxiety sensitivity, and the expectations for alcohol use: subjective and physiological reactivity to alcohol cues. Author(s): Mulligan ME, McKay D. Source: Addictive Behaviors. 2001 May-June; 26(3): 375-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11436929&dopt=Abstract
•
Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. Author(s): Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH. Source: Journal of Affective Disorders. 2002 May; 69(1-3): 209-17. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12103468&dopt=Abstract
•
Iatrogenic anxiety disorder related to failure of implantable defibrillator. Author(s): Hundertmark JD. Source: General Hospital Psychiatry. 2001 May-June; 23(3): 166-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11447986&dopt=Abstract
•
Illness experience, depression, and anxiety in chronic fatigue syndrome. Author(s): Lehman AM, Lehman DR, Hemphill KJ, Mandel DR, Cooper LM. Source: Journal of Psychosomatic Research. 2002 June; 52(6): 461-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12069870&dopt=Abstract
•
Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Author(s): Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M. Source: Psychiatry Research. 2001 December 15; 105(1-2): 45-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11740974&dopt=Abstract
•
Impact of alcohol detoxification on anxiety and depressive symptoms. Author(s): Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G. Source: Drug and Alcohol Dependence. 2002 October 1; 68(2): 215-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12234651&dopt=Abstract
184 Anxiety
•
Impact of generalized social anxiety disorder in managed care. Author(s): Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP. Source: The American Journal of Psychiatry. 2001 December; 158(12): 1999-2007. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11729016&dopt=Abstract
•
Implicit memory bias and trait anxiety: a psychophysiological analysis. Author(s): Harrison LK, Turpin G. Source: Biological Psychology. 2003 February; 62(2): 97-114. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12581686&dopt=Abstract
•
Implicit self-esteem and social anxiety: differential self-favouring effects in high and low anxious individuals. Author(s): de Jong PJ. Source: Behaviour Research and Therapy. 2002 May; 40(5): 501-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12038643&dopt=Abstract
•
Improvement of agitation and anxiety in demented patients after psychoeducative group intervention with their caregivers. Author(s): Haupt M, Karger A, Janner M. Source: International Journal of Geriatric Psychiatry. 2000 December; 15(12): 1125-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11180469&dopt=Abstract
•
Improving access for rural Australians to treatment for anxiety and depression: The University of Melbourne Depression and Anxiety Research and Treatment GroupBendigo Health Care Group initiative. Author(s): Judd FK, Jackson H, Davis J, Cockram A, Komiti A, Allen N, Murray G, Kyrios M, Hodgins G. Source: The Australian Journal of Rural Health. 2001 April; 9(2): 91-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11259963&dopt=Abstract
•
Improving homework compliance in the treatment of generalized anxiety disorder. Author(s): Leahy RL. Source: Journal of Clinical Psychology. 2002 May; 58(5): 499-511. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11967876&dopt=Abstract
•
In defense of Promethean anxieties. The Promethean hazard of creativity compared to nonfruitful endemic anxiety. Author(s): Barach AL. Source: Journal of the American Geriatrics Society. 1967 December; 15(12): 1096-113. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6058479&dopt=Abstract
Studies 185
•
Increased amygdala: hippocampal volume ratios associated with severity of anxiety in pediatric major depression. Author(s): MacMillan S, Szeszko PR, Moore GJ, Madden R, Lorch E, Ivey J, Banerjee SP, Rosenberg DR. Source: Journal of Child and Adolescent Psychopharmacology. 2003 Spring; 13(1): 65-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12804127&dopt=Abstract
•
Increased incidence of affective disorders, anxiety disorders, and non-natural mortality in women after breast cancer diagnosis: a nation-wide cohort study in Denmark. Author(s): Hjerl K, Andersen EW, Keiding N, Mortensen PB, Jorgensen T. Source: Acta Psychiatrica Scandinavica. 2002 April; 105(4): 258-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11942929&dopt=Abstract
•
Increased incidence of anxiety and depression during bone marrow transplantation. Author(s): Illescas-Rico R, Amaya-Ayala F, Jimenez-Lopez JL, Caballero-Mendez ME, Gonzalez-Llaven J. Source: Archives of Medical Research. 2002 March-April; 33(2): 144-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11886712&dopt=Abstract
•
Increased incidence of anxiety and depressive disorders in persons with organic solvent exposure. Author(s): Morrow LA, Gibson C, Bagovich GR, Stein L, Condray R, Scott A. Source: Psychosomatic Medicine. 2000 November-December; 62(6): 746-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11138992&dopt=Abstract
•
Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents. Author(s): Stahl SM. Source: The Journal of Clinical Psychiatry. 2002 October; 63(10): 854-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12416593&dopt=Abstract
•
Induced emotional interpretation bias and anxiety. Author(s): Mathews A, Mackintosh B. Source: Journal of Abnormal Psychology. 2000 November; 109(4): 602-15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11195984&dopt=Abstract
186 Anxiety
•
Indwelling catheters used from the onset of diabetes decrease injection pain and preinjection anxiety. Author(s): Hanas R, Adolfsson P, Elfvin-Akesson K, Hammaren L, Ilvered R, Jansson I, Johansson C, Kroon M, Lindgren J, Lindh A, Ludvigsson J, Sigstrom L, Wiik A, Aman J, Jansson I, Wilk A. Source: The Journal of Pediatrics. 2002 March; 140(3): 315-20. Erratum In: J Pediatr 2002 August; 141(2): 298. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11953729&dopt=Abstract
•
Influence of age, the autonomic nervous system and anxiety on QT-interval variability. Author(s): Piccirillo G, Cacciafesta M, Lionetti M, Nocco M, Di Giuseppe V, Moise A, Naso C, Marigliano V. Source: Clinical Science (London, England : 1979). 2001 October; 101(4): 429-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11566081&dopt=Abstract
•
Influence of test anxiety on measurement of intelligence. Author(s): Oostdam R, Meijer J. Source: Psychological Reports. 2003 February; 92(1): 3-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12674250&dopt=Abstract
•
Injectable medication for the treatment of multiple sclerosis: the influence of selfefficacy expectations and injection anxiety on adherence and ability to self-inject. Author(s): Mohr DC, Boudewyn AC, Likosky W, Levine E, Goodkin DE. Source: Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 2001 Spring; 23(2): 125-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11394554&dopt=Abstract
•
Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Author(s): Redeker NS, Lev EL, Ruggiero J. Source: Sch Inq Nurs Pract. 2000 Winter; 14(4): 275-90; Discussion 291-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11372188&dopt=Abstract
•
Insufficient sleep, cognitive anxiety and health transition in men with coronary artery disease: a self-report and polysomnographic study. Author(s): Edell-Gustaffson UM. Source: Journal of Advanced Nursing. 2002 March; 37(5): 414-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11843979&dopt=Abstract
Studies 187
•
Interaction analysis of physician-patient communication: the influence of trait anxiety on communication and outcome. Author(s): Graugaard PK, Eide H, Finset A. Source: Patient Education and Counseling. 2003 February; 49(2): 149-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12566209&dopt=Abstract
•
Interaction between cognitive style and school environment: consequences on selfevaluated anxiety and depression. Author(s): Russo P, Persegani C, Carucci C, Vallini I, Papeschi LL, Trimarchi M. Source: The International Journal of Neuroscience. 2001 September; 110(1-2): 79-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11697213&dopt=Abstract
•
Interaction between mother's and father's affection as a risk factor for anxiety and depression symptoms--evidence for increased risk in adults who rate their father as having been more affectionate than their mother. Author(s): Jorm AF, Dear KB, Rodgers B, Christensen H. Source: Social Psychiatry and Psychiatric Epidemiology. 2003 April; 38(4): 173-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12664227&dopt=Abstract
•
Intercultural communication between patients and health care providers: an exploration of intercultural communication effectiveness, cultural sensitivity, stress, and anxiety. Author(s): Ulrey KL, Amason P. Source: Health Communication. 2001; 13(4): 449-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11771806&dopt=Abstract
•
Interface between vestibular dysfunction and anxiety: more than just psychogenicity. Author(s): Furman JM, Balaban CD, Jacob RG. Source: Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2001 May; 22(3): 426-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11347651&dopt=Abstract
•
Internal validity of an anxiety disorder screening instrument across five ethnic groups. Author(s): Ritsher JB, Struening EL, Hellman F, Guardino M. Source: Psychiatry Research. 2002 August 30; 111(2-3): 199-213. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12374637&dopt=Abstract
188 Anxiety
•
Internal versus external attention in social anxiety: an investigation using a novel paradigm. Author(s): Mansell W, Clark DM, Ehlers A. Source: Behaviour Research and Therapy. 2003 May; 41(5): 555-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12711264&dopt=Abstract
•
Interpretations for anxiety symptoms in social phobia. Author(s): Roth D, Antony MM, Swinson RP. Source: Behaviour Research and Therapy. 2001 February; 39(2): 129-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11153968&dopt=Abstract
•
Interrelationships between anxiety, lifestyle self-reports and fitness in a sample of Hong Kong University students. Author(s): Jones AY, Dean E, Lo SK. Source: Stress (Amsterdam, Netherlands). 2002 February; 5(1): 65-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12171769&dopt=Abstract
•
Interventions to decrease family anxiety. Author(s): Leske JS. Source: Critical Care Nurse. 2002 December; 22(6): 61-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12518569&dopt=Abstract
•
Intrinsic religiosity and social anxiety of intercollegiate athletes. Author(s): Storch EA, Storch JB, Adams BG. Source: Psychological Reports. 2002 August; 91(1): 186. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12353778&dopt=Abstract
•
Introduction to the Special Issue on “Anxiety Sensitivity and Addictive Behaviors”. Author(s): Stewart SH, Kushner MG. Source: Addictive Behaviors. 2001 November-December; 26(6): 775-85. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768544&dopt=Abstract
•
Introduction to the special issue: the role of disgust in anxiety disorders. Author(s): McKay D. Source: Journal of Anxiety Disorders. 2002; 16(5): 475-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12396206&dopt=Abstract
Studies 189
•
Inverse agonist binding of peripheral benzodiazepine receptors in anxiety disorder. Author(s): Chiu S, Singh AN, Chiu P, Mishra RK. Source: European Archives of Psychiatry and Clinical Neuroscience. 2001 June; 251(3): 136-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11697575&dopt=Abstract
•
Investigating the effects of anxiety sensitivity and coping on the perception of cold pressor pain in healthy women. Author(s): Keogh E, Mansoor L. Source: European Journal of Pain (London, England). 2001; 5(1): 11-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11394918&dopt=Abstract
•
Irritable bowel syndrome, anxiety, and depression: what are the links? Author(s): Lydiard RB. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 8: 38-45; Discussion 46-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12108820&dopt=Abstract
•
Is “shy bladder syndrome” a subtype of social anxiety disorder? A survey of people with paruresis. Author(s): Vythilingum B, Stein DJ, Soifer S. Source: Depression and Anxiety. 2002; 16(2): 84-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12219340&dopt=Abstract
•
Is anxiety a more common disorder than depression in rheumatoid arthritis? Author(s): el-Miedany YM, el-Rasheed AH. Source: Joint, Bone, Spine : Revue Du Rhumatisme. 2002 May; 69(3): 300-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12102277&dopt=Abstract
•
Is any female preponderance in depression secondary to a primary female preponderance in anxiety disorders? Author(s): Parker G, Hadzi-Pavlovic D. Source: Acta Psychiatrica Scandinavica. 2001 April; 103(4): 252-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11328237&dopt=Abstract
•
Is fluvoxamine safe and effective for treating anxiety disorders in children? Author(s): Burke JM, Baker RC. Source: The Journal of Family Practice. 2001 August; 50(8): 719. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11509170&dopt=Abstract
190 Anxiety
•
Is kava extract effective for treating anxiety? Author(s): Abadi S, Papoushek C, Evans MF. Source: Can Fam Physician. 2001 September; 47: 1745-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11570299&dopt=Abstract
•
Is patient anxiety about osteoporosis sufficient indication for measuring bone mineral density? Author(s): Mulherin DM, Smith JA, Price T. Source: Clin Exp Rheumatol. 2000 November-December; 18(6): 789. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11138355&dopt=Abstract
•
Is the attentional dysfunction in schizotypy related to anxiety? Author(s): Braunstein-Bercovitz H. Source: Schizophrenia Research. 2000 December 15; 46(2-3): 255-67. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11120437&dopt=Abstract
•
Is the breadth of individualized ranges of optimal anxiety (IZOF) equal for all athletes? A graphical method for establishing IZOF. Author(s): Pons D, Balaguer I, Garcia-Merita ML. Source: Span J Psychol. 2001 May; 4(1): 3-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11705340&dopt=Abstract
•
Is there a negative association between anxiety sensitivity and arousal-increasing substances and activities? Author(s): McWilliams LA, Asmundson GJ. Source: Journal of Anxiety Disorders. 2001 May-June; 15(3): 161-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11442136&dopt=Abstract
•
Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Author(s): Kiefer F, Horntrich M, Jahn H, Wiedemann K. Source: Psychopharmacology. 2002 August; 162(4): 433-7. Epub 2002 June 25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12172698&dopt=Abstract
•
I've been worrying so much lately that I sometimes have trouble sleeping at night. Could I have an anxiety disorder? Author(s): Barlow DH. Source: Health News. 2003 July; 9(7): 12. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12838929&dopt=Abstract
Studies 191
•
Joint factor analysis of the Children's Depression Inventory and the Revised Children's Manifest Anxiety Scale. Author(s): Stark KD, Laurent J. Source: Journal of Clinical Child Psychology. 2001 December; 30(4): 552-67. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11708242&dopt=Abstract
•
Kava extract for treating anxiety. Author(s): Pittler MH, Ernst E. Source: Cochrane Database Syst Rev. 2003; (1): Cd003383. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12535473&dopt=Abstract
•
Kava extract for treating anxiety. Author(s): Pittler MH, Ernst E. Source: Cochrane Database Syst Rev. 2002; (2): Cd003383. Review. Update In: http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12076477&dopt=Abstract
•
Kava extract for treating anxiety. Author(s): Pittler MH, Edzard E. Source: Cochrane Database Syst Rev. 2001; (4): Cd003383. Review. Update In: http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11687196&dopt=Abstract
•
Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia. Author(s): Boerner RJ. Source: Phytotherapy Research : Ptr. 2001 November; 15(7): 646-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11746854&dopt=Abstract
•
Kava-Kava administration reduces anxiety in perimenopausal women. Author(s): Cagnacci A, Arangino S, Renzi A, Zanni AL, Malmusi S, Volpe A. Source: Maturitas. 2003 February 25; 44(2): 103-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12590005&dopt=Abstract
•
Kava-kava and anxiety: growing knowledge about the efficacy and safety. Author(s): Bilia AR, Gallon S, Vincieri FF. Source: Life Sciences. 2002 April 19; 70(22): 2581-97. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12269386&dopt=Abstract
192 Anxiety
•
Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Author(s): Boerner RJ, Sommer H, Berger W, Kuhn U, Schmidt U, Mannel M. Source: Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2003; 10 Suppl 4: 38-49. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12807341&dopt=Abstract
•
Kindling of withdrawal: a study of craving and anxiety after multiple detoxifications in alcoholic inpatients. Author(s): Duka T, Townshend JM, Collier K, Stephens DN. Source: Alcoholism, Clinical and Experimental Research. 2002 June; 26(6): 785-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12068246&dopt=Abstract
•
Lack of association of a single-nucleotide polymorphism of the mu-opioid receptor gene with anxiety-related traits: results from a cross-sectional study of adults and a longitudinal study of children. Author(s): Jorm AF, Prior M, Sanson A, Smart D, Zhang Y, Tan S, Easteal S. Source: American Journal of Medical Genetics. 2002 August 8; 114(6): 659-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12210283&dopt=Abstract
•
Laparoscopic antireflux surgery in gastro-oesophageal reflux disease patients with concomitant anxiety disorders. Author(s): Kamolz T, Bammer T, Granderath FA, Pointner R. Source: Dig Liver Dis. 2001 November; 33(8): 659-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11785710&dopt=Abstract
•
Latent class analysis of child behavior checklist anxiety/depression in children and adolescents. Author(s): Wadsworth ME, Hudziak JJ, Heath AC, Achenbach TM. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 January; 40(1): 106-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11195551&dopt=Abstract
•
Latent inhibition deficits in high-schizotypal normals: symptom-specific or anxietyrelated? Author(s): Braunstein-Bercovitz H, Rammsayer T, Gibbons H, Lubow RE. Source: Schizophrenia Research. 2002 January 1; 53(1-2): 109-21. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11728844&dopt=Abstract
Studies 193
•
Laterality of lesions and trait-anxiety on working memory performance. Author(s): Killgore WD. Source: Percept Mot Skills. 2002 April; 94(2): 551-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12027352&dopt=Abstract
•
Levels of anxiety and hostility in South African Navy divers. Author(s): van Wijk CH. Source: Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc. 2002 Winter; 29(4): 271-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12797668&dopt=Abstract
•
Life course outcomes of young people with anxiety disorders in adolescence. Author(s): Woodward LJ, Fergusson DM. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 September; 40(9): 1086-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11556633&dopt=Abstract
•
Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Author(s): Kendler KS, Hettema JM, Butera F, Gardner CO, Prescott CA. Source: Archives of General Psychiatry. 2003 August; 60(8): 789-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12912762&dopt=Abstract
•
Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community. Author(s): Goodwin RD, Hamilton SP. Source: Psychiatry Research. 2003 February 15; 117(2): 159-66. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12606017&dopt=Abstract
•
Linking temperamental fearfulness and anxiety symptoms: a behavior-genetic perspective. Author(s): Goldsmith HH, Lemery KS. Source: Biological Psychiatry. 2000 December 15; 48(12): 1199-209. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11137060&dopt=Abstract
•
Links between body mass index, total body fat, cholesterol, high-density lipoprotein, and insulin sensitivity in patients with obesity related to depression, anger, and anxiety. Author(s): Laederach-Hofmann K, Kupferschmid S, Mussgay L. Source: The International Journal of Eating Disorders. 2002 July; 32(1): 58-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12183947&dopt=Abstract
194 Anxiety
•
Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor. Author(s): Huppert JD, Smith TE. Source: The Journal of Nervous and Mental Disease. 2001 October; 189(10): 669-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11708667&dopt=Abstract
•
Long-term partial 5-HT depletion: interference of anxiety and impulsivity? Author(s): Harro J. Source: Psychopharmacology. 2002 December; 164(4): 433-4. Epub 2002 October 24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12457276&dopt=Abstract
•
Longterm predictors of anxiety and depressed mood in early rheumatoid arthritis: a 3 and 5 year followup. Author(s): Evers AW, Kraaimaat FW, Geenen R, Jacobs JW, Bijlsma JW. Source: The Journal of Rheumatology. 2002 November; 29(11): 2327-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12415588&dopt=Abstract
•
Low intensity pain reported during elicitation of the H-reflex: no effects of trait anxiety and high intensity cycling exercise. Author(s): Motl RW, O'Connor PJ, Boyd CM, Dishman RK. Source: Brain Research. 2002 September 27; 951(1): 53-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12231456&dopt=Abstract
•
Make them laugh. Therapeutic humor for patients with grief-related stress or anxiety. Author(s): Moore DB. Source: Adv Nurse Pract. 2000 August; 8(8): 34-7. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11761520&dopt=Abstract
•
Mammography-related anxiety: effect of preprocedural patient education. Author(s): Mainiero MB, Schepps B, Clements NC, Bird CE. Source: Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. 2001 March-April; 11(2): 110-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11275514&dopt=Abstract
•
Management of acute pain and anxiety in children undergoing procedures in the emergency department. Author(s): Krauss B. Source: Pediatric Emergency Care. 2001 April; 17(2): 115-22; Quiz 123-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11334092&dopt=Abstract
Studies 195
•
Management of anxiety after acute myocardial infarction. Author(s): Frazier SK, Moser DK, O'Brien JL, Garvin BJ, An K, Macko M. Source: Heart & Lung : the Journal of Critical Care. 2002 November-December; 31(6): 411-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12434142&dopt=Abstract
•
Management of anxiety and depression in HIV-infected patients. Author(s): Cabaj RP. Source: J Int Assoc Physicians Aids Care. 1996 June; 2(6): 11-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11363692&dopt=Abstract
•
Management of anxiety disorders: the added challenge of comorbidity. Author(s): Dunner DL. Source: Depression and Anxiety. 2001; 13(2): 57-71. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11301922&dopt=Abstract
•
Management of anxiety in primary care. Author(s): Dearman SP, Nathoo V. Source: The British Journal of General Practice : the Journal of the Royal College of General Practitioners. 2002 November; 52(484): 943-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12434974&dopt=Abstract
•
Management of anxiety in the refractive surgery patient. Author(s): Katzen J. Source: Insight (American Society of Ophthalmic Registered Nurses). 2002 OctoberDecember; 27(4): 103-7; Quiz 108-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12520985&dopt=Abstract
•
Management of background pain and anxiety in critically burned children requiring protracted mechanical ventilation. Author(s): Sheridan R, Stoddard F, Querzoli E. Source: The Journal of Burn Care & Rehabilitation. 2001 March-April; 22(2): 150-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11302604&dopt=Abstract
•
Managing acute pain and anxiety in children undergoing procedures in the emergency department. Author(s): Krauss B. Source: Emergency Medicine (Fremantle, W.A.). 2001 September; 13(3): 293-304. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11554860&dopt=Abstract
196 Anxiety
•
Managing depression and anxiety in the elderly patient. Author(s): Katona C. Source: European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2000 December; 10 Suppl 4: S427-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11114487&dopt=Abstract
•
Managing the endodontic patient with disabling anxiety or phobia. Author(s): Saxen MA, Newton CW. Source: J Indiana Dent Assoc. 1999-00 Winter; 78(4): 21-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10863457&dopt=Abstract
•
Mania or anxiety disorders linked to panic disorder. Author(s): Parvin MM, Swartz CM. Source: The American Journal of Psychiatry. 2002 December; 159(12): 2115-6; Author Reply 2116. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12450975&dopt=Abstract
•
Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer. Author(s): Fujii M, Ohno Y, Tokumaru Y, Imanishi Y, Kanke M, Tomita T, Kanzaki J. Source: Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 2001 July; 9(5): 366-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11497391&dopt=Abstract
•
Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. Author(s): O'Connor TG, Heron J, Golding J, Beveridge M, Glover V. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2002 June; 180: 502-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12042228&dopt=Abstract
•
Maternal anxiety and depression, poverty and marital relationship factors during early childhood as predictors of anxiety and depressive symptoms in adolescence. Author(s): Spence SH, Najman JM, Bor W, O'Callaghan MJ, Williams GM. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2002 May; 43(4): 457-69. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12030592&dopt=Abstract
•
Maternal anxiety in late pregnancy: effect on fetal movements and fetal heart rate. Author(s): Sjostrom K, Valentin L, Thelin T, Marsal K. Source: Early Human Development. 2002 April; 67(1-2): 87-100. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11893440&dopt=Abstract
Studies 197
•
Maternal assignment of fetal personhood to a previous pregnancy loss: relationship to anxiety in the current pregnancy. Author(s): Cjte-Arsenault D, Dombeck MT. Source: Health Care for Women International. 2001 October-November; 22(7): 649-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12141842&dopt=Abstract
•
Maternal pain and anxiety in genetic amniocentesis: expectation versus reality. Author(s): Ferber A, Onyeije CI, Zelop CM, O'Reilly-Green C, Divon MY. Source: Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2002 January; 19(1): 13-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11851963&dopt=Abstract
•
Maternal stress or anxiety during pregnancy and the development of the baby. Author(s): Glover V. Source: Pract Midwife. 1999 May; 2(5): 20-2. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12024606&dopt=Abstract
•
Mathematics anxiety among eighth-grade students of the United Arab Emirates. Author(s): Abed AS, Alkhateeb HM. Source: Psychological Reports. 2001 August; 89(1): 65-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11729553&dopt=Abstract
•
Mathematics self-concept and mathematics anxiety of undergraduate majors in education. Author(s): Alkhateeb HM, Taha N. Source: Psychological Reports. 2002 December; 91(3 Pt 2): 1273-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12585549&dopt=Abstract
•
Measurement issues in postpartum depression part 1: anxiety as a feature of postpartum depression. Author(s): Ross LE, Gilbert Evans SE, Sellers EM, Romach MK. Source: Archives of Women's Mental Health. 2003 February; 6(1): 51-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12715264&dopt=Abstract
•
Measures of self-efficacy and optimism in older adults with generalized anxiety. Author(s): Stanley MA, Novy DM, Hopko DR, Beck JG, Averill PM, Swann AC. Source: Assessment. 2002 March; 9(1): 70-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11911237&dopt=Abstract
198 Anxiety
•
Measuring anxiety in animal models: an introduction to the symposium. Author(s): Kavaliers M, Ossenkopp KP. Source: Neuroscience and Biobehavioral Reviews. 2001 May; 25(3): 203-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11378176&dopt=Abstract
•
Measuring anxiety: parent-child reporting differences in clinical samples. Author(s): Barbosa J, Tannock R, Manassis K. Source: Depression and Anxiety. 2002; 15(2): 61-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11891994&dopt=Abstract
•
Measuring normal and pathological anxiety-like behaviour in mice: a review. Author(s): Belzung C, Griebel G. Source: Behavioural Brain Research. 2001 November 1; 125(1-2): 141-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11682105&dopt=Abstract
•
Measuring outcomes in patients with depression or anxiety: an essential part of clinical practice. Author(s): Andersen-Dalheim H. Source: The Medical Journal of Australia. 2003 March 17; 178(6): 302-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12776735&dopt=Abstract
•
Measuring outcomes in patients with depression or anxiety: an essential part of clinical practice. Author(s): Boettcher BM. Source: The Medical Journal of Australia. 2003 March 17; 178(6): 302. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12633494&dopt=Abstract
•
Measuring outcomes in patients with depression or anxiety: an essential part of clinical practice. Author(s): Dinnen A. Source: The Medical Journal of Australia. 2003 January 6; 178(1): 48; Author Reply 48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12492398&dopt=Abstract
•
Measuring outcomes in patients with depression or anxiety: an essential part of clinical practice. Author(s): Hickie IB, Andrews G, Davenport TA. Source: The Medical Journal of Australia. 2002 August 19; 177(4): 205-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12175326&dopt=Abstract
Studies 199
•
Measuring social anxiety and obsessive-compulsive spectra: comparison of interviews and self-report instruments. Author(s): Dell'Osso L, Rucci P, Cassano GB, Maser JD, Endicott J, Shear MK, Sarno N, Saettoni M, Grochocinski VJ, Frank E. Source: Comprehensive Psychiatry. 2002 March-April; 43(2): 81-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11893984&dopt=Abstract
•
Mechanisms of action in the treatment of anxiety. Author(s): Shelton RC, Brown LL. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 12: 10-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11430613&dopt=Abstract
•
Mediating functions of maternal anxiety and participation in care on young children's posthospital adjustment. Author(s): Melnyk BM, Feinstein NF. Source: Research in Nursing & Health. 2001 February; 24(1): 18-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11260582&dopt=Abstract
•
Medication for the management of anxiety disorders in children and adolescents. Author(s): Williams T, Hodgman C. Source: Pediatric Annals. 2001 March; 30(3): 146-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11257944&dopt=Abstract
•
Memory biases in the anxiety disorders: current status. Author(s): Coles ME, Heimberg RG. Source: Clinical Psychology Review. 2002 May; 22(4): 587-627. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12094512&dopt=Abstract
•
Mental health care in Japan: recognition and treatment of depression and anxiety disorders. Author(s): Tajima O. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 13: 39-44; Discussion 45-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11434417&dopt=Abstract
•
Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Author(s): Wall PM, Messier C. Source: Neuroscience and Biobehavioral Reviews. 2001 May; 25(3): 275-86. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11378181&dopt=Abstract
200 Anxiety
•
Methods for managing pelvic examination anxiety: individual differences and relaxation techniques. Author(s): Hennigen L, Kollar LM, Rosenthal SL. Source: Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners. 2000 January-February; 14(1): 9-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11141829&dopt=Abstract
•
Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety? Author(s): Gass P, Reichardt HM, Strekalova T, Henn F, Tronche F. Source: Physiology & Behavior. 2001 August; 73(5): 811-25. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11566214&dopt=Abstract
•
Mindfulness meditation, anxiety reduction, and heart disease: a pilot study. Author(s): Tacon AM, McComb J, Caldera Y, Randolph P. Source: Family & Community Health. 2003 January-March; 26(1): 25-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12802125&dopt=Abstract
•
Mindsets in social anxiety: a new look at selective information processing. Author(s): Hiemisch A, Ehlers A, Westermann R. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2002 June; 33(2): 10314. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12472174&dopt=Abstract
•
Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. Author(s): Connor KM, Kobak KA, Churchill LE, Katzelnick D, Davidson JR. Source: Depression and Anxiety. 2001; 14(2): 137-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11668666&dopt=Abstract
•
Mirtazapine in social anxiety disorder: a pilot study. Author(s): Van Veen JF, Van Vliet IM, Westenberg HG. Source: International Clinical Psychopharmacology. 2002 November; 17(6): 315-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12409686&dopt=Abstract
•
Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. Author(s): Stein DJ, Cameron A, Amrein R, Montgomery SA; Moclobemide Social Phobia Clinical Study Group. Source: International Clinical Psychopharmacology. 2002 July; 17(4): 161-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12131599&dopt=Abstract
Studies 201
•
Modulation of anxiety through blockade of anandamide hydrolysis. Author(s): Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D. Source: Nature Medicine. 2003 January; 9(1): 76-81. Epub 2002 December 02. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12461523&dopt=Abstract
•
Molecular foundation of anxiety disorders. Author(s): Lesch KP. Source: Journal of Neural Transmission (Vienna, Austria : 1996). 2001; 108(6): 717-46. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11478423&dopt=Abstract
•
Molecular pathways of anxiety revealed by knockout mice. Author(s): Wood SJ, Toth M. Source: Molecular Neurobiology. 2001 April-June; 23(2-3): 101-19. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11817214&dopt=Abstract
•
Molecular targets in the treatment of anxiety. Author(s): Kent JM, Mathew SJ, Gorman JM. Source: Biological Psychiatry. 2002 November 15; 52(10): 1008-30. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12437941&dopt=Abstract
•
Mood and anxiety disorders following pediatric traumatic brain injury: a prospective study. Author(s): Luis CA, Mittenberg W. Source: J Clin Exp Neuropsychol. 2002 May; 24(3): 270-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11992209&dopt=Abstract
•
Mood and anxiety symptoms among 140 children from alcoholic and control families. Author(s): Preuss UW, Schuckit MA, Smith TL, Barnow S, Danko GP. Source: Drug and Alcohol Dependence. 2002 August 1; 67(3): 235-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12127194&dopt=Abstract
•
Mood states and anxiety influence abilities to maintain balance control in healthy human subjects. Author(s): Bolmont B, Gangloff P, Vouriot A, Perrin PP. Source: Neuroscience Letters. 2002 August 23; 329(1): 96-100. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12161271&dopt=Abstract
202 Anxiety
•
Moral panic versus the risk society: the implications of the changing sites of social anxiety. Author(s): Ungar S. Source: The British Journal of Sociology. 2001 June; 52(2): 271-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11440057&dopt=Abstract
•
Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Author(s): Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Source: Psychosomatic Medicine. 2001 March-April; 63(2): 221-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11292269&dopt=Abstract
•
Motor cortex excitability correlates with an anxiety-related personality trait. Author(s): Wassermann EM, Greenberg BD, Nguyen MB, Murphy DL. Source: Biological Psychiatry. 2001 September 1; 50(5): 377-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11543742&dopt=Abstract
•
Multidisciplinary management of fetal surgical anomalies: the impact on maternal anxiety. Author(s): Aite L, Trucchi A, Nahom A, Spina V, Bilancioni E, Bagolan P. Source: European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery. [et Al] = Zeitschrift Fur Kinderchirurgie. 2002 April; 12(2): 90-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12015651&dopt=Abstract
•
Multimethod assessment of treatment process in chronic low back pain: comparison of reported pain-related anxiety with directly measured physical capacity. Author(s): McCracken LM, Gross RT, Eccleston C. Source: Behaviour Research and Therapy. 2002 May; 40(5): 585-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12038650&dopt=Abstract
•
Multiple informant agreement and the anxiety disorders interview schedule for parents and children. Author(s): Grills AE, Ollendick TH. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 January; 42(1): 30-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12500074&dopt=Abstract
Studies 203
•
Multisensory integration for spatial orientation in trait anxiety subjects: absence of visual dependence. Author(s): Viaud-Delmon I, Berthoz A, Jouvent R. Source: European Psychiatry : the Journal of the Association of European Psychiatrists. 2002 July; 17(4): 194-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12231264&dopt=Abstract
•
Music and preoperative anxiety: a randomized, controlled study. Author(s): Wang SM, Kulkarni L, Dolev J, Kain ZN. Source: Anesthesia and Analgesia. 2002 June; 94(6): 1489-94, Table of Contents. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12032013&dopt=Abstract
•
Music as a therapeutic intervention for anxiety in patients receiving radiation therapy. Author(s): Smith M, Casey L, Johnson D, Gwede C, Riggin OZ. Source: Oncology Nursing Forum. 2001 June; 28(5): 855-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11421145&dopt=Abstract
•
Music decreases anxiety and provides sedation in extracorporeal shock wave lithotripsy. Author(s): Yilmaz E, Ozcan S, Basar M, Basar H, Batislam E, Ferhat M. Source: Urology. 2003 February; 61(2): 282-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12597931&dopt=Abstract
•
Music therapy for assistance with pain and anxiety management in burn treatment. Author(s): Prensner JD, Yowler CJ, Smith LF, Steele AL, Fratianne RB. Source: The Journal of Burn Care & Rehabilitation. 2001 January-February; 22(1): 83-8; Discussion 82-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11227691&dopt=Abstract
•
Music versus distraction for procedural pain and anxiety in patients with cancer. Author(s): Kwekkeboom KL. Source: Oncology Nursing Forum. 2003 May-June; 30(3): 433-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12719743&dopt=Abstract
•
Needs and feelings of anxiety of relatives of patients hospitalized in intensive care units: implications for social work. Author(s): Delva D, Vanoost S, Bijttebier P, Lauwers P, Wilmer A. Source: Soc Work Health Care. 2002; 35(4): 21-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12425448&dopt=Abstract
204 Anxiety
•
Nefazodone decreases anxiety during marijuana withdrawal in humans. Author(s): Haney M, Hart CL, Ward AS, Foltin RW. Source: Psychopharmacology. 2003 January; 165(2): 157-65. Epub 2002 November 19. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12439626&dopt=Abstract
•
Nefazodone may increase anxiety in panic disorder. Author(s): Strohle A, Ehrenthal HD. Source: Journal of Clinical Psychopharmacology. 2002 February; 22(1): 95-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11799352&dopt=Abstract
•
Negative life events of anxiety disordered children: bad fortune, vulnerability, or reporter bias? Author(s): Boer F, Markus MT, Maingay R, Lindhout IE, Borst SR, Hoogendijk TH. Source: Child Psychiatry and Human Development. 2002 Spring; 32(3): 187-99. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11894841&dopt=Abstract
•
Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers. Author(s): Mataix-Cols D, Cullen S, Lange K, Zelaya F, Andrew C, Amaro E, Brammer MJ, Williams SC, Speckens A, Phillips ML. Source: Biological Psychiatry. 2003 March 15; 53(6): 482-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12644353&dopt=Abstract
•
Neural substrates linking balance control and anxiety. Author(s): Balaban CD. Source: Physiology & Behavior. 2002 December; 77(4-5): 469-75. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12526985&dopt=Abstract
•
Neuroactive steroid levels in patients with generalized anxiety disorder. Author(s): Semeniuk T, Jhangri GS, Le Melledo JM. Source: The Journal of Neuropsychiatry and Clinical Neurosciences. 2001 Summer; 13(3): 396-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11514647&dopt=Abstract
•
Neuroactive steroids and anxiety disorders. Author(s): Le Melledo JM, Baker GB. Source: Journal of Psychiatry & Neuroscience : Jpn. 2002 May; 27(3): 161-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12066445&dopt=Abstract
Studies 205
•
Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety. Author(s): Penza KM, Heim C, Nemeroff CB. Source: Archives of Women's Mental Health. 2003 February; 6(1): 15-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12715261&dopt=Abstract
•
Neurobiological mechanisms in generalized anxiety disorder. Author(s): Nutt DJ. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 11: 22-7; Discussion 28. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11414547&dopt=Abstract
•
Neurobiological mechanisms of social anxiety disorder. Author(s): Mathew SJ, Coplan JD, Gorman JM. Source: The American Journal of Psychiatry. 2001 October; 158(10): 1558-67. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11578981&dopt=Abstract
•
Neurobiology of anxiety and fear: challenges for genomic science of the new millennium. Author(s): Moldin SO. Source: Biological Psychiatry. 2000 December 15; 48(12): 1144-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11137055&dopt=Abstract
•
Neurobiology of generalized anxiety disorder. Author(s): Jetty PV, Charney DS, Goddard AW. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 75-97. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225510&dopt=Abstract
•
Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Author(s): Klaassen T, Riedel WJ, van Praag HM, Menheere PP, Griez E. Source: Psychiatry Research. 2002 December 15; 113(1-2): 29-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12467943&dopt=Abstract
•
Neuroimaging studies of amygdala function in anxiety disorders. Author(s): Rauch SL, Shin LM, Wright CI. Source: Annals of the New York Academy of Sciences. 2003 April; 985: 389-410. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12724173&dopt=Abstract
206 Anxiety
•
Neurological bases for balance-anxiety links. Author(s): Balaban CD, Thayer JF. Source: Journal of Anxiety Disorders. 2001 January-April; 15(1-2): 53-79. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11388358&dopt=Abstract
•
Neuropeptides and anxiety-related behavior. Author(s): Landgraf R. Source: Endocr J. 2001 October; 48(5): 517-33. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11789556&dopt=Abstract
•
New insights into the diagnosis and pharmacologic management of generalized anxiety disorder. Author(s): Ninan PT. Source: Psychopharmacology Bulletin. 2002 Spring; 36(2): 105-22. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12397844&dopt=Abstract
•
Nightmare frequency, nightmare distress, and anxiety. Author(s): Nguyen TT, Madrid S, Marquez H, Hicks RA. Source: Percept Mot Skills. 2002 August; 95(1): 219-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12365257&dopt=Abstract
•
Nightmares and anxiety in elementary-aged children: is there a relationship. Author(s): Mindell JA, Barrett KM. Source: Child: Care, Health and Development. 2002 July; 28(4): 317-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12211191&dopt=Abstract
•
Non-human primate models for investigating fear and anxiety. Author(s): Barros M, Tomaz C. Source: Neuroscience and Biobehavioral Reviews. 2002 March; 26(2): 187-201. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11856558&dopt=Abstract
•
Nonhuman primate studies of fear, anxiety, and temperament and the role of benzodiazepine receptors and GABA systems. Author(s): Kalin NH. Source: The Journal of Clinical Psychiatry. 2003; 64 Suppl 3: 41-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12662133&dopt=Abstract
Studies 207
•
Non-institutionalized elderly dental patients in Israel: socio-demographics, health concerns, and dental anxiety. Author(s): Peretz B, Mersel A. Source: Spec Care Dentist. 2000 March-April; 20(2): 61-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11203880&dopt=Abstract
•
Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders. Author(s): Kehne J, De Lombaert S. Source: Current Drug Targets. Cns and Neurological Disorders. 2002 October; 1(5): 46793. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12769601&dopt=Abstract
•
Number of teeth, body mass index, and dental anxiety in middle-aged Swedish women. Author(s): Forslund HB, Lindroos AK, Blomkvist K, Hakeberg M, Berggren U, Jontell M, Torgerson JS. Source: Acta Odontologica Scandinavica. 2002 December; 60(6): 346-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12512884&dopt=Abstract
•
Nursing intervention for pre-operative anxiety. Author(s): Mitchell M. Source: Nursing Standard : Official Newspaper of the Royal College of Nursing. 2000 May 31-June 6; 14(37): 40-3. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11974020&dopt=Abstract
•
Nursing nomenclatures and eye-roll anxiety control. Author(s): Pesut DJ. Source: Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing. 2002 January-February; 18(1): 3-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11859484&dopt=Abstract
•
Nursing staff anxiety versus smoking habits. Author(s): Tselebis A, Panaghiotou A, Theotoka I, Ilias I. Source: International Journal of Nursing Practice. 2001 June; 7(3): 221-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11811818&dopt=Abstract
•
Obsessive-compulsive disorder and separation anxiety co-morbidity in early onset panic disorder. Author(s): Goodwin R, Lipsitz JD, Chapman TF, Mannuzza S, Fyer AJ. Source: Psychological Medicine. 2001 October; 31(7): 1307-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11681556&dopt=Abstract
208 Anxiety
•
Obstetric complications and anxiety during pregnancy: is there a relationship? Author(s): Johnson RC, Slade P. Source: Journal of Psychosomatic Obstetrics and Gynaecology. 2003 March; 24(1): 1-14. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12685335&dopt=Abstract
•
Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. Author(s): Mintzer J, Faison W, Street JS, Sutton VK, Breier A. Source: International Journal of Geriatric Psychiatry. 2001 December; 16 Suppl 1: S71-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11748790&dopt=Abstract
•
On the physiological symptom constellation in youth with Generalized Anxiety Disorder (GAD). Author(s): Kendall PC, Pimentel SS. Source: Journal of Anxiety Disorders. 2003; 17(2): 211-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12614663&dopt=Abstract
•
On the scientific status of cognitive appraisal models of anxiety disorder. Author(s): McNally RJ. Source: Behaviour Research and Therapy. 2001 May; 39(5): 513-21. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11341248&dopt=Abstract
•
One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Author(s): Carter RM, Wittchen HU, Pfister H, Kessler RC. Source: Depression and Anxiety. 2001; 13(2): 78-88. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11301924&dopt=Abstract
•
Onset of and patterns of change in dental anxiety in adolescence and early adulthood: a birth cohort study. Author(s): Locker D, Thomson WM, Poulton R. Source: Community Dent Health. 2001 June; 18(2): 99-104. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11461066&dopt=Abstract
•
Opening Pandora's box: parental anxiety and the assessment of childhood murmurs. Author(s): Giuffre RM, Walker I, Vaillancourt S, Gupta S. Source: The Canadian Journal of Cardiology. 2002 April; 18(4): 406-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11992134&dopt=Abstract
Studies 209
•
Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response. Author(s): Perugi G, Frare F, Toni C, Ruffolo G, Torti C. Source: Neuropsychobiology. 2002; 46(3): 145-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12422062&dopt=Abstract
•
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. Author(s): Moller HJ, Volz HP, Reimann IW, Stoll KD. Source: Journal of Clinical Psychopharmacology. 2001 February; 21(1): 59-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11199949&dopt=Abstract
•
Opposite effects of nefazodone in two human models of anxiety. Author(s): Silva M, Hetem LA, Guimaraes FS, Graeff FG. Source: Psychopharmacology. 2001 August; 156(4): 454-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11498723&dopt=Abstract
•
Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission. Author(s): Pollack MH. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 19: 20-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11577787&dopt=Abstract
•
Outcomes of a brief inpatient treatment program for mood and anxiety disorders. Author(s): Tucker S, Moore W, Luedtke C. Source: Outcomes Management for Nursing Practice. 2000 July-September; 4(3): 117-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11299580&dopt=Abstract
•
Overcoming social anxiety disorder. Author(s): Roy-Byrne P. Source: Health News. 2001 May; 7(5): 3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11851152&dopt=Abstract
•
Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress. Author(s): Clark MS, Sexton TJ, McClain M, Root D, Kohen R, Neumaier JF. Source: The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 2002 June 1; 22(11): 4550-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12040062&dopt=Abstract
210 Anxiety
•
Overview and clinical presentation of generalized anxiety disorder. Author(s): Rickels K, Rynn M. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 1-17. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225502&dopt=Abstract
•
Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. Author(s): Ballenger JC. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 19: 11-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11577786&dopt=Abstract
•
Pain and anxiety control in dentistry. Author(s): Wraith A. Source: Saad Dig. 1999 July; 16(3): 2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11833136&dopt=Abstract
•
Pain and anxiety management in the postoperative gastro-surgical setting. Author(s): Manias E. Source: Journal of Advanced Nursing. 2003 March; 41(6): 585-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622867&dopt=Abstract
•
Pain and anxiety with burn dressing changes: patient self-report. Author(s): Weinberg K, Birdsall C, Vail D, Marano MA, Petrone SJ, Mansour EH. Source: The Journal of Burn Care & Rehabilitation. 2000 March-April; 21(2): 155-6; Discussion 157-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10752749&dopt=Abstract
•
Pain anxiety among chronic pain patients: specific phobia or manifestation of anxiety sensitivity? Author(s): Greenberg J, Burns JW. Source: Behaviour Research and Therapy. 2003 February; 41(2): 223-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12547382&dopt=Abstract
•
Pain, anxiety and insomnia--a global perspective on the relief of suffering: comparative review. Author(s): Ghodse H. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2003 July; 183: 15-21. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12835238&dopt=Abstract
Studies 211
•
Pain, anxiety, distress, and suffering: interrelated, but not interchangeable. Author(s): Berde C, Wolfe J. Source: The Journal of Pediatrics. 2003 April; 142(4): 361-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12712049&dopt=Abstract
•
Panic attack in a context of comorbid anxiety and depression in a Tibetan refugee. Author(s): Jacobson E. Source: Culture, Medicine and Psychiatry. 2002 June; 26(2): 259-79. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12211327&dopt=Abstract
•
Panic, hyperventilation and perpetuation of anxiety. Author(s): Dratcu L. Source: Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2000 October; 24(7): 1069-89. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11131173&dopt=Abstract
•
Parental anxiety as a possible predisposing factor to child dental anxiety in patients seen in a suburban dental hospital in Nigeria. Author(s): Folayan MO, Adekoya-Sofowora CA, D Otuyemi O, Ufomata D. Source: International Journal of Paediatric Dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children. 2002 July; 12(4): 255-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12121535&dopt=Abstract
•
Parental anxiety associated with referral of a child to a pediatric cardiologist for evaluation of a Still's murmur. Author(s): Geggel RL, Horowitz LM, Brown EA, Parsons M, Wang PS, Fulton DR. Source: The Journal of Pediatrics. 2002 June; 140(6): 747-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12072881&dopt=Abstract
•
Parental anxiety disorders, child anxiety disorders, and the perceived parent-child relationship in an Australian high-risk sample. Author(s): McClure EB, Brennan PA, Hammen C, Le Brocque RM. Source: Journal of Abnormal Child Psychology. 2001 February; 29(1): 1-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11316331&dopt=Abstract
•
Parental bonding and anxiety: differences between African American and European American college students. Author(s): Carter MM, Sbrocco T, Lewis EL, Friedman EK. Source: Journal of Anxiety Disorders. 2001 November-December; 15(6): 555-69. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11764312&dopt=Abstract
212 Anxiety
•
Parental control, trait anxiety, and satisfaction with life in college students. Author(s): Seibel FL, Johnson WB. Source: Psychological Reports. 2001 April; 88(2): 473-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11351892&dopt=Abstract
•
Parental problem drinking and anxiety disorder symptoms in adult offspring: examining the mediating role of anxiety sensitivity components. Author(s): MacPherson PS, Stewart SH, McWilliams LA. Source: Addictive Behaviors. 2001 November-December; 26(6): 917-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11768552&dopt=Abstract
•
Parent-child concordance for separation anxiety: a clinical study. Author(s): Manicavasagar V, Silove D, Rapee R, Waters F, Momartin S. Source: Journal of Affective Disorders. 2001 June; 65(1): 81-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11426514&dopt=Abstract
•
Parent-child interactions and anxiety disorders: an observational study. Author(s): Hudson JL, Rapee RM. Source: Behaviour Research and Therapy. 2001 December; 39(12): 1411-27. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11758699&dopt=Abstract
•
Parenting and childhood anxiety: theory, empirical findings, and future directions. Author(s): Wood JJ, McLeod BD, Sigman M, Hwang WC, Chu BC. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2003 January; 44(1): 134-51. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12553416&dopt=Abstract
•
Parenting behaviors in parents with anxiety disorders. Author(s): Turner SM, Beidel DC, Roberson-Nay R, Tervo K. Source: Behaviour Research and Therapy. 2003 May; 41(5): 541-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12711263&dopt=Abstract
•
Parenting received in childhood and early separation anxiety in male conscripts with adjustment disorder. Author(s): Giotakos O, Konstantakopoulos G. Source: Military Medicine. 2002 January; 167(1): 28-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11799809&dopt=Abstract
Studies 213
•
Parkinson's disease and anxiety. Author(s): Walsh K, Bennett G. Source: Postgraduate Medical Journal. 2001 February; 77(904): 89-93. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11161073&dopt=Abstract
•
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Author(s): Randall CL, Johnson MR, Thevos AK, Sonne SC, Thomas SE, Willard SL, Brady KT, Davidson JR. Source: Depression and Anxiety. 2001; 14(4): 255-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11754136&dopt=Abstract
•
Paroxetine in the treatment of generalized anxiety disorder: results of a placebocontrolled, flexible-dosage trial. Author(s): Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK. Source: The Journal of Clinical Psychiatry. 2001 May; 62(5): 350-7. Erratum In: J Clin Psychiatry 2001 August; 62(8): 658. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11411817&dopt=Abstract
•
Paroxetine treatment of generalized anxiety disorder: a double-blind, placebocontrolled study. Author(s): Rickels K, Zaninelli R, McCafferty J, Bellew K, Iyengar M, Sheehan D. Source: The American Journal of Psychiatry. 2003 April; 160(4): 749-56. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12668365&dopt=Abstract
•
Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis. Author(s): Wozniak J, Biederman J, Monuteaux MC, Richards J, Faraone SV. Source: Journal of Child and Adolescent Psychopharmacology. 2002 Summer; 12(2): 10111. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12188979&dopt=Abstract
•
Partner anxiety prior to elective Caesarean section under regional anaesthesia. Author(s): Taylor IR, Bullough AS, van Hamel JC, Campbell DN. Source: Anaesthesia. 2002 June; 57(6): 600-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12073950&dopt=Abstract
214 Anxiety
•
Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. Author(s): Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Source: Journal of Clinical Pharmacy and Therapeutics. 2001 October; 26(5): 363-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11679026&dopt=Abstract
•
Patient anxiety while on a waiting list for coronary artery bypass surgery: a qualitative and quantitative analysis. Author(s): Fitzsimons D, Parahoo K, Richardson SG, Stringer M. Source: Heart & Lung : the Journal of Critical Care. 2003 January-February; 32(1): 23-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12571545&dopt=Abstract
•
Patients' views on anxiety and depression. Author(s): Launer J. Source: The British Journal of General Practice : the Journal of the Royal College of General Practitioners. 2001 August; 51(469): 676. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11510408&dopt=Abstract
•
Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. Author(s): Meoni P, Salinas E, Brault Y, Hackett D. Source: The Journal of Clinical Psychiatry. 2001 November; 62(11): 888-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11775049&dopt=Abstract
•
Patterns and correlates of generalized anxiety disorder in community samples. Author(s): Kessler RC, Wittchen HU. Source: The Journal of Clinical Psychiatry. 2002; 63 Suppl 8: 4-10. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12044107&dopt=Abstract
•
Patterns of association between alcohol consumption and symptoms of depression and anxiety in young adults. Author(s): Caldwell TM, Rodgers B, Jorm AF, Christensen H, Jacomb PA, Korten AE, Lynskey MT. Source: Addiction (Abingdon, England). 2002 May; 97(5): 583-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12033659&dopt=Abstract
Studies 215
•
Patterns of personality pathology in patients with generalized anxiety disorder, panic disorder with and without agoraphobia, and social phobia. Author(s): Dyck IR, Phillips KA, Warshaw MG, Dolan RT, Shea MT, Stout RL, Massion AO, Zlotnick C, Keller MB. Source: Journal of Personality Disorders. 2001 February; 15(1): 60-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11236815&dopt=Abstract
•
Patterns of processing bias for emotional information across clinical disorders: a comparison of attention, memory, and prospective cognition in children and adolescents with depression, generalized anxiety, and posttraumatic stress disorder. Author(s): Dalgleish T, Taghavi R, Neshat-Doost H, Moradi A, Canterbury R, Yule W. Source: Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 2003 March; 32(1): 10-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12573928&dopt=Abstract
•
PC anxiety: reliability and validity of a brief scale. Author(s): Yang B, Lester D. Source: Percept Mot Skills. 2002 October; 95(2): 670. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12434866&dopt=Abstract
•
Peer conflict avoidance: associations with loneliness, social anxiety, and social avoidance. Author(s): Johnson HD, LaVoie JC, Spenceri MC, Mahoney-Wernli MA. Source: Psychological Reports. 2001 February; 88(1): 227-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11293033&dopt=Abstract
•
Peer instruction in the learning laboratory: a strategy to decrease student anxiety. Author(s): Owens LD, Walden DJ. Source: The Journal of Nursing Education. 2001 November; 40(8): 375-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11725998&dopt=Abstract
•
Peer victimization, global self-worth, and anxiety in middle school children. Author(s): Grills AE, Ollendick TH. Source: Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 2002 March; 31(1): 59-68. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11845651&dopt=Abstract
216 Anxiety
•
Pentagastrin test for anxiety--psychophysiology and personality. Author(s): Radu D, Ahlin A, Svanborg P, Lindefors N. Source: Psychopharmacology. 2003 March; 166(2): 139-45. Epub 2003 January 16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12529809&dopt=Abstract
•
Perceived control of anxiety and its relationship to self-confidence and performance. Author(s): Hanton S, Connaughton D. Source: Research Quarterly for Exercise and Sport. 2002 March; 73(1): 87-97. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11926488&dopt=Abstract
•
Perceived control over anxiety-related events as a predictor of pain behaviors in a cold pressor task. Author(s): Feldner MT, Hekmat H. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2001 December; 32(4): 191-202. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12102581&dopt=Abstract
•
Perceived criticism predicts severity of anxiety symptoms after behavioral treatment in patients with obsessive-compulsive disorder and panic disorder with agoraphobia. Author(s): Renshaw KD, Chambless DL, Steketee G. Source: Journal of Clinical Psychology. 2003 April; 59(4): 411-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12652634&dopt=Abstract
•
Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Author(s): Mojtabai R, Olfson M, Mechanic D. Source: Archives of General Psychiatry. 2002 January; 59(1): 77-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11779286&dopt=Abstract
•
Perceptions of pain in women with headache: a laboratory investigation of the influence of pain-related anxiety and fear. Author(s): Bishop KL, Holm JE, Borowiak DM, Wilson BA. Source: Headache. 2001 May; 41(5): 494-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11380647&dopt=Abstract
•
Percutaneous core biopsy of the breast: correlates of anxiety. Author(s): Novy DM, Price M, Huynh PT, Schuetz A. Source: Academic Radiology. 2001 June; 8(6): 467-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11394538&dopt=Abstract
Studies 217
•
Performance anxiety: loss of the spoken edge. Author(s): Merritt L, Richards A, Davis P. Source: Journal of Voice : Official Journal of the Voice Foundation. 2001 June; 15(2): 25769. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11411479&dopt=Abstract
•
Peripheral-type benzodiazepine receptors on platelets are correlated with the degrees of anxiety in normal human subjects. Author(s): Nakamura K, Fukunishi I, Nakamoto Y, Iwahashi K, Yoshii M. Source: Psychopharmacology. 2002 July; 162(3): 301-3. Epub 2002 May 14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12122488&dopt=Abstract
•
Personality characteristics, psychological symptoms and anxiety levels of drivers in charge of urban transportation in Istanbul. Author(s): Issever H, Onen L, Sabuncu HH, Altunkaynak O. Source: Occupational Medicine (Oxford, England). 2002 September; 52(6): 297-303. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12361990&dopt=Abstract
•
Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. Author(s): Massion AO, Dyck IR, Shea MT, Phillips KA, Warshaw MG, Keller MB. Source: Archives of General Psychiatry. 2002 May; 59(5): 434-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11982447&dopt=Abstract
•
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. Author(s): Salazar DE, Frackiewicz EJ, Dockens R, Kollia G, Fulmor IE, Tigel PD, Uderman HD, Shiovitz TM, Sramek JJ, Cutler NR. Source: Journal of Clinical Pharmacology. 2001 December; 41(12): 1351-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11762563&dopt=Abstract
•
Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program. Author(s): Salzman C, Goldenberg I, Bruce SE, Keller MB. Source: The Journal of Clinical Psychiatry. 2001 March; 62(3): 149-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11305698&dopt=Abstract
•
Pharmacologic treatment of generalized anxiety disorder. Author(s): Brawman-Mintzer O. Source: The Psychiatric Clinics of North America. 2001 March; 24(1): 119-37. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11225503&dopt=Abstract
218 Anxiety
•
Pharmacological approach to the management of dental anxiety in children-comments from a Scandinavian point of view. Author(s): Klingberg G. Source: International Journal of Paediatric Dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children. 2002 September; 12(5): 3578. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12199896&dopt=Abstract
•
Pharmacological management of pain and anxiety during emergency procedures in children. Author(s): Kennedy RM, Luhmann JD. Source: Paediatric Drugs. 2001; 3(5): 337-54. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11393327&dopt=Abstract
•
Pharmacology of human experimental anxiety. Author(s): Graeff FG, Parente A, Del-Ben CM, Guimaraes FS. Source: Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas / Sociedade Brasileira De Biofisica. [et Al.]. 2003 April; 36(4): 421-32. Epub 2003 April 08. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12700819&dopt=Abstract
•
Pharmacotherapy of childhood anxiety disorders. Author(s): Kratochvil CJ, Harrington MJ, Burke WJ, March JS. Source: Current Psychiatry Reports. 2002 August; 4(4): 264-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12126594&dopt=Abstract
•
Pharmacotherapy of generalized anxiety disorder. Author(s): Rickels K, Rynn M. Source: The Journal of Clinical Psychiatry. 2002; 63 Suppl 14: 9-16. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12562113&dopt=Abstract
•
Pharmacotherapy of generalized anxiety disorder. Author(s): Davidson JR. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 11: 46-50; Discussion 51-2. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11414551&dopt=Abstract
•
Pharmacotherapy of social anxiety disorder at the turn of the millennium. Author(s): Van Ameringen M, Mancini C. Source: The Psychiatric Clinics of North America. 2001 December; 24(4): 783-803. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11723633&dopt=Abstract
Studies 219
•
Pharmacotherapy of social anxiety disorder. Author(s): Blanco C, Antia SX, Liebowitz MR. Source: Biological Psychiatry. 2002 January 1; 51(1): 109-20. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11801236&dopt=Abstract
•
Phenomenology of panic attacks reflects human evolutionary history of separation anxiety. Author(s): Matthews S, Charlton BG. Source: Ir Med J. 2000 September; 93(6): 184-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11105445&dopt=Abstract
•
Phobic anxiety changes the function of brain-gut axis in irritable bowel syndrome. Author(s): Blomhoff S, Spetalen S, Jacobsen MB, Malt UF. Source: Psychosomatic Medicine. 2001 November-December; 63(6): 959-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11719635&dopt=Abstract
•
Phobic anxiety in 11 nations. Part I: Dimensional constancy of the five-factor model. Author(s): Arrindell WA, Eisemann M, Richter J, Oei TP, Caballo VE, van der Ende J, Sanavio E, Bages N, Feldman L, Torres B, Sica C, Iwawaki S, Edelmann RJ, Crozier WR, Furnham A, Hudson BL, Aguilar G, Arrindell WA, Bages N, Bentall R, Bridges KR, Buchanan A, Caballo VE, Calvo MG, Canalda G, Castro J, Crozier WR, Davis M, Edelmann RJ, Eisemann M, Farrer RJ, Felman L, Frindte W, Furnham A, Garling T, Gaszner P, Gillholm R, Gustafsson M, Hansson SB, Harris P, Hatzichristou C, Hudson BL, Iwawaki S, Johnston M, Kallai J, Kasielke E, Kenardy J, Leong CC, Liddell A, Montgomery I, Oei TP, Palenzuela DL, Pennington D, Peter M, Pickersgill MJ, Recinos LA, Richards JC, Richter J, Ryden O, Sanavio E, Sica C, Simon MA, Surman M, Torres B, van der Ende J, Zaldivar F; Cultural Clinical Psychology Study Group. Source: Behaviour Research and Therapy. 2003 April; 41(4): 461-79. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12643968&dopt=Abstract
•
Physical activity and physique anxiety in older adults: fitness, and efficacy influences. Author(s): McAuley E, Marquez DX, Jerome GJ, Blissmer B, Katula J. Source: Aging & Mental Health. 2002 August; 6(3): 222-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12217090&dopt=Abstract
•
Physical activity dose-response effects on outcomes of depression and anxiety. Author(s): Dunn AL, Trivedi MH, O'Neal HA. Source: Medicine and Science in Sports and Exercise. 2001 June; 33(6 Suppl): S587-97; Discussion 609-10. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11427783&dopt=Abstract
220 Anxiety
•
Physical self and physical activity relationships in college women: does social physique anxiety moderate effects? Author(s): Kowalski NP, Crocker PR, Kowalski KC. Source: Research Quarterly for Exercise and Sport. 2001 March; 72(1): 55-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11253320&dopt=Abstract
•
Physical symptoms as indicators of depression and anxiety. Author(s): Larson GE, Booth-Kewley S, Merrill LL, Stander VA. Source: Military Medicine. 2001 September; 166(9): 796-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11569444&dopt=Abstract
•
Physician office visits of adults for anxiety disorders in the United States, 1985-1998. Author(s): Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK. Source: Journal of General Internal Medicine : Official Journal of the Society for Research and Education in Primary Care Internal Medicine. 2002 March; 17(3): 165-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11929501&dopt=Abstract
•
Physiologic instability in panic disorder and generalized anxiety disorder. Author(s): Wilhelm FH, Trabert W, Roth WT. Source: Biological Psychiatry. 2001 April 1; 49(7): 596-605. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11297717&dopt=Abstract
•
Physiological and psychological reactivity in women with asthma: the effects of anxiety and menstrual cycle phase. Author(s): Dorhofer DM, Sigmon ST. Source: Behaviour Research and Therapy. 2002 January; 40(1): 3-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11762425&dopt=Abstract
•
Place of chronic insomnia in the course of depressive and anxiety disorders. Author(s): Ohayon MM, Roth T. Source: Journal of Psychiatric Research. 2003 January-February; 37(1): 9-15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12482465&dopt=Abstract
•
Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Author(s): Rynn MA, Siqueland L, Rickels K. Source: The American Journal of Psychiatry. 2001 December; 158(12): 2008-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11729017&dopt=Abstract
Studies 221
•
Plasma and serum serotonin levels and their relationship to orofacial pain and anxiety in fibromyalgia. Author(s): Ernberg M, Voog U, Alstergren P, Lundeberg T, Kopp S. Source: J Orofac Pain. 2000 Winter; 14(1): 37-46. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11203736&dopt=Abstract
•
Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety. Author(s): Zwanzger P, Jarry H, Eser D, Padberg F, Baghai T, Schule C, Ella R, Moller HJ, Rupprecht R. Source: Journal of Neural Transmission (Vienna, Austria : 1996). 2003 March; 110(3): 313-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12658378&dopt=Abstract
•
Platelet alpha2-adrenoceptor density in humans: relationships to stress-induced anxiety, psychasthenic constitution, gender and stress-induced changes in the inflammatory response system. Author(s): Maes M, Van Gastel A, Delmeire L, Kenis G, Bosmans E, Song C. Source: Psychological Medicine. 2002 July; 32(5): 919-28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12171386&dopt=Abstract
•
Positive thinking in bereavement: is it related to depression, anxiety, or grief symptomatology? Author(s): Boelen PA, van den Bout J. Source: Psychological Reports. 2002 December; 91(3 Pt 1): 857-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12530735&dopt=Abstract
•
Positively channeling workplace anger and anxiety. Part I. Author(s): Helge D. Source: Aaohn Journal : Official Journal of the American Association of Occupational Health Nurses. 2001 September; 49(9): 445-52; Quiz 453-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11760508&dopt=Abstract
•
Positively channeling workplace anger and anxiety. Part II. Author(s): Helge D. Source: Aaohn Journal : Official Journal of the American Association of Occupational Health Nurses. 2001 October; 49(10): 482-9; Quiz 490-1. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11760532&dopt=Abstract
222 Anxiety
•
Postconcussional disorder following mild to moderate traumatic brain injury: anxiety, depression, and social support as risk factors and comorbidities. Author(s): McCauley SR, Boake C, Levin HS, Contant CF, Song JX. Source: J Clin Exp Neuropsychol. 2001 December; 23(6): 792-808. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11910545&dopt=Abstract
•
Postnatal depression, anxiety and unsettled infant behaviour. Author(s): McMahon C, Barnett B, Kowalenko N, Tennant C, Don N. Source: The Australian and New Zealand Journal of Psychiatry. 2001 October; 35(5): 5818. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11551272&dopt=Abstract
•
Potentially traumatizing events in panic disorder and other anxiety disorders. Author(s): Hofmann SG, Levitt JT, Hoffman EC, Greene K, Litz BT, Barlow DH. Source: Depression and Anxiety. 2001; 13(2): 101-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11301919&dopt=Abstract
•
Practitioner review: psychological management of anxiety disorders in childhood. Author(s): Dadds MR, Barrett PM. Source: Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2001 November; 42(8): 999-1011. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11806693&dopt=Abstract
•
Pragmatic evaluation of computer-aided self-help for anxiety and depression. Author(s): Marks IM, Mataix-Cols D, Kenwright M, Cameron R, Hirsch S, Gega L. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2003 July; 183: 57-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12835245&dopt=Abstract
•
Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life. Author(s): Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, Hurley K, Hann LE, Colon J, Spriggs D. Source: Gynecologic Oncology. 2003 June; 89(3): 440-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12798709&dopt=Abstract
•
Pre-competitive feeling states and directional anxiety interpretations. Author(s): Jones G, Hanton S. Source: Journal of Sports Sciences. 2001 June; 19(6): 385-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11411775&dopt=Abstract
Studies 223
•
Predictability of the one-year course of depression and generalized anxiety in primary care. Author(s): van den Brink RH, Ormel J, Tiemens BG, Smit A, Jenner JA, van der Meer K, van Os TW. Source: General Hospital Psychiatry. 2002 May-June; 24(3): 156-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12062140&dopt=Abstract
•
Predicting anxiety and depression among cancer patients: a clinical model. Author(s): Nordin K, Berglund G, Glimelius B, Sjoden PO. Source: European Journal of Cancer (Oxford, England : 1990). 2001 February; 37(3): 37684. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11239760&dopt=Abstract
•
Predicting anxious response to a social challenge: the predictive utility of the social interaction anxiety scale and the social phobia scale in a college population. Author(s): Gore KL, Carter MM, Parker S. Source: Behaviour Research and Therapy. 2002 June; 40(6): 689-700. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12051487&dopt=Abstract
•
Prediction of anxiety disorders using the state-trait anxiety inventory for multiethnic adolescents. Author(s): Hishinuma ES, Miyamoto RH, Nishimura ST, Goebert DA, Yuen NY, Makini GK Jr, Andrade NN, Johnson RC, Carlton BS. Source: Journal of Anxiety Disorders. 2001 November-December; 15(6): 511-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11764310&dopt=Abstract
•
Prediction of psychological reactions to bone density screening for osteoporosis using a cognitive-behavioral model of health anxiety. Author(s): Rimes KA, Salkovskis PM. Source: Behaviour Research and Therapy. 2002 April; 40(4): 359-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12002895&dopt=Abstract
•
Predictive genetic testing: mediators and moderators of anxiety. Author(s): Michie S, French DP, Marteau TM. Source: International Journal of Behavioral Medicine. 2002; 9(4): 309-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12508668&dopt=Abstract
•
Predictive validity of an Implicit Association Test for assessing anxiety. Author(s): Egloff B, Schmukle SC. Source: Journal of Personality and Social Psychology. 2002 December; 83(6): 1441-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12500823&dopt=Abstract
224 Anxiety
•
Predictors of preoperative anxiety in children. Author(s): Wollin SR, Plummer JL, Owen H, Hawkins RM, Materazzo F. Source: Anaesthesia and Intensive Care. 2003 February; 31(1): 69-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12635399&dopt=Abstract
•
Predictors of response in anxiety disorders. Author(s): Solvason HB, Ernst H, Roth W. Source: The Psychiatric Clinics of North America. 2003 June; 26(2): 411-33. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12778841&dopt=Abstract
•
Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials. Author(s): Stein DJ, Stein MB, Pitts CD, Kumar R, Hunter B. Source: The Journal of Clinical Psychiatry. 2002 February; 63(2): 152-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11874217&dopt=Abstract
•
Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders. Author(s): Koh KB, Kim CH, Park JK. Source: The Journal of Clinical Psychiatry. 2002 June; 63(6): 486-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12088159&dopt=Abstract
•
Pre-exercise anxiety and the anxiolytic responses to acute bouts of self-selected and prescribed intensity resistance exercise. Author(s): Focht BC. Source: The Journal of Sports Medicine and Physical Fitness. 2002 June; 42(2): 217-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12032419&dopt=Abstract
•
Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Author(s): Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT, Weisler R, Londborg PD, Bielski RJ, Zimbroff DL, Davidson JR, Liu-Dumaw M. Source: The American Journal of Psychiatry. 2003 March; 160(3): 533-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12611835&dopt=Abstract
•
Preliminary data from the Hungarian toddler behavior rating scale: caregivers' and mothers' ratings and anxiety. Author(s): Nagy E, Kovacs EF. Source: Percept Mot Skills. 2000 December; 91(3 Pt 1): 910-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11153868&dopt=Abstract
Studies 225
•
Preliminary psychologic survey of orofacial outpatients. Part 1: Predictors of anxiety or depression. Author(s): Kino K, Sugisaki M, Ishikawa T, Shibuya T, Amagasa T, Miyaoka H. Source: J Orofac Pain. 2001 Summer; 15(3): 235-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11575194&dopt=Abstract
•
Preliminary report on the use of Reiki HIV-related pain and anxiety. Author(s): Miles P. Source: Alternative Therapies in Health and Medicine. 2003 March-April; 9(2): 36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12652881&dopt=Abstract
•
Premedication for anxiety in adult day surgery. Author(s): Smith AF, Pittaway AJ. Source: Cochrane Database Syst Rev. 2003; (1): Cd002192. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12535433&dopt=Abstract
•
Premenstrual symptomatology, locus of control, anxiety and depression in women with normal menstrual cycles. Author(s): Lane T, Francis A. Source: Archives of Women's Mental Health. 2003 April; 6(2): 127-38. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12720063&dopt=Abstract
•
Preoperative alprazolam reduces anxiety in ambulatory surgery patients: a comparison with oral midazolam. Author(s): De Witte JL, Alegret C, Sessler DI, Cammu G. Source: Anesthesia and Analgesia. 2002 December; 95(6): 1601-6, Table of Contents. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12456424&dopt=Abstract
•
Preoperative anxiety and postoperative pain in women undergoing hysterectomy. A repeated-measures design. Author(s): Kain ZN, Sevarino F, Alexander GM, Pincus S, Mayes LC. Source: Journal of Psychosomatic Research. 2000 December; 49(6): 417-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11182434&dopt=Abstract
•
Preoperative dental anxiety and mood changes during nitrous oxide inhalation. Author(s): Zacny JP, Hurst RJ, Graham L, Janiszewski DJ. Source: The Journal of the American Dental Association. 2002 January; 133(1): 82-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11811748&dopt=Abstract
226 Anxiety
•
Prescribing patterns for depression and anxiety worldwide. Author(s): Lecrubier Y. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 13: 31-6; Discussion 37-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11434416&dopt=Abstract
•
Prevalence and correlates of anxiety symptoms in well-functioning older adults: findings from the health aging and body composition study. Author(s): Mehta KM, Simonsick EM, Penninx BW, Schulz R, Rubin SM, Satterfield S, Yaffe K. Source: Journal of the American Geriatrics Society. 2003 April; 51(4): 499-504. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12657069&dopt=Abstract
•
Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Author(s): Tibbo P, Swainson J, Chue P, LeMelledo JM. Source: Depression and Anxiety. 2003; 17(2): 65-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12621594&dopt=Abstract
•
Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Author(s): Dew MA, Kormos RL, DiMartini AF, Switzer GE, Schulberg HC, Roth LH, Griffith BP. Source: Psychosomatics. 2001 July-August; 42(4): 300-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11496019&dopt=Abstract
•
Prevalence of and factors associated with anxiety and depression among women in a lower middle class semi-urban community of Karachi, Pakistan. Author(s): Ali BS, Rahbar MH, Naeem S, Tareen AL, Gul A, Samad L. Source: J Pak Med Assoc. 2002 November; 52(11): 513-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12585371&dopt=Abstract
•
Prevalence of anxiety and depression among medical students of private university. Author(s): Inam SN, Saqib A, Alam E. Source: J Pak Med Assoc. 2003 February; 53(2): 44-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12705482&dopt=Abstract
•
Prevalence of anxiety and depression in Australian adolescents: comparisons with worldwide data. Author(s): Boyd CP, Kostanski M, Gullone E, Ollendick TH, Shek DT. Source: The Journal of Genetic Psychology; Child Behavior, Animal Behavior, and Comparative Psychology. 2000 December; 161(4): 479-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11117103&dopt=Abstract
Studies 227
•
Prevalence of anxiety in adults with diabetes: a systematic review. Author(s): Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Source: Journal of Psychosomatic Research. 2002 December; 53(6): 1053-60. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12479986&dopt=Abstract
•
Prevalence of childhood ADHD among patients with Generalized Anxiety Disorder and a comparison condition, Social Phobia. Author(s): Safren SA, Lanka GD, Otto MW, Pollack MH. Source: Depression and Anxiety. 2001; 13(4): 190-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11413566&dopt=Abstract
•
Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Author(s): Goulding C, O'Connell P, Murray FE. Source: European Journal of Gastroenterology & Hepatology. 2001 May; 13(5): 507-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11396529&dopt=Abstract
•
Prevalence of generalized anxiety at eight weeks postpartum. Author(s): Wenzel A, Haugen EN, Jackson LC, Robinson K. Source: Archives of Women's Mental Health. 2003 February; 6(1): 43-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12715263&dopt=Abstract
•
Prevalence, detection and management of anxiety and depressive symptoms in unemployed patients attending general practitioners. Author(s): Comino EJ, Harris E, Silove D, Manicavasagar V, Harris MF. Source: The Australian and New Zealand Journal of Psychiatry. 2000 February; 34(1): 107-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11185922&dopt=Abstract
•
Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Author(s): Rincon HG, Granados M, Unutzer J, Gomez M, Duran R, Badiel M, Salas C, Martinez J, Mejia J, Ordonez C, Florez N, Rosso F, Echeverri P. Source: Psychosomatics. 2001 September-October; 42(5): 391-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11739905&dopt=Abstract
•
Prevalence, recognition, and treatment of comorbid depression and anxiety. Author(s): Rapaport MH. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 24: 6-10. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11676431&dopt=Abstract
228 Anxiety
•
Preventing anxiety and depression in gynaecological cancer: a randomised controlled trial. Author(s): Petersen RW, Quinlivan JA. Source: Bjog : an International Journal of Obstetrics and Gynaecology. 2002 April; 109(4): 386-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12013159&dopt=Abstract
•
Prevention of anxiety symptoms in primary school children: preliminary results from a universal school-based trial. Author(s): Barrett P, Turner C. Source: The British Journal of Clinical Psychology / the British Psychological Society. 2001 November; 40(Pt 4): 399-410. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11760616&dopt=Abstract
•
Probability of assertive behaviour, interpersonal anxiety and self-efficacy of South African registered dietitians. Author(s): Paterson M, Green JM, Basson CJ, Ross F. Source: Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association. 2002 February; 15(1): 9-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11903785&dopt=Abstract
•
Processing emotional facial expressions: the role of anxiety and awareness. Author(s): Fox E. Source: Cognitive, Affective & Behavioral Neuroscience. 2002 March; 2(1): 52-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12452584&dopt=Abstract
•
Prognosis of depression and generalised anxiety in primary care. Author(s): Furukawa TA. Source: The British Journal of Psychiatry; the Journal of Mental Science. 2001 August; 179: 177-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11483485&dopt=Abstract
•
Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice? Author(s): Tyrer P, Seivewright H, Simmonds S, Johnson T. Source: European Archives of Psychiatry and Clinical Neuroscience. 2001; 251 Suppl 2: Ii53-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11824837&dopt=Abstract
Studies 229
•
Psychogenic hearing loss with panic anxiety attack after the onset of acute inner ear disorder. Author(s): Mori S, Fujieda S, Yamamoto T, Takahashi N, Saito T, Saito H. Source: Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties. 2002 January-February; 64(1): 41-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11891398&dopt=Abstract
•
Psychological comorbidity and stress reactivity in children and adolescents with recurrent abdominal pain and anxiety disorders. Author(s): Dorn LD, Campo JC, Thato S, Dahl RE, Lewin D, Chandra R, Di Lorenzo C. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2003 January; 42(1): 66-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12500078&dopt=Abstract
•
Psychological disorder, conditioning experiences, and the onset of dental anxiety in early adulthood. Author(s): Locker D, Thomson WM, Poulton R. Source: Journal of Dental Research. 2001 June; 80(6): 1588-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11499519&dopt=Abstract
•
Psychological disorders and dental anxiety in a young adult population. Author(s): Locker D, Poulton R, Thomson WM. Source: Community Dentistry and Oral Epidemiology. 2001 December; 29(6): 456-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11784289&dopt=Abstract
•
Psychological stress, anxiety, depression, job satisfaction, and personality characteristics in preregistration house officers. Author(s): Newbury-Birch D, Kamali F. Source: Postgraduate Medical Journal. 2001 February; 77(904): 109-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11161078&dopt=Abstract
•
Psychometric comparability of English- and Spanish-language measures of anxiety and related affective symptoms. Author(s): Novy DM, Stanley MA, Averill P, Daza P. Source: Psychological Assessment. 2001 September; 13(3): 347-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11556271&dopt=Abstract
•
Psychometric evaluation of the Beck Depression Inventory in adults with social anxiety disorder. Author(s): Coles ME, Gibb BE, Heimberg RG. Source: Depression and Anxiety. 2001; 14(2): 145-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11668668&dopt=Abstract
230 Anxiety
•
Psychometric properties and three proposed subscales of a self-report version of the Liebowitz Social Anxiety Scale translated into Hebrew. Author(s): Levin JB, Marom S, Gur S, Wechter D, Hermesh H. Source: Depression and Anxiety. 2002; 16(4): 143-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12497645&dopt=Abstract
•
Psychometric properties of the Portuguese version of the State-Trait Anxiety Inventory applied to college students: factor analysis and relation to the Beck Depression Inventory. Author(s): Andrade L, Gorenstein C, Vieira Filho AH, Tung TC, Artes R. Source: Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas / Sociedade Brasileira De Biofisica. [et Al.]. 2001 March; 34(3): 367-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11262588&dopt=Abstract
•
Psychometric properties of the Spanish form of Templer's Death Anxiety Scale. Author(s): Tomas-Sabado J, Gomez-Benito J. Source: Psychological Reports. 2002 December; 91(3 Pt 2): 1116-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12585522&dopt=Abstract
•
Psychometric properties of the state part of the Spielberger State-Trait Anxiety Inventory (STAI) in geriatric patients. Author(s): Kvaal K, Laake K, Engedal K. Source: International Journal of Geriatric Psychiatry. 2001 October; 16(10): 980-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11607943&dopt=Abstract
•
Psychometric properties of the statistics anxiety rating scale. Author(s): Baloglu M. Source: Psychological Reports. 2002 February; 90(1): 315-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11899004&dopt=Abstract
•
Psychopathological correlates of anxiety sensitivity: evidence from clinical interviews and self-report measures. Author(s): Cox BJ, Fuentes K, Borger SC, Taylor S. Source: Journal of Anxiety Disorders. 2001 July-August; 15(4): 317-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11474817&dopt=Abstract
•
Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression. Author(s): Goodwin RD, Gorman JM. Source: The American Journal of Psychiatry. 2002 November; 159(11): 1935-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12411233&dopt=Abstract
Studies 231
•
Psychopharmacological and electroconvulsive treatment of anxiety and depression in the elderly. Author(s): Heffern WA. Source: Journal of Psychiatric and Mental Health Nursing. 2000 June; 7(3): 199-204. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11249312&dopt=Abstract
•
Psychosocial assessment and management of depression and anxiety in pregnancy. Key aspects of antenatal care for general practice. Author(s): Austin MP. Source: Aust Fam Physician. 2003 March; 32(3): 119-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12666348&dopt=Abstract
•
Psychosocial consequences of dental fear and anxiety. Author(s): Locker D. Source: Community Dentistry and Oral Epidemiology. 2003 April; 31(2): 144-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12641596&dopt=Abstract
•
Psychosocial correlates of death anxiety among Chinese college students. Author(s): Tang CS, Wu AM, Yan EC. Source: Death Studies. 2002 July-August; 26(6): 491-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12136882&dopt=Abstract
•
Psychosocial predictors of anxiety among immigrant Mexican migrant farmworkers: implications for prevention and treatment. Author(s): Hovey JD, Magana CG. Source: Cultural Diversity & Ethnic Minority Psychology. 2002 August; 8(3): 274-89. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12143104&dopt=Abstract
•
Psychotherapy for generalized anxiety disorder. Author(s): Borkovec TD, Ruscio AM. Source: The Journal of Clinical Psychiatry. 2001; 62 Suppl 11: 37-42; Discussion 43-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11414549&dopt=Abstract
•
Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. Author(s): Blier P, Abbott FV. Source: Journal of Psychiatry & Neuroscience : Jpn. 2001 January; 26(1): 37-43. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11212592&dopt=Abstract
232 Anxiety
•
Quality of life following cognitive behavioral treatment for social anxiety disorder: preliminary findings. Author(s): Eng W, Coles ME, Heimberg RG, Safren SA. Source: Depression and Anxiety. 2001; 13(4): 192-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11413567&dopt=Abstract
•
Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community-based study. Author(s): Stein MB, Barrett-Connor E. Source: The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry. 2002 September-October; 10(5): 568-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12213691&dopt=Abstract
•
Quality of life in schizophrenia: contributions of anxiety and depression. Author(s): Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Source: Schizophrenia Research. 2001 September 1; 51(2-3): 171-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11518637&dopt=Abstract
•
Quality of life in social anxiety disorder compared with panic disorder and the general population. Author(s): Simon NM, Otto MW, Korbly NB, Peters PM, Nicolaou DC, Pollack MH. Source: Psychiatric Services (Washington, D.C.). 2002 June; 53(6): 714-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12045308&dopt=Abstract
•
Quality of life in the anxiety disorders. Author(s): Mogotsi M, Kaminer D, Stein DJ. Source: Harvard Review of Psychiatry. 2000 December; 8(6): 273-82. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11133822&dopt=Abstract
•
Quality of life, anxiety, and depression in patients with an untreated intracranial aneurysm or arteriovenous malformation. Author(s): van der Schaaf IC, Brilstra EH, Rinkel GJ, Bossuyt PM, van Gijn J. Source: Stroke; a Journal of Cerebral Circulation. 2002 February; 33(2): 440-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11823649&dopt=Abstract
•
Questionnaires for depression and anxiety. Routine screening entails additional pitfalls. Author(s): Coyne JC, Palmer SC, Thompson R. Source: Bmj (Clinical Research Ed.). 2001 July 21; 323(7305): 168. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11484724&dopt=Abstract
Studies 233
•
Questionnaires for depression and anxiety. Systematic review is incomplete. Author(s): Pignone M, Gaynes BN, Lohr KN, Orleans CT, Mulrow C. Source: Bmj (Clinical Research Ed.). 2001 July 21; 323(7305): 167-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11463699&dopt=Abstract
•
Questionnaires for depression and anxiety. Two screening questions may be helpful. Author(s): Arroll B. Source: Bmj (Clinical Research Ed.). 2001 July 21; 323(7305): 168-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11484726&dopt=Abstract
•
Rages and refusals. Managing the many faces of adolescent anxiety. Author(s): Garland EJ. Source: Can Fam Physician. 2001 May; 47: 1023-30. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11398717&dopt=Abstract
•
Randomized controlled trial of a telephone intervention by nurses to provide information and support to patients and their partners after elective coronary artery bypass graft surgery: effects of anxiety. Author(s): Hartford K, Wong C, Zakaria D. Source: Heart & Lung : the Journal of Critical Care. 2002 May-June; 31(3): 199-206. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12011810&dopt=Abstract
•
Rapid anxiety assessment in medical patients: evidence for the validity of verbal anxiety ratings. Author(s): Benotsch EG, Lutgendorf SK, Watson D, Fick LJ, Lang EV. Source: Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 2000 Summer; 22(3): 199-203. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11126464&dopt=Abstract
•
Rapid resolution of social anxiety disorder, selective mutism, and separation anxiety with paroxetine in an 8-year-old girl. Author(s): Lehman RB. Source: Journal of Psychiatry & Neuroscience : Jpn. 2002 March; 27(2): 124-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11944508&dopt=Abstract
•
Rationale and principles for early intervention with young children at risk for anxiety disorders. Author(s): Hirshfeld-Becker DR, Biederman J. Source: Clinical Child and Family Psychology Review. 2002 September; 5(3): 161-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12240705&dopt=Abstract
234 Anxiety
•
Rationing of health care: clinical decision making in an outpatient clinic for anxiety disorders. Author(s): Issakidis C, Andrews G. Source: Journal of Anxiety Disorders. 2003; 17(1): 59-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12464289&dopt=Abstract
•
rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Author(s): Boshuisen ML, Ter Horst GJ, Paans AM, Reinders AA, den Boer JA. Source: Biological Psychiatry. 2002 July 15; 52(2): 126-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12114004&dopt=Abstract
•
Recent perspectives on the diagnosis and treatment of generalized anxiety disorder. Author(s): Ninan PT. Source: Am J Manag Care. 2001 September; 7(11 Suppl): S367-76. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11570027&dopt=Abstract
•
Receptor binding and drug modulation in anxiety. Author(s): Malizia AL. Source: European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2002 December; 12(6): 567-74. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12468019&dopt=Abstract
•
Recognizing and treating childhood anxiety disorders. Author(s): Piacentini J, Roblek T. Source: The Western Journal of Medicine. 2002 May; 176(3): 149-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12016234&dopt=Abstract
•
Recognizing and treating social anxiety disorder. Author(s): Muzina DJ, El-Sayegh S. Source: Cleve Clin J Med. 2001 July; 68(7): 649-57. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11453083&dopt=Abstract
•
Recollection of dreams after short general anaesthesia: influence on patient anxiety and satisfaction. Author(s): Hellwagner K, Holzer A, Gustorff B, Schroegendorfer K, Greher M, Weindlmayr-Goettel M, Saletu B, Lackner FX. Source: European Journal of Anaesthesiology. 2003 April; 20(4): 282-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12703832&dopt=Abstract
Studies 235
•
Reducing anxiety in parents before and during pediatric anesthesia induction. Author(s): Zuwala R, Barber KR. Source: Aana Journal. 2001 February; 69(1): 21-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11759134&dopt=Abstract
•
Reducing anxiety in patients and families discharged from ICU. Author(s): Choate K, Stewart M. Source: Australian Nursing Journal (July 1993). 2002 November; 10(5): 29. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12503383&dopt=Abstract
•
Reducing family members' anxiety while waiting on the day of surgery: systematic review of studies and implications of HIPAA health information privacy rules. Author(s): Dexter F, Epstein RH. Source: Journal of Clinical Anesthesia. 2001 November; 13(7): 478-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11704443&dopt=Abstract
•
Reducing patients' state anxiety in general dental practice: a randomized controlled trial. Author(s): Dailey YM, Humphris GM, Lennon MA. Source: Journal of Dental Research. 2002 May; 81(5): 319-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12097444&dopt=Abstract
•
Relation between anxiety and depressive disorders in childhood and adolescence. Author(s): Axelson DA, Birmaher B. Source: Depression and Anxiety. 2001; 14(2): 67-78. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11668659&dopt=Abstract
•
Relation between depression and anxiety in dystonic patients: implications for clinical management. Author(s): Moraru E, Schnider P, Wimmer A, Wenzel T, Birner P, Griengl H, Auff E. Source: Depression and Anxiety. 2002; 16(3): 100-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12415533&dopt=Abstract
•
Relation of test-specific motivation and anxiety to test performance. Author(s): Smith LF, Smith JK. Source: Psychological Reports. 2002 December; 91(3 Pt 1): 1011-21. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12530760&dopt=Abstract
236 Anxiety
•
Relations between anxiety sensitivity and panic symptoms in nonreferred children and adolescents. Author(s): Calamari JE, Hale LR, Heffelfinger SK, Janeck AS, Lau JJ, Weerts MA, Taglione PA, Schisler RL. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2001 September; 32(3): 117-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11934125&dopt=Abstract
•
Relations of positive and negative affectivity to anxiety and depression in children: evidence from a latent variable longitudinal study. Author(s): Lonigan CJ, Phillips BM, Hooe ES. Source: Journal of Consulting and Clinical Psychology. 2003 June; 71(3): 465-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12795571&dopt=Abstract
•
Relationship between anxiety, depression, and morbidity in adult asthma patients. Author(s): Rimington LD, Davies DH, Lowe D, Pearson MG. Source: Thorax. 2001 April; 56(4): 266-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11254816&dopt=Abstract
•
Relationship between anxiety/depression and nausea: causal or associative? Author(s): Jagadisha D. Source: General Hospital Psychiatry. 2003 January-February; 25(1): 52; Author Reply 53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12583930&dopt=Abstract
•
Relationship between children's first dental visit and their dental anxiety in the Veneto Region of Italy. Author(s): Rantavuori K, Zerman N, Ferro R, Lahti S. Source: Acta Odontologica Scandinavica. 2002 October; 60(5): 297-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12418720&dopt=Abstract
•
Relationship between clinical variables and symptomatic anxiety in late-life depression. Author(s): Flint AJ, Rifat SL. Source: The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry. 2002 May-June; 10(3): 292-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11994216&dopt=Abstract
•
Relationship between depression, anxiety and quality of life: a study of stroke patients compared to chronic low back pain and myocardial ischemia patients. Author(s): Fruhwald S, Loffler H, Eher R, Saletu B, Baumhackl U. Source: Psychopathology. 2001 January; 34(1): 50-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11150931&dopt=Abstract
Studies 237
•
Relationship between outpatients' perceptions of physicians' communication styles and patients' anxiety levels in a Japanese oncology setting. Author(s): Takayama T, Yamazaki Y, Katsumata N. Source: Social Science & Medicine (1982). 2001 November; 53(10): 1335-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11676404&dopt=Abstract
•
Relationship between separation anxiety disorder, parental panic disorder, and atopic disorders in children: a controlled high-risk study. Author(s): Slattery MJ, Klein DF, Mannuzza S, Moulton JL 3rd, Pine DS, Klein RG. Source: Journal of the American Academy of Child and Adolescent Psychiatry. 2002 August; 41(8): 947-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12162630&dopt=Abstract
•
Relationship between trait anxiety, brain activity and natural killer cell activity in cancer patients: a preliminary PET study. Author(s): Tashiro M, Itoh M, Kubota K, Kumano H, Masud MM, Moser E, Arai H, Sasaki H. Source: Psycho-Oncology. 2001 November-December; 10(6): 541-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11747066&dopt=Abstract
•
Relationship of anhedonia and anxiety to social rank, defeat and entrapment. Author(s): Gilbert P, Allan S, Brough S, Melley S, Miles JN. Source: Journal of Affective Disorders. 2002 September; 71(1-3): 141-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12167510&dopt=Abstract
•
Relationship of criminality to endogeneity and anxiety in patients with unipolar depression. Author(s): Modestin J, Thiel C, Erni T. Source: Psychiatry and Clinical Neurosciences. 2002 April; 56(2): 153-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11952918&dopt=Abstract
•
Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children. Author(s): Oguz A, Kurul S, Dirik E. Source: Journal of Child Neurology. 2002 January; 17(1): 37-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11913568&dopt=Abstract
•
Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. Author(s): Yehuda R, Halligan SL, Bierer LM. Source: Journal of Psychiatric Research. 2001 September-October; 35(5): 261-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11591428&dopt=Abstract
238 Anxiety
•
Relationship of the 'fear-inhibited light reflex' to the level of state/trait anxiety in healthy subjects. Author(s): Bitsios P, Szabadi E, Bradshaw CM. Source: International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 2002 February; 43(2): 177-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11809520&dopt=Abstract
•
Relationships between the anxiety sensitivity index, the suffocation fear scale, and responses to CO2 inhalation. Author(s): Shipherd JC, Beck JG, Ohtake PJ. Source: Journal of Anxiety Disorders. 2001 May-June; 15(3): 247-58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11442142&dopt=Abstract
•
Relaxation and imagery for anxiety and depression control in community patients with advanced cancer. Author(s): Sloman R. Source: Cancer Nursing. 2002 December; 25(6): 432-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12464834&dopt=Abstract
•
Relaxing music prevents stress-induced increases in subjective anxiety, systolic blood pressure, and heart rate in healthy males and females. Author(s): Knight WE, Rickard PhD NS. Source: J Music Ther. 2001 Winter; 38(4): 254-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11796077&dopt=Abstract
•
Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Author(s): Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM. Source: Depression and Anxiety. 2001; 13(4): 166-78. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11413563&dopt=Abstract
•
Reliability and validity of the Spence Children's Anxiety Scale and the Screen for Child Anxiety Related Emotional Disorders in German children. Author(s): Essau CA, Muris P, Ederer EM. Source: Journal of Behavior Therapy and Experimental Psychiatry. 2002 March; 33(1): 118. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12389796&dopt=Abstract
Studies 239
•
Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. Author(s): Brown TA, Di Nardo PA, Lehman CL, Campbell LA. Source: Journal of Abnormal Psychology. 2001 February; 110(1): 49-58. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11261399&dopt=Abstract
•
Reliability testing of the hospital anxiety and depression (HAD) scale in the English, Maltese and back-translation versions. Author(s): Baldacchino DR, Bowman GS, Buhagiar A. Source: International Journal of Nursing Studies. 2002 February; 39(2): 207-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11755451&dopt=Abstract
•
Relieving anxiety by entering the operating room on foot. Author(s): Kojima Y, Ina H, Fujita T, Mitono H. Source: Canadian Journal of Anaesthesia = Journal Canadien D'anesthesie. 2002 October; 49(8): 885-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12374724&dopt=Abstract
•
Research on children's anxiety needed. Author(s): Mitka M. Source: Jama : the Journal of the American Medical Association. 2000 April 5; 283(13): 1677. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10755479&dopt=Abstract
•
Resource utilization of patients with hypochondriacal health anxiety and somatization. Author(s): Barsky AJ, Ettner SL, Horsky J, Bates DW. Source: Medical Care. 2001 July; 39(7): 705-15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11458135&dopt=Abstract
•
Respiratory dysregulation in anxiety, functional cardiac, and pain disorders. Assessment, phenomenology, and treatment. Author(s): Wilhelm FH, Gevirtz R, Roth WT. Source: Behavior Modification. 2001 September; 25(4): 513-45. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11530714&dopt=Abstract
•
Respiratory sinus arrhythmia in persons with organic solvent exposure: comparisons with anxiety patients and controls. Author(s): Steinhauer SR, Morrow LA, Condray R, Scott AJ. Source: Archives of Environmental Health. 2001 March-April; 56(2): 175-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11339682&dopt=Abstract
240 Anxiety
•
Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline. Author(s): Rush AJ, Trivedi MH, Carmody TJ, Donahue RM, Houser TL, Bolden-Watson C, Batey SR, Ascher JA, Metz A. Source: Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 2001 July; 25(1): 131-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11377926&dopt=Abstract
•
Response to “The therapist's anxiety and resistance to group psychotherapy”. Author(s): Scheidlinger S. Source: Int J Group Psychother. 2002 April; 52(2): 295-7; 299-301; Author Reply 299-301. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11928205&dopt=Abstract
•
Response to 'A comparative study of death anxiety in hospice and emergency nurses' by S.A. Payne, S.J. Dean & C. Kalus (1998) Journal of Advanced Nursing 28, 700-706. Author(s): Ashfield O. Source: Journal of Adv